1309946	Sodium	Gellens ME	Primary structure and functional expression of the human cardiac tetrodotoxin-insensitive voltage-dependent sodium channel.	Proceedings of the National Academy of Sciences of the United States of America	1992	146
8819477	Sodium	Showalter VM	Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.	The Journal of pharmacology and experimental therapeutics	1996	129
10449787	Sodium	Andrés ME	CoREST: a functional corepressor required for regulation of neural-specific gene expression.	Proceedings of the National Academy of Sciences of the United States of America	1999	155
10491605	Sodium	Huang Y	Transcriptional repression by REST: recruitment of Sin3A and histone deacetylase to neuronal genes.	Nature neuroscience	1999	108
11516394	Sodium	Ballas N	Regulation of neuronal traits by a novel transcriptional complex.	Neuron	2001	135
11891345	Sodium	Maier SK	An unexpected role for brain-type sodium channels in coupling of cell surface depolarization to contraction in the heart.	Proceedings of the National Academy of Sciences of the United States of America	2002	84
12676175	Sodium	McKinley MJ	The brain renin-angiotensin system: location and physiological roles.	The international journal of biochemistry & cell biology	2003	102
17347258	Sodium	Harkin LA	The spectrum of SCN1A-related infantile epileptic encephalopathies.	Brain 	2007	69
17517448	Sodium	Sheldon AL	The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention.	Neurochemistry international	2007	119
17519130	Sodium	Osborn JW	Circulating angiotensin II and dietary salt: converging signals for neurogenic hypertension.	Current hypertension reports	2007	84
17576410	Sodium	Kim DY	BACE1 regulates voltage-gated sodium channels and neuronal activity.	Nature cell biology	2007	106
17678857	Sodium	Goldfarb M	Fibroblast growth factor homologous factors control neuronal excitability through modulation of voltage-gated sodium channels.	Neuron	2007	73
18446519	Sodium	Ganapathy V	Sodium-coupled monocarboxylate transporters in normal tissues and in cancer.	The AAPS journal	2008	54
18804930	Sodium	Lossin C	A catalog of SCN1A variants.	Brain & development	2009	53
19228957	Sodium	Aman TK	Regulation of persistent Na current by interactions between beta subunits of voltage-gated Na channels.	The Journal of neuroscience 	2009	64
19465131	Sodium	Laezza F	FGF14 N-terminal splice variants differentially modulate Nav1.2 and Nav1.6-encoded sodium channels.	Molecular and cellular neurosciences	2009	47
19710327	Sodium	Patino GA	A functional null mutation of SCN1B in a patient with Dravet syndrome.	The Journal of neuroscience 	2009	65
20194124	Sodium	Catterall WA	NaV1.1 channels and epilepsy.	The Journal of physiology	2010	88
21441906	Sodium	Weiss J	Loss-of-function mutations in sodium channel Nav1.7 cause anosmia.	Nature	2011	58
22365152	Sodium	Veeramah KR	De novo pathogenic SCN8A mutation identified by whole-genome sequencing of a family quartet affected by infantile epileptic encephalopathy and SUDEP.	American journal of human genetics	2012	110
22495306	Sodium	Sanders SJ	De novo mutations revealed by whole-exome sequencing are strongly associated with autism.	Nature	2012	593
22541439	Sodium	Verret L	Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model.	Cell	2012	191
22905747	Sodium	Oliva M	Sodium channels and the neurobiology of epilepsy.	Epilepsia	2012	33
23640885	Sodium	Shavkunov AS	The fibroblast growth factor 14·voltage-gated sodium channel complex is a new target of glycogen synthase kinase 3 (GSK3).	The Journal of biological chemistry	2013	36
23741036	Sodium	Hargus NJ	Evidence for a role of Nav1.6 in facilitating increases in neuronal hyperexcitability during epileptogenesis.	Journal of neurophysiology	2013	27
23821540	Sodium	Liu Y	Dravet syndrome patient-derived neurons suggest a novel epilepsy mechanism.	Annals of neurology	2013	58
24194747	Sodium	O'Brien JE	Sodium channel SCN8A (Nav1.6): properties and de novo mutations in epileptic encephalopathy and intellectual disability.	Frontiers in genetics	2013	48
24265240	Sodium	Halestrap AP	Monocarboxylic acid transport.	Comprehensive Physiology	2013	42
24776970	Sodium	Huang J	Gain-of-function mutations in sodium channel Na(v)1.9 in painful neuropathy.	Brain 	2014	44
24874546	Sodium	Estacion M	A novel de novo mutation of SCN8A (Nav1.6) with enhanced channel activation in a child with epileptic encephalopathy.	Neurobiology of disease	2014	32
25239001	Sodium	de Kovel CG	Characterization of a de novo SCN8A mutation in a patient with epileptic encephalopathy.	Epilepsy research	2014	28
25568300	Sodium	Larsen J	The phenotypic spectrum of SCN8A encephalopathy.	Neurology	2015	45
25725044	Sodium	Blanchard MG	De novo gain-of-function and loss-of-function mutations of SCN8A in patients with intellectual disabilities and epilepsy.	Journal of medical genetics	2015	29
25753944	Sodium	McKinley MJ	The median preoptic nucleus: front and centre for the regulation of body fluid, sodium, temperature, sleep and cardiovascular homeostasis.	Acta physiologica	2015	17
26645390	Sodium	Schwarz N	Mutations in the sodium channel gene SCN2A cause neonatal epilepsy with late-onset episodic ataxia.	Journal of neurology	2016	12
26700687	Sodium	Zaharieva IT	Loss-of-function mutations in SCN4A cause severe foetal hypokinesia or 'classical' congenital myopathy.	Brain 	2016	14
26803770	Sodium	Malan D	Human iPS cell model of type 3 long QT syndrome recapitulates drug-based phenotype correction.	Basic research in cardiology	2016	15
27270488	Sodium	Meisler MH	SCN8A encephalopathy: Research progress and prospects.	Epilepsia	2016	17
28113019	Sodium	Magnuson WJ	Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis.	Journal of clinical oncology 	2017	15
28238546	Sodium	Makinson CD	Regulation of Thalamic and Cortical Network Synchrony by Scn8a.	Neuron	2017	9
9348186	Estradiol	Couse JF	Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse.	Endocrinology	1997	136
9472688	Estradiol	Zhu BT	Functional role of estrogen metabolism in target cells: review and perspectives.	Carcinogenesis	1998	168
11040417	Estradiol	Garcia-Segura LM	Neuroprotection by estradiol.	Progress in neurobiology	2001	124
16373418	Estradiol	Dungan HM	Minireview: kisspeptin neurons as central processors in the regulation of gonadotropin-releasing hormone secretion.	Endocrinology	2006	77
18294621	Estradiol	Oh EC	Rod differentiation factor NRL activates the expression of nuclear receptor NR2E3 to suppress the development of cone photoreceptors.	Brain research	2008	51
19416735	Estradiol	Micevych P	Membrane estradiol signaling in the brain.	Frontiers in neuroendocrinology	2009	61
19428444	Estradiol	Lebesgue D	Estradiol rescues neurons from global ischemia-induced cell death: multiple cellular pathways of neuroprotection.	Steroids	2009	61
19559056	Estradiol	Chen JQ	Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications.	Biochimica et biophysica acta	2009	49
19632787	Estradiol	Domes G	Effects of intranasal oxytocin on emotional face processing in women.	Psychoneuroendocrinology	2010	130
20028456	Estradiol	Son TG	Plumbagin, a novel Nrf2/ARE activator, protects against cerebral ischemia.	Journal of neurochemistry	2010	49
20807803	Estradiol	Jiang H	The RB-E2F1 pathway regulates autophagy.	Cancer research	2010	47
20943885	Estradiol	Giordano C	Oestrogens ameliorate mitochondrial dysfunction in Leber's hereditary optic neuropathy.	Brain 	2011	42
21320576	Estradiol	Azcoitia I	Estradiol synthesis within the human brain.	Neuroscience	2011	46
21458561	Estradiol	Meitzen J	Estrogen receptors stimulate brain region specific metabotropic glutamate receptors to rapidly initiate signal transduction pathways.	Journal of chemical neuroanatomy	2011	41
21762880	Estradiol	Zeidan MA	Estradiol modulates medial prefrontal cortex and amygdala activity during fear extinction in women and female rats.	Biological psychiatry	2011	66
21907136	Estradiol	Barros RP	Estrogen receptors and the metabolic network.	Cell metabolism	2011	78
23079626	Estradiol	Luine V	Interactions between estradiol, BDNF and dendritic spines in promoting memory.	Neuroscience	2013	38
23300088	Estradiol	Akama KT	Post-synaptic density-95 (PSD-95) binding capacity of G-protein-coupled receptor 30 (GPR30), an estrogen receptor that can be identified in hippocampal dendritic spines.	The Journal of biological chemistry	2013	37
23689534	Estradiol	Guintivano J	Antenatal prediction of postpartum depression with blood DNA methylation biomarkers.	Molecular psychiatry	2014	24
25960081	Estradiol	Frick KM	Molecular mechanisms underlying the memory-enhancing effects of estradiol.	Hormones and behavior	2015	22
8530621	Estrogens	Morishima A	Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens.	The Journal of clinical endocrinology and metabolism	1995	136
9111344	Estrogens	Hong H	GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors.	Molecular and cellular biology	1997	125
10227624	Estrogens	Jack CR Jr	Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment.	Neurology	1999	322
10833057	Estrogens	Roof RL	Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone.	Journal of neurotrauma	2000	114
11041447	Estrogens	Challis JRG	Endocrine and paracrine regulation of birth at term and preterm.	Endocrine reviews	2000	161
11181953	Estrogens	Pettersson K	Role of estrogen receptor beta in estrogen action.	Annual review of physiology	2001	94
11717247	Estrogens	McEwen BS	Invited review: Estrogens effects on the brain: multiple sites and molecular mechanisms.	Journal of applied physiology	2001	123
11826265	Estrogens	Simpson ER	Aromatase--a brief overview.	Annual review of physiology	2002	123
11906203	Estrogens	Bethea CL	Diverse actions of ovarian steroids in the serotonin neural system.	Frontiers in neuroendocrinology	2002	103
12400004	Estrogens	Real PJ	Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells.	Oncogene	2002	88
12697714	Estrogens	Mitra SW	Immunolocalization of estrogen receptor beta in the mouse brain: comparison with estrogen receptor alpha.	Endocrinology	2003	202
14623515	Estrogens	Simpson ER	Sources of estrogen and their importance.	The Journal of steroid biochemistry and molecular biology	2003	126
16310321	Estrogens	De Vries GJ	Sexual differentiation of central vasopressin and vasotocin systems in vertebrates: different mechanisms, similar endpoints.	Neuroscience	2006	71
16780796	Estrogens	Funakoshi T	G protein-coupled receptor 30 is an estrogen receptor in the plasma membrane.	Biochemical and biophysical research communications	2006	103
16931954	Estrogens	Hicks DG	Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR.	The American journal of surgical pathology	2006	71
17055560	Estrogens	Scharfman HE	Estrogen and brain-derived neurotrophic factor (BDNF) in hippocampus: complexity of steroid hormone-growth factor interactions in the adult CNS.	Frontiers in neuroendocrinology	2006	66
17308356	Estrogens	Zhao H	Phosphoinositide-3-kinase/akt survival signal pathways are implicated in neuronal survival after stroke.	Molecular neurobiology	2006	77
17488799	Estrogens	Rometo AM	Hypertrophy and increased kisspeptin gene expression in the hypothalamic infundibular nucleus of postmenopausal women and ovariectomized monkeys.	The Journal of clinical endocrinology and metabolism	2007	88
18253054	Estrogens	Raz L	Rapid estrogen signaling in the brain.	Neuro-Signals	2008	67
18334610	Estrogens	Gao Q	Cross-talk between estrogen and leptin signaling in the hypothalamus.	American journal of physiology. Endocrinology and metabolism	2008	56
18443585	Estrogens	Ben-Porath I	An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors.	Nature genetics	2008	811
18753370	Estrogens	Clarkson J	Kisspeptin-GPR54 signaling is essential for preovulatory gonadotropin-releasing hormone neuron activation and the luteinizing hormone surge.	The Journal of neuroscience 	2008	139
18829137	Estrogens	Selvamani A	Reproductive age modulates the impact of focal ischemia on the forebrain as well as the effects of estrogen treatment in female rats.	Neurobiology of aging	2010	50
19828794	Estrogens	McCarthy MM	The epigenetics of sex differences in the brain.	The Journal of neuroscience 	2009	132
20031276	Estrogens	Rasgon NL	Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease.	Neurobiology of aging	2011	48
20478440	Estrogens	Boon WC	The multiple roles of estrogens and the enzyme aromatase.	Progress in brain research	2010	43
20813970	Estrogens	Esteva FJ	PTEN, PIK3CA, p-AKT, and p-p70S6K status: association with trastuzumab response and survival in patients with HER2-positive metastatic breast cancer.	The American journal of pathology	2010	100
20863372	Estrogens	Hoefnagel LD	Receptor conversion in distant breast cancer metastases.	Breast cancer research 	2010	52
21057539	Estrogens	Patel JB	Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22.	Oncogene	2011	39
21350482	Estrogens	Ressler KJ	Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor.	Nature	2011	209
21472708	Estrogens	Anders CK	The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases.	Cancer	2011	35
21914172	Estrogens	Sihto H	Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study.	Breast cancer research 	2011	50
22072656	Estrogens	Srivastava DP	Rapid estrogen signaling in the brain: implications for the fine-tuning of neuronal circuitry.	The Journal of neuroscience 	2011	41
22151997	Estrogens	Chimge NO	Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2.	Breast cancer research 	2011	38
22544643	Estrogens	Lin NU	Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network.	Cancer	2012	64
22587940	Estrogens	Daniel JM	Estrogens, estrogen receptors, and female cognitive aging: the impact of timing.	Hormones and behavior	2013	29
23142339	Estrogens	Baudry M	Progesterone-estrogen interactions in synaptic plasticity and neuroprotection.	Neuroscience	2013	29
23542418	Estrogens	Nagpal N	MicroRNA-191, an estrogen-responsive microRNA, functions as an oncogenic regulator in human breast cancer.	Carcinogenesis	2013	29
23697635	Estrogens	Sarachana T	Genome-wide identification of transcriptional targets of RORA reveals direct regulation of multiple genes associated with autism spectrum disorder.	Molecular autism	2013	34
24954179	Estrogens	Bondesson M	Estrogen receptor signaling during vertebrate development.	Biochimica et biophysica acta	2015	23
25303530	Estrogens	Liu Z	Enhancer activation requires trans-recruitment of a mega transcription factor complex.	Cell	2014	32
26109339	Estrogens	Hara Y	Estrogen Effects on Cognitive and Synaptic Health Over the Lifecourse.	Physiological reviews	2015	27
26909695	Estrogens	Rostami R	Brain metastasis in breast cancer: a comprehensive literature review.	Journal of neuro-oncology	2016	13
27557300	Estrogens	Cardoso F	70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.	The New England journal of medicine	2016	91
27926948	Estrogens	Priedigkeit N	Intrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases.	JAMA oncology	2017	9
11873706	Levodopa	Seeman P	Atypical antipsychotics: mechanism of action.	Canadian journal of psychiatry. Revue canadienne de psychiatrie	2002	104
15788542	Levodopa	Williams DR	Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.	Brain 	2005	77
16272164	Levodopa	Khan NL	Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data.	Brain 	2005	75
16429411	Levodopa	Lang AE	Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease.	Annals of neurology	2006	170
16844713	Levodopa	Asanuma K	Network modulation in the treatment of Parkinson's disease.	Brain 	2006	92
20669327	Levodopa	Paisán-Ruiz C	Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations.	Movement disorders 	2010	52
21967988	Levodopa	Arnoux JB	Congenital hyperinsulinism: current trends in diagnosis and therapy.	Orphanet journal of rare diseases	2011	39
23404372	Levodopa	Kiely AP	α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy?	Acta neuropathologica	2013	85
23804577	Levodopa	Quadri M	Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset Parkinsonism.	Human mutation	2013	35
25080285	Levodopa	Nombela C	Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study.	Brain 	2014	30
27766724	Levodopa	Schlenstedt C	Effect of high-frequency subthalamic neurostimulation on gait and freezing of gait in Parkinson's disease: a systematic review and meta-analysis.	European journal of neurology	2017	7
11015620	Prolactin	Freeman ME	Prolactin: structure, function, and regulation of secretion.	Physiological reviews	2000	273
18057139	Prolactin	Ben-Jonathan N	What can we learn from rodents about prolactin in humans?	Endocrine reviews	2008	94
24677189	Prolactin	Peuskens J	The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.	CNS drugs	2014	31
24695685	Prolactin	Iwama S	Pituitary expression of CTLA-4 mediates hypophysitis secondary to administration of CTLA-4 blocking antibody.	Science translational medicine	2014	36
25781857	Prolactin	Bernard V	New insights in prolactin: pathological implications.	Nature reviews. Endocrinology	2015	18
17239802	Aldosterone	Dichgans M	Genetics of ischaemic stroke.	The Lancet. Neurology	2007	95
19620517	Aldosterone	Pimenta E	Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial.	Hypertension	2009	74
20810473	Aldosterone	Jabbour A	Parenteral administration of recombinant human neuregulin-1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses.	European journal of heart failure	2011	52
23821090	Aldosterone	Ledwidge M	Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial.	JAMA	2013	46
23883676	Aldosterone	Xue B	Sex differences in angiotensin II- and aldosterone-induced hypertension: the central protective effects of estrogen.	American journal of physiology. Regulatory, integrative and comparative physiology	2013	27
24490814	Aldosterone	Zucker IH	The central renin-angiotensin system and sympathetic nerve activity in chronic heart failure.	Clinical science	2014	33
24569031	Aldosterone	Assmus B	Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival.	European heart journal	2014	26
25767285	Aldosterone	Hall JE	Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms.	Circulation research	2015	66
2032290	Insulin	Boulton TG	ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF.	Cell	1991	361
2645527	Insulin	James DE	Molecular cloning and characterization of an insulin-regulatable glucose transporter.	Nature	1989	161
8156941	Insulin	Thissen JP	Nutritional regulation of the insulin-like growth factors.	Endocrine reviews	1994	136
10774732	Insulin	Man HY	Regulation of AMPA receptor-mediated synaptic transmission by clathrin-dependent receptor internalization.	Neuron	2000	155
11377828	Insulin	Zhao WQ	Role of insulin and insulin receptor in learning and memory.	Molecular and cellular endocrinology	2001	97
12634421	Insulin	Farris W	Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2003	329
12820960	Insulin	Garami A	Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2.	Molecular cell	2003	302
14980532	Insulin	Craft S	Insulin and neurodegenerative disease: shared and specific mechanisms.	The Lancet. Neurology	2004	176
15094069	Insulin	Banks WA	The source of cerebral insulin.	European journal of pharmacology	2004	90
15094071	Insulin	Bondy CA	Signaling by insulin-like growth factor 1 in brain.	European journal of pharmacology	2004	72
15094074	Insulin	Zhao WQ	Insulin and the insulin receptor in experimental models of learning and memory.	European journal of pharmacology	2004	86
15288712	Insulin	Benedict C	Intranasal insulin improves memory in humans.	Psychoneuroendocrinology	2004	120
15734146	Insulin	Plum L	The role of insulin receptor signaling in the brain.	Trends in endocrinology and metabolism	2005	111
15750214	Insulin	de la Monte SM	Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease.	Journal of Alzheimer's disease 	2005	129
15964100	Insulin	Reger MA	Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype.	Neurobiology of aging	2006	123
16266773	Insulin	Craft S	Insulin resistance syndrome and Alzheimer's disease: age- and obesity-related effects on memory, amyloid, and inflammation.	Neurobiology of aging	2005	82
16399206	Insulin	Qiu WQ	Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis.	Neurobiology of aging	2006	106
16627931	Insulin	Lester-Coll N	Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease.	Journal of Alzheimer's disease 	2006	109
16873964	Insulin	de la Monte SM	Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease.	Journal of Alzheimer's disease 	2006	67
16916571	Insulin	van der Heide LP	Insulin signaling in the central nervous system: learning to survive.	Progress in neurobiology	2006	92
17430239	Insulin	Craft S	Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment.	Current Alzheimer research	2007	138
17855343	Insulin	Townsend M	Soluble Abeta inhibits specific signal transduction cascades common to the insulin receptor pathway.	The Journal of biological chemistry	2007	97
17942819	Insulin	Reger MA	Intranasal insulin improves cognition and modulates beta-amyloid in early AD.	Neurology	2008	173
18230654	Insulin	Benedict C	Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin.	The Journal of clinical endocrinology and metabolism	2008	59
18285524	Insulin	Hill JW	Hypothalamic pathways linking energy balance and reproduction.	American journal of physiology. Endocrinology and metabolism	2008	85
18328671	Insulin	Suarez EC	Self-reported symptoms of sleep disturbance and inflammation, coagulation, insulin resistance and psychosocial distress: evidence for gender disparity.	Brain, behavior, and immunity	2008	68
18676370	Insulin	Wang X	Re-evaluating the roles of proposed modulators of mammalian target of rapamycin complex 1 (mTORC1) signaling.	The Journal of biological chemistry	2008	52
18948730	Insulin	Bartke A	Insulin and aging.	Cell cycle	2008	54
19144826	Insulin	Lee HK	The insulin/Akt signaling pathway is targeted by intracellular beta-amyloid.	Molecular biology of the cell	2009	58
19376193	Insulin	Confavreux CB	A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms.	Molecular and cellular endocrinology	2009	51
19406747	Insulin	Zhao WQ	Insulin receptor dysfunction impairs cellular clearance of neurotoxic oligomeric a{beta}.	The Journal of biological chemistry	2009	47
19490822	Insulin	Gross DN	The role of FOXO in the regulation of metabolism.	Current diabetes reports	2009	57
19662657	Insulin	Raji CA	Brain structure and obesity.	Human brain mapping	2010	161
19864431	Insulin	Foster KG	Regulation of mTOR complex 1 (mTORC1) by raptor Ser863 and multisite phosphorylation.	The Journal of biological chemistry	2010	58
20022465	Insulin	Das UN	Obesity: genes, brain, gut, and environment.	Nutrition	2010	49
20357365	Insulin	Sarruf DA	Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats.	Diabetes	2010	68
20381510	Insulin	de Kloet AD	The renin angiotensin system and the metabolic syndrome.	Physiology & behavior	2010	47
21598254	Insulin	Liu Y	Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes.	The Journal of pathology	2011	91
21865652	Insulin	Kim KY	Parkin is a lipid-responsive regulator of fat uptake in mice and mutant human cells.	The Journal of clinical investigation	2011	62
21986512	Insulin	Newbern D	Placental hormones and the control of maternal metabolism and fetal growth.	Current opinion in endocrinology, diabetes, and obesity	2011	57
22426422	Insulin	Liao GY	Dendritically targeted Bdnf mRNA is essential for energy balance and response to leptin.	Nature medicine	2012	52
22476196	Insulin	Bomfim TR	An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers.	The Journal of clinical investigation	2012	123
22476197	Insulin	Talbot K	Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.	The Journal of clinical investigation	2012	269
22820012	Insulin	Banks WA	Insulin in the brain: there and back again.	Pharmacology & therapeutics	2012	71
23021220	Insulin	Rajan A	Drosophila cytokine unpaired 2 regulates physiological homeostasis by remotely controlling insulin secretion.	Cell	2012	117
23069840	Insulin	Jastreboff AM	Neural correlates of stress- and food cue-induced food craving in obesity: association with insulin levels.	Diabetes care	2013	45
23374353	Insulin	Sohn JW	Melanocortin 4 receptors reciprocally regulate sympathetic and parasympathetic preganglionic neurons.	Cell	2013	70
23728177	Insulin	Oury F	Osteocalcin regulates murine and human fertility through a pancreas-bone-testis axis.	The Journal of clinical investigation	2013	29
24380887	Insulin	de la Monte SM	Brain metabolic dysfunction at the core of Alzheimer's disease.	Biochemical pharmacology	2014	55
24529663	Insulin	Werner H	Insulin and insulin-like growth factor receptors in the brain: physiological and pathological aspects.	European neuropsychopharmacology 	2014	24
24567379	Insulin	Cai W	Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans.	Proceedings of the National Academy of Sciences of the United States of America	2014	24
24582776	Insulin	Bassil F	Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: targets for disease modification?	Progress in neurobiology	2014	38
24931033	Insulin	De Felice FG	Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease.	Diabetes	2014	66
24931034	Insulin	Kleinridders A	Insulin action in brain regulates systemic metabolism and brain function.	Diabetes	2014	52
24931035	Insulin	Yarchoan M	Repurposing diabetes drugs for brain insulin resistance in Alzheimer disease.	Diabetes	2014	33
24958311	Insulin	Murray S	Hormonal and neural mechanisms of food reward, eating behaviour and obesity.	Nature reviews. Endocrinology	2014	34
25028522	Insulin	Heni M	Central insulin administration improves whole-body insulin sensitivity via hypothalamus and parasympathetic outputs in men.	Diabetes	2014	26
25247581	Insulin	Jenwitheesuk A	Melatonin regulates aging and neurodegeneration through energy metabolism, epigenetics, autophagy and circadian rhythm pathways.	International journal of molecular sciences	2014	20
25287289	Insulin	Frier BM	Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications.	Nature reviews. Endocrinology	2014	35
25631608	Insulin	Wessel J	Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.	Nature communications	2015	44
25673412	Insulin	Shungin D	New genetic loci link adipose and insulin biology to body fat distribution.	Nature	2015	208
25673413	Insulin	Locke AE	Genetic studies of body mass index yield new insights for obesity biology.	Nature	2015	564
25766618	Insulin	Kim B	Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome.	Experimental & molecular medicine	2015	28
25795413	Insulin	Kullmann S	Selective insulin resistance in homeostatic and cognitive control brain areas in overweight and obese adults.	Diabetes care	2015	18
26040423	Insulin	Lioutas VA	Intranasal Insulin and Insulin-Like Growth Factor 1 as Neuroprotectants in Acute Ischemic Stroke.	Translational stroke research	2015	16
26159692	Insulin	Dibble CC	Regulation of mTORC1 by PI3K signaling.	Trends in cell biology	2015	103
26908106	Insulin	Stanley CA	Perspective on the Genetics and Diagnosis of Congenital Hyperinsulinism Disorders.	The Journal of clinical endocrinology and metabolism	2016	22
27432942	Insulin	Stanley M	Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?	The Journal of experimental medicine	2016	13
27489306	Insulin	Kullmann S	Brain Insulin Resistance at the Crossroads of Metabolic and Cognitive Disorders in Humans.	Physiological reviews	2016	18
27916275	Insulin	Li J	Artemisinins Target GABAA Receptor Signaling and Impair α Cell Identity.	Cell	2017	22
28112808	Insulin	Skaper SD	Nerve growth factor: a neuroimmune crosstalk mediator for all seasons.	Immunology	2017	6
8688086	Hormones	Howard AD	A receptor in pituitary and hypothalamus that functions in growth hormone release.	Science	1996	218
15159173	Hormones	Schneider JE	Energy balance and reproduction.	Physiology & behavior	2004	74
18279846	Hormones	Webster Marketon JI	Stress hormones and immune function.	Cellular immunology	2008	66
18977694	Hormones	Lage R	AMPK: a metabolic gauge regulating whole-body energy homeostasis.	Trends in molecular medicine	2008	101
20182414	Hormones	Verstuyf A	Vitamin D: a pleiotropic hormone.	Kidney international	2010	64
21939733	Hormones	Morris CJ	Circadian system, sleep and endocrinology.	Molecular and cellular endocrinology	2012	53
22899902	Hormones	Suzuki K	Obesity and appetite control.	Experimental diabetes research	2012	35
8387282	Peptides	Kitamura K	Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma.	Biochemical and biophysical research communications	1993	185
8446617	Peptides	Strittmatter WJ	Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.	Proceedings of the National Academy of Sciences of the United States of America	1993	664
10531052	Peptides	Vassar R	Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE.	Science	1999	746
10604470	Peptides	Kojima M	Ghrelin is a growth-hormone-releasing acylated peptide from stomach.	Nature	1999	1062
10742146	Peptides	Lu DC	A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor.	Nature medicine	2000	101
11147798	Peptides	Bonny C	Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death.	Diabetes	2001	117
12118245	Peptides	Fulda S	Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo.	Nature medicine	2002	133
14507923	Peptides	Lynch JR	APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response.	The Journal of biological chemistry	2003	78
15269340	Peptides	Brain SD	Vascular actions of calcitonin gene-related peptide and adrenomedullin.	Physiological reviews	2004	104
15664175	Peptides	Grieco TM	Open-channel block by the cytoplasmic tail of sodium channel beta4 as a mechanism for resurgent sodium current.	Neuron	2005	99
15820677	Peptides	Rajan S	Sumoylation silences the plasma membrane leak K+ channel K2P1.	Cell	2005	74
16061868	Peptides	Liau LM	Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment.	Clinical cancer research 	2005	144
16837572	Peptides	Rajendran L	Alzheimer's disease beta-amyloid peptides are released in association with exosomes.	Proceedings of the National Academy of Sciences of the United States of America	2006	251
18000063	Peptides	Ghosh A	Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease.	Proceedings of the National Academy of Sciences of the United States of America	2007	119
18346832	Peptides	Anisman H	Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders.	Progress in neurobiology	2008	68
18467332	Peptides	Reynolds CH	Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.	The Journal of biological chemistry	2008	60
18726697	Peptides	Hervé F	CNS delivery via adsorptive transcytosis.	The AAPS journal	2008	61
18757748	Peptides	Hansson Petersen CA	The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae.	Proceedings of the National Academy of Sciences of the United States of America	2008	159
19785645	Peptides	Kalliokoski A	Impact of OATP transporters on pharmacokinetics.	British journal of pharmacology	2009	119
21873229	Peptides	Chen J	Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions.	Proceedings of the National Academy of Sciences of the United States of America	2011	57
22418738	Peptides	Dutoit V	Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy.	Brain 	2012	39
22872572	Peptides	Crane CA	Individual patient-specific immunity against high-grade glioma after vaccination with autologous tumor derived peptides bound to the 96 KD chaperone protein.	Clinical cancer research 	2013	43
23360448	Peptides	Carroll FI	Development of κ opioid receptor antagonists.	Journal of medicinal chemistry	2013	44
23415312	Peptides	Ash PE	Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS.	Neuron	2013	255
23664811	Peptides	Iyyathurai J	Peptides and peptide-derived molecules targeting the intracellular domains of Cx43: gap junctions versus hemichannels.	Neuropharmacology	2013	26
23740901	Peptides	Lutterotti A	Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis.	Science translational medicine	2013	72
25071023	Peptides	van Bloemendaal L	GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans.	Diabetes	2014	42
25433637	Peptides	Su P	A dopamine D2 receptor-DISC1 protein complex may contribute to antipsychotic-like effects.	Neuron	2014	23
25990016	Peptides	Jones MV	Pathogenic aquaporin-4 reactive T cells are sufficient to induce mouse model of neuromyelitis optica.	Acta neuropathologica communications	2015	16
8592548	Glucose	Reiman EM	Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.	The New England journal of medicine	1996	330
10466143	Glucose	Magistretti PJ	Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging.	Philosophical transactions of the Royal Society of London. Series B, Biological sciences	1999	136
10582706	Glucose	Zhong H	Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.	Cancer research	1999	534
10811879	Glucose	Small GW	Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease.	Proceedings of the National Academy of Sciences of the United States of America	2000	156
11022058	Glucose	Vila N	Proinflammatory cytokines and early neurological worsening in ischemic stroke.	Stroke	2000	110
11210998	Glucose	Wang GJ	Brain dopamine and obesity.	Lancet	2001	409
11248079	Glucose	Reiman EM	Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease.	Proceedings of the National Academy of Sciences of the United States of America	2001	146
11445252	Glucose	De Santi S	Hippocampal formation glucose metabolism and volume losses in MCI and AD.	Neurobiology of aging	2001	128
12162730	Glucose	Abbott NJ	Astrocyte-endothelial interactions and blood-brain barrier permeability.	Journal of anatomy	2002	180
12589027	Glucose	Duan W	Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice.	Proceedings of the National Academy of Sciences of the United States of America	2003	116
12615957	Glucose	Mayo KE	International Union of Pharmacology. XXXV. The glucagon receptor family.	Pharmacological reviews	2003	94
12728191	Glucose	Mattson MP	Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders.	Neuromolecular medicine	2003	90
12858170	Glucose	Mattiasson G	Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma.	Nature medicine	2003	111
12909083	Glucose	Mattson MP	Neuronal and glial calcium signaling in Alzheimer's disease.	Cell calcium	2003	81
14688411	Glucose	Reiman EM	Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia.	Proceedings of the National Academy of Sciences of the United States of America	2004	282
14697204	Glucose	Aarts M	A key role for TRPM7 channels in anoxic neuronal death.	Cell	2003	198
15094078	Glucose	Hoyer S	Glucose metabolism and insulin receptor signal transduction in Alzheimer disease.	European journal of pharmacology	2004	75
15448079	Glucose	Levin BE	Neuronal glucosensing: what do we know after 50 years?	Diabetes	2004	116
15520383	Glucose	Zhang EE	Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism.	Proceedings of the National Academy of Sciences of the United States of America	2004	99
15750215	Glucose	Steen E	Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?	Journal of Alzheimer's disease 	2005	298
15932949	Glucose	Reiman EM	Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism.	Proceedings of the National Academy of Sciences of the United States of America	2005	124
15953344	Glucose	Pierre K	Monocarboxylate transporters in the central nervous system: distribution, regulation and function.	Journal of neurochemistry	2005	112
16473887	Glucose	Neumann J	Microglia provide neuroprotection after ischemia.	FASEB journal 	2006	73
16505665	Glucose	Vespa P	Intensive insulin therapy reduces microdialysis glucose values without altering glucose utilization or improving the lactate/pyruvate ratio after traumatic brain injury.	Critical care medicine	2006	61
16622416	Glucose	Mao X	APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function.	Nature cell biology	2006	168
16678181	Glucose	Hunt NH	Immunopathogenesis of cerebral malaria.	International journal for parasitology	2006	84
16709629	Glucose	Xue B	AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance through effects in the hypothalamus and peripheral tissues.	The Journal of physiology	2006	78
16823473	Glucose	Plum L	Central insulin action in energy and glucose homeostasis.	The Journal of clinical investigation	2006	112
16835632	Glucose	Hertz L	Energy metabolism in astrocytes: high rate of oxidative metabolism and spatiotemporal dependence on glycolysis/glycogenolysis.	Journal of cerebral blood flow and metabolism 	2007	158
16979422	Glucose	McEwen BS	Sleep deprivation as a neurobiologic and physiologic stressor: Allostasis and allostatic load.	Metabolism	2006	110
17079810	Glucose	Mosconi L	Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease.	Journal of nuclear medicine 	2006	77
17200485	Glucose	Zhang Y	Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease.	Neurology	2007	156
17225955	Glucose	Virgintino D	An intimate interplay between precocious, migrating pericytes and endothelial cells governs human fetal brain angiogenesis.	Angiogenesis	2007	60
17493050	Glucose	Chang L	Structural and metabolic brain changes in the striatum associated with methamphetamine abuse.	Addiction	2007	139
17504212	Glucose	Lykissas MG	The role of neurotrophins in axonal growth, guidance, and regeneration.	Current neurovascular research	2007	58
17579656	Glucose	Simpson IA	Supply and demand in cerebral energy metabolism: the role of nutrient transporters.	Journal of cerebral blood flow and metabolism 	2007	191
17609686	Glucose	Cucullo L	Immortalized human brain endothelial cells and flow-based vascular modeling: a marriage of convenience for rational neurovascular studies.	Journal of cerebral blood flow and metabolism 	2008	51
17627510	Glucose	Maiese K	Mechanistic insights into diabetes mellitus and oxidative stress.	Current medicinal chemistry	2007	63
17699877	Glucose	Marty N	Brain glucose sensing, counterregulation, and energy homeostasis.	Physiology	2007	75
17940659	Glucose	Dias WB	O-GlcNAc modification in diabetes and Alzheimer's disease.	Molecular bioSystems	2007	77
18003925	Glucose	Mosconi L	Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism.	Proceedings of the National Academy of Sciences of the United States of America	2007	95
18332434	Glucose	Liang WS	Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons.	Proceedings of the National Academy of Sciences of the United States of America	2008	143
18344986	Glucose	Lee KS	Drosophila short neuropeptide F signalling regulates growth by ERK-mediated insulin signalling.	Nature cell biology	2008	68
18707012	Glucose	Komulainen P	BDNF is a novel marker of cognitive function in ageing women: the DR's EXTRA Study.	Neurobiology of learning and memory	2008	63
18726182	Glucose	Iynedjian PB	Molecular physiology of mammalian glucokinase.	Cellular and molecular life sciences 	2009	80
18854155	Glucose	Zhang X	Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity.	Cell	2008	337
19009016	Glucose	Rabe K	Adipokines and insulin resistance.	Molecular medicine	2008	141
19076441	Glucose	Mosconi L	Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease.	Annals of the New York Academy of Sciences	2008	100
19247306	Glucose	Beenken A	The FGF family: biology, pathophysiology and therapy.	Nature reviews. Drug discovery	2009	342
19357959	Glucose	Jensen RL	Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target.	Journal of neuro-oncology	2009	81
19451179	Glucose	Liu F	Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease.	Brain 	2009	68
19460373	Glucose	Sassone J	Huntington's disease: the current state of research with peripheral tissues.	Experimental neurology	2009	46
19696361	Glucose	Pedersen BK	Edward F. Adolph distinguished lecture: muscle as an endocrine organ: IL-6 and other myokines.	Journal of applied physiology	2009	50
19714445	Glucose	Marcus HJ	In vivo assessment of high-grade glioma biochemistry using microdialysis: a study of energy-related molecules, growth factors and cytokines.	Journal of neuro-oncology	2010	43
19723875	Glucose	Palmieri D	Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosis.	Molecular cancer research 	2009	52
19800254	Glucose	Lynn FC	Meta-regulation: microRNA regulation of glucose and lipid metabolism.	Trends in endocrinology and metabolism	2009	59
20026663	Glucose	Yin F	Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice.	The Journal of experimental medicine	2010	137
20048154	Glucose	Inoue K	Zinc-induced neurotoxicity mediated by transient receptor potential melastatin 7 channels.	The Journal of biological chemistry	2010	43
20065132	Glucose	Baker LD	Effects of aerobic exercise on mild cognitive impairment: a controlled trial.	Archives of neurology	2010	223
20065246	Glucose	Honea RA	Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease.	Neurology	2010	52
20140248	Glucose	Xin H	Increasing tPA activity in astrocytes induced by multipotent mesenchymal stromal cells facilitate neurite outgrowth after stroke in the mouse.	PloS one	2010	42
20190196	Glucose	Tao YX	The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology.	Endocrine reviews	2010	93
20227367	Glucose	Godlewski J	MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells.	Molecular cell	2010	134
20353613	Glucose	Gallagher IJ	Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes.	Genome medicine	2010	61
20489155	Glucose	Wang WX	miR-107 regulates granulin/progranulin with implications for traumatic brain injury and neurodegenerative disease.	The American journal of pathology	2010	61
20647762	Glucose	Godlewski J	microRNA-451: A conditional switch controlling glioma cell proliferation and migration.	Cell cycle	2010	58
20688814	Glucose	Villain N	Sequential relationships between grey matter and white matter atrophy and brain metabolic abnormalities in early Alzheimer's disease.	Brain 	2010	58
20829514	Glucose	Lima FO	The pattern of leptomeningeal collaterals on CT angiography is a strong predictor of long-term functional outcome in stroke patients with large vessel intracranial occlusion.	Stroke	2010	48
20837822	Glucose	Baker LD	Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes.	Archives of neurology	2011	138
20962220	Glucose	Boumezbeur F	The contribution of blood lactate to brain energy metabolism in humans measured by dynamic 13C nuclear magnetic resonance spectroscopy.	The Journal of neuroscience 	2010	77
21035308	Glucose	Cunnane S	Brain fuel metabolism, aging, and Alzheimer's disease.	Nutrition	2011	93
21291474	Glucose	Uchida Y	Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors.	Journal of neurochemistry	2011	93
21435176	Glucose	Bosco D	Possible implications of insulin resistance and glucose metabolism in Alzheimer's disease pathogenesis.	Journal of cellular and molecular medicine	2011	45
21489811	Glucose	Marino JS	Central insulin and leptin-mediated autonomic control of glucose homeostasis.	Trends in endocrinology and metabolism	2011	40
21569296	Glucose	Cucullo L	The role of shear stress in Blood-Brain Barrier endothelial physiology.	BMC neuroscience	2011	57
21622984	Glucose	Xu L	Phospholipase D mediates nutrient input to mammalian target of rapamycin complex 1 (mTORC1).	The Journal of biological chemistry	2011	43
21633176	Glucose	Gautron L	Sixteen years and counting: an update on leptin in energy balance.	The Journal of clinical investigation	2011	117
21917523	Glucose	Diano S	Mitochondrial uncoupling protein 2 (UCP2) in glucose and lipid metabolism.	Trends in molecular medicine	2012	46
22191795	Glucose	de la Monte SM	Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease.	Drugs	2012	43
22354151	Glucose	del Zoppo GJ	Microglial cell activation is a source of metalloproteinase generation during hemorrhagic transformation.	Journal of cerebral blood flow and metabolism 	2012	37
22500228	Glucose	Duarte AI	Insulin in central nervous system: more than just a peripheral hormone.	Journal of aging research	2012	50
22936011	Glucose	Craft S	Insulin and Alzheimer's disease: untangling the web.	Journal of Alzheimer's disease 	2013	42
22972646	Glucose	Lo RY	Vascular burden and Alzheimer disease pathologic progression.	Neurology	2012	50
23069842	Glucose	Willette AA	Insulin resistance, brain atrophy, and cognitive performance in late middle-aged adults.	Diabetes care	2013	42
23134073	Glucose	Woo YC	Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives.	Clinical endocrinology	2013	47
23146889	Glucose	Varela L	Leptin and insulin pathways in POMC and AgRP neurons that modulate energy balance and glucose homeostasis.	EMBO reports	2012	63
23197693	Glucose	Sato A	Glioma-initiating cell elimination by metformin activation of FOXO3 via AMPK.	Stem cells translational medicine	2012	40
23249272	Glucose	Passos-Silva DG	Angiotensin-(1-7): beyond the cardio-renal actions.	Clinical science	2013	37
23265947	Glucose	Vogt MC	CNS insulin signaling in the control of energy homeostasis and glucose metabolism - from embryo to old age.	Trends in endocrinology and metabolism	2013	39
23332916	Glucose	Martin E	Loss of function of glucocerebrosidase GBA2 is responsible for motor neuron defects in hereditary spastic paraplegia.	American journal of human genetics	2013	32
23542692	Glucose	Dus M	Taste-independent nutrient selection is mediated by a brain-specific Na+ /solute co-transporter in Drosophila.	Nature neuroscience	2013	27
23599929	Glucose	Protas HD	Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease.	JAMA neurology	2013	31
23636237	Glucose	Tanaka T	Genome-wide meta-analysis of observational studies shows common genetic variants associated with macronutrient intake.	The American journal of clinical nutrition	2013	48
23657158	Glucose	Ruiz-Núñez B	Lifestyle and nutritional imbalances associated with Western diseases: causes and consequences of chronic systemic low-grade inflammation in an evolutionary context.	The Journal of nutritional biochemistry	2013	26
23850509	Glucose	Chen Z	Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.	Progress in neurobiology	2013	66
23886976	Glucose	Geurts L	Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.	Beneficial microbes	2014	46
23943882	Glucose	O'Carroll AM	The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis.	The Journal of endocrinology	2013	37
23995067	Glucose	Flavahan WA	Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake.	Nature neuroscience	2013	83
24008734	Glucose	Fann DY	Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke.	Cell death & disease	2013	46
24077098	Glucose	Erickson JR	Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation.	Nature	2013	117
24238363	Glucose	Oh KJ	CREB and FoxO1: two transcription factors for the regulation of hepatic gluconeogenesis.	BMB reports	2013	32
24269021	Glucose	Johnson SC	Amyloid burden and neural function in people at risk for Alzheimer's Disease.	Neurobiology of aging	2014	35
24411018	Glucose	Morris JK	Impaired glycemia increases disease progression in mild cognitive impairment.	Neurobiology of aging	2014	23
24462935	Glucose	Urbanek T	Rapamycin induces of protective autophagy in vascular endothelial cells exposed to oxygen-glucose deprivation.	Brain research	2014	20
24619488	Glucose	Hafez S	Hyperglycemia, acute ischemic stroke, and thrombolytic therapy.	Translational stroke research	2014	22
24708805	Glucose	Sajja RK	Impact of altered glycaemia on blood-brain barrier endothelium: an in vitro study using the hCMEC/D3 cell line.	Fluids and barriers of the CNS	2014	20
24838911	Glucose	Liu Y	APOE genotype and neuroimaging markers of Alzheimer's disease: systematic review and meta-analysis.	Journal of neurology, neurosurgery, and psychiatry	2015	23
24847886	Glucose	Deng D	Crystal structure of the human glucose transporter GLUT1.	Nature	2014	98
24951766	Glucose	Ryan JJ	The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure.	Circulation research	2014	42
24995978	Glucose	Pekkurnaz G	Glucose regulates mitochondrial motility via Milton modification by O-GlcNAc transferase.	Cell	2014	46
25336656	Glucose	Zhu Y	The emerging link between O-GlcNAc and Alzheimer disease.	The Journal of biological chemistry	2014	36
25342129	Glucose	Kapogiannis D	Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer's disease.	FASEB journal 	2015	49
25392482	Glucose	van Praag H	Exercise, energy intake, glucose homeostasis, and the brain.	The Journal of neuroscience 	2014	25
25448601	Glucose	Sekar S	Alzheimer's disease is associated with altered expression of genes involved in immune response and mitochondrial processes in astrocytes.	Neurobiology of aging	2015	25
25476155	Glucose	Reuter B	Effect of simvastatin on MMPs and TIMPs in human brain endothelial cells and experimental stroke.	Translational stroke research	2015	16
25512305	Glucose	Harfmann BD	Circadian rhythms, the molecular clock, and skeletal muscle.	Journal of biological rhythms	2015	17
25580592	Glucose	Fleisher AS	Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional study.	JAMA neurology	2015	29
25621950	Glucose	Fong MY	Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis.	Nature cell biology	2015	93
25662277	Glucose	Kumar Jha P	Circadian rhythms in glucose and lipid metabolism in nocturnal and diurnal mammals.	Molecular and cellular endocrinology	2015	18
25668019	Glucose	Valdearcos M	Hypothalamic inflammation in the control of metabolic function.	Annual review of physiology	2015	25
25796566	Glucose	Perluigi M	mTOR signaling in aging and neurodegeneration: At the crossroad between metabolism dysfunction and impairment of autophagy.	Neurobiology of disease	2015	32
25826432	Glucose	Peake JM	Cytokine expression and secretion by skeletal muscle cells: regulatory mechanisms and exercise effects.	Exercise immunology review	2015	37
25892112	Glucose	Mlynarski EE	Copy-Number Variation of the Glucose Transporter Gene SLC2A3 and Congenital Heart Defects in the 22q11.2 Deletion Syndrome.	American journal of human genetics	2015	21
26214150	Glucose	Willette AA	Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease.	JAMA neurology	2015	36
26373605	Glucose	Portelius E	Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.	Brain 	2015	34
26643952	Glucose	Soriano-Tárraga C	Epigenome-wide association study identifies TXNIP gene associated with type 2 diabetes mellitus and sustained hyperglycemia.	Human molecular genetics	2016	17
26711459	Glucose	Love S	Cerebrovascular disease in ageing and Alzheimer's disease.	Acta neuropathologica	2016	21
26743041	Glucose	Akhtar MW	Elevated glucose and oligomeric β-amyloid disrupt synapses via a common pathway of aberrant protein S-nitrosylation.	Nature communications	2016	15
26786898	Glucose	Kwon O	Leptin signalling pathways in hypothalamic neurons.	Cellular and molecular life sciences 	2016	16
26801191	Glucose	Patching SG	Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.	Molecular neurobiology	2017	7
26813969	Glucose	Rodriguez-Vieitez E	Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease.	Brain 	2016	24
27199291	Glucose	López M	Hypothalamic AMPK: a canonical regulator of whole-body energy balance.	Nature reviews. Endocrinology	2016	15
27233446	Glucose	Abolhassani N	Molecular pathophysiology of impaired glucose metabolism, mitochondrial dysfunction, and oxidative DNA damage in Alzheimer's disease brain.	Mechanisms of ageing and development	2017	6
27591677	Glucose	Talasila KM	The angiogenic switch leads to a metabolic shift in human glioblastoma.	Neuro-oncology	2017	11
27807285	Glucose	Kennedy ME	The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer's disease patients.	Science translational medicine	2016	18
28199306	Glucose	Wolfson RL	KICSTOR recruits GATOR1 to the lysosome and is necessary for nutrients to regulate mTORC1.	Nature	2017	19
28462931	Glucose	Hasel P	Neurons and neuronal activity control gene expression in astrocytes to regulate their development and metabolism.	Nature communications	2017	9
28559417	Glucose	Kleinberger G	The FTD-like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism.	The EMBO journal	2017	6
28846098	Glucose	Emmerson PJ	The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL.	Nature medicine	2017	12
8986209	Ethanol	Volkow ND	Decreases in dopamine receptors but not in dopamine transporters in alcoholics.	Alcoholism, clinical and experimental research	1996	120
9040115	Ethanol	Herz A	Endogenous opioid systems and alcohol addiction.	Psychopharmacology	1997	122
11458532	Ethanol	Weiss F	Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors.	Annals of the New York Academy of Sciences	2001	116
15911795	Ethanol	Enzinger C	Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects.	Neurology	2005	80
15956766	Ethanol	Sulik KK	Genesis of alcohol-induced craniofacial dysmorphism.	Experimental biology and medicine	2005	70
15956769	Ethanol	Goodlett CR	Alcohol teratogenesis: mechanisms of damage and strategies for intervention.	Experimental biology and medicine	2005	96
16573591	Ethanol	Crews FT	Cytokines and alcohol.	Alcoholism, clinical and experimental research	2006	104
17629579	Ethanol	Heilig M	A key role for corticotropin-releasing factor in alcohol dependence.	Trends in neurosciences	2007	202
18077569	Ethanol	Lipsky RH	Brain-derived neurotrophic factor in neuronal survival and behavior-related plasticity.	Annals of the New York Academy of Sciences	2007	71
18190912	Ethanol	He J	Increased MCP-1 and microglia in various regions of the human alcoholic brain.	Experimental neurology	2008	146
18514163	Ethanol	Marsland AL	Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults.	Biological psychiatry	2008	92
18575590	Ethanol	Ancuta P	Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients.	PloS one	2008	198
18940959	Ethanol	Crews FT	Mechanisms of neurodegeneration and regeneration in alcoholism.	Alcohol and alcoholism	2009	165
19157986	Ethanol	Knackstedt LA	Glutamate and reinstatement.	Current opinion in pharmacology	2009	65
20561675	Ethanol	O'Donnell MJ	Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study.	Lancet	2010	439
21091952	Ethanol	Kalaria RN	Vascular basis for brain degeneration: faltering controls and risk factors for dementia.	Nutrition reviews	2010	60
21184583	Ethanol	Zlojutro M	Genome-wide association study of theta band event-related oscillations identifies serotonin receptor gene HTR7 influencing risk of alcohol dependence.	American journal of medical genetics. Part B, Neuropsychiatric genetics 	2011	36
21272009	Ethanol	Crabbe JC	Preclinical studies of alcohol binge drinking.	Annals of the New York Academy of Sciences	2011	59
21402143	Ethanol	Crews FT	Induction of innate immune genes in brain create the neurobiology of addiction.	Brain, behavior, and immunity	2011	97
21471458	Ethanol	Schumann G	Genome-wide association and genetic functional studies identify autism susceptibility candidate 2 gene (AUTS2) in the regulation of alcohol consumption.	Proceedings of the National Academy of Sciences of the United States of America	2011	94
21657944	Ethanol	Alfonso-Loeches S	Molecular and behavioral aspects of the actions of alcohol on the adult and developing brain.	Critical reviews in clinical laboratory sciences	2011	54
21740894	Ethanol	Tuesta LM	Recent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior.	Biochemical pharmacology	2011	41
21878650	Ethanol	Yadav S	miR-497 and miR-302b regulate ethanol-induced neuronal cell death through BCL2 protein and cyclin D2.	The Journal of biological chemistry	2011	50
21985328	Ethanol	Trepanier CH	Regulation of NMDA receptors by the tyrosine kinase Fyn.	The FEBS journal	2012	41
22064162	Ethanol	Edwards AC	Genome-wide association study of comorbid depressive syndrome and alcohol dependence.	Psychiatric genetics	2012	35
22090472	Ethanol	Goebel-Goody SM	Therapeutic implications for striatal-enriched protein tyrosine phosphatase (STEP) in neuropsychiatric disorders.	Pharmacological reviews	2012	51
22459871	Ethanol	Pava MJ	A review of the interactions between alcohol and the endocannabinoid system: implications for alcohol dependence and future directions for research.	Alcohol	2012	37
23206318	Ethanol	Crews FT	High mobility group box 1/Toll-like receptor danger signaling increases brain neuroimmune activation in alcohol dependence.	Biological psychiatry	2013	76
23867237	Ethanol	Vetreno RP	Increased receptor for advanced glycation end product expression in the human alcoholic prefrontal cortex is linked to adolescent drinking.	Neurobiology of disease	2013	45
23919770	Ethanol	Jiang T	Epidemiology and etiology of Alzheimer's disease: from genetic to non-genetic factors.	Current Alzheimer research	2013	27
24275185	Ethanol	Coleman LG Jr	Adolescent binge ethanol treatment alters adult brain regional volumes, cortical extracellular matrix protein and behavioral flexibility.	Pharmacology, biochemistry, and behavior	2014	29
24551070	Ethanol	Zou JY	Release of neuronal HMGB1 by ethanol through decreased HDAC activity activates brain neuroimmune signaling.	PloS one	2014	48
24586787	Ethanol	Kietzman HW	The teratogenic effects of prenatal ethanol exposure are exacerbated by Sonic Hedgehog or GLI2 haploinsufficiency in the mouse.	PloS one	2014	28
25175868	Ethanol	Crews FT	Neuroimmune basis of alcoholic brain damage.	International review of neurobiology	2014	28
25330738	Ethanol	Darcq E	MicroRNA-30a-5p in the prefrontal cortex controls the transition from moderate to excessive alcohol consumption.	Molecular psychiatry	2015	21
25450227	Ethanol	Farris SP	Transcriptome organization for chronic alcohol abuse in human brain.	Molecular psychiatry	2015	26
25672924	Ethanol	Wang R	Effects of vascular risk factors and APOE ε4 on white matter integrity and cognitive decline.	Neurology	2015	20
25787746	Ethanol	Crews FT	Mechanisms of neuroimmune gene induction in alcoholism.	Psychopharmacology	2016	34
25878269	Ethanol	Siciliano CA	Voluntary ethanol intake predicts κ-opioid receptor supersensitivity and regionally distinct dopaminergic adaptations in macaques.	The Journal of neuroscience 	2015	16
25976297	Ethanol	Mantsch JR	Stress-Induced Reinstatement of Drug Seeking: 20 Years of Progress.	Neuropsychopharmacology 	2016	60
26210739	Ethanol	Hasin DS	The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings.	Social psychiatry and psychiatric epidemiology	2015	36
26392368	Ethanol	Schwantes-An TH	Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts.	Behavior genetics	2016	21
26482880	Ethanol	Buch S	A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis.	Nature genetics	2015	35
26549202	Ethanol	Wills TA	Chronic intermittent alcohol disrupts the GluN2B-associated proteome and specifically regulates group I mGlu receptor-dependent long-term depression.	Addiction biology	2017	6
26639834	Ethanol	Borkum JM	Migraine Triggers and Oxidative Stress: A Narrative Review and Synthesis.	Headache	2016	17
26683974	Ethanol	Valenta JP	Chronic Intracerebroventricular Infusion of Monocyte Chemoattractant Protein-1 Leads to a Persistent Increase in Sweetened Ethanol Consumption During Operant Self-Administration But Does Not Influence Sucrose Consumption in Long-Evans Rats.	Alcoholism, clinical and experimental research	2016	11
26695754	Ethanol	Crews FT	Neuroimmune Function and the Consequences of Alcohol Exposure.	Alcohol research 	2015	19
26763658	Ethanol	Wang F	DNA co-methylation modules in postmortem prefrontal cortex tissues of European Australians with alcohol use disorders.	Scientific reports	2016	10
26949123	Ethanol	Rubio-Araiz A	Disruption of blood-brain barrier integrity in postmortem alcoholic brain: preclinical evidence of TLR4 involvement from a binge-like drinking model.	Addiction biology	2017	15
27110438	Ethanol	Dretsch MN	Brain-derived neurotropic factor polymorphisms, traumatic stress, mild traumatic brain injury, and combat exposure contribute to postdeployment traumatic stress.	Brain and behavior	2016	11
27431356	Ethanol	O'Donnell MJ	Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study.	Lancet	2016	48
27531626	Ethanol	Polimanti R	The Interplay Between Risky Sexual Behaviors and Alcohol Dependence: Genome-Wide Association and Neuroimaging Support for LHPP as a Risk Gene.	Neuropsychopharmacology 	2017	7
27650785	Ethanol	Montesinos J	Impact of the Innate Immune Response in the Actions of Ethanol on the Central Nervous System.	Alcoholism, clinical and experimental research	2016	20
28107775	Ethanol	Varga ZV	β-Caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice.	British journal of pharmacology	2018	6
28118842	Ethanol	Coleman LG Jr	Microglial-derived miRNA let-7 and HMGB1 contribute to ethanol-induced neurotoxicity via TLR7.	Journal of neuroinflammation	2017	10
28159648	Ethanol	Crews FT	The role of neuroimmune signaling in alcoholism.	Neuropharmacology	2017	9
28273337	Ethanol	Lawrimore CJ	Ethanol, TLR3, and TLR4 Agonists Have Unique Innate Immune Responses in Neuron-Like SH-SY5Y and Microglia-Like BV2.	Alcoholism, clinical and experimental research	2017	6
8298639	Copper	Bull PC	The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene.	Nature genetics	1993	208
9414160	Copper	Brown DR	The cellular prion protein binds copper in vivo.	Nature	1997	191
12955875	Copper	Ferenci P	Diagnosis and phenotypic classification of Wilson disease.	Liver international 	2003	80
18552350	Copper	Furukawa Y	Complete loss of post-translational modifications triggers fibrillar aggregation of SOD1 in the familial form of amyotrophic lateral sclerosis.	The Journal of biological chemistry	2008	64
19815002	Copper	Volkening K	Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS).	Brain research	2009	57
19862561	Copper	Hung YH	Copper in the brain and Alzheimer's disease.	Journal of biological inorganic chemistry 	2010	48
21647776	Copper	Vašák M	Chemistry and biology of mammalian metallothioneins.	Journal of biological inorganic chemistry 	2011	35
22115751	Copper	Zheng W	Regulation of brain iron and copper homeostasis by brain barrier systems: implication in neurodegenerative diseases.	Pharmacology & therapeutics	2012	40
22307640	Copper	You H	Aβ neurotoxicity depends on interactions between copper ions, prion protein, and N-methyl-D-aspartate receptors.	Proceedings of the National Academy of Sciences of the United States of America	2012	54
22635102	Copper	Bush AI	The metal theory of Alzheimer's disease.	Journal of Alzheimer's disease 	2013	32
23959870	Copper	Singh I	Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance.	Proceedings of the National Academy of Sciences of the United States of America	2013	32
25830219	Copper	Cui L	A PEGylation-Free Biomimetic Porphyrin Nanoplatform for Personalized Cancer Theranostics.	ACS nano	2015	17
26657039	Copper	Kaur SJ	Mutant SOD1 mediated pathogenesis of Amyotrophic Lateral Sclerosis.	Gene	2016	20
7871435	Zinc	Schoenherr CJ	The neuron-restrictive silencer factor (NRSF): a coordinate repressor of multiple neuron-specific genes.	Science	1995	260
8962159	Zinc	Palmiter RD	ZnT-3, a putative transporter of zinc into synaptic vesicles.	Proceedings of the National Academy of Sciences of the United States of America	1996	128
11940666	Zinc	Coquelle FM	LIS1, CLIP-170's key to the dynein/dynactin pathway.	Molecular and cellular biology	2002	81
12875979	Zinc	An WL	Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease.	The American journal of pathology	2003	84
12960961	Zinc	Wang X	Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator.	Nature medicine	2003	129
16354688	Zinc	Filion GJ	A family of human zinc finger proteins that bind methylated DNA and repress transcription.	Molecular and cellular biology	2006	73
16406505	Zinc	Kasper M	GLI transcription factors: mediators of oncogenic Hedgehog signalling.	European journal of cancer	2006	122
18235444	Zinc	Wendt KS	Cohesin mediates transcriptional insulation by CCCTC-binding factor.	Nature	2008	450
18554812	Zinc	Treves A	What is the mammalian dentate gyrus good for?	Neuroscience	2008	83
19339596	Zinc	Deshpande A	A role for synaptic zinc in activity-dependent Abeta oligomer formation and accumulation at excitatory synapses.	The Journal of neuroscience 	2009	67
19701203	Zinc	Han YG	Dual and opposing roles of primary cilia in medulloblastoma development.	Nature medicine	2009	134
20617034	Zinc	Plum LM	The essential toxin: impact of zinc on human health.	International journal of environmental research and public health	2010	67
20974010	Zinc	Lee SJ	Roles of zinc and metallothionein-3 in oxidative stress-induced lysosomal dysfunction, cell death, and autophagy in neurons and astrocytes.	Molecular brain	2010	46
21599891	Zinc	Thirumoorthy N	A review of metallothionein isoforms and their role in pathophysiology.	World journal of surgical oncology	2011	39
22341971	Zinc	Quadri M	Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease.	American journal of human genetics	2012	65
22341972	Zinc	Tuschl K	Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man.	American journal of human genetics	2012	52
23123196	Zinc	Yang W	EGFR-induced and PKCε monoubiquitylation-dependent NF-κB activation upregulates PKM2 expression and promotes tumorigenesis.	Molecular cell	2012	61
24277719	Zinc	Grabrucker S	Zinc deficiency dysregulates the synaptic ProSAP/Shank scaffold and might contribute to autism spectrum disorders.	Brain 	2014	33
24710731	Zinc	Kambe T	Current understanding of ZIP and ZnT zinc transporters in human health and diseases.	Cellular and molecular life sciences 	2014	30
25155142	Zinc	Wild EJ	Targets for future clinical trials in Huntington's disease: what's in the pipeline?	Movement disorders 	2014	39
25162540	Zinc	Tao R	Expression of ZNF804A in human brain and alterations in schizophrenia, bipolar disorder, and major depressive disorder: a novel transcript fetally regulated by the psychosis risk variant rs1344706.	JAMA psychiatry	2014	24
28349823	Zinc	Lv QL	Upregulation of long noncoding RNA zinc finger antisense 1 enhances epithelial-mesenchymal transition in vitro and predicts poor prognosis in glioma.	Tumour biology 	2017	6
28536273	Zinc	Aydemir TB	Metal Transporter Zip14 (Slc39a14) Deletion in Mice Increases Manganese Deposition and Produces Neurotoxic Signatures and Diminished Motor Activity.	The Journal of neuroscience 	2017	6
11438811	Iron	Curtis AR	Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease.	Nature genetics	2001	92
11479594	Iron	Zhou B	A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome.	Nature genetics	2001	126
12510040	Iron	Hayflick SJ	Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome.	The New England journal of medicine	2003	88
16783378	Iron	Morgan NV	PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron.	Nature genetics	2006	101
16908409	Iron	Cheah JH	NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase Dexras1.	Neuron	2006	66
17101452	Iron	Rouault TA	Brain iron metabolism.	Seminars in pediatric neurology	2006	62
17261733	Iron	Hua Y	Brain injury after intracerebral hemorrhage: the role of thrombin and iron.	Stroke	2007	63
17623039	Iron	Uversky VN	Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation.	Journal of neurochemistry	2007	134
18305254	Iron	Shinzawa K	Neuroaxonal dystrophy caused by group VIA phospholipase A2 deficiency in mice: a model of human neurodegenerative disease.	The Journal of neuroscience 	2008	61
18443312	Iron	McNeill A	T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation.	Neurology	2008	52
18570303	Iron	Paisan-Ruiz C	Characterization of PLA2G6 as a locus for dystonia-parkinsonism.	Annals of neurology	2009	75
18799783	Iron	Gregory A	Neurodegeneration associated with genetic defects in phospholipase A(2).	Neurology	2008	63
18981035	Iron	Gregory A	Clinical and genetic delineation of neurodegeneration with brain iron accumulation.	Journal of medical genetics	2009	63
19144359	Iron	Zamboni P	The value of cerebral Doppler venous haemodynamics in the assessment of multiple sclerosis.	Journal of the neurological sciences	2009	50
19457088	Iron	Schipper HM	Heme oxygenase-1 and neurodegeneration: expanding frontiers of engagement.	Journal of neurochemistry	2009	59
19540040	Iron	Bolignano D	Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene.	Cancer letters	2010	47
20398920	Iron	Hastie AT	Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes.	The Journal of allergy and clinical immunology	2010	93
20406573	Iron	Lukowski AF	Iron deficiency in infancy and neurocognitive functioning at 19 years: evidence of long-term deficits in executive function and recognition memory.	Nutritional neuroscience	2010	56
20484814	Iron	Liu M	The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice.	The Journal of clinical investigation	2010	42
20619503	Iron	Paisán-Ruiz C	Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations.	Neurobiology of aging	2012	42
20736190	Iron	Péran P	Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature.	Brain 	2010	90
21981780	Iron	Hartig MB	Absence of an orphan mitochondrial protein, c19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation.	American journal of human genetics	2011	36
22171355	Iron	Bagnato F	Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla.	Brain 	2011	65
22232660	Iron	Jahanshad N	Brain structure in healthy adults is related to serum transferrin and the H63D polymorphism in the HFE gene.	Proceedings of the National Academy of Sciences of the United States of America	2012	40
22266337	Iron	Dusek P	Iron dysregulation in movement disorders.	Neurobiology of disease	2012	32
22306201	Iron	Poulsen HE	RNA modifications by oxidation: a novel disease mechanism?	Free radical biology & medicine	2012	39
23176820	Iron	Haack TB	Exome sequencing reveals de novo WDR45 mutations causing a phenotypically distinct, X-linked dominant form of NBIA.	American journal of human genetics	2012	66
23266600	Iron	Farina M	Metals, oxidative stress and neurodegeneration: a focus on iron, manganese and mercury.	Neurochemistry international	2013	36
23435086	Iron	Saitsu H	De novo mutations in the autophagy gene WDR45 cause static encephalopathy of childhood with neurodegeneration in adulthood.	Nature genetics	2013	76
23474058	Iron	Boeve BF	Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder.	Sleep medicine	2013	41
23537975	Iron	Klip IT	Iron deficiency in chronic heart failure: an international pooled analysis.	American heart journal	2013	36
23687123	Iron	Hayflick SJ	β-Propeller protein-associated neurodegeneration: a new X-linked dominant disorder with brain iron accumulation.	Brain 	2013	33
23843466	Iron	Blazejewska AI	Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI.	Neurology	2013	26
23868451	Iron	Hametner S	Iron and neurodegeneration in the multiple sclerosis brain.	Annals of neurology	2013	65
24334290	Iron	Baker PR 2nd	Variant non ketotic hyperglycinemia is caused by mutations in LIAS, BOLA3 and the novel gene GLRX5.	Brain 	2014	24
24622774	Iron	Schuh C	Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models.	Acta neuropathologica	2014	20
25315861	Iron	Simpson IA	A novel model for brain iron uptake: introducing the concept of regulation.	Journal of cerebral blood flow and metabolism 	2015	20
25734736	Iron	Chey WD	Irritable bowel syndrome: a clinical review.	JAMA	2015	86
25870938	Iron	Arber CE	Review: Insights into molecular mechanisms of disease in neurodegeneration with brain iron accumulation: unifying theories.	Neuropathology and applied neurobiology	2016	15
25988319	Iron	Ayton S	Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE.	Nature communications	2015	23
26461092	Iron	Schonberg DL	Preferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells.	Cancer cell	2015	35
26545340	Iron	Belaidi AA	Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics.	Journal of neurochemistry	2016	22
26894396	Iron	Zhang Z	Microglial Polarization and Inflammatory Mediators After Intracerebral Hemorrhage.	Molecular neurobiology	2017	16
27296779	Iron	Lowe VJ	An autoradiographic evaluation of AV-1451 Tau PET in dementia.	Acta neuropathologica communications	2016	57
7550350	Acetylcholine	Steinlein OK	A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy.	Nature genetics	1995	116
9861036	Acetylcholine	Impagnatiello F	A decrease of reelin expression as a putative vulnerability factor in schizophrenia.	Proceedings of the National Academy of Sciences of the United States of America	1998	165
10759066	Acetylcholine	Paterson D	Neuronal nicotinic receptors in the human brain.	Progress in neurobiology	2000	114
10839541	Acetylcholine	Borovikova LV	Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin.	Nature	2000	603
12097496	Acetylcholine	Gras C	A third vesicular glutamate transporter expressed by cholinergic and serotoninergic neurons.	The Journal of neuroscience 	2002	141
12436423	Acetylcholine	Zhou FM	Cholinergic interneuron characteristics and nicotinic properties in the striatum.	Journal of neurobiology	2002	120
12470124	Acetylcholine	Leonard S	Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia.	Archives of general psychiatry	2002	117
12527804	Acetylcholine	Nelson ME	Alternate stoichiometries of alpha4beta2 nicotinic acetylcholine receptors.	Molecular pharmacology	2003	164
12783266	Acetylcholine	Hogg RC	Nicotinic acetylcholine receptors: from structure to brain function.	Reviews of physiology, biochemistry and pharmacology	2003	104
12805474	Acetylcholine	Terry AV Jr	The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development.	The Journal of pharmacology and experimental therapeutics	2003	106
14766981	Acetylcholine	Gais S	Low acetylcholine during slow-wave sleep is critical for declarative memory consolidation.	Proceedings of the National Academy of Sciences of the United States of America	2004	72
15164017	Acetylcholine	Steinman L	Elaborate interactions between the immune and nervous systems.	Nature immunology	2004	108
15383648	Acetylcholine	Lynch JW	Molecular structure and function of the glycine receptor chloride channel.	Physiological reviews	2004	190
15474976	Acetylcholine	Tuppo EE	The role of inflammation in Alzheimer's disease.	The international journal of biochemistry & cell biology	2005	133
15748848	Acetylcholine	Grudzinska J	The beta subunit determines the ligand binding properties of synaptic glycine receptors.	Neuron	2005	113
15979501	Acetylcholine	Giniatullin R	Desensitization of nicotinic ACh receptors: shaping cholinergic signaling.	Trends in neurosciences	2005	105
16275899	Acetylcholine	Greig NH	Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent.	Proceedings of the National Academy of Sciences of the United States of America	2005	67
17222916	Acetylcholine	Heneka MT	Inflammatory processes in Alzheimer's disease.	Journal of neuroimmunology	2007	171
17349863	Acetylcholine	Martin LF	Schizophrenia and the alpha7 nicotinic acetylcholine receptor.	International review of neurobiology	2007	72
17409234	Acetylcholine	Jones GJ	HIV-1 Vpr causes neuronal apoptosis and in vivo neurodegeneration.	The Journal of neuroscience 	2007	63
17468046	Acetylcholine	McCarley RW	Neurobiology of REM and NREM sleep.	Sleep medicine	2007	106
17597586	Acetylcholine	Gotti C	Heterogeneity and complexity of native brain nicotinic receptors.	Biochemical pharmacology	2007	88
18160701	Acetylcholine	Fink KB	5-HT receptor regulation of neurotransmitter release.	Pharmacological reviews	2007	81
18381563	Acetylcholine	Kuryatov A	Roles of accessory subunits in alpha4beta2(*) nicotinic receptors.	Molecular pharmacology	2008	84
19126755	Acetylcholine	Albuquerque EX	Mammalian nicotinic acetylcholine receptors: from structure to function.	Physiological reviews	2009	403
19641103	Acetylcholine	Martella G	Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine.	Brain 	2009	57
20109142	Acetylcholine	Thomsen MS	Cognitive improvement by activation of alpha7 nicotinic acetylcholine receptors: from animal models to human pathophysiology.	Current pharmaceutical design	2010	49
20472064	Acetylcholine	Panula P	The comparative neuroanatomy and neurochemistry of zebrafish CNS systems of relevance to human neuropsychiatric diseases.	Neurobiology of disease	2010	42
20590830	Acetylcholine	Aosaki T	Acetylcholine-dopamine balance hypothesis in the striatum: an update.	Geriatrics & gerontology international	2010	45
21145918	Acetylcholine	Schliebs R	The cholinergic system in aging and neuronal degeneration.	Behavioural brain research	2011	152
21154909	Acetylcholine	Rudy B	Three groups of interneurons account for nearly 100% of neocortical GABAergic neurons.	Developmental neurobiology	2011	272
21472769	Acetylcholine	Puzzo D	Endogenous amyloid-β is necessary for hippocampal synaptic plasticity and memory.	Annals of neurology	2011	64
21575610	Acetylcholine	Williams DK	Positive allosteric modulators as an approach to nicotinic acetylcholine receptor-targeted therapeutics: advantages and limitations.	Biochemical pharmacology	2011	67
21731134	Acetylcholine	España RA	Sleep neurobiology from a clinical perspective.	Sleep	2011	40
21741954	Acetylcholine	Wallace TL	Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease.	Biochemical pharmacology	2011	47
22348642	Acetylcholine	Loubinoux I	Post-stroke depression: mechanisms, translation and therapy.	Journal of cellular and molecular medicine	2012	47
23641218	Acetylcholine	Hendrickson LM	Neuronal nicotinic acetylcholine receptors: common molecular substrates of nicotine and alcohol dependence.	Frontiers in psychiatry	2013	35
23658161	Acetylcholine	Moran RJ	Free energy, precision and learning: the role of cholinergic neuromodulation.	The Journal of neuroscience 	2013	56
23791072	Acetylcholine	Nakajima S	The potential role of dopamine D₃ receptor neurotransmission in cognition.	European neuropsychopharmacology 	2013	26
24077696	Acetylcholine	Toro L	MaxiK channel and cell signalling.	Pflugers Archiv 	2014	26
24240280	Acetylcholine	Benoit RM	Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin A.	Nature	2014	22
24355708	Acetylcholine	Synofzik M	PNPLA6 mutations cause Boucher-Neuhauser and Gordon Holmes syndromes as part of a broad neurodegenerative spectrum.	Brain 	2014	29
24763339	Acetylcholine	Cho HH	Isl1 directly controls a cholinergic neuronal identity in the developing forebrain and spinal cord by forming cell type-specific complexes.	PLoS genetics	2014	26
25460185	Acetylcholine	Zoli M	Diversity of native nicotinic receptor subtypes in mammalian brain.	Neuropharmacology	2015	30
25639674	Acetylcholine	Dineley KT	Nicotinic ACh receptors as therapeutic targets in CNS disorders.	Trends in pharmacological sciences	2015	46
26314631	Acetylcholine	Puzzo D	The keystone of Alzheimer pathogenesis might be sought in Aβ physiology.	Neuroscience	2015	16
27059884	Acetylcholine	Bonaz B	Anti-inflammatory properties of the vagus nerve: potential therapeutic implications of vagus nerve stimulation.	The Journal of physiology	2016	15
9305631	Adenosine Triphosphate	Takayama S	BAG-1 modulates the chaperone activity of Hsp70/Hsc70.	The EMBO journal	1997	107
9987804	Adenosine Triphosphate	Millan MJ	The induction of pain: an integrative review.	Progress in neurobiology	1999	203
10508238	Adenosine Triphosphate	Lipton P	Ischemic cell death in brain neurons.	Physiological reviews	1999	461
11054482	Adenosine Triphosphate	White BC	Brain ischemia and reperfusion: molecular mechanisms of neuronal injury.	Journal of the neurological sciences	2000	112
11282418	Adenosine Triphosphate	Burnstock G	Purine-mediated signalling in pain and visceral perception.	Trends in pharmacological sciences	2001	88
12535572	Adenosine Triphosphate	Schinkel AH	Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.	Advanced drug delivery reviews	2003	207
14576852	Adenosine Triphosphate	Ambudkar SV	P-glycoprotein: from genomics to mechanism.	Oncogene	2003	169
14713298	Adenosine Triphosphate	Bijur GN	Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3-kinase activation.	Journal of neurochemistry	2003	94
15706348	Adenosine Triphosphate	Kasper D	Loss of the chloride channel ClC-7 leads to lysosomal storage disease and neurodegeneration.	The EMBO journal	2005	71
15717060	Adenosine Triphosphate	Löscher W	Blood-brain barrier active efflux transporters: ATP-binding cassette gene family.	NeuroRx 	2005	111
15831501	Adenosine Triphosphate	David DC	Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice.	The Journal of biological chemistry	2005	81
15845415	Adenosine Triphosphate	Leslie EM	Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.	Toxicology and applied pharmacology	2005	197
15914252	Adenosine Triphosphate	Hanani M	Satellite glial cells in sensory ganglia: from form to function.	Brain research. Brain research reviews	2005	164
16124856	Adenosine Triphosphate	Dean M	Evolution of the ATP-binding cassette (ABC) transporter superfamily in vertebrates.	Annual review of genomics and human genetics	2005	132
16378731	Adenosine Triphosphate	Sultana R	Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach.	Neurobiology of disease	2006	90
16452661	Adenosine Triphosphate	Suadicani SO	P2X7 receptors mediate ATP release and amplification of astrocytic intercellular Ca2+ signaling.	The Journal of neuroscience 	2006	154
16543131	Adenosine Triphosphate	Ishibashi T	Astrocytes promote myelination in response to electrical impulses.	Neuron	2006	179
16685256	Adenosine Triphosphate	Kanmogne GD	HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis.	Journal of cerebral blood flow and metabolism 	2007	81
17322922	Adenosine Triphosphate	Lou H	Targeted therapy for cancer stem cells: the patched pathway and ABC transporters.	Oncogene	2007	62
17360912	Adenosine Triphosphate	Thies E	Missorting of tau in neurons causes degeneration of synapses that can be rescued by the kinase MARK2/Par-1.	The Journal of neuroscience 	2007	85
17938633	Adenosine Triphosphate	Klempan TA	Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression.	Molecular psychiatry	2009	69
18222991	Adenosine Triphosphate	Zanna C	OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion.	Brain 	2008	80
18560012	Adenosine Triphosphate	Miller DS	Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy.	Pharmacological reviews	2008	79
18704197	Adenosine Triphosphate	Lo Bianco C	Hsp104 antagonizes alpha-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease.	The Journal of clinical investigation	2008	60
18816186	Adenosine Triphosphate	Orellana JA	Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration.	Antioxidants & redox signaling	2009	60
18923405	Adenosine Triphosphate	Altar CA	Target identification for CNS diseases by transcriptional profiling.	Neuropsychopharmacology 	2009	49
18991631	Adenosine Triphosphate	Donnelly A	Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocket.	Current medicinal chemistry	2008	74
19240739	Adenosine Triphosphate	Zhao H	Ischemic postconditioning as a novel avenue to protect against brain injury after stroke.	Journal of cerebral blood flow and metabolism 	2009	61
19523516	Adenosine Triphosphate	Serenó L	A novel GSK-3beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo.	Neurobiology of disease	2009	69
19892975	Adenosine Triphosphate	Cartier N	Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy.	Science	2009	382
19948188	Adenosine Triphosphate	Parpura V	Gliotransmission: Exocytotic release from astrocytes.	Brain research reviews	2010	102
20022389	Adenosine Triphosphate	MacVicar BA	Non-junction functions of pannexin-1 channels.	Trends in neurosciences	2010	94
20101004	Adenosine Triphosphate	Hartz AM	Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease.	Molecular pharmacology	2010	66
20513237	Adenosine Triphosphate	Ross-Inta C	Evidence of mitochondrial dysfunction in fragile X-associated tremor/ataxia syndrome.	The Biochemical journal	2010	66
20658967	Adenosine Triphosphate	Halestrap AP	A pore way to die: the role of mitochondria in reperfusion injury and cardioprotection.	Biochemical Society transactions	2010	79
20826314	Adenosine Triphosphate	Nishijima T	Neuronal activity drives localized blood-brain-barrier transport of serum insulin-like growth factor-I into the CNS.	Neuron	2010	57
20880502	Adenosine Triphosphate	Yenari MA	Microglial activation in stroke: therapeutic targets.	Neurotherapeutics 	2010	84
21145355	Adenosine Triphosphate	Reddy PH	Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases.	Brain research reviews	2011	76
21196229	Adenosine Triphosphate	Richard D	Brown fat biology and thermogenesis.	Frontiers in bioscience	2011	60
21250988	Adenosine Triphosphate	Matute C	Glutamate and ATP signalling in white matter pathology.	Journal of anatomy	2011	39
21576264	Adenosine Triphosphate	Zaugg K	Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress.	Genes & development	2011	123
21707071	Adenosine Triphosphate	Shawahna R	Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels.	Molecular pharmaceutics	2011	55
21715610	Adenosine Triphosphate	Eugenin EA	Human immunodeficiency virus infection of human astrocytes disrupts blood-brain barrier integrity by a gap junction-dependent mechanism.	The Journal of neuroscience 	2011	74
21724849	Adenosine Triphosphate	Tan J	Regulation of intracellular manganese homeostasis by Kufor-Rakeb syndrome-associated ATP13A2 protein.	The Journal of biological chemistry	2011	37
21907261	Adenosine Triphosphate	Burnstock G	Purinergic signalling: from normal behaviour to pathological brain function.	Progress in neurobiology	2011	97
21967057	Adenosine Triphosphate	Sharom FJ	The P-glycoprotein multidrug transporter.	Essays in biochemistry	2011	73
22003197	Adenosine Triphosphate	Hoegen T	The NLRP3 inflammasome contributes to brain injury in pneumococcal meningitis and is activated through ATP-dependent lysosomal cathepsin B release.	Journal of immunology	2011	46
22077634	Adenosine Triphosphate	Sheng B	Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease.	Journal of neurochemistry	2012	66
22098950	Adenosine Triphosphate	Nakanishi T	Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression.	Chinese journal of cancer	2012	49
22198378	Adenosine Triphosphate	Gusdon AM	ATP13A2 regulates mitochondrial bioenergetics through macroautophagy.	Neurobiology of disease	2012	39
22436748	Adenosine Triphosphate	Hardie DG	AMPK: a nutrient and energy sensor that maintains energy homeostasis.	Nature reviews. Molecular cell biology	2012	780
22487547	Adenosine Triphosphate	Zhu XH	Quantitative imaging of energy expenditure in human brain.	NeuroImage	2012	33
22525272	Adenosine Triphosphate	Galavotti S	The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells.	Oncogene	2013	55
22544529	Adenosine Triphosphate	Franke H	Pathophysiology of astroglial purinergic signalling.	Purinergic signalling	2012	34
22588883	Adenosine Triphosphate	Vivanco I	Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors.	Cancer discovery	2012	91
22613083	Adenosine Triphosphate	Trang T	Brain-derived neurotrophic factor from microglia: a molecular substrate for neuropathic pain.	Neuron glia biology	2011	43
22647602	Adenosine Triphosphate	Dehay B	Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration.	Proceedings of the National Academy of Sciences of the United States of America	2012	63
22714048	Adenosine Triphosphate	Simard JM	Sulfonylurea receptor 1 in central nervous system injury: a focused review.	Journal of cerebral blood flow and metabolism 	2012	42
22771709	Adenosine Triphosphate	Dahl G	Pannexin: from discovery to bedside in 11±4 years?	Brain research	2012	43
22784115	Adenosine Triphosphate	Srivastava R	Potassium channel KIR4.1 as an immune target in multiple sclerosis.	The New England journal of medicine	2012	80
22892528	Adenosine Triphosphate	Onat OE	Missense mutation in the ATPase, aminophospholipid transporter protein ATP8A2 is associated with cerebellar atrophy and quadrupedal locomotion.	European journal of human genetics 	2013	30
22926141	Adenosine Triphosphate	Manczak M	Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer's disease.	Human molecular genetics	2012	37
23291500	Adenosine Triphosphate	Fujiwara Y	Discovery of a novel type of autophagy targeting RNA.	Autophagy	2013	30
23298398	Adenosine Triphosphate	Strazielle N	Physiology of blood-brain interfaces in relation to brain disposition of small compounds and macromolecules.	Molecular pharmaceutics	2013	34
23374323	Adenosine Triphosphate	Sun AX	MicroRNAs: regulators of neuronal fate.	Current opinion in cell biology	2013	64
23460667	Adenosine Triphosphate	Golebiewska A	Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells.	Brain 	2013	28
23498975	Adenosine Triphosphate	Bartolome F	Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels.	Neuron	2013	38
23518715	Adenosine Triphosphate	Coffey AJ	A genetic study of Wilson's disease in the United Kingdom.	Brain 	2013	31
23571587	Adenosine Triphosphate	Reitz C	Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans.	JAMA	2013	83
23625868	Adenosine Triphosphate	Minkiewicz J	Human astrocytes express a novel NLRP2 inflammasome.	Glia	2013	48
23651857	Adenosine Triphosphate	Hubert CG	Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A.	Genes & development	2013	36
23688078	Adenosine Triphosphate	Choi YH	ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development.	Current pharmaceutical design	2014	42
23716663	Adenosine Triphosphate	Jiang D	Letm1, the mitochondrial Ca2+/H+ antiporter, is essential for normal glucose metabolism and alters brain function in Wolf-Hirschhorn syndrome.	Proceedings of the National Academy of Sciences of the United States of America	2013	26
23776229	Adenosine Triphosphate	Feng S	Canonical transient receptor potential 3 channels regulate mitochondrial calcium uptake.	Proceedings of the National Academy of Sciences of the United States of America	2013	26
23953109	Adenosine Triphosphate	Hertz NT	A neo-substrate that amplifies catalytic activity of parkinson's-disease-related kinase PINK1.	Cell	2013	42
23994581	Adenosine Triphosphate	Rettberg JR	Estrogen: a master regulator of bioenergetic systems in the brain and body.	Frontiers in neuroendocrinology	2014	43
24393808	Adenosine Triphosphate	Akula N	RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms and GTPase binding in bipolar disorder.	Molecular psychiatry	2014	21
24398940	Adenosine Triphosphate	de Rivero Vaccari JP	Activation and regulation of cellular inflammasomes: gaps in our knowledge for central nervous system injury.	Journal of cerebral blood flow and metabolism 	2014	42
24568233	Adenosine Triphosphate	Naeser MA	Significant improvements in cognitive performance post-transcranial, red/near-infrared light-emitting diode treatments in chronic, mild traumatic brain injury: open-protocol study.	Journal of neurotrauma	2014	31
24619111	Adenosine Triphosphate	Götzl JK	Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis.	Acta neuropathologica	2014	38
24652937	Adenosine Triphosphate	Morais VA	PINK1 loss-of-function mutations affect mitochondrial complex I activity via NdufA10 ubiquinone uncoupling.	Science	2014	65
24770881	Adenosine Triphosphate	Nelson PT	ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology.	Acta neuropathologica	2014	23
24777293	Adenosine Triphosphate	Shi L	miR-145 inhibits migration and invasion of glioma stem cells by targeting ABCG2.	Neuromolecular medicine	2014	24
25188341	Adenosine Triphosphate	Beecham GW	Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias.	PLoS genetics	2014	54
25727638	Adenosine Triphosphate	Zorec R	Astrocytic vesicles and gliotransmitters: Slowness of vesicular release and synaptobrevin2-laden vesicle nanoarchitecture.	Neuroscience	2016	10
25920953	Adenosine Triphosphate	Mosienko V	Is L-lactate a novel signaling molecule in the brain?	Journal of cerebral blood flow and metabolism 	2015	21
26519060	Adenosine Triphosphate	Zhai L	Molecular Pathways: Targeting IDO1 and Other Tryptophan Dioxygenases for Cancer Immunotherapy.	Clinical cancer research 	2015	24
26549853	Adenosine Triphosphate	Engel T	ATPergic signalling during seizures and epilepsy.	Neuropharmacology	2016	11
26553936	Adenosine Triphosphate	Harikumar A	Chromatin remodeling and bivalent histone modifications in embryonic stem cells.	EMBO reports	2015	18
26803500	Adenosine Triphosphate	Bhattacharya A	Role of neuro-immunological factors in the pathophysiology of mood disorders.	Psychopharmacology	2016	13
26947070	Adenosine Triphosphate	Cárdenas C	Selective Vulnerability of Cancer Cells by Inhibition of Ca(2+) Transfer from Endoplasmic Reticulum to Mitochondria.	Cell reports	2016	22
27219534	Adenosine Triphosphate	Bhattacharya A	The microglial ATP-gated ion channel P2X7 as a CNS drug target.	Glia	2016	17
27254664	Adenosine Triphosphate	Ali YO	NMNAT2:HSP90 Complex Mediates Proteostasis in Proteinopathies.	PLoS biology	2016	13
27350397	Adenosine Triphosphate	Daulatzai MA	Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.	Journal of neuroscience research	2017	14
27599716	Adenosine Triphosphate	Kim DI	Aβ-Induced Drp1 phosphorylation through Akt activation promotes excessive mitochondrial fission leading to neuronal apoptosis.	Biochimica et biophysica acta	2016	11
28165338	Adenosine Triphosphate	Whittaker DE	The chromatin remodeling factor CHD7 controls cerebellar development by regulating reelin expression.	The Journal of clinical investigation	2017	8
9619147	Amphetamine	Abi-Dargham A	Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort.	The American journal of psychiatry	1998	139
10882542	Amphetamine	Ahima RS	Leptin regulation of neuroendocrine systems.	Frontiers in neuroendocrinology	2000	99
12079865	Amphetamine	Jéquier E	Leptin signaling, adiposity, and energy balance.	Annals of the New York Academy of Sciences	2002	128
12716966	Amphetamine	Mattay VS	Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine.	Proceedings of the National Academy of Sciences of the United States of America	2003	258
14612135	Amphetamine	Rothman RB	Monoamine transporters and psychostimulant drugs.	European journal of pharmacology	2003	116
15728379	Amphetamine	Kahlig KM	Amphetamine induces dopamine efflux through a dopamine transporter channel.	Proceedings of the National Academy of Sciences of the United States of America	2005	82
15950014	Amphetamine	Madras BK	The dopamine transporter and attention-deficit/hyperactivity disorder.	Biological psychiatry	2005	76
16099997	Amphetamine	Fu YS	Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism.	Stem cells	2006	85
16616726	Amphetamine	Munro CA	Sex differences in striatal dopamine release in healthy adults.	Biological psychiatry	2006	86
16971520	Amphetamine	McCoy MK	Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease.	The Journal of neuroscience 	2006	100
18614672	Amphetamine	Mazei-Robison MS	Anomalous dopamine release associated with a human dopamine transporter coding variant.	The Journal of neuroscience 	2008	53
18617632	Amphetamine	Binda F	Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux.	Molecular pharmacology	2008	57
18753372	Amphetamine	Papaleo F	Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice.	The Journal of neuroscience 	2008	103
20798034	Amphetamine	Hargus G	Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats.	Proceedings of the National Academy of Sciences of the United States of America	2010	134
21073468	Amphetamine	Miller GM	The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity.	Journal of neurochemistry	2011	41
22434142	Amphetamine	Gorbatyuk MS	Glucose regulated protein 78 diminishes α-synuclein neurotoxicity in a rat model of Parkinson disease.	Molecular therapy 	2012	40
22514303	Amphetamine	Sakrikar D	Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation.	The Journal of neuroscience 	2012	41
23657438	Amphetamine	Felger JC	Chronic interferon-α decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primates.	Neuropsychopharmacology 	2013	25
24613933	Amphetamine	Ng J	Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood.	Brain 	2014	27
24785761	Amphetamine	van de Giessen E	Dopamine D2/3 receptor availability and amphetamine-induced dopamine release in obesity.	Journal of psychopharmacology	2014	22
24996399	Amphetamine	Berger SM	The role of L-type voltage-gated calcium channels Cav1.2 and Cav1.3 in normal and pathological brain function.	Cell and tissue research	2014	27
26093169	Amphetamine	Paumier KL	Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration.	Neurobiology of disease	2015	41
26171719	Amphetamine	Hryhorczuk C	Dampened Mesolimbic Dopamine Function and Signaling by Saturated but not Monounsaturated Dietary Lipids.	Neuropsychopharmacology 	2016	21
7830766	Dopamine	Tomac A	Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo.	Nature	1995	117
8493557	Dopamine	Lin LF	GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons.	Science	1993	389
8640565	Dopamine	Wilson JM	Striatal dopamine nerve terminal markers in human, chronic methamphetamine users.	Nature medicine	1996	160
9429233	Dopamine	Thompson J	D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele.	Pharmacogenetics	1997	114
9457173	Dopamine	Missale C	Dopamine receptors: from structure to function.	Physiological reviews	1998	553
9651129	Dopamine	Williams SM	Widespread origin of the primate mesofrontal dopamine system.	Cerebral cortex	1998	121
10570493	Dopamine	Piccini P	Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient.	Nature neuroscience	1999	99
10648446	Dopamine	Sabatini U	Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study.	Brain 	2000	98
10689037	Dopamine	Swainson R	Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication.	Neuropsychologia	2000	102
11130742	Dopamine	Zuckerman M	Personality and risk-taking: common biosocial factors.	Journal of personality	2000	124
11160455	Dopamine	Volkow ND	Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain.	The Journal of neuroscience 	2001	111
11229977	Dopamine	Volkow ND	Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.	The American journal of psychiatry	2001	236
11732708	Dopamine	Lisman JE	Storage, recall, and novelty detection of sequences by the hippocampus: elaborating on the SOCRATIC model to account for normal and aberrant effects of dopamine.	Hippocampus	2001	97
11743939	Dopamine	Weinberger DR	Prefrontal neurons and the genetics of schizophrenia.	Biological psychiatry	2001	115
11906697	Dopamine	Mansvelder HD	Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas.	Neuron	2002	218
11923443	Dopamine	Kirik D	Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system.	The Journal of neuroscience 	2002	159
11925305	Dopamine	Malhotra AK	A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition.	The American journal of psychiatry	2002	127
11988175	Dopamine	Pittenger C	Reversible inhibition of CREB/ATF transcription factors in region CA1 of the dorsal hippocampus disrupts hippocampus-dependent spatial memory.	Neuron	2002	129
12042811	Dopamine	Xu J	Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease.	Nature medicine	2002	150
12457396	Dopamine	Mill J	Expression of the dopamine transporter gene is regulated by the 3' UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR.	American journal of medical genetics	2002	85
12587665	Dopamine	Ritchie T	Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics.	Neurochemical research	2003	78
12601150	Dopamine	Kirik D	Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson's disease.	Proceedings of the National Academy of Sciences of the United States of America	2003	89
12669033	Dopamine	Gill SS	Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease.	Nature medicine	2003	193
12773616	Dopamine	Fan J	Mapping the genetic variation of executive attention onto brain activity.	Proceedings of the National Academy of Sciences of the United States of America	2003	86
12953054	Dopamine	Sariola H	Novel functions and signalling pathways for GDNF.	Journal of cell science	2003	134
12963670	Dopamine	Goldberg TE	Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia.	Archives of general psychiatry	2003	153
13679416	Dopamine	Morón JA	Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity.	The Journal of neuroscience 	2003	78
14593166	Dopamine	Dawson TM	Molecular pathways of neurodegeneration in Parkinson's disease.	Science	2003	362
14636960	Dopamine	Koob GF	Neuroadaptive mechanisms of addiction: studies on the extended amygdala.	European neuropsychopharmacology 	2003	89
14642974	Dopamine	Meltzer HY	Serotonin receptors: their key role in drugs to treat schizophrenia.	Progress in neuro-psychopharmacology & biological psychiatry	2003	112
14702260	Dopamine	Diamond A	Genetic and neurochemical modulation of prefrontal cognitive functions in children.	The American journal of psychiatry	2004	80
14744247	Dopamine	Svenningsson P	DARPP-32: an integrator of neurotransmission.	Annual review of pharmacology and toxicology	2004	211
14999077	Dopamine	Spires TL	Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism.	The Journal of neuroscience 	2004	76
15118803	Dopamine	Goldman-Rakic PS	Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction.	Psychopharmacology	2004	115
15263907	Dopamine	Harrison PJ	Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence.	Molecular psychiatry	2005	529
15310843	Dopamine	Perrier AL	Derivation of midbrain dopamine neurons from human embryonic stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2004	250
15457501	Dopamine	Bowirrat A	Relationship between dopaminergic neurotransmission, alcoholism, and Reward Deficiency syndrome.	American journal of medical genetics. Part B, Neuropsychiatric genetics 	2005	71
15502868	Dopamine	Martinat C	Sensitivity to oxidative stress in DJ-1-deficient dopamine neurons: an ES- derived cell model of primary Parkinsonism.	PLoS biology	2004	81
15536184	Dopamine	Zeng X	Dopaminergic differentiation of human embryonic stem cells.	Stem cells	2004	82
15576511	Dopamine	Lo Bianco C	Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease.	Proceedings of the National Academy of Sciences of the United States of America	2004	75
15777250	Dopamine	Nagatsu T	Inflammatory process in Parkinson's disease: role for cytokines.	Current pharmaceutical design	2005	72
15805310	Dopamine	Wood MA	Transgenic mice expressing a truncated form of CREB-binding protein (CBP) exhibit deficits in hippocampal synaptic plasticity and memory storage.	Learning & memory	2005	118
15821730	Dopamine	Meyer-Lindenberg A	Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype.	Nature neuroscience	2005	117
15872020	Dopamine	Mendez I	Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease.	Brain 	2005	108
15917474	Dopamine	Yan Y	Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells.	Stem cells	2005	130
15936806	Dopamine	Gardner EL	Endocannabinoid signaling system and brain reward: emphasis on dopamine.	Pharmacology, biochemistry, and behavior	2005	104
15987937	Dopamine	Sánchez-González MA	The primate thalamus is a key target for brain dopamine.	The Journal of neuroscience 	2005	67
16209725	Dopamine	Depue RA	A neurobehavioral model of affiliative bonding: implications for conceptualizing a human trait of affiliation.	The Behavioral and brain sciences	2005	105
16217123	Dopamine	Dubocovich ML	Functional MT1 and MT2 melatonin receptors in mammals.	Endocrine	2005	97
16227987	Dopamine	LaVoie MJ	Dopamine covalently modifies and functionally inactivates parkin.	Nature medicine	2005	113
16237129	Dopamine	McKeith IG	Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.	Neurology	2005	930
16361025	Dopamine	Tolosa E	The diagnosis of Parkinson's disease.	The Lancet. Neurology	2006	68
16518646	Dopamine	Johanson CE	Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers.	Psychopharmacology	2006	66
16534505	Dopamine	Ebstein RP	The molecular genetic architecture of human personality: beyond self-report questionnaires.	Molecular psychiatry	2006	65
16571765	Dopamine	Leblois A	Competition between feedback loops underlies normal and pathological dynamics in the basal ganglia.	The Journal of neuroscience 	2006	65
16611807	Dopamine	Bertolino A	Additive effects of genetic variation in dopamine regulating genes on working memory cortical activity in human brain.	The Journal of neuroscience 	2006	77
16716201	Dopamine	Savitz J	The molecular genetics of cognition: dopamine, COMT and BDNF.	Genes, brain, and behavior	2006	69
16774975	Dopamine	Li D	Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD).	Human molecular genetics	2006	114
16786032	Dopamine	Meyer-Lindenberg A	Impact of complex genetic variation in COMT on human brain function.	Molecular psychiatry	2006	102
16818870	Dopamine	Brody AL	Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens.	Archives of general psychiatry	2006	76
16908408	Dopamine	Fog JU	Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport.	Neuron	2006	92
16930158	Dopamine	Koob GF	The neurobiology of addiction: a neuroadaptational view relevant for diagnosis.	Addiction	2006	108
16950222	Dopamine	Bertolino A	Prefrontal-hippocampal coupling during memory processing is modulated by COMT val158met genotype.	Biological psychiatry	2006	63
17038668	Dopamine	Sonntag KC	Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist noggin.	Stem cells	2007	71
17049611	Dopamine	Alex KD	Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission.	Pharmacology & therapeutics	2007	112
17050717	Dopamine	Scott DJ	Variations in the human pain stress experience mediated by ventral and dorsal basal ganglia dopamine activity.	The Journal of neuroscience 	2006	81
17055279	Dopamine	Chu Y	Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?	Neurobiology of disease	2007	101
17146014	Dopamine	Drabant EM	Catechol O-methyltransferase val158met genotype and neural mechanisms related to affective arousal and regulation.	Archives of general psychiatry	2006	87
17234596	Dopamine	Puopolo M	Roles of subthreshold calcium current and sodium current in spontaneous firing of mouse midbrain dopamine neurons.	The Journal of neuroscience 	2007	98
17290303	Dopamine	Meyer-Lindenberg A	Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition.	The Journal of clinical investigation	2007	64
17318414	Dopamine	Swanson JM	Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis.	Neuropsychology review	2007	120
17412603	Dopamine	Cantuti-Castelvetri I	Effects of gender on nigral gene expression and parkinson disease.	Neurobiology of disease	2007	57
17499115	Dopamine	Tepper JM	GABAergic control of substantia nigra dopaminergic neurons.	Progress in brain research	2007	60
17507572	Dopamine	Cools R	Impulsive personality predicts dopamine-dependent changes in frontostriatal activity during component processes of working memory.	The Journal of neuroscience 	2007	86
17550429	Dopamine	Balcioglu A	Dopamine release is impaired in a mouse model of DYT1 dystonia.	Journal of neurochemistry	2007	56
17679637	Dopamine	Shaw P	Polymorphisms of the dopamine D4 receptor, clinical outcome, and cortical structure in attention-deficit/hyperactivity disorder.	Archives of general psychiatry	2007	63
17689985	Dopamine	Caldú X	Impact of the COMT Val108/158 Met and DAT genotypes on prefrontal function in healthy subjects.	NeuroImage	2007	62
17720159	Dopamine	Tansey MG	Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention.	Experimental neurology	2007	117
17761882	Dopamine	Kim J	A MicroRNA feedback circuit in midbrain dopamine neurons.	Science	2007	367
17805313	Dopamine	Harrison PJ	Catechol-O-methyltransferase (COMT): a gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders.	Neuropsychopharmacology 	2008	82
17893706	Dopamine	Forbes EE	Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity.	Molecular psychiatry	2009	133
17904601	Dopamine	White LD	New and evolving concepts in the neurotoxicology of lead.	Toxicology and applied pharmacology	2007	75
17913879	Dopamine	Frank MJ	Genetic triple dissociation reveals multiple roles for dopamine in reinforcement learning.	Proceedings of the National Academy of Sciences of the United States of America	2007	172
17956909	Dopamine	Kish SJ	Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease.	Brain 	2008	72
17992686	Dopamine	McCann UD	Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users.	Synapse	2008	71
18037926	Dopamine	Exley R	Presynaptic nicotinic receptors: a dynamic and diverse cholinergic filter of striatal dopamine neurotransmission.	British journal of pharmacology	2008	82
18057197	Dopamine	Tan HY	Catechol-O-methyltransferase Val158Met modulation of prefrontal-parietal-striatal brain systems during arithmetic and temporal transformations in working memory.	The Journal of neuroscience 	2007	58
18063800	Dopamine	Klein TA	Genetically determined differences in learning from errors.	Science	2007	135
18077373	Dopamine	Zhang Y	Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory.	Proceedings of the National Academy of Sciences of the United States of America	2007	129
18178617	Dopamine	Gorbatyuk OS	The phosphorylation state of Ser-129 in human alpha-synuclein determines neurodegeneration in a rat model of Parkinson disease.	Proceedings of the National Academy of Sciences of the United States of America	2008	81
18345022	Dopamine	Thomas MJ	Neuroplasticity in the mesolimbic dopamine system and cocaine addiction.	British journal of pharmacology	2008	155
18497887	Dopamine	Tan HY	Genetic variation in AKT1 is linked to dopamine-associated prefrontal cortical structure and function in humans.	The Journal of clinical investigation	2008	55
18540916	Dopamine	Filbey FM	Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotypes.	Alcoholism, clinical and experimental research	2008	58
18598772	Dopamine	Volkow ND	Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors.	NeuroImage	2008	155
18620336	Dopamine	Durstewitz D	The dual-state theory of prefrontal cortex dopamine function with relevance to catechol-o-methyltransferase genotypes and schizophrenia.	Biological psychiatry	2008	119
18702696	Dopamine	Fleming SM	Olfactory deficits in mice overexpressing human wildtype alpha-synuclein.	The European journal of neuroscience	2008	51
18704100	Dopamine	Franklin TR	DAT genotype modulates brain and behavioral responses elicited by cigarette cues.	Neuropsychopharmacology 	2009	48
18718885	Dopamine	van Winkel R	Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction.	Schizophrenia bulletin	2008	69
18793712	Dopamine	Miller AH	Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface.	Brain, behavior, and immunity	2009	54
18829695	Dopamine	Bertolino A	Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia.	Brain 	2009	50
18927395	Dopamine	Stice E	Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele.	Science	2008	252
18945945	Dopamine	Figlewicz DP	Insulin, leptin, and food reward: update 2008.	American journal of physiology. Regulatory, integrative and comparative physiology	2009	63
19006193	Dopamine	Kordower JH	Transplanted dopaminergic neurons develop PD pathologic changes: a second case report.	Movement disorders 	2008	72
19091889	Dopamine	van de Giessen E	Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3.	Journal of nuclear medicine 	2009	51
19104049	Dopamine	Dreher JC	Variation in dopamine genes influences responsivity of the human reward system.	Proceedings of the National Academy of Sciences of the United States of America	2009	114
19104149	Dopamine	Brochard V	Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease.	The Journal of clinical investigation	2009	191
19164583	Dopamine	Li Y	GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism.	Proceedings of the National Academy of Sciences of the United States of America	2009	109
19179847	Dopamine	Le Foll B	Genetics of dopamine receptors and drug addiction: a comprehensive review.	Behavioural pharmacology	2009	82
19197069	Dopamine	McNab F	Changes in cortical dopamine D1 receptor binding associated with cognitive training.	Science	2009	112
19230552	Dopamine	Braak H	Neuroanatomy and pathology of sporadic Parkinson's disease.	Advances in anatomy, embryology, and cell biology	2009	59
19244517	Dopamine	Joshi PR	Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease.	The Journal of neuroscience 	2009	59
19282821	Dopamine	Davis CA	Dopamine for "wanting" and opioids for "liking": a comparison of obese adults with and without binge eating.	Obesity	2009	77
19295143	Dopamine	Chung CY	Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV alpha-synucleinopathy.	The Journal of neuroscience 	2009	97
19321766	Dopamine	Jocham G	Dopamine DRD2 polymorphism alters reversal learning and associated neural activity.	The Journal of neuroscience 	2009	58
19328819	Dopamine	Stice E	Relation of obesity to consummatory and anticipatory food reward.	Physiology & behavior	2009	69
19409267	Dopamine	Mosharov EV	Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons.	Neuron	2009	139
19410597	Dopamine	Bourque M	Neuroprotective actions of sex steroids in Parkinson's disease.	Frontiers in neuroendocrinology	2009	53
19433789	Dopamine	O'Keeffe GC	Dopamine-induced proliferation of adult neural precursor cells in the mammalian subventricular zone is mediated through EGF.	Proceedings of the National Academy of Sciences of the United States of America	2009	53
19467991	Dopamine	Connor JR	Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome.	Brain 	2009	59
19490899	Dopamine	Enard W	A humanized version of Foxp2 affects cortico-basal ganglia circuits in mice.	Cell	2009	138
19540212	Dopamine	Govind AP	Nicotine-induced upregulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction.	Biochemical pharmacology	2009	81
19571808	Dopamine	Stefansson H	Common variants conferring risk of schizophrenia.	Nature	2009	497
19620978	Dopamine	Frank MJ	Prefrontal and striatal dopaminergic genes predict individual differences in exploration and exploitation.	Nature neuroscience	2009	127
19661443	Dopamine	Gaskill PJ	Human immunodeficiency virus (HIV) infection of human macrophages is increased by dopamine: a bridge between HIV-associated neurologic disorders and drug abuse.	The American journal of pathology	2009	45
19694908	Dopamine	Kitada T	Absence of nigral degeneration in aged parkin/DJ-1/PINK1 triple knockout mice.	Journal of neurochemistry	2009	58
19711116	Dopamine	Jellinger KA	Formation and development of Lewy pathology: a critical update.	Journal of neurology	2009	49
19822738	Dopamine	Krugel LK	Genetic variation in dopaminergic neuromodulation influences the ability to rapidly and flexibly adapt decisions.	Proceedings of the National Academy of Sciences of the United States of America	2009	71
19828788	Dopamine	Brandon NJ	Understanding the role of DISC1 in psychiatric disease and during normal development.	The Journal of neuroscience 	2009	64
19828868	Dopamine	Christine CW	Safety and tolerability of putaminal AADC gene therapy for Parkinson disease.	Neurology	2009	103
19874574	Dopamine	Tabakoff B	Genetical genomic determinants of alcohol consumption in rats and humans.	BMC biology	2009	84
19903734	Dopamine	Tong J	Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.	Brain 	2010	42
19914287	Dopamine	Ghitza UE	Role of BDNF and GDNF in drug reward and relapse: a review.	Neuroscience and biobehavioral reviews	2010	50
19933774	Dopamine	Marek GJ	Glutamatergic (N-methyl-D-aspartate receptor) hypofrontality in schizophrenia: too little juice or a miswired brain?	Molecular pharmacology	2010	43
20048751	Dopamine	Ayhan Y	Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders.	Molecular psychiatry	2011	75
20194823	Dopamine	Kegeles LS	Increased synaptic dopamine function in associative regions of the striatum in schizophrenia.	Archives of general psychiatry	2010	128
20230849	Dopamine	Figlewicz DP	Energy regulatory signals and food reward.	Pharmacology, biochemistry, and behavior	2010	44
20388498	Dopamine	Berridge KC	The tempted brain eats: pleasure and desire circuits in obesity and eating disorders.	Brain research	2010	157
20427663	Dopamine	Bowton E	Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder.	The Journal of neuroscience 	2010	45
20463658	Dopamine	Aarts E	Striatal dopamine mediates the interface between motivational and cognitive control in humans: evidence from genetic imaging.	Neuropsychopharmacology 	2010	43
20479755	Dopamine	Ramchandani VA	A genetic determinant of the striatal dopamine response to alcohol in men.	Molecular psychiatry	2011	98
20534649	Dopamine	Garcia-Reitböck P	SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease.	Brain 	2010	66
20557568	Dopamine	Baskerville TA	Dopamine and oxytocin interactions underlying behaviors: potential contributions to behavioral disorders.	CNS neuroscience & therapeutics	2010	52
20560996	Dopamine	Seeman P	All roads to schizophrenia lead to dopamine supersensitivity and elevated dopamine D2(high) receptors.	CNS neuroscience & therapeutics	2011	51
20592420	Dopamine	Politis M	Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants.	Science translational medicine	2010	60
20614802	Dopamine	Nikolaus S	Cortical GABA, striatal dopamine and midbrain serotonin as the key players in compulsive and anxiety disorders--results from in vivo imaging studies.	Reviews in the neurosciences	2010	52
20659558	Dopamine	Melrose HL	Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice.	Neurobiology of disease	2010	88
20846908	Dopamine	Iranzo A	Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study corrected.	The Lancet. Neurology	2010	50
20858707	Dopamine	Duan H	Selective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3.	The Journal of pharmacology and experimental therapeutics	2010	45
20962241	Dopamine	Stelzel C	Frontostriatal involvement in task switching depends on genetic differences in d2 receptor density.	The Journal of neuroscience 	2010	44
21152952	Dopamine	Domire JS	Dopamine receptor 1 localizes to neuronal cilia in a dynamic process that requires the Bardet-Biedl syndrome proteins.	Cellular and molecular life sciences 	2011	64
21179162	Dopamine	Bevilacqua L	A population-specific HTR2B stop codon predisposes to severe impulsivity.	Nature	2010	55
21349901	Dopamine	O'Sullivan SS	Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours.	Brain 	2011	44
21376232	Dopamine	Shin JH	PARIS (ZNF746) repression of PGC-1α contributes to neurodegeneration in Parkinson's disease.	Cell	2011	255
21397212	Dopamine	Barnes JJ	The molecular genetics of executive function: role of monoamine system genes.	Biological psychiatry	2011	43
21471363	Dopamine	Jacobs E	Estrogen shapes dopamine-dependent cognitive processes: implications for women's health.	The Journal of neuroscience 	2011	76
21488084	Dopamine	Lam HA	Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human α-synuclein.	Journal of neuroscience research	2011	41
21499141	Dopamine	Kim SH	Reduced striatal dopamine D2 receptors in people with Internet addiction.	Neuroreport	2011	47
21508242	Dopamine	Doll BB	Dopaminergic genes predict individual differences in susceptibility to confirmation bias.	The Journal of neuroscience 	2011	58
21514925	Dopamine	Dumontheil I	Influence of the COMT genotype on working memory and brain activity changes during development.	Biological psychiatry	2011	38
21525407	Dopamine	Revel FG	TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity.	Proceedings of the National Academy of Sciences of the United States of America	2011	60
21592779	Dopamine	Enard W	FOXP2 and the role of cortico-basal ganglia circuits in speech and language evolution.	Current opinion in neurobiology	2011	37
21593733	Dopamine	Nikolova YS	Multilocus genetic profile for dopamine signaling predicts ventral striatum reactivity.	Neuropsychopharmacology 	2011	71
21704115	Dopamine	Shiflett MW	Molecular substrates of action control in cortico-striatal circuits.	Progress in neurobiology	2011	40
21712347	Dopamine	Decressac M	GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease.	Brain 	2011	43
21717292	Dopamine	Purohit V	Drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia.	Molecular neurobiology	2011	51
21768599	Dopamine	Ahlskog JE	Does vigorous exercise have a neuroprotective effect in Parkinson disease?	Neurology	2011	53
21802993	Dopamine	Iranzo A	Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.	The Lancet. Neurology	2011	37
21812969	Dopamine	Liu X	Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population.	BMC medical genetics	2011	47
21844870	Dopamine	González S	Dopamine D4 receptor, but not the ADHD-associated D4.7 variant, forms functional heteromers with the dopamine D2S receptor in the brain.	Molecular psychiatry	2012	31
21877920	Dopamine	Sánchez-Danés A	Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of LMX1A in human embryonic stem cells and induced pluripotent stem cells.	Human gene therapy	2012	34
21902800	Dopamine	Carnell S	Neuroimaging and obesity: current knowledge and future directions.	Obesity reviews 	2012	112
21951160	Dopamine	Strathearn L	Maternal neglect: oxytocin, dopamine and the neurobiology of attachment.	Journal of neuroendocrinology	2011	39
22134477	Dopamine	Izquierdo A	Reversal learning as a measure of impulsive and compulsive behavior in addictions.	Psychopharmacology	2012	67
22182688	Dopamine	Decressac M	Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons.	Neurobiology of disease	2012	54
22294258	Dopamine	Fusar-Poli P	Striatal dopamine transporter alterations in ADHD: pathophysiology or adaptation to psychostimulants? A meta-analysis.	The American journal of psychiatry	2012	32
22315428	Dopamine	Lundblad M	Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons.	Proceedings of the National Academy of Sciences of the United States of America	2012	71
22442194	Dopamine	Sclafani A	Role of gut nutrient sensing in stimulating appetite and conditioning food preferences.	American journal of physiology. Regulatory, integrative and comparative physiology	2012	57
22474070	Dopamine	Howes OD	The nature of dopamine dysfunction in schizophrenia and what this means for treatment.	Archives of general psychiatry	2012	171
22539846	Dopamine	Groman SM	Dysregulation of D₂-mediated dopamine transmission in monkeys after chronic escalating methamphetamine exposure.	The Journal of neuroscience 	2012	33
22691454	Dopamine	Savitz JB	Neuroreceptor imaging in depression.	Neurobiology of disease	2013	29
22785313	Dopamine	Lim BK	Anhedonia requires MC4R-mediated synaptic adaptations in nucleus accumbens.	Nature	2012	93
22815523	Dopamine	Stice E	Multilocus genetic composite reflecting dopamine signaling capacity predicts reward circuitry responsivity.	The Journal of neuroscience 	2012	46
22885871	Dopamine	Burkett JP	The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction.	Psychopharmacology	2012	48
23065479	Dopamine	Dale RC	Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders.	Brain 	2012	49
23072726	Dopamine	Felger JC	Tyrosine metabolism during interferon-alpha administration: association with fatigue and CSF dopamine concentrations.	Brain, behavior, and immunity	2013	32
23220632	Dopamine	Decressac M	α-Synuclein-induced down-regulation of Nurr1 disrupts GDNF signaling in nigral dopamine neurons.	Science translational medicine	2012	55
23363473	Dopamine	Rilstone JJ	Brain dopamine-serotonin vesicular transport disease and its treatment.	The New England journal of medicine	2013	28
23380716	Dopamine	Kaye WH	Does a shared neurobiology for foods and drugs of abuse contribute to extremes of food ingestion in anorexia and bulimia nervosa?	Biological psychiatry	2013	32
23395371	Dopamine	MacLeod DA	RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk.	Neuron	2013	138
23468190	Dopamine	Miller AH	Cytokine targets in the brain: impact on neurotransmitters and neurocircuits.	Depression and anxiety	2013	70
23562390	Dopamine	Iranzo A	Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study.	The Lancet. Neurology	2013	62
23568856	Dopamine	Schmitt KC	Nonclassical pharmacology of the dopamine transporter: atypical inhibitors, allosteric modulators, and partial substrates.	The Journal of pharmacology and experimental therapeutics	2013	30
23610405	Dopamine	Decressac M	TFEB-mediated autophagy rescues midbrain dopamine neurons from α-synuclein toxicity.	Proceedings of the National Academy of Sciences of the United States of America	2013	126
23921954	Dopamine	Chefer VI	Kappa opioid receptors on dopaminergic neurons are necessary for kappa-mediated place aversion.	Neuropsychopharmacology 	2013	26
23966584	Dopamine	Kohno M	Risk-taking behavior: dopamine D2/D3 receptors, feedback, and frontolimbic activity.	Cerebral cortex	2015	32
23968837	Dopamine	Gordon EM	Resting-state striato-frontal functional connectivity is sensitive to DAT1 genotype and predicts executive function.	Cerebral cortex	2015	20
24061496	Dopamine	Faraone SV	Functional effects of dopamine transporter gene genotypes on in vivo dopamine transporter functioning: a meta-analysis.	Molecular psychiatry	2014	24
24082145	Dopamine	Janezic S	Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model.	Proceedings of the National Academy of Sciences of the United States of America	2013	51
24267657	Dopamine	den Ouden HE	Dissociable effects of dopamine and serotonin on reversal learning.	Neuron	2013	34
24315443	Dopamine	Miller JD	Human iPSC-based modeling of late-onset disease via progerin-induced aging.	Cell stem cell	2013	146
24375753	Dopamine	Diggs-Andrews KA	Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.	Annals of neurology	2014	23
24411733	Dopamine	Baldan LC	Histidine decarboxylase deficiency causes tourette syndrome: parallel findings in humans and mice.	Neuron	2014	49
24431445	Dopamine	Murphy JA	Phosphorylation of Ser1166 on GluN2B by PKA is critical to synaptic NMDA receptor function and Ca2+ signaling in spines.	The Journal of neuroscience 	2014	33
24654857	Dopamine	Jentsch JD	Dissecting impulsivity and its relationships to drug addictions.	Annals of the New York Academy of Sciences	2014	48
24658464	Dopamine	Li J	Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastoma.	Oncotarget	2014	23
24736453	Dopamine	Cebrián C	MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration.	Nature communications	2014	37
24757112	Dopamine	Halliday GM	The neurobiological basis of cognitive impairment in Parkinson's disease.	Movement disorders 	2014	43
24911152	Dopamine	Hansen FH	Missense dopamine transporter mutations associate with adult parkinsonism and ADHD.	The Journal of clinical investigation	2014	25
24995986	Dopamine	Rothwell PE	Autism-associated neuroligin-3 mutations commonly impair striatal circuits to boost repetitive behaviors.	Cell	2014	81
25124431	Dopamine	Rilling JK	The biology of mammalian parenting and its effect on offspring social development.	Science	2014	76
25127144	Dopamine	Panman L	Sox6 and Otx2 control the specification of substantia nigra and ventral tegmental area dopamine neurons.	Cell reports	2014	20
25128877	Dopamine	Skriver K	Acute exercise improves motor memory: exploring potential biomarkers.	Neurobiology of learning and memory	2014	27
25225386	Dopamine	Schreiweis C	Humanized Foxp2 accelerates learning by enhancing transitions from declarative to procedural performance.	Proceedings of the National Academy of Sciences of the United States of America	2014	27
25251388	Dopamine	Martin I	LRRK2 pathobiology in Parkinson's disease.	Journal of neurochemistry	2014	28
25562824	Dopamine	Cox SM	Striatal D1 and D2 signaling differentially predict learning from positive and negative outcomes.	NeuroImage	2015	26
25772380	Dopamine	Tremblay L	Selective dysfunction of basal ganglia subterritories: From movement to behavioral disorders.	Movement disorders 	2015	24
25788518	Dopamine	Anastasaki C	Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning.	Human molecular genetics	2015	18
25915474	Dopamine	Laguna A	Dopaminergic control of autophagic-lysosomal function implicates Lmx1b in Parkinson's disease.	Nature neuroscience	2015	15
26049025	Dopamine	Kuhn C	Emergence of sex differences in the development of substance use and abuse during adolescence.	Pharmacology & therapeutics	2015	20
26101377	Dopamine	Grattan DR	60 YEARS OF NEUROENDOCRINOLOGY: The hypothalamo-prolactin axis.	The Journal of endocrinology	2015	17
26106146	Dopamine	Arnsten AF	Dopamine's Actions in Primate Prefrontal Cortex: Challenges for Treating Cognitive Disorders.	Pharmacological reviews	2015	17
26552591	Dopamine	Felger JC	Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression.	Molecular psychiatry	2016	36
26601965	Dopamine	Alam Q	Inflammatory Process in Alzheimer's and Parkinson's Diseases: Central Role of Cytokines.	Current pharmaceutical design	2016	16
26616211	Dopamine	Lindholm D	Current disease modifying approaches to treat Parkinson's disease.	Cellular and molecular life sciences 	2016	14
26839413	Dopamine	Mazzulli JR	α-Synuclein-induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models.	Proceedings of the National Academy of Sciences of the United States of America	2016	25
26857251	Dopamine	Ritz BR	Of Pesticides and Men: a California Story of Genes and Environment in Parkinson's Disease.	Current environmental health reports	2016	11
26903621	Dopamine	Hirth N	Convergent evidence from alcohol-dependent humans and rats for a hyperdopaminergic state in protracted abstinence.	Proceedings of the National Academy of Sciences of the United States of America	2016	19
27300435	Dopamine	Dolma S	Inhibition of Dopamine Receptor D4 Impedes Autophagic Flux, Proliferation, and Survival of Glioblastoma Stem Cells.	Cancer cell	2016	18
27514754	Dopamine	Würth R	Phenotypical and Pharmacological Characterization of Stem-Like Cells in Human Pituitary Adenomas.	Molecular neurobiology	2017	5
27523502	Dopamine	Datta D	Altered Expression of ARP2/3 Complex Signaling Pathway Genes in Prefrontal Layer 3 Pyramidal Cells in Schizophrenia.	The American journal of psychiatry	2017	6
27602521	Dopamine	Takeuchi T	Locus coeruleus and dopaminergic consolidation of everyday memory.	Nature	2016	28
27632223	Dopamine	Cilia R	Survival and dementia in GBA-associated Parkinson's disease: The mutation matters.	Annals of neurology	2016	11
27647894	Dopamine	Crittenden JR	Striosome-dendron bouquets highlight a unique striatonigral circuit targeting dopamine-containing neurons.	Proceedings of the National Academy of Sciences of the United States of America	2016	13
27720198	Dopamine	Howes OD	The Role of Genes, Stress, and Dopamine in the Development of Schizophrenia.	Biological psychiatry	2017	20
27813530	Dopamine	Moreines JL	Involvement of Infralimbic Prefrontal Cortex but not Lateral Habenula in Dopamine Attenuation After Chronic Mild Stress.	Neuropsychopharmacology 	2017	7
27956050	Dopamine	Chen C	The exercise-glucocorticoid paradox: How exercise is beneficial to cognition, mood, and the brain while increasing glucocorticoid levels.	Frontiers in neuroendocrinology	2017	6
28386699	Dopamine	Kraehenmann R	Dreamlike effects of LSD on waking imagery in humans depend on serotonin 2A receptor activation.	Psychopharmacology	2017	7
28398344	Dopamine	Rivetti di Val Cervo P	Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson's disease model.	Nature biotechnology	2017	11
16227993	Anticonvulsants	Dzhala VI	NKCC1 transporter facilitates seizures in the developing brain.	Nature medicine	2005	241
16914578	Anticonvulsants	Wen PY	Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08.	Clinical cancer research 	2006	100
17116015	Anticonvulsants	Oby E	The blood-brain barrier and epilepsy.	Epilepsia	2006	82
18367594	Anticonvulsants	Oberheim NA	Loss of astrocytic domain organization in the epileptic brain.	The Journal of neuroscience 	2008	80
20096151	Anticonvulsants	Gauthier S	Management of behavioral problems in Alzheimer's disease.	International psychogeriatrics	2010	44
20716591	Anticonvulsants	Sathornsumetee S	Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant glioma.	Neuro-oncology	2010	52
21416487	Anticonvulsants	Irani SR	Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis.	Annals of neurology	2011	100
21701065	Anticonvulsants	Masino SA	A ketogenic diet suppresses seizures in mice through adenosine A₁ receptors.	The Journal of clinical investigation	2011	73
22705273	Anticonvulsants	Löscher W	Cation-chloride cotransporters NKCC1 and KCC2 as potential targets for novel antiepileptic and antiepileptogenic treatments.	Neuropharmacology	2013	46
23401547	Anticonvulsants	Jiang J	Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammation.	Proceedings of the National Academy of Sciences of the United States of America	2013	44
23773995	Anticonvulsants	Jiao J	Modeling Dravet syndrome using induced pluripotent stem cells (iPSCs) and directly converted neurons.	Human molecular genetics	2013	30
24446952	Anticonvulsants	Rojas A	Cyclooxygenase-2 in epilepsy.	Epilepsia	2014	29
24854329	Anticonvulsants	Devinsky O	Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.	Epilepsia	2014	65
9809557	Bromodeoxyuridine	Eriksson PS	Neurogenesis in the adult human hippocampus.	Nature medicine	1998	1036
10751442	Bromodeoxyuridine	Aberg MA	Peripheral infusion of IGF-I selectively induces neurogenesis in the adult rat hippocampus.	The Journal of neuroscience 	2000	144
10936180	Bromodeoxyuridine	Encinas M	Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells.	Journal of neurochemistry	2000	134
15473967	Bromodeoxyuridine	Feng Y	Mitotic spindle regulation by Nde1 controls cerebral cortical size.	Neuron	2004	142
15684031	Bromodeoxyuridine	Dayer AG	New GABAergic interneurons in the adult neocortex and striatum are generated from different precursors.	The Journal of cell biology	2005	113
17077815	Bromodeoxyuridine	Li Y	Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice.	Journal of cerebral blood flow and metabolism 	2007	65
18059437	Bromodeoxyuridine	Wang CZ	Postnatal phencyclidine administration selectively reduces adult cortical parvalbumin-containing interneurons.	Neuropsychopharmacology 	2008	50
18803808	Bromodeoxyuridine	Yamasaki N	Alpha-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders.	Molecular brain	2008	100
21646517	Bromodeoxyuridine	Kohler SJ	Maturation time of new granule cells in the dentate gyrus of adult macaque monkeys exceeds six months.	Proceedings of the National Academy of Sciences of the United States of America	2011	43
22338017	Bromodeoxyuridine	Christie LA	Impaired cognitive function and hippocampal neurogenesis following cancer chemotherapy.	Clinical cancer research 	2012	44
25028469	Bromodeoxyuridine	Zhang YX	Antiproliferative effects of CDK4/6 inhibition in CDK4-amplified human liposarcoma in vitro and in vivo.	Molecular cancer therapeutics	2014	29
7493923	Cysteine	Leung T	A novel serine/threonine kinase binding the Ras-related RhoA GTPase which translocates the kinase to peripheral membranes.	The Journal of biological chemistry	1995	143
7620916	Cysteine	Zimmer DB	The S100 protein family: history, function, and expression.	Brain research bulletin	1995	126
7958843	Cysteine	Kumar S	Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene ced-3 and the mammalian IL-1 beta-converting enzyme.	Genes & development	1994	120
8242740	Cysteine	Yuan J	The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme.	Cell	1993	352
9177350	Cysteine	Pan Y	Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation.	Nature	1997	111
9697698	Cysteine	Wallace RH	Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel beta1 subunit gene SCN1B.	Nature genetics	1998	168
12930796	Cysteine	Yu FH	Sodium channel beta4, a new disulfide-linked auxiliary subunit with similarity to beta2.	The Journal of neuroscience 	2003	115
14665635	Cysteine	Olzmann JA	Familial Parkinson's disease-associated L166P mutation disrupts DJ-1 protein folding and function.	The Journal of biological chemistry	2004	74
15094120	Cysteine	Bellail AC	Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion.	The international journal of biochemistry & cell biology	2004	124
16362181	Cysteine	Büki A	All roads lead to disconnection?--Traumatic axonal injury revisited.	Acta neurochirurgica	2006	121
18316367	Cysteine	Karch CM	A limited role for disulfide cross-linking in the aggregation of mutant SOD1 linked to familial amyotrophic lateral sclerosis.	The Journal of biological chemistry	2008	50
19342591	Cysteine	Cho DH	S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury.	Science	2009	300
19539236	Cysteine	Chabriat H	Cadasil.	The Lancet. Neurology	2009	135
19567589	Cysteine	Lucio-Eterovic AK	Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy.	Clinical cancer research 	2009	75
20357106	Cysteine	Li X	Aberrant Rab11-dependent trafficking of the neuronal glutamate transporter EAAC1 causes oxidative stress and cell death in Huntington's disease.	The Journal of neuroscience 	2010	56
21820099	Cysteine	Nosková L	Mutations in DNAJC5, encoding cysteine-string protein alpha, cause autosomal-dominant adult-onset neuronal ceroid lipofuscinosis.	American journal of human genetics	2011	79
21844361	Cysteine	Qu J	S-Nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by beta-amyloid peptide.	Proceedings of the National Academy of Sciences of the United States of America	2011	45
22193716	Cysteine	Cohen TJ	Redox signalling directly regulates TDP-43 via cysteine oxidation and disulphide cross-linking.	The EMBO journal	2012	35
22500636	Cysteine	Zhang YQ	Identification of CSPα clients reveals a role in dynamin 1 regulation.	Neuron	2012	38
23649698	Cysteine	Monet-Leprêtre M	Abnormal recruitment of extracellular matrix proteins by excess Notch3 ECD: a new pathomechanism in CADASIL.	Brain 	2013	25
24186977	Cysteine	Ke J	Structure and function of Norrin in assembly and activation of a Frizzled 4-Lrp5/6 complex.	Genes & development	2013	25
24491257	Cysteine	Kimura H	The physiological role of hydrogen sulfide and beyond.	Nitric oxide 	2014	34
25326800	Cysteine	Zhang Z	Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease.	Nature medicine	2014	47
25823923	Cysteine	Qin L	WNT5A promotes stemness characteristics in nasopharyngeal carcinoma cells leading to metastasis and tumorigenesis.	Oncotarget	2015	23
26119044	Cysteine	Gillrie MR	Diverse functional outcomes of Plasmodium falciparum ligation of EPCR: potential implications for malarial pathogenesis.	Cellular microbiology	2015	22
26170293	Cysteine	McGlinchey RP	Cysteine cathepsins are essential in lysosomal degradation of α-synuclein.	Proceedings of the National Academy of Sciences of the United States of America	2015	16
26966189	Cysteine	Herguedas B	Structure and organization of heteromeric AMPA-type glutamate receptors.	Science	2016	23
8402898	Guanosine Triphosphate	Gout I	The GTPase dynamin binds to and is activated by a subset of SH3 domains.	Cell	1993	150
8772201	Guanosine Triphosphate	Nakagawa O	ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice.	FEBS letters	1996	163
10559861	Guanosine Triphosphate	Takei K	Functional partnership between amphiphysin and dynamin in clathrin-mediated endocytosis.	Nature cell biology	1999	194
11856727	Guanosine Triphosphate	Fukuda M	Slac2-a/melanophilin, the missing link between Rab27 and myosin Va: implications of a tripartite protein complex for melanosome transport.	The Journal of biological chemistry	2002	84
15340059	Guanosine Triphosphate	Li Y	Biochemical and functional characterizations of small GTPase Rheb and TSC2 GAP activity.	Molecular and cellular biology	2004	77
15629704	Guanosine Triphosphate	Brown TC	NMDA receptor-dependent activation of the small GTPase Rab5 drives the removal of synaptic AMPA receptors during hippocampal LTD.	Neuron	2005	78
15854902	Guanosine Triphosphate	Long X	Rheb binds and regulates the mTOR kinase.	Current biology 	2005	279
16980962	Guanosine Triphosphate	Smith WW	Kinase activity of mutant LRRK2 mediates neuronal toxicity.	Nature neuroscience	2006	227
17218254	Guanosine Triphosphate	Keays DA	Mutations in alpha-tubulin cause abnormal neuronal migration in mice and lissencephaly in humans.	Cell	2007	128
17928295	Guanosine Triphosphate	Li Y	Bnip3 mediates the hypoxia-induced inhibition on mammalian target of rapamycin by interacting with Rheb.	The Journal of biological chemistry	2007	72
17991864	Guanosine Triphosphate	Bai X	Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38.	Science	2007	126
18497260	Guanosine Triphosphate	Sancak Y	The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1.	Science	2008	736
19299511	Guanosine Triphosphate	Sato T	Specific activation of mTORC1 by Rheb G-protein in vitro involves enhanced recruitment of its substrate protein.	The Journal of biological chemistry	2009	72
20157015	Guanosine Triphosphate	Yu-Wai-Man P	Multi-system neurological disease is common in patients with OPA1 mutations.	Brain 	2010	81
23137377	Guanosine Triphosphate	Ohtsuki S	Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model.	Molecular pharmaceutics	2013	28
24166846	Guanosine Triphosphate	Thomas S	A homozygous PDE6D mutation in Joubert syndrome impairs targeting of farnesylated INPP5E protein to the primary cilium.	Human mutation	2014	33
26067754	Guanosine Triphosphate	Kollareddy M	Regulation of nucleotide metabolism by mutant p53 contributes to its gain-of-function activities.	Nature communications	2015	20
26194181	Guanosine Triphosphate	Kim S	Evidence that the rab5 effector APPL1 mediates APP-βCTF-induced dysfunction of endosomes in Down syndrome and Alzheimer's disease.	Molecular psychiatry	2016	24
7846062	Corticotropin-Releasing Hormone	Lovenberg TW	Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain.	Proceedings of the National Academy of Sciences of the United States of America	1995	134
9854171	Corticotropin-Releasing Hormone	Arborelius L	The role of corticotropin-releasing factor in depression and anxiety disorders.	The Journal of endocrinology	1999	220
10560023	Corticotropin-Releasing Hormone	Koob GF	Corticotropin-releasing factor, norepinephrine, and stress.	Biological psychiatry	1999	130
10816663	Corticotropin-Releasing Hormone	Perrin MH	Corticotropin releasing factor receptors and their ligand family.	Annals of the New York Academy of Sciences	1999	96
11226328	Corticotropin-Releasing Hormone	Reyes TM	Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors.	Proceedings of the National Academy of Sciences of the United States of America	2001	163
11356984	Corticotropin-Releasing Hormone	Sarnyai Z	The role of corticotropin-releasing factor in drug addiction.	Pharmacological reviews	2001	107
11589138	Corticotropin-Releasing Hormone	Champagne F	Like mother, like daughter: evidence for non-genomic transmission of parental behavior and stress responsivity.	Progress in brain research	2001	87
12220880	Corticotropin-Releasing Hormone	Avishai-Eliner S	Stressed-out, or in (utero)?	Trends in neurosciences	2002	108
12377295	Corticotropin-Releasing Hormone	Tsigos C	Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress.	Journal of psychosomatic research	2002	306
12597862	Corticotropin-Releasing Hormone	Cowley MA	The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis.	Neuron	2003	301
12605072	Corticotropin-Releasing Hormone	Koob GF	Alcoholism: allostasis and beyond.	Alcoholism, clinical and experimental research	2003	244
12973355	Corticotropin-Releasing Hormone	Müller MB	Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress.	Nature neuroscience	2003	106
12975524	Corticotropin-Releasing Hormone	Dallman MF	Chronic stress and obesity: a new view of "comfort food".	Proceedings of the National Academy of Sciences of the United States of America	2003	262
14644820	Corticotropin-Releasing Hormone	Mastorakos G	Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum.	Annals of the New York Academy of Sciences	2003	86
14728093	Corticotropin-Releasing Hormone	Nemeroff CB	Neurobiological consequences of childhood trauma.	The Journal of clinical psychiatry	2004	96
14960621	Corticotropin-Releasing Hormone	Merali Z	Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region.	The Journal of neuroscience 	2004	81
15297468	Corticotropin-Releasing Hormone	Heinrichs SC	Corticotropin-releasing factor in brain: a role in activation, arousal, and affect regulation.	The Journal of pharmacology and experimental therapeutics	2004	82
15893820	Corticotropin-Releasing Hormone	Maier SF	Stressor controllability and learned helplessness: the roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor.	Neuroscience and biobehavioral reviews	2005	196
15944067	Corticotropin-Releasing Hormone	Dallman MF	Chronic stress and comfort foods: self-medication and abdominal obesity.	Brain, behavior, and immunity	2005	125
16918397	Corticotropin-Releasing Hormone	Hauger RL	Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets.	CNS & neurological disorders drug targets	2006	105
17083971	Corticotropin-Releasing Hormone	Fekete EM	Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs.	Frontiers in neuroendocrinology	2007	69
17115806	Corticotropin-Releasing Hormone	Davis M	Neural systems involved in fear and anxiety measured with fear-potentiated startle.	The American psychologist	2006	154
18154498	Corticotropin-Releasing Hormone	Koob GF	Addiction and the brain antireward system.	Annual review of psychology	2008	352
18184783	Corticotropin-Releasing Hormone	Land BB	The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system.	The Journal of neuroscience 	2008	199
18255055	Corticotropin-Releasing Hormone	Valentino RJ	Convergent regulation of locus coeruleus activity as an adaptive response to stress.	European journal of pharmacology	2008	110
18651175	Corticotropin-Releasing Hormone	Smith RJ	Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence.	Brain structure & function	2008	84
18653439	Corticotropin-Releasing Hormone	Koob GF	Review. Neurobiological mechanisms for opponent motivational processes in addiction.	Philosophical transactions of the Royal Society of London. Series B, Biological sciences	2008	185
18725236	Corticotropin-Releasing Hormone	Koob GF	Neurobiological substrates for the dark side of compulsivity in addiction.	Neuropharmacology	2009	133
18801471	Corticotropin-Releasing Hormone	Raison CL	Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression.	Biological psychiatry	2009	100
18991954	Corticotropin-Releasing Hormone	Sinha R	Chronic stress, drug use, and vulnerability to addiction.	Annals of the New York Academy of Sciences	2008	315
19332030	Corticotropin-Releasing Hormone	Koob GF	Brain stress systems in the amygdala and addiction.	Brain research	2009	105
19406581	Corticotropin-Releasing Hormone	Lopez-Duran NL	Hypothalamic-pituitary-adrenal axis dysregulation in depressed children and adolescents: a meta-analysis.	Psychoneuroendocrinology	2009	85
19488073	Corticotropin-Releasing Hormone	Chrousos GP	Stress and disorders of the stress system.	Nature reviews. Endocrinology	2009	284
19596121	Corticotropin-Releasing Hormone	Tyrka AR	Interaction of childhood maltreatment with the corticotropin-releasing hormone receptor gene: effects on hypothalamic-pituitary-adrenal axis reactivity.	Biological psychiatry	2009	81
19631614	Corticotropin-Releasing Hormone	Shalev U	Role of CRF and other neuropeptides in stress-induced reinstatement of drug seeking.	Brain research	2010	59
19716811	Corticotropin-Releasing Hormone	Bruchas MR	The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors.	Brain research	2010	150
19912996	Corticotropin-Releasing Hormone	Koob GF	The role of CRF and CRF-related peptides in the dark side of addiction.	Brain research	2010	91
20047160	Corticotropin-Releasing Hormone	Koob GF	Neurobiological mechanisms of addiction: focus on corticotropin-releasing factor.	Current opinion in investigational drugs	2010	52
20405238	Corticotropin-Releasing Hormone	Hammack SE	Roles for pituitary adenylate cyclase-activating peptide (PACAP) expression and signaling in the bed nucleus of the stria terminalis (BNST) in mediating the behavioral consequences of chronic stress.	Journal of molecular neuroscience 	2010	44
20833240	Corticotropin-Releasing Hormone	Aguilera G	HPA axis responsiveness to stress: implications for healthy aging.	Experimental gerontology	2011	36
20881118	Corticotropin-Releasing Hormone	Ivy AS	Hippocampal dysfunction and cognitive impairments provoked by chronic early-life stress involve excessive activation of CRH receptors.	The Journal of neuroscience 	2010	88
20881321	Corticotropin-Releasing Hormone	Stengel A	Corticotropin-releasing factor signaling and visceral response to stress.	Experimental biology and medicine	2010	43
21575632	Corticotropin-Releasing Hormone	Larauche M	Stress and visceral pain: from animal models to clinical therapies.	Experimental neurology	2012	46
21744309	Corticotropin-Releasing Hormone	Koob GF	Theoretical frameworks and mechanistic aspects of alcohol addiction: alcohol addiction as a reward deficit disorder.	Current topics in behavioral neurosciences	2013	99
21907973	Corticotropin-Releasing Hormone	Touma C	FK506 binding protein 5 shapes stress responsiveness: modulation of neuroendocrine reactivity and coping behavior.	Biological psychiatry	2011	48
22386641	Corticotropin-Releasing Hormone	Maras PM	Sculpting the hippocampus from within: stress, spines, and CRH.	Trends in neurosciences	2012	44
22488525	Corticotropin-Releasing Hormone	Bangasser DA	Sex differences in molecular and cellular substrates of stress.	Cellular and molecular neurobiology	2012	39
22992525	Corticotropin-Releasing Hormone	Lemos JC	Severe stress switches CRF action in the nucleus accumbens from appetitive to aversive.	Nature	2012	59
23747571	Corticotropin-Releasing Hormone	Koob GF	Addiction as a stress surfeit disorder.	Neuropharmacology	2014	96
23836029	Corticotropin-Releasing Hormone	Van't Veer A	Role of kappa-opioid receptors in stress and anxiety-related behavior.	Psychopharmacology	2013	64
23939821	Corticotropin-Releasing Hormone	Slominski AT	Key role of CRF in the skin stress response system.	Endocrine reviews	2013	82
24246855	Corticotropin-Releasing Hormone	Handa RJ	Gonadal steroid hormones and the hypothalamo-pituitary-adrenal axis.	Frontiers in neuroendocrinology	2014	53
24456850	Corticotropin-Releasing Hormone	Zorrilla EP	Corticotropin releasing factor: a key role in the neurobiology of addiction.	Frontiers in neuroendocrinology	2014	46
25307567	Corticotropin-Releasing Hormone	Koob GF	Neurocircuitry of alcohol addiction: synthesis from animal models.	Handbook of clinical neurology	2014	24
25402857	Corticotropin-Releasing Hormone	Grieder TE	VTA CRF neurons mediate the aversive effects of nicotine withdrawal and promote intake escalation.	Nature neuroscience	2014	26
25486982	Corticotropin-Releasing Hormone	Gold PW	The organization of the stress system and its dysregulation in depressive illness.	Molecular psychiatry	2015	55
26096838	Corticotropin-Releasing Hormone	Daniel SE	Stress Modulation of Opposing Circuits in the Bed Nucleus of the Stria Terminalis.	Neuropsychopharmacology 	2016	29
7560060	Dexamethasone	Schinkel AH	Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.	The Journal of clinical investigation	1995	122
9626108	Dexamethasone	Rosmond R	Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities.	The Journal of clinical endocrinology and metabolism	1998	135
16214171	Dexamethasone	de Kloet CS	Assessment of HPA-axis function in posttraumatic stress disorder: pharmacological and non-pharmacological challenge tests, a review.	Journal of psychiatric research	2006	86
17236958	Dexamethasone	Gonzalez J	Effect of bevacizumab on radiation necrosis of the brain.	International journal of radiation oncology, biology, physics	2007	67
18275977	Dexamethasone	Nieuwenhuizen AG	The hypothalamic-pituitary-adrenal-axis in the regulation of energy balance.	Physiology & behavior	2008	66
19245695	Dexamethasone	Haram K	The HELLP syndrome: clinical issues and management. A Review.	BMC pregnancy and childbirth	2009	55
19349600	Dexamethasone	Nghiemphu PL	Bevacizumab and chemotherapy for recurrent glioblastoma: a single-institution experience.	Neurology	2009	69
20702575	Dexamethasone	Evanson NK	Fast feedback inhibition of the HPA axis by glucocorticoids is mediated by endocannabinoid signaling.	Endocrinology	2010	67
22740309	Dexamethasone	Melief J	Phenotyping primary human microglia: tight regulation of LPS responsiveness.	Glia	2012	34
23303060	Dexamethasone	Anacker C	Glucocorticoid-related molecular signaling pathways regulating hippocampal neurogenesis.	Neuropsychopharmacology 	2013	38
23406438	Dexamethasone	Menke A	Genetic variation in FKBP5 associated with the extent of stress hormone dysregulation in major depression.	Genes, brain, and behavior	2013	41
26305478	Dexamethasone	Kaminsky Z	Epigenetic and genetic variation at SKA2 predict suicidal behavior and post-traumatic stress disorder.	Translational psychiatry	2015	16
11168837	Glucocorticoids	Welberg LA	Prenatal stress, glucocorticoids and the programming of the brain.	Journal of neuroendocrinology	2001	162
11250914	Glucocorticoids	Seckl JR	Minireview: 11beta-hydroxysteroid dehydrogenase type 1- a tissue-specific amplifier of glucocorticoid action.	Endocrinology	2001	104
12119665	Glucocorticoids	Björntorp P	Do stress reactions cause abdominal obesity and comorbidities?	Obesity reviews 	2001	190
14596810	Glucocorticoids	Herman JP	Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness.	Frontiers in neuroendocrinology	2003	320
15728214	Glucocorticoids	Buckley TM	On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders.	The Journal of clinical endocrinology and metabolism	2005	103
15877308	Glucocorticoids	McEwen BS	Glucocorticoids, depression, and mood disorders: structural remodeling in the brain.	Metabolism	2005	131
16271821	Glucocorticoids	Herman JP	Limbic system mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis.	Progress in neuro-psychopharmacology & biological psychiatry	2005	253
17514590	Glucocorticoids	Chrousos GP	Glucocorticoid action networks and complex psychiatric and/or somatic disorders.	Stress	2007	56
17515892	Glucocorticoids	Seckl JR	Mechanisms of disease: glucocorticoids, their placental metabolism and fetal 'programming' of adult pathophysiology.	Nature clinical practice. Endocrinology & metabolism	2007	119
17965624	Glucocorticoids	Weaver IC	Epigenetic programming by maternal behavior and pharmacological intervention. Nature versus nurture: let's call the whole thing off.	Epigenetics	2007	59
18282566	Glucocorticoids	McEwen BS	Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators.	European journal of pharmacology	2008	293
18440494	Glucocorticoids	Miller GE	A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-kappaB signaling.	Biological psychiatry	2008	147
19926299	Glucocorticoids	Dallman MF	Stress-induced obesity and the emotional nervous system.	Trends in endocrinology and metabolism	2010	123
20106676	Glucocorticoids	Nader N	Interactions of the circadian CLOCK system and the HPA axis.	Trends in endocrinology and metabolism	2010	57
20591431	Glucocorticoids	Harris A	Glucocorticoids, prenatal stress and the programming of disease.	Hormones and behavior	2011	159
20842176	Glucocorticoids	Lightman SL	The crucial role of pulsatile activity of the HPA axis for continuous dynamic equilibration.	Nature reviews. Neuroscience	2010	53
20854893	Glucocorticoids	Bower JE	Fatigue and gene expression in human leukocytes: increased NF-κB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue.	Brain, behavior, and immunity	2011	56
21144857	Glucocorticoids	Wyrwoll CS	11β-hydroxysteroid dehydrogenases and the brain: from zero to hero, a decade of progress.	Frontiers in neuroendocrinology	2011	42
21801830	Glucocorticoids	Pace TW	Increased peripheral NF-κB pathway activity in women with childhood abuse-related posttraumatic stress disorder.	Brain, behavior, and immunity	2012	46
21864867	Glucocorticoids	Peckett AJ	The effects of glucocorticoids on adipose tissue lipid metabolism.	Metabolism	2011	67
22823394	Glucocorticoids	Silverman MN	Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction.	Annals of the New York Academy of Sciences	2012	93
22922121	Glucocorticoids	Gray JD	Dynamic plasticity: the role of glucocorticoids, brain-derived neurotrophic factor and other trophic factors.	Neuroscience	2013	43
22967840	Glucocorticoids	Suri D	Glucocorticoid regulation of brain-derived neurotrophic factor: relevance to hippocampal structural and functional plasticity.	Neuroscience	2013	34
22981834	Glucocorticoids	van Zuiden M	Predicting PTSD: pre-existing vulnerabilities in glucocorticoid-signaling and implications for preventive interventions.	Brain, behavior, and immunity	2013	28
22998948	Glucocorticoids	Reynolds RM	Glucocorticoid excess and the developmental origins of disease: two decades of testing the hypothesis--2012 Curt Richter Award Winner.	Psychoneuroendocrinology	2013	59
23069755	Glucocorticoids	Numakawa T	Brain-derived neurotrophic factor and glucocorticoids: reciprocal influence on the central nervous system.	Neuroscience	2013	36
23164950	Glucocorticoids	Volden PA	The influence of glucocorticoid signaling on tumor progression.	Brain, behavior, and immunity	2013	25
23201972	Glucocorticoids	Klengel T	Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions.	Nature neuroscience	2013	274
23899562	Glucocorticoids	Chapman K	11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.	Physiological reviews	2013	77
24113652	Glucocorticoids	Finsterwald C	Stress and glucocorticoid receptor-dependent mechanisms in long-term memory: from adaptive responses to psychopathologies.	Neurobiology of learning and memory	2014	28
24636458	Glucocorticoids	Spanagel R	Stress and alcohol interactions: animal studies and clinical significance.	Trends in neurosciences	2014	27
25227506	Glucocorticoids	Cruz-Topete D	One hormone, two actions: anti- and pro-inflammatory effects of glucocorticoids.	Neuroimmunomodulation	2015	29
26250598	Glucocorticoids	Zannas AS	Gene-Stress-Epigenetic Regulation of FKBP5: Clinical and Translational Implications.	Neuropsychopharmacology 	2016	22
27065163	Glucocorticoids	Herman JP	Regulation of the Hypothalamic-Pituitary-Adrenocortical Stress Response.	Comprehensive Physiology	2016	26
17183314	Growth Hormone	Niedernhofer LJ	A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis.	Nature	2006	235
11027914	Hydrocortisone	Holsboer F	The corticosteroid receptor hypothesis of depression.	Neuropsychopharmacology 	2000	315
11502812	Hydrocortisone	Vgontzas AN	Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications.	The Journal of clinical endocrinology and metabolism	2001	113
11920153	Hydrocortisone	Gold PW	Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states.	Molecular psychiatry	2002	233
12764120	Hydrocortisone	Benedetti F	Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses.	The Journal of neuroscience 	2003	104
14575731	Hydrocortisone	Kudielka BM	HPA axis responses to laboratory psychosocial stress in healthy elderly adults, younger adults, and children: impact of age and gender.	Psychoneuroendocrinology	2004	127
15039002	Hydrocortisone	Barr CS	Rearing condition and rh5-HTTLPR interact to influence limbic-hypothalamic-pituitary-adrenal axis response to stress in infant macaques.	Biological psychiatry	2004	112
15514410	Hydrocortisone	O'Brien JT	A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects.	The American journal of psychiatry	2004	84
15531540	Hydrocortisone	Spiegel K	Leptin levels are dependent on sleep duration: relationships with sympathovagal balance, carbohydrate regulation, cortisol, and thyrotropin.	The Journal of clinical endocrinology and metabolism	2004	243
17254445	Hydrocortisone	Kremen WS	Genes, environment, and time: the Vietnam Era Twin Study of Aging (VETSA).	Twin research and human genetics 	2006	74
17521871	Hydrocortisone	Carlson LE	One year pre-post intervention follow-up of psychological, immune, endocrine and blood pressure outcomes of mindfulness-based stress reduction (MBSR) in breast and prostate cancer outpatients.	Brain, behavior, and immunity	2007	128
17543357	Hydrocortisone	Adam TC	Stress, eating and the reward system.	Physiology & behavior	2007	246
17945232	Hydrocortisone	Gordis EB	Salivary alpha amylase-cortisol asymmetry in maltreated youth.	Hormones and behavior	2008	55
17958710	Hydrocortisone	Feldman R	Evidence for a neuroendocrinological foundation of human affiliation: plasma oxytocin levels across pregnancy and the postpartum period predict mother-infant bonding.	Psychological science	2007	120
18005940	Hydrocortisone	Gotlib IH	HPA axis reactivity: a mechanism underlying the associations among 5-HTTLPR, stress, and depression.	Biological psychiatry	2008	139
18222063	Hydrocortisone	Choi J	Reduced telomerase activity in human T lymphocytes exposed to cortisol.	Brain, behavior, and immunity	2008	74
18258663	Hydrocortisone	Förster C	Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier.	The Journal of physiology	2008	66
18359186	Hydrocortisone	Witek-Janusek L	Effect of mindfulness based stress reduction on immune function, quality of life and coping in women newly diagnosed with early stage breast cancer.	Brain, behavior, and immunity	2008	82
18521089	Hydrocortisone	Raison CL	Interferon-alpha effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior.	Molecular psychiatry	2010	69
18536531	Hydrocortisone	Oberlander TF	Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses.	Epigenetics	2008	319
18722511	Hydrocortisone	Klehmet J	Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial.	Neuroscience	2009	56
18929315	Hydrocortisone	Van Cauter E	Metabolic consequences of sleep and sleep loss.	Sleep medicine	2008	99
19085093	Hydrocortisone	Maes M	The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression.	Metabolic brain disease	2009	128
19240794	Hydrocortisone	van Leeuwen WM	Sleep restriction increases the risk of developing cardiovascular diseases by augmenting proinflammatory responses through IL-17 and CRP.	PloS one	2009	87
19393990	Hydrocortisone	Yehuda R	Gene expression patterns associated with posttraumatic stress disorder following exposure to the World Trade Center attacks.	Biological psychiatry	2009	81
19433690	Hydrocortisone	Rohleder N	Biologic cost of caring for a cancer patient: dysregulation of pro- and anti-inflammatory signaling pathways.	Journal of clinical oncology 	2009	57
20026350	Hydrocortisone	Clow A	The cortisol awakening response: more than a measure of HPA axis function.	Neuroscience and biobehavioral reviews	2010	81
20227485	Hydrocortisone	O'Donovan A	Clinical anxiety, cortisol and interleukin-6: evidence for specificity in emotion-biology relationships.	Brain, behavior, and immunity	2010	49
20398008	Hydrocortisone	Lange T	Effects of sleep and circadian rhythm on the human immune system.	Annals of the New York Academy of Sciences	2010	73
21508514	Hydrocortisone	Sarapas C	Genetic markers for PTSD risk and resilience among survivors of the World Trade Center attacks.	Disease markers	2011	37
21672499	Hydrocortisone	Mondelli V	Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume.	The Journal of clinical psychiatry	2011	42
21741804	Hydrocortisone	Zohar J	High dose hydrocortisone immediately after trauma may alter the trajectory of PTSD: interplay between clinical and animal studies.	European neuropsychopharmacology 	2011	48
21980503	Hydrocortisone	Charmandari E	Peripheral CLOCK regulates target-tissue glucocorticoid receptor transcriptional activity in a circadian fashion in man.	PloS one	2011	38
22055018	Hydrocortisone	Wikgren M	Short telomeres in depression and the general population are associated with a hypocortisolemic state.	Biological psychiatry	2012	42
22158016	Hydrocortisone	Papakostas GI	Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a pilot and replication study.	Molecular psychiatry	2013	31
22778226	Hydrocortisone	Meyer JS	Minireview: Hair cortisol: a novel biomarker of hypothalamic-pituitary-adrenocortical activity.	Endocrinology	2012	41
22801723	Hydrocortisone	Soares HD	Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease.	Archives of neurology	2012	62
23089630	Hydrocortisone	Lamers F	Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression.	Molecular psychiatry	2013	78
23274505	Hydrocortisone	Mahon PB	Genetic association of FKBP5 and CRHR1 with cortisol response to acute psychosocial stress in healthy adults.	Psychopharmacology	2013	34
24304824	Hydrocortisone	Pagliaccio D	Stress-system genes and life stress predict cortisol levels and amygdala and hippocampal volumes in children.	Neuropsychopharmacology 	2014	29
24439483	Hydrocortisone	Révész D	Dysregulated physiological stress systems and accelerated cellular aging.	Neurobiology of aging	2014	22
24485481	Hydrocortisone	Kaliman P	Rapid changes in histone deacetylases and inflammatory gene expression in expert meditators.	Psychoneuroendocrinology	2014	28
24687146	Hydrocortisone	Breen DP	Sleep and circadian rhythm regulation in early Parkinson disease.	JAMA neurology	2014	46
24722204	Hydrocortisone	Hanin G	Competing targets of microRNA-608 affect anxiety and hypertension.	Human molecular genetics	2014	22
25355243	Hydrocortisone	Vogel S	Blocking the mineralocorticoid receptor in humans prevents the stress-induced enhancement of centromedial amygdala connectivity with the dorsal striatum.	Neuropsychopharmacology 	2015	16
25449699	Hydrocortisone	Schmidt K	Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers.	Psychopharmacology	2015	31
25462896	Hydrocortisone	Skoluda N	Intra-individual psychological and physiological responses to acute laboratory stressors of different intensity.	Psychoneuroendocrinology	2015	17
25563749	Hydrocortisone	Ziegler C	Oxytocin receptor gene methylation: converging multilevel evidence for a role in social anxiety.	Neuropsychopharmacology 	2015	20
25640603	Hydrocortisone	Wright KP Jr	Influence of sleep deprivation and circadian misalignment on cortisol, inflammatory markers, and cytokine balance.	Brain, behavior, and immunity	2015	18
25647344	Hydrocortisone	Schrepf A	Diurnal cortisol and survival in epithelial ovarian cancer.	Psychoneuroendocrinology	2015	16
25875334	Hydrocortisone	Braithwaite EC	Maternal prenatal depressive symptoms predict infant NR3C1 1F and BDNF IV DNA methylation.	Epigenetics	2015	32
26050039	Hydrocortisone	Arloth J	Genetic Differences in the Immediate Transcriptome Response to Stress Predict Risk-Related Brain Function and Psychiatric Disorders.	Neuron	2015	21
26067718	Hydrocortisone	Pivonello R	The Treatment of Cushing's Disease.	Endocrine reviews	2015	24
26291403	Hydrocortisone	Engler H	Men and women differ in inflammatory and neuroendocrine responses to endotoxin but not in the severity of sickness symptoms.	Brain, behavior, and immunity	2016	12
26356039	Hydrocortisone	Incollingo Rodriguez AC	Hypothalamic-pituitary-adrenal axis dysregulation and cortisol activity in obesity: A systematic review.	Psychoneuroendocrinology	2015	18
26361058	Hydrocortisone	Boks MP	SKA2 Methylation is Involved in Cortisol Stress Reactivity and Predicts the Development of Post-Traumatic Stress Disorder (PTSD) After Military Deployment.	Neuropsychopharmacology 	2016	11
26547798	Hydrocortisone	Belvederi Murri M	The HPA axis in bipolar disorder: Systematic review and meta-analysis.	Psychoneuroendocrinology	2016	12
26997371	Hydrocortisone	Houtepen LC	Genome-wide DNA methylation levels and altered cortisol stress reactivity following childhood trauma in humans.	Nature communications	2016	18
9707588	Catecholamines	Gogos JA	Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior.	Proceedings of the National Academy of Sciences of the United States of America	1998	208
12114286	Catecholamines	Elenkov IJ	Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity.	Annals of the New York Academy of Sciences	2002	118
12535946	Catecholamines	Matsumoto M	Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function.	Neuroscience	2003	82
12595695	Catecholamines	Zubieta JK	COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor.	Science	2003	226
16476412	Catecholamines	Tunbridge EM	Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond.	Biological psychiatry	2006	187
16781084	Catecholamines	Black PH	The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.	Medical hypotheses	2006	62
17185007	Catecholamines	Winter B	High impact running improves learning.	Neurobiology of learning and memory	2007	102
17434919	Catecholamines	Arnsten AF	Catecholamine and second messenger influences on prefrontal cortical networks of "representational knowledge": a rational bridge between genetics and the symptoms of mental illness.	Cerebral cortex	2007	68
18591484	Catecholamines	Brennan AR	Neuronal mechanisms underlying attention deficit hyperactivity disorder: the influence of arousal on prefrontal cortical function.	Annals of the New York Academy of Sciences	2008	66
20237240	Catecholamines	Christian CA	The neurobiology of preovulatory and estradiol-induced gonadotropin-releasing hormone surges.	Endocrine reviews	2010	61
22094370	Catecholamines	Jain S	Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis.	Neurobiology of disease	2012	36
22146091	Catecholamines	Pervanidou P	Metabolic consequences of stress during childhood and adolescence.	Metabolism	2012	49
25358781	Catecholamines	Hook V	Human iPSC neurons display activity-dependent neurotransmitter secretion: aberrant catecholamine levels in schizophrenia neurons.	Stem cell reports	2014	32
26406372	Catecholamines	Zeng W	Sympathetic neuro-adipose connections mediate leptin-driven lipolysis.	Cell	2015	39
26883121	Catecholamines	Di Battista AP	Inflammatory cytokine and chemokine profiles are associated with patient outcome and the hyperadrenergic state following acute brain injury.	Journal of neuroinflammation	2016	12
1279431	Oxygen	Shweiki D	Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.	Nature	1992	672
11015506	Oxygen	Costeloe K	The EPICure study: outcomes to discharge from hospital for infants born at the threshold of viability.	Pediatrics	2000	100
11029004	Oxygen	Burmester T	A vertebrate globin expressed in the brain.	Nature	2000	196
11507045	Oxygen	Fukumura D	Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo.	Cancer research	2001	91
11516994	Oxygen	Semenza GL	Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology.	Trends in molecular medicine	2001	162
11927290	Oxygen	Semenza GL	HIF-1 and tumor progression: pathophysiology and therapeutics.	Trends in molecular medicine	2002	183
12379907	Oxygen	Husemann J	Scavenger receptors in neurobiology and neuropathology: their role on microglia and other cells of the nervous system.	Glia	2002	87
12621155	Oxygen	Sun Y	Neuroglobin protects the brain from experimental stroke in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2003	93
12663857	Oxygen	Calvillo L	Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling.	Proceedings of the National Academy of Sciences of the United States of America	2003	88
14572528	Oxygen	Horn NR	Response inhibition and impulsivity: an fMRI study.	Neuropsychologia	2003	119
15073152	Oxygen	Pesah Y	Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress.	Development	2004	133
15152194	Oxygen	Sharp FR	HIF1 and oxygen sensing in the brain.	Nature reviews. Neuroscience	2004	94
15882775	Oxygen	Chong ZZ	Oxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative disease.	Progress in neurobiology	2005	149
16210396	Oxygen	Caspersen C	Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease.	FASEB journal 	2005	208
16483933	Oxygen	Liu L	Hypoxia-induced energy stress regulates mRNA translation and cell growth.	Molecular cell	2006	178
17084552	Oxygen	Blazek ER	Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133- cells, and the CD133+ sector is enlarged by hypoxia.	International journal of radiation oncology, biology, physics	2007	60
17284606	Oxygen	Gruber M	Acute postnatal ablation of Hif-2alpha results in anemia.	Proceedings of the National Academy of Sciences of the United States of America	2007	157
17479184	Oxygen	Frangogiannis NG	Chemokines in ischemia and reperfusion.	Thrombosis and haemostasis	2007	69
17643088	Oxygen	Jain RK	Angiogenesis in brain tumours.	Nature reviews. Neuroscience	2007	335
17962575	Oxygen	Secher NH	Cerebral blood flow and metabolism during exercise: implications for fatigue.	Journal of applied physiology	2008	51
18160646	Oxygen	Boettiger CA	Immediate reward bias in humans: fronto-parietal networks and a role for the catechol-O-methyltransferase 158(Val/Val) genotype.	The Journal of neuroscience 	2007	109
18325636	Oxygen	Fleisher AS	Cerebral perfusion and oxygenation differences in Alzheimer's disease risk.	Neurobiology of aging	2009	66
18439825	Oxygen	Goense JB	Neurophysiology of the BOLD fMRI signal in awake monkeys.	Current biology 	2008	163
18535813	Oxygen	Bidlingmaier S	The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells.	Journal of molecular medicine	2008	83
18675321	Oxygen	Ridder DA	NF-kappaB signaling in cerebral ischemia.	Neuroscience	2009	77
19023125	Oxygen	Potkin SG	A genome-wide association study of schizophrenia using brain activation as a quantitative phenotype.	Schizophrenia bulletin	2009	95
19087196	Oxygen	Amantea D	Post-ischemic brain damage: pathophysiology and role of inflammatory mediators.	The FEBS journal	2009	95
19101265	Oxygen	Slater JP	Cerebral oxygen desaturation predicts cognitive decline and longer hospital stay after cardiac surgery.	The Annals of thoracic surgery	2009	62
19245828	Oxygen	Zawia NH	Epigenetics, oxidative stress, and Alzheimer disease.	Free radical biology & medicine	2009	69
19357304	Oxygen	Filippini N	Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele.	Proceedings of the National Academy of Sciences of the United States of America	2009	499
19372578	Oxygen	McCord AM	Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro.	Molecular cancer research 	2009	70
19441077	Oxygen	Panchision DM	The role of oxygen in regulating neural stem cells in development and disease.	Journal of cellular physiology	2009	78
19686841	Oxygen	Kahle PJ	DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders.	Free radical biology & medicine	2009	79
19718046	Oxygen	Soeda A	Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha.	Oncogene	2009	169
19805328	Oxygen	Kanninen K	Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer's disease.	Proceedings of the National Academy of Sciences of the United States of America	2009	66
19816235	Oxygen	Ballabh P	Intraventricular hemorrhage in premature infants: mechanism of disease.	Pediatric research	2010	84
19909994	Oxygen	Andropoulos DB	Brain immaturity is associated with brain injury before and after neonatal cardiac surgery with high-flow bypass and cerebral oxygenation monitoring.	The Journal of thoracic and cardiovascular surgery	2010	54
20053346	Oxygen	Paakki JJ	Alterations in regional homogeneity of resting-state brain activity in autism spectrum disorders.	Brain research	2010	83
20057496	Oxygen	Zhang D	Disease and the brain's dark energy.	Nature reviews. Neurology	2010	251
20065135	Oxygen	Thambisetty M	APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging.	Archives of neurology	2010	42
20116437	Oxygen	Stice E	Reward circuitry responsivity to food predicts future increases in body mass: moderating effects of DRD2 and DRD4.	NeuroImage	2010	102
20357180	Oxygen	Gottlieb RA	Autophagy in health and disease. 5. Mitophagy as a way of life.	American journal of physiology. Cell physiology	2010	77
20679588	Oxygen	Erk S	Brain function in carriers of a genome-wide supported bipolar disorder variant.	Archives of general psychiatry	2010	48
20921115	Oxygen	Nicodemus KK	Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls.	Archives of general psychiatry	2010	41
21127501	Oxygen	Hjelmeland AB	Acidic stress promotes a glioma stem cell phenotype.	Cell death and differentiation	2011	92
21245297	Oxygen	Hess A	Blockade of TNF-α rapidly inhibits pain responses in the central nervous system.	Proceedings of the National Academy of Sciences of the United States of America	2011	59
21486813	Oxygen	Sato K	The distribution of blood flow in the carotid and vertebral arteries during dynamic exercise in humans.	The Journal of physiology	2011	43
21550379	Oxygen	Jeppesen DK	DNA repair deficiency in neurodegeneration.	Progress in neurobiology	2011	86
21810628	Oxygen	Rasetti R	Altered cortical network dynamics: a potential intermediate phenotype for schizophrenia and association with ZNF804A.	Archives of general psychiatry	2011	56
21836617	Oxygen	Heddleston JM	Hypoxia-induced mixed-lineage leukemia 1 regulates glioma stem cell tumorigenic potential.	Cell death and differentiation	2012	41
21931738	Oxygen	Zotev V	Self-regulation of amygdala activation using real-time FMRI neurofeedback.	PloS one	2011	55
22108059	Oxygen	Caprara C	From oxygen to erythropoietin: relevance of hypoxia for retinal development, health and disease.	Progress in retinal and eye research	2012	40
22885059	Oxygen	Schapiro AC	Shaping of object representations in the human medial temporal lobe based on temporal regularities.	Current biology 	2012	73
22899010	Oxygen	Janiszewska M	Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells.	Genes & development	2012	68
22979952	Oxygen	White MG	FKBP5 and emotional neglect interact to predict individual differences in amygdala reactivity.	Genes, brain, and behavior	2012	41
23240858	Oxygen	Courtney KE	Fronto-striatal functional connectivity during response inhibition in alcohol dependence.	Addiction biology	2013	31
23335372	Oxygen	Drewniak A	Invasive fungal infection and impaired neutrophil killing in human CARD9 deficiency.	Blood	2013	59
23407841	Oxygen	Fani N	FKBP5 and attention bias for threat: associations with hippocampal function and shape.	JAMA psychiatry	2013	43
23589885	Oxygen	Kucharzewska P	Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development.	Proceedings of the National Academy of Sciences of the United States of America	2013	148
23735260	Oxygen	Hacker CD	Resting state network estimation in individual subjects.	NeuroImage	2013	53
24259479	Oxygen	Bilgic B	Fast quantitative susceptibility mapping with L1-regularization and automatic parameter selection.	Magnetic resonance in medicine	2014	22
24281743	Oxygen	Jickling GC	Hemorrhagic transformation after ischemic stroke in animals and humans.	Journal of cerebral blood flow and metabolism 	2014	49
24522549	Oxygen	Gaki GS	Oxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson's disease.	Neuromolecular medicine	2014	22
24595981	Oxygen	Nguyen AQ	Erythropoietin: powerful protection of ischemic and post-ischemic brain.	Experimental biology and medicine	2014	22
24622944	Oxygen	Grimm O	Striatal response to reward anticipation: evidence for a systems-level intermediate phenotype for schizophrenia.	JAMA psychiatry	2014	26
24702246	Oxygen	Gohel SR	Functional integration between brain regions at rest occurs in multiple-frequency bands.	Brain connectivity	2015	30
24835170	Oxygen	Trangmar SJ	Dehydration affects cerebral blood flow but not its metabolic rate for oxygen during maximal exercise in trained humans.	The Journal of physiology	2014	20
24865512	Oxygen	Abdul-Muneer PM	Interactions of oxidative stress and neurovascular inflammation in the pathogenesis of traumatic brain injury.	Molecular neurobiology	2015	36
24956047	Oxygen	Barkhof F	Resting-state functional MR imaging: a new window to the brain.	Radiology	2014	48
25583481	Oxygen	Bartesaghi S	Inhibition of oxidative metabolism leads to p53 genetic inactivation and transformation in neural stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2015	15
25661091	Oxygen	Thornton C	Role of mitochondria in apoptotic and necroptotic cell death in the developing brain.	Clinica chimica acta; international journal of clinical chemistry	2015	15
25791797	Oxygen	van Tellingen O	Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.	Drug resistance updates 	2015	44
26452729	Oxygen	Miners JS	Pathophysiology of Hypoperfusion of the Precuneus in Early Alzheimer's Disease.	Brain pathology	2016	10
26543043	Oxygen	Camici GG	Molecular mechanism of endothelial and vascular aging: implications for cardiovascular disease.	European heart journal	2015	22
26942675	Oxygen	Li X	Mitochondria-Translocated PGK1 Functions as a Protein Kinase to Coordinate Glycolysis and the TCA Cycle in Tumorigenesis.	Molecular cell	2016	19
27321753	Oxygen	Ham PB 3rd	Mitochondrial function in hypoxic ischemic injury and influence of aging.	Progress in neurobiology	2017	17
27769868	Oxygen	Jiang T	Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson's disease and Alzheimer's disease.	Progress in neurobiology	2016	22
27845201	Oxygen	Tarantini S	Impaired neurovascular coupling in aging and Alzheimer's disease: Contribution of astrocyte dysfunction and endothelial impairment to cognitive decline.	Experimental gerontology	2017	13
15082521	Gonadotropin-Releasing Hormone	Millar RP	Gonadotropin-releasing hormone receptors.	Endocrine reviews	2004	112
15452575	Gonadotropin-Releasing Hormone	Sisk CL	The neural basis of puberty and adolescence.	Nature neuroscience	2004	196
17699664	Gonadotropin-Releasing Hormone	Kauffman AS	The kisspeptin receptor GPR54 is required for sexual differentiation of the brain and behavior.	The Journal of neuroscience 	2007	57
18450966	Gonadotropin-Releasing Hormone	d'Anglemont de Tassigny X	Kisspeptin can stimulate gonadotropin-releasing hormone (GnRH) release by a direct action at GnRH nerve terminals.	Endocrinology	2008	66
18708085	Gonadotropin-Releasing Hormone	Naor Z	Signaling by G-protein-coupled receptor (GPCR): studies on the GnRH receptor.	Frontiers in neuroendocrinology	2009	66
19581535	Gonadotropin-Releasing Hormone	Merchant TE	Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: prospective evaluation of cognitive, endocrine, and hearing deficits.	Journal of clinical oncology 	2009	59
20529119	Gonadotropin-Releasing Hormone	Hrabovszky E	The kisspeptin system of the human hypothalamus: sexual dimorphism and relationship with gonadotropin-releasing hormone and neurokinin B neurons.	The European journal of neuroscience	2010	54
20650288	Gonadotropin-Releasing Hormone	Wierman ME	Gonadotropin-releasing hormone (GnRH) neuron migration: initiation, maintenance and cessation as critical steps to ensure normal reproductive function.	Frontiers in neuroendocrinology	2011	42
23738509	Gonadotropin-Releasing Hormone	Abreu AP	Central precocious puberty caused by mutations in the imprinted gene MKRN3.	The New England journal of medicine	2013	52
24056171	Gonadotropin-Releasing Hormone	Thompson IR	GnRH pulse frequency-dependent differential regulation of LH and FSH gene expression.	Molecular and cellular endocrinology	2014	20
25649243	Gonadotropin-Releasing Hormone	Levine JM	Infertility in reproductive-age female cancer survivors.	Cancer	2015	18
26753790	Gonadotropin-Releasing Hormone	Cimino I	Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion.	Nature communications	2016	12
26852255	Gonadotropin-Releasing Hormone	Latronico AC	Causes, diagnosis, and treatment of central precocious puberty.	The lancet. Diabetes & endocrinology	2016	10
27199290	Gonadotropin-Releasing Hormone	Herbison AE	Control of puberty onset and fertility by gonadotropin-releasing hormone neurons.	Nature reviews. Endocrinology	2016	16
3283935	Cholesterol	Mahley RW	Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.	Science	1988	637
8035924	Cholesterol	Breteler MM	Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study.	Neurology	1994	143
9794114	Cholesterol	Pickup JC	Is type II diabetes mellitus a disease of the innate immune system?	Diabetologia	1998	161
10377398	Cholesterol	Lund EG	cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain.	Proceedings of the National Academy of Sciences of the United States of America	1999	108
10701998	Cholesterol	Seidah NG	Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides.	Brain research	1999	145
11264981	Cholesterol	Dietschy JM	Cholesterol metabolism in the brain.	Current opinion in lipidology	2001	166
11692019	Cholesterol	Rost NS	Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study.	Stroke	2001	111
12050382	Cholesterol	Liu NQ	Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogen-activated protein kinase signaling pathway.	Journal of virology	2002	80
12658281	Cholesterol	Puglielli L	Alzheimer's disease: the cholesterol connection.	Nature neuroscience	2003	163
14970312	Cholesterol	Cutler RG	Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease.	Proceedings of the National Academy of Sciences of the United States of America	2004	223
15066264	Cholesterol	Guirland C	Lipid rafts mediate chemotropic guidance of nerve growth cones.	Neuron	2004	70
15269217	Cholesterol	Wahrle SE	ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE.	The Journal of biological chemistry	2004	114
15465426	Cholesterol	Walkley SU	Consequences of NPC1 and NPC2 loss of function in mammalian neurons.	Biochimica et biophysica acta	2004	80
15583033	Cholesterol	Abad-Rodriguez J	Neuronal membrane cholesterol loss enhances amyloid peptide generation.	The Journal of cell biology	2004	71
15699277	Cholesterol	Oei HH	Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study.	Circulation	2005	84
16216937	Cholesterol	Jagust W	Central obesity and the aging brain.	Archives of neurology	2005	69
16314544	Cholesterol	Ballantyne CM	Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.	Archives of internal medicine	2005	66
16565714	Cholesterol	Bosco DA	Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization.	Nature chemical biology	2006	67
16709608	Cholesterol	Dumitrescu AM	Tissue-specific thyroid hormone deprivation and excess in monocarboxylate transporter (mct) 8-deficient mice.	Endocrinology	2006	70
17053810	Cholesterol	Herz J	Reelin, lipoprotein receptors and synaptic plasticity.	Nature reviews. Neuroscience	2006	159
17940007	Cholesterol	DiFiglia M	Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits.	Proceedings of the National Academy of Sciences of the United States of America	2007	129
18410513	Cholesterol	Thirumangalakudi L	High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice.	Journal of neurochemistry	2008	68
18751914	Cholesterol	Adibhatla RM	Altered lipid metabolism in brain injury and disorders.	Sub-cellular biochemistry	2008	78
18987181	Cholesterol	Riddell DR	Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels.	The Journal of neuroscience 	2008	93
18992768	Cholesterol	Rohe HJ	PGRMC1 (progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling, P450 activation and drug binding.	Pharmacology & therapeutics	2009	49
19029462	Cholesterol	Weikert C	Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke.	Circulation	2008	62
19321517	Cholesterol	Manna PR	Regulation of the steroidogenic acute regulatory protein gene expression: present and future perspectives.	Molecular human reproduction	2009	59
19647672	Cholesterol	NP-C Guidelines Working Group.	Recommendations on the diagnosis and management of Niemann-Pick disease type C.	Molecular genetics and metabolism	2009	56
19651157	Cholesterol	Nuutinen T	Clusterin: a forgotten player in Alzheimer's disease.	Brain research reviews	2009	86
19660552	Cholesterol	Liu JP	Cholesterol involvement in the pathogenesis of neurodegenerative diseases.	Molecular and cellular neurosciences	2010	48
19781428	Cholesterol	Förhécz Z	Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state.	American heart journal	2009	90
20170744	Cholesterol	Vance JE	Formation and function of apolipoprotein E-containing lipoproteins in the nervous system.	Biochimica et biophysica acta	2010	41
20213545	Cholesterol	Lund-Katz S	High density lipoprotein structure-function and role in reverse cholesterol transport.	Sub-cellular biochemistry	2010	67
20404173	Cholesterol	Ho AJ	A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly.	Proceedings of the National Academy of Sciences of the United States of America	2010	90
20404913	Cholesterol	Golden E	Circulating brain-derived neurotrophic factor and indices of metabolic and cardiovascular health: data from the Baltimore Longitudinal Study of Aging.	PloS one	2010	50
20444434	Cholesterol	Frisardi V	Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease.	Ageing research reviews	2010	46
20600583	Cholesterol	Batarseh A	Regulation of translocator protein 18 kDa (TSPO) expression in health and disease states.	Molecular and cellular endocrinology	2010	63
20847045	Cholesterol	Lewis TL	Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer disease.	The Journal of biological chemistry	2010	46
21119734	Cholesterol	Rupprecht R	Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders.	Nature reviews. Drug discovery	2010	159
21885853	Cholesterol	Ramirez CM	MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1.	Arteriosclerosis, thrombosis, and vascular biology	2011	62
21900234	Cholesterol	Bate C	Amyloid-β-induced synapse damage is mediated via cross-linkage of cellular prion proteins.	The Journal of biological chemistry	2011	40
22048958	Cholesterol	Maue RA	A novel mouse model of Niemann-Pick type C disease carrying a D1005G-Npc1 mutation comparable to commonly observed human mutations.	Human molecular genetics	2012	32
22130662	Cholesterol	Lee CY	Apolipoprotein E promotes β-amyloid trafficking and degradation by modulating microglial cholesterol levels.	The Journal of biological chemistry	2012	45
22367557	Cholesterol	Cai Z	Roles of AMP-activated protein kinase in Alzheimer's disease.	Neuromolecular medicine	2012	34
22572546	Cholesterol	Patterson MC	Recommendations for the diagnosis and management of Niemann-Pick disease type C: an update.	Molecular genetics and metabolism	2012	89
22922446	Cholesterol	Schon EA	Mitochondria-associated ER membranes in Alzheimer disease.	Molecular and cellular neurosciences	2013	52
23065638	Cholesterol	Vance JE	Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases.	Disease models & mechanisms	2012	48
23296339	Cholesterol	Liu CC	Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy.	Nature reviews. Neurology	2013	318
23585901	Cholesterol	Suzuki T	A randomized controlled trial of multicomponent exercise in older adults with mild cognitive impairment.	PloS one	2013	29
23628605	Cholesterol	Miller WL	Steroid hormone synthesis in mitochondria.	Molecular and cellular endocrinology	2013	41
24013639	Cholesterol	Westra HJ	Systematic identification of trans eQTLs as putative drivers of known disease associations.	Nature genetics	2013	432
24097125	Cholesterol	Park S	The physiological roles of apolipoprotein J/clusterin in metabolic and cardiovascular diseases.	Reviews in endocrine & metabolic disorders	2014	21
24366527	Cholesterol	McKee AC	The neuropathology of sport.	Acta neuropathologica	2014	56
24378418	Cholesterol	Reed B	Associations between serum cholesterol levels and cerebral amyloidosis.	JAMA neurology	2014	36
24559670	Cholesterol	Kanekiyo T	ApoE and Aβ in Alzheimer's disease: accidental encounters or partners?	Neuron	2014	83
24633158	Cholesterol	Holmen OL	Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk.	Nature genetics	2014	57
24970568	Cholesterol	Morris MC	Dietary fat composition and dementia risk.	Neurobiology of aging	2014	28
25425283	Cholesterol	Vanier MT	Complex lipid trafficking in Niemann-Pick disease type C.	Journal of inherited metabolic disease	2015	33
25871773	Cholesterol	Hu J	Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice.	Molecular neurodegeneration	2015	19
26049157	Cholesterol	Hoefer IE	Novel methodologies for biomarker discovery in atherosclerosis.	European heart journal	2015	18
27174096	Cholesterol	Mahley RW	Central Nervous System Lipoproteins: ApoE and Regulation of Cholesterol Metabolism.	Arteriosclerosis, thrombosis, and vascular biology	2016	18
27540175	Cholesterol	Franzén O	Cardiometabolic risk loci share downstream cis- and trans-gene regulation across tissues and diseases.	Science	2016	25
17498507	Cholecystokinin	Wren AM	Gut hormones and appetite control.	Gastroenterology	2007	84
17920013	Cholecystokinin	Freund TF	Perisomatic inhibition.	Neuron	2007	214
18061414	Cholecystokinin	Valassi E	Neuroendocrine control of food intake.	Nutrition, metabolism, and cardiovascular diseases 	2008	95
18402643	Cholecystokinin	Berthoud HR	Vagal and hormonal gut-brain communication: from satiation to satisfaction.	Neurogastroenterology and motility 	2008	66
19741117	Cholecystokinin	Daw MI	Asynchronous transmitter release from cholecystokinin-containing inhibitory interneurons is widespread and target-cell independent.	The Journal of neuroscience 	2009	63
22157397	Cholecystokinin	Dockray GJ	Cholecystokinin.	Current opinion in endocrinology, diabetes, and obesity	2012	31
22429904	Cholecystokinin	Bowers ME	Neuropeptide regulation of fear and anxiety: Implications of cholecystokinin, endogenous opioids, and neuropeptide Y.	Physiology & behavior	2012	30
24183705	Cholecystokinin	Trouche S	Fear extinction causes target-specific remodeling of perisomatic inhibitory synapses.	Neuron	2013	36
26683796	Cholecystokinin	Mishra AK	Obesity: An overview of possible role(s) of gut hormones, lipid sensing and gut microbiota.	Metabolism	2016	15
27419272	Cholecystokinin	Bandelow B	Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition.	The world journal of biological psychiatry 	2017	6
8651649	Methionine	Parchi P	Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease.	Annals of neurology	1996	139
10443888	Methionine	Parchi P	Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects.	Annals of neurology	1999	224
12553913	Methionine	Egan MF	The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function.	Cell	2003	777
15128854	Methionine	Chen ZY	Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons.	The Journal of neuroscience 	2004	188
15302196	Methionine	Peden AH	Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient.	Lancet	2004	147
15901785	Methionine	Blasi G	Effect of catechol-O-methyltransferase val158met genotype on attentional control.	The Journal of neuroscience 	2005	96
15987945	Methionine	Chen ZY	Sortilin controls intracellular sorting of brain-derived neurotrophic factor to the regulated secretory pathway.	The Journal of neuroscience 	2005	104
16517609	Methionine	Choi J	Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases.	The Journal of biological chemistry	2006	115
16818862	Methionine	Ho BC	Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.	Archives of general psychiatry	2006	64
16869232	Methionine	Bath KG	Variant BDNF (Val66Met) impact on brain structure and function.	Cognitive, affective & behavioral neuroscience	2006	76
17217930	Methionine	Gratacòs M	Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia.	Biological psychiatry	2007	85
17369310	Methionine	Ohlson J	Editing modifies the GABA(A) receptor subunit alpha3.	RNA	2007	82
18413375	Methionine	Terakawa Y	Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy.	Journal of nuclear medicine 	2008	57
19854267	Methionine	Butterfield DA	In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid beta-peptide of APP.	Free radical biology & medicine	2010	52
20070383	Methionine	Peden A	Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia.	Haemophilia 	2010	43
20695009	Methionine	Zou WQ	Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein.	Annals of neurology	2010	49
21577214	Methionine	Gerritsen L	BDNF Val66Met genotype modulates the effect of childhood adversity on subgenual anterior cingulate cortex volume in healthy subjects.	Molecular psychiatry	2012	33
21727254	Methionine	Lyoo IK	The neurobiological role of the dorsolateral prefrontal cortex in recovery from trauma. Longitudinal brain imaging study among survivors of the South Korean subway disaster.	Archives of general psychiatry	2011	35
22138198	Methionine	Witte AV	Effects of COMT polymorphisms on brain function and behavior in health and disease.	Brain research bulletin	2012	37
23539183	Methionine	Lewis PW	Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma.	Science	2013	226
24699458	Methionine	Watts JC	Evidence that bank vole PrP is a universal acceptor for prions.	PLoS pathogens	2014	23
25525250	Methionine	Funato K	Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation.	Science	2014	60
27121947	Methionine	Justin N	Structural basis of oncogenic histone H3K27M inhibition of human polycomb repressive complex 2.	Nature communications	2016	42
28263307	Methionine	Piunti A	Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas.	Nature medicine	2017	16
28263309	Methionine	Mohammad F	EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas.	Nature medicine	2017	17
12151749	Nicotine	Picciotto MR	Effect of nicotine and nicotinic receptors on anxiety and depression.	Neuroreport	2002	96
15944384	Nicotine	Vallejo YF	Chronic nicotine exposure upregulates nicotinic receptors by a novel mechanism.	The Journal of neuroscience 	2005	73
17503330	Nicotine	Lou XY	A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence.	American journal of human genetics	2007	165
18690555	Nicotine	Kenney JW	Modulation of hippocampus-dependent learning and synaptic plasticity by nicotine.	Molecular neurobiology	2008	89
19270530	Nicotine	Hung SY	Autophagy protects neuron from Abeta-induced cytotoxicity.	Autophagy	2009	47
20400469	Nicotine	Jackson KJ	Role of alpha5 nicotinic acetylcholine receptors in pharmacological and behavioral effects of nicotine in mice.	The Journal of pharmacology and experimental therapeutics	2010	58
20584212	Nicotine	Saccone NL	Multiple cholinergic nicotinic receptor genes affect nicotine dependence risk in African and European Americans.	Genes, brain, and behavior	2010	50
20700436	Nicotine	Saccone NL	Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD.	PLoS genetics	2010	190
21576462	Nicotine	Ray R	Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers.	Proceedings of the National Academy of Sciences of the United States of America	2011	37
21795541	Nicotine	McGranahan TM	α4β2 nicotinic acetylcholine receptors on dopaminergic neurons mediate nicotine reward and anxiety relief.	The Journal of neuroscience 	2011	45
22315316	Nicotine	Martínez de Morentin PB	Nicotine induces negative energy balance through hypothalamic AMP-activated protein kinase.	Diabetes	2012	40
23143843	Nicotine	Picciotto MR	Molecular mechanisms underlying behaviors related to nicotine addiction.	Cold Spring Harbor perspectives in medicine	2013	45
24296975	Nicotine	Morel C	Nicotine consumption is regulated by a human polymorphism in dopamine neurons.	Molecular psychiatry	2014	26
25476971	Nicotine	Antolin-Fontes B	The habenulo-interpeduncular pathway in nicotine aversion and withdrawal.	Neuropharmacology	2015	20
26407342	Nicotine	Loukola A	A Genome-Wide Association Study of a Biomarker of Nicotine Metabolism.	PLoS genetics	2015	20
28112735	Nicotine	Koukouli F	Nicotine reverses hypofrontality in animal models of addiction and schizophrenia.	Nature medicine	2017	6
3399080	Choline	McGeer PL	Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains.	Neurology	1988	446
9664076	Choline	Ring A	Pneumococcal trafficking across the blood-brain barrier. Molecular analysis of a novel bidirectional pathway.	The Journal of clinical investigation	1998	110
12541307	Choline	Kishi T	Expression of melanocortin 4 receptor mRNA in the central nervous system of the rat.	The Journal of comparative neurology	2003	150
15935057	Choline	Peng S	Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease.	Journal of neurochemistry	2005	121
19941350	Choline	Kataoka Y	Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome.	The Journal of comparative neurology	2010	111
22374882	Choline	Brummelte S	Procedural pain and brain development in premature newborns.	Annals of neurology	2012	70
22549509	Choline	Jiang X	Maternal choline intake alters the epigenetic state of fetal cortisol-regulating genes in humans.	FASEB journal 	2012	32
23318559	Choline	Ross RG	Perinatal choline effects on neonatal pathophysiology related to later schizophrenia risk.	The American journal of psychiatry	2013	28
24529280	Choline	Perez SE	Resilience of precuneus neurotrophic signaling pathways despite amyloid pathology in prodromal Alzheimer's disease.	Biological psychiatry	2015	16
25062696	Choline	Hall H	Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease.	Brain 	2014	32
7702443	gamma-Aminobutyric Acid	Akbarian S	Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.	Archives of general psychiatry	1995	250
9872316	gamma-Aminobutyric Acid	White JH	Heterodimerization is required for the formation of a functional GABA(B) receptor.	Nature	1998	201
10711910	gamma-Aminobutyric Acid	Volk DW	Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia.	Archives of general psychiatry	2000	195
11074872	gamma-Aminobutyric Acid	Guidotti A	Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study.	Archives of general psychiatry	2000	319
11373681	gamma-Aminobutyric Acid	Cowley MA	Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus.	Nature	2001	501
11793011	gamma-Aminobutyric Acid	Costa RM	Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1.	Nature	2002	147
12050665	gamma-Aminobutyric Acid	Letinic K	Origin of GABAergic neurons in the human neocortex.	Nature	2002	179
12209120	gamma-Aminobutyric Acid	Owens DF	Is there more to GABA than synaptic inhibition?	Nature reviews. Neuroscience	2002	236
12372652	gamma-Aminobutyric Acid	Fatemi SH	Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices.	Biological psychiatry	2002	125
12372661	gamma-Aminobutyric Acid	Beasley CL	Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins.	Biological psychiatry	2002	101
12434059	gamma-Aminobutyric Acid	Cohen I	On the origin of interictal activity in human temporal lobe epilepsy in vitro.	Science	2002	210
12867516	gamma-Aminobutyric Acid	Hashimoto T	Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia.	The Journal of neuroscience 	2003	302
12904794	gamma-Aminobutyric Acid	Passafaro M	Induction of dendritic spines by an extracellular domain of AMPA receptor subunit GluR2.	Nature	2003	93
14684836	gamma-Aminobutyric Acid	Veldic M	DNA-methyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains.	Proceedings of the National Academy of Sciences of the United States of America	2004	84
15024690	gamma-Aminobutyric Acid	Edenberg HJ	Variations in GABRA2, encoding the alpha 2 subunit of the GABA(A) receptor, are associated with alcohol dependence and with brain oscillations.	American journal of human genetics	2004	249
15121991	gamma-Aminobutyric Acid	Muhle R	The genetics of autism.	Pediatrics	2004	215
15193778	gamma-Aminobutyric Acid	Morimoto K	Kindling and status epilepticus models of epilepsy: rewiring the brain.	Progress in neurobiology	2004	150
15210304	gamma-Aminobutyric Acid	Conti F	GABA transporters in the mammalian cerebral cortex: localization, development and pathological implications.	Brain research. Brain research reviews	2004	71
15560956	gamma-Aminobutyric Acid	Fatemi SH	GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum.	Schizophrenia research	2005	73
15620359	gamma-Aminobutyric Acid	Graf ER	Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins.	Cell	2004	299
15691526	gamma-Aminobutyric Acid	Torrey EF	Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains.	Biological psychiatry	2005	122
16080114	gamma-Aminobutyric Acid	Ma DQ	Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism.	American journal of human genetics	2005	93
16154288	gamma-Aminobutyric Acid	Hayley S	The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity.	Neuroscience	2005	66
16230605	gamma-Aminobutyric Acid	Choudary PV	Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression.	Proceedings of the National Academy of Sciences of the United States of America	2005	152
16373420	gamma-Aminobutyric Acid	Ojeda SR	Minireview: the neuroendocrine regulation of puberty: is the time ripe for a systems biology approach?	Endocrinology	2006	60
16759710	gamma-Aminobutyric Acid	Akbarian S	Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders.	Brain research reviews	2006	128
17030651	gamma-Aminobutyric Acid	Lewis DA	Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations.	Archives of neurology	2006	133
17146052	gamma-Aminobutyric Acid	Klaassen A	Seizures and enhanced cortical GABAergic inhibition in two mouse models of human autosomal dominant nocturnal frontal lobe epilepsy.	Proceedings of the National Academy of Sciences of the United States of America	2006	62
17235515	gamma-Aminobutyric Acid	Yip J	Decreased GAD67 mRNA levels in cerebellar Purkinje cells in autism: pathophysiological implications.	Acta neuropathologica	2007	77
17259994	gamma-Aminobutyric Acid	Brisbare-Roch C	Promotion of sleep by targeting the orexin system in rats, dogs and humans.	Nature medicine	2007	112
17339270	gamma-Aminobutyric Acid	Hogart A	15q11-13 GABAA receptor genes are normally biallelically expressed in brain yet are subject to epigenetic dysregulation in autism-spectrum disorders.	Human molecular genetics	2007	75
17379385	gamma-Aminobutyric Acid	Zuccato C	Role of brain-derived neurotrophic factor in Huntington's disease.	Progress in neurobiology	2007	123
17511618	gamma-Aminobutyric Acid	Rajkowska G	Gliogenesis and glial pathology in depression.	CNS & neurological disorders drug targets	2007	130
17553960	gamma-Aminobutyric Acid	Benes FM	Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars.	Proceedings of the National Academy of Sciences of the United States of America	2007	152
17726539	gamma-Aminobutyric Acid	Huang HS	GAD1 mRNA expression and DNA methylation in prefrontal cortex of subjects with schizophrenia.	PloS one	2007	73
17765749	gamma-Aminobutyric Acid	Dudek FE	Epileptogenesis in the dentate gyrus: a critical perspective.	Progress in brain research	2007	84
17965125	gamma-Aminobutyric Acid	Bayatti N	A molecular neuroanatomical study of the developing human neocortex from 8 to 17 postconceptional weeks revealing the early differentiation of the subplate and subventricular zone.	Cerebral cortex	2008	56
18032561	gamma-Aminobutyric Acid	Medrihan L	Early defects of GABAergic synapses in the brain stem of a MeCP2 mouse model of Rett syndrome.	Journal of neurophysiology	2008	90
18171687	gamma-Aminobutyric Acid	Cavallaro M	Impaired generation of mature neurons by neural stem cells from hypomorphic Sox2 mutants.	Development	2008	52
18281411	gamma-Aminobutyric Acid	Hashimoto T	Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia.	The American journal of psychiatry	2008	155
18287555	gamma-Aminobutyric Acid	Vierling-Claassen D	Modeling GABA alterations in schizophrenia: a link between impaired inhibition and altered gamma and beta range auditory entrainment.	Journal of neurophysiology	2008	67
18599766	gamma-Aminobutyric Acid	Klausberger T	Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operations.	Science	2008	584
18606950	gamma-Aminobutyric Acid	Eggan SM	Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia.	Archives of general psychiatry	2008	63
18821008	gamma-Aminobutyric Acid	Fatemi SH	GABA(A) receptor downregulation in brains of subjects with autism.	Journal of autism and developmental disorders	2009	129
18830410	gamma-Aminobutyric Acid	Loerch PM	Evolution of the aging brain transcriptome and synaptic regulation.	PloS one	2008	95
19002745	gamma-Aminobutyric Acid	Fatemi SH	Expression of GABA(B) receptors is altered in brains of subjects with autism.	Cerebellum	2009	75
19188247	gamma-Aminobutyric Acid	Huang ZJ	Activity-dependent development of inhibitory synapses and innervation pattern: role of GABA signalling and beyond.	The Journal of physiology	2009	51
19321177	gamma-Aminobutyric Acid	Thompson M	Decreased glutamic acid decarboxylase(67) mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders.	Journal of psychiatric research	2009	50
19719810	gamma-Aminobutyric Acid	Lawrence YA	Parvalbumin-, calbindin-, and calretinin-immunoreactive hippocampal interneuron density in autism.	Acta neurologica Scandinavica	2010	45
19727065	gamma-Aminobutyric Acid	Benes FM	Amygdalocortical circuitry in schizophrenia: from circuits to molecules.	Neuropsychopharmacology 	2010	54
20066485	gamma-Aminobutyric Acid	Fatemi SH	mRNA and protein levels for GABAAalpha4, alpha5, beta1 and GABABR1 receptors are altered in brains from subjects with autism.	Journal of autism and developmental disorders	2010	64
20100621	gamma-Aminobutyric Acid	Duncan CE	Prefrontal GABA(A) receptor alpha-subunit expression in normal postnatal human development and schizophrenia.	Journal of psychiatric research	2010	71
20643379	gamma-Aminobutyric Acid	Wang LW	Fragile X: leading the way for targeted treatments in autism.	Neurotherapeutics 	2010	53
20722471	gamma-Aminobutyric Acid	Streeter CC	Effects of yoga versus walking on mood, anxiety, and brain GABA levels: a randomized controlled MRS study.	Journal of alternative and complementary medicine	2010	54
20843900	gamma-Aminobutyric Acid	Beneyto M	Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia.	Cerebral cortex	2011	50
20876035	gamma-Aminobutyric Acid	Dydak U	In vivo measurement of brain GABA concentrations by magnetic resonance spectroscopy in smelters occupationally exposed to manganese.	Environmental health perspectives	2011	44
20881131	gamma-Aminobutyric Acid	Zhang TY	Maternal care and DNA methylation of a glutamic acid decarboxylase 1 promoter in rat hippocampus.	The Journal of neuroscience 	2010	81
20888227	gamma-Aminobutyric Acid	Boy F	Individual differences in subconscious motor control predicted by GABA concentration in SMA.	Current biology 	2010	47
20888417	gamma-Aminobutyric Acid	Massone S	17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease.	Neurobiology of disease	2011	46
20929730	gamma-Aminobutyric Acid	Lee S	Channel-mediated tonic GABA release from glia.	Science	2010	132
21046567	gamma-Aminobutyric Acid	Lee M	Astrocytes are GABAergic cells that modulate microglial activity.	Glia	2011	40
21068836	gamma-Aminobutyric Acid	Haubensak W	Genetic dissection of an amygdala microcircuit that gates conditioned fear.	Nature	2010	226
21139075	gamma-Aminobutyric Acid	Jakovcevski I	Multiple origins of human neocortical interneurons are supported by distinct expression of transcription factors.	Cerebral cortex	2011	50
21215806	gamma-Aminobutyric Acid	Gaetz W	Relating MEG measured motor cortical oscillations to resting γ-aminobutyric acid (GABA) concentration.	NeuroImage	2011	56
21226980	gamma-Aminobutyric Acid	Sibille E	GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders.	The international journal of neuropsychopharmacology	2011	59
21315745	gamma-Aminobutyric Acid	Powell SB	Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia.	Neuropharmacology	2012	46
21419704	gamma-Aminobutyric Acid	LeWitt PA	AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial.	The Lancet. Neurology	2011	134
21632647	gamma-Aminobutyric Acid	Curley AA	Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features.	The American journal of psychiatry	2011	92
21795557	gamma-Aminobutyric Acid	Hyde TM	Expression of GABA signaling molecules KCC2, NKCC1, and GAD1 in cortical development and schizophrenia.	The Journal of neuroscience 	2011	80
21856318	gamma-Aminobutyric Acid	Berretta S	Extracellular matrix abnormalities in schizophrenia.	Neuropharmacology	2012	34
21901840	gamma-Aminobutyric Acid	Fatemi SH	Metabotropic glutamate receptor 5 upregulation in children with autism is associated with underexpression of both Fragile X mental retardation protein and GABAA receptor beta 3 in adults with autism.	Anatomical record	2011	37
22159125	gamma-Aminobutyric Acid	Volman V	Downregulation of parvalbumin at cortical GABA synapses reduces network gamma oscillatory activity.	The Journal of neuroscience 	2011	47
22355184	gamma-Aminobutyric Acid	Gonzalez-Burgos G	NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia.	Schizophrenia bulletin	2012	90
22396415	gamma-Aminobutyric Acid	Pattwell SS	The BDNF Val66Met polymorphism impairs synaptic transmission and plasticity in the infralimbic medial prefrontal cortex.	The Journal of neuroscience 	2012	42
22626542	gamma-Aminobutyric Acid	Waite A	The dystrophin-glycoprotein complex in brain development and disease.	Trends in neurosciences	2012	36
22848101	gamma-Aminobutyric Acid	Daniel C	A distant cis acting intronic element induces site-selective RNA editing.	Nucleic acids research	2012	32
23049970	gamma-Aminobutyric Acid	Gelman BB	The National NeuroAIDS Tissue Consortium brain gene array: two types of HIV-associated neurocognitive impairment.	PloS one	2012	55
23128924	gamma-Aminobutyric Acid	Tripp A	Brain-derived neurotrophic factor signaling and subgenual anterior cingulate cortex dysfunction in major depressive disorder.	The American journal of psychiatry	2012	55
23334592	gamma-Aminobutyric Acid	Koeppen AH	Friedreich ataxia: neuropathology revised.	Journal of neuropathology and experimental neurology	2013	38
23498139	gamma-Aminobutyric Acid	Silveri MM	Frontal lobe γ-aminobutyric acid levels during adolescence: associations with impulsivity and response inhibition.	Biological psychiatry	2013	31
23604284	gamma-Aminobutyric Acid	Liu Y	Medial ganglionic eminence-like cells derived from human embryonic stem cells correct learning and memory deficits.	Nature biotechnology	2013	59
23642365	gamma-Aminobutyric Acid	Maroof AM	Directed differentiation and functional maturation of cortical interneurons from human embryonic stem cells.	Cell stem cell	2013	153
23928500	gamma-Aminobutyric Acid	Liu Y	Directed differentiation of forebrain GABA interneurons from human pluripotent stem cells.	Nature protocols	2013	56
24149188	gamma-Aminobutyric Acid	Felipo V	Hepatic encephalopathy: effects of liver failure on brain function.	Nature reviews. Neuroscience	2013	39
24217255	gamma-Aminobutyric Acid	Glausier JR	Altered parvalbumin basket cell inputs in the dorsolateral prefrontal cortex of schizophrenia subjects.	Molecular psychiatry	2014	39
24395782	gamma-Aminobutyric Acid	Neman J	Human breast cancer metastases to the brain display GABAergic properties in the neural niche.	Proceedings of the National Academy of Sciences of the United States of America	2014	41
24650500	gamma-Aminobutyric Acid	Lewis DA	Inhibitory neurons in human cortical circuits: substrate for cognitive dysfunction in schizophrenia.	Current opinion in neurobiology	2014	41
24650502	gamma-Aminobutyric Acid	Kaila K	GABA actions and ionic plasticity in epilepsy.	Current opinion in neurobiology	2014	30
24791913	gamma-Aminobutyric Acid	Halson SL	Sleep in elite athletes and nutritional interventions to enhance sleep.	Sports medicine	2014	25
24923909	gamma-Aminobutyric Acid	Wu Z	Tonic inhibition in dentate gyrus impairs long-term potentiation and memory in an Alzheimer's corrected disease model.	Nature communications	2014	27
24968779	gamma-Aminobutyric Acid	Trudeau LE	The multilingual nature of dopamine neurons.	Progress in brain research	2014	22
24993056	gamma-Aminobutyric Acid	Glausier JR	Lower glutamic acid decarboxylase 65-kDa isoform messenger RNA and protein levels in the prefrontal cortex in schizoaffective disorder but not schizophrenia.	Biological psychiatry	2015	15
25168736	gamma-Aminobutyric Acid	Ben-Ari Y	The GABA excitatory/inhibitory developmental sequence: a personal journey.	Neuroscience	2014	32
25380696	gamma-Aminobutyric Acid	Walls AB	The glutamine-glutamate/GABA cycle: function, regional differences in glutamate and GABA production and effects of interference with GABA metabolism.	Neurochemical research	2015	18
25738424	gamma-Aminobutyric Acid	Ruzicka WB	Circuit- and Diagnosis-Specific DNA Methylation Changes at γ-Aminobutyric Acid-Related Genes in Postmortem Human Hippocampus in Schizophrenia and Bipolar Disorder.	JAMA psychiatry	2015	23
25738457	gamma-Aminobutyric Acid	Besse A	The GABA transaminase, ABAT, is essential for mitochondrial nucleoside metabolism.	Cell metabolism	2015	18
25869804	gamma-Aminobutyric Acid	Ibrahim-Verbaas CA	GWAS for executive function and processing speed suggests involvement of the CADM2 gene.	Molecular psychiatry	2016	17
25904555	gamma-Aminobutyric Acid	Yuan H	Ionotropic GABA and Glutamate Receptor Mutations and Human Neurologic Diseases.	Molecular pharmacology	2015	38
26041822	gamma-Aminobutyric Acid	Puts NA	Reduced GABAergic inhibition and abnormal sensory symptoms in children with Tourette syndrome.	Journal of neurophysiology	2015	17
26152864	gamma-Aminobutyric Acid	Ben-Ari Y	Is birth a critical period in the pathogenesis of autism spectrum disorders?	Nature reviews. Neuroscience	2015	17
26186191	gamma-Aminobutyric Acid	Mariani J	FOXG1-Dependent Dysregulation of GABA/Glutamate Neuron Differentiation in Autism Spectrum Disorders.	Cell	2015	105
26733678	gamma-Aminobutyric Acid	Tang X	KCC2 rescues functional deficits in human neurons derived from patients with Rett syndrome.	Proceedings of the National Academy of Sciences of the United States of America	2016	20
26743492	gamma-Aminobutyric Acid	Nakajima K	Gs-coupled GPCR signalling in AgRP neurons triggers sustained increase in food intake.	Nature communications	2016	20
26772433	gamma-Aminobutyric Acid	Singh H	MaxiK channel interactome reveals its interaction with GABA transporter 3 and heat shock protein 60 in the mammalian brain.	Neuroscience	2016	10
26780170	gamma-Aminobutyric Acid	Kim HK	Neuropathological relationship between major depression and dementia: A hypothetical model and review.	Progress in neuro-psychopharmacology & biological psychiatry	2016	10
26830140	gamma-Aminobutyric Acid	Canetta S	Maternal immune activation leads to selective functional deficits in offspring parvalbumin interneurons.	Molecular psychiatry	2016	16
26869529	gamma-Aminobutyric Acid	Jarius S	Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.	Multiple sclerosis	2016	14
27225074	gamma-Aminobutyric Acid	Urban-Ciecko J	Somatostatin-expressing neurons in cortical networks.	Nature reviews. Neuroscience	2016	18
27956747	gamma-Aminobutyric Acid	Mazzone CM	Acute engagement of Gq-mediated signaling in the bed nucleus of the stria terminalis induces anxiety-like behavior.	Molecular psychiatry	2018	5
27986928	gamma-Aminobutyric Acid	Lee SJ	Presynaptic Neuronal Pentraxin Receptor Organizes Excitatory and Inhibitory Synapses.	The Journal of neuroscience 	2017	6
10433861	Somatostatin	Patel YC	Somatostatin and its receptor family.	Frontiers in neuroendocrinology	1999	184
10753124	Somatostatin	Rocheville M	Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity.	Science	2000	90
18203698	Somatostatin	Morris HM	Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder.	Cerebral cortex	2008	77
21232602	Somatostatin	Tripp A	Reduced somatostatin in subgenual anterior cingulate cortex in major depression.	Neurobiology of disease	2011	39
21745723	Somatostatin	Konradi C	Hippocampal interneurons are abnormal in schizophrenia.	Schizophrenia research	2011	72
22983435	Somatostatin	Volk DW	Deficits in transcriptional regulators of cortical parvalbumin neurons in schizophrenia.	The American journal of psychiatry	2012	59
24361861	Somatostatin	Hoftman GD	Altered cortical expression of GABA-related genes in schizophrenia: illness progression vs developmental disturbance.	Schizophrenia bulletin	2015	37
24436034	Somatostatin	Balu DT	D-serine and serine racemase are localized to neurons in the adult mouse and human forebrain.	Cellular and molecular neurobiology	2014	31
24742460	Somatostatin	Vogt D	Lhx6 directly regulates Arx and CXCR7 to determine cortical interneuron fate and laminar position.	Neuron	2014	28
25043046	Somatostatin	Xue M	Equalizing excitation-inhibition ratios across visual cortical neurons.	Nature	2014	99
25937288	Somatostatin	Vogt D	The parvalbumin/somatostatin ratio is increased in Pten mutant mice and by human PTEN ASD alleles.	Cell reports	2015	15
17164235	Melatonin	Klein DC	Arylalkylamine N-acetyltransferase: "the Timezyme".	The Journal of biological chemistry	2007	81
18571301	Melatonin	Pandi-Perumal SR	Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways.	Progress in neurobiology	2008	84
19060908	Melatonin	Lyssenko V	Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion.	Nature genetics	2009	179
19716732	Melatonin	Dijk DJ	PERIOD3, circadian phenotypes, and sleep homeostasis.	Sleep medicine reviews	2010	45
20478436	Melatonin	Reiter RJ	Melatonin: a multitasking molecule.	Progress in brain research	2010	69
21415172	Melatonin	Cajochen C	Evening exposure to a light-emitting diodes (LED)-backlit computer screen affects circadian physiology and cognitive performance.	Journal of applied physiology	2011	48
23183236	Melatonin	Robertson NJ	Melatonin augments hypothermic neuroprotection in a perinatal asphyxia model.	Brain 	2013	48
24449876	Melatonin	Archer SN	Mistimed sleep disrupts circadian regulation of the human transcriptome.	Proceedings of the National Academy of Sciences of the United States of America	2014	53
9760699	Nitric Oxide	Stoll G	Inflammation and glial responses in ischemic brain lesions.	Progress in neurobiology	1998	122
10483914	Nitric Oxide	Fawcett JW	The glial scar and central nervous system repair.	Brain research bulletin	1999	287
10488080	Nitric Oxide	Christopherson KS	PSD-95 assembles a ternary complex with the N-methyl-D-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain.	The Journal of biological chemistry	1999	110
10668900	Nitric Oxide	del Zoppo G	Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia.	Brain pathology	2000	109
10825356	Nitric Oxide	Bitsch A	Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation.	Brain 	2000	130
11698024	Nitric Oxide	Zimmermann M	Pathobiology of neuropathic pain.	European journal of pharmacology	2001	137
12183632	Nitric Oxide	Gu Z	S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death.	Science	2002	227
12666098	Nitric Oxide	Hunot S	Neuroinflammatory processes in Parkinson's disease.	Annals of neurology	2003	91
12849456	Nitric Oxide	Smith KJ	The role of nitric oxide in multiple sclerosis.	The Lancet. Neurology	2002	90
15831232	Nitric Oxide	Kaur B	Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis.	Neuro-oncology	2005	145
16357085	Nitric Oxide	Andresen J	Endothelial influences on cerebrovascular tone.	Journal of applied physiology	2006	60
16771683	Nitric Oxide	Saha RN	Regulation of inducible nitric oxide synthase gene in glial cells.	Antioxidants & redox signaling	2006	64
16805776	Nitric Oxide	Moncada S	Nitric oxide, cell bioenergetics and neurodegeneration.	Journal of neurochemistry	2006	98
17982277	Nitric Oxide	Walter S	Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease.	Cellular physiology and biochemistry 	2007	103
18801863	Nitric Oxide	Cade WT	Diabetes-related microvascular and macrovascular diseases in the physical therapy setting.	Physical therapy	2008	80
19075734	Nitric Oxide	Tuttolomondo A	Inflammatory cytokines in acute ischemic stroke.	Current pharmaceutical design	2008	65
19234067	Nitric Oxide	Fertuzinhos S	Selective depletion of molecularly defined cortical interneurons in human holoprosencephaly with severe striatal hypoplasia.	Cerebral cortex	2009	51
19293146	Nitric Oxide	Toda N	Cerebral blood flow regulation by nitric oxide: recent advances.	Pharmacological reviews	2009	66
19298861	Nitric Oxide	Zhou L	Neuronal nitric oxide synthase: structure, subcellular localization, regulation, and clinical implications.	Nitric oxide 	2009	98
19411199	Nitric Oxide	Wilkins A	Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro.	Stem cell research	2009	60
19488045	Nitric Oxide	Rao JS	Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients.	Molecular psychiatry	2010	89
20010958	Nitric Oxide	Li J	Effects of AMP-activated protein kinase in cerebral ischemia.	Journal of cerebral blood flow and metabolism 	2010	45
20147544	Nitric Oxide	Tricoire L	Common origins of hippocampal Ivy and nitric oxide synthase expressing neurogliaform cells.	The Journal of neuroscience 	2010	53
20385632	Nitric Oxide	Elmahdy H	Human recombinant erythropoietin in asphyxia neonatorum: pilot trial.	Pediatrics	2010	40
20971854	Nitric Oxide	Maezawa I	Amyloid-beta protein oligomer at low nanomolar concentrations activates microglia and induces microglial neurotoxicity.	The Journal of biological chemistry	2011	60
21036891	Nitric Oxide	Guazzi M	PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled study.	Circulation. Heart failure	2011	82
21196259	Nitric Oxide	Chrissobolis S	Oxidative stress and endothelial dysfunction in cerebrovascular disease.	Frontiers in bioscience	2011	41
21729780	Nitric Oxide	Eyler CE	Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2.	Cell	2011	88
22311128	Nitric Oxide	Rao JS	Neuroinflammation and synaptic loss.	Neurochemical research	2012	36
22496842	Nitric Oxide	Kim B	Impaired inflammatory responses in murine Lrrk2-knockdown brain microglia.	PloS one	2012	49
22579290	Nitric Oxide	Kwan KY	Species-dependent posttranscriptional regulation of NOS1 by FMRP in the developing cerebral cortex.	Cell	2012	42
23935251	Nitric Oxide	More SV	Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's disease.	Mediators of inflammation	2013	44
24357508	Nitric Oxide	Katusic ZS	Endothelial nitric oxide: protector of a healthy mind.	European heart journal	2014	33
24418464	Nitric Oxide	Pieper C	Brain capillary pericytes contribute to the immune defense in response to cytokines or LPS in vitro.	Brain research	2014	27
24733928	Nitric Oxide	Heinecke JL	Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression.	Proceedings of the National Academy of Sciences of the United States of America	2014	34
24918289	Nitric Oxide	Zhang Y	Erythropoietin action in stress response, tissue maintenance and metabolism.	International journal of molecular sciences	2014	26
25331846	Nitric Oxide	Cifuentes D	Hypertension accelerates the progression of Alzheimer-like pathology in a mouse model of the disease.	Hypertension	2015	19
25384799	Nitric Oxide	Mesci P	System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice.	Brain 	2015	16
25391251	Nitric Oxide	Lee RJ	Bitter and sweet taste receptors in the respiratory epithelium in health and disease.	Journal of molecular medicine	2014	22
25447937	Nitric Oxide	Garry PS	The role of the nitric oxide pathway in brain injury and its treatment--from bench to bedside.	Experimental neurology	2015	29
25575647	Nitric Oxide	Teich AF	Synaptic therapy in Alzheimer's disease: a CREB-centric approach.	Neurotherapeutics 	2015	17
25879545	Nitric Oxide	Dange RB	Toll-like receptor 4 inhibition within the paraventricular nucleus attenuates blood pressure and inflammatory response in a genetic model of hypertension.	Journal of neuroinflammation	2015	18
26129625	Nitric Oxide	Nakagawa Y	Diversity and plasticity of microglial cells in psychiatric and neurological disorders.	Pharmacology & therapeutics	2015	17
27514990	Nitric Oxide	Balez R	Neuroprotective effects of apigenin against inflammation, neuronal excitability and apoptosis in an induced pluripotent stem cell model of Alzheimer's disease.	Scientific reports	2016	11
11431323	Phosphatidylinositols	Sonoda Y	Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma.	Cancer research	2001	90
12376533	Phosphatidylinositols	Beffert U	Reelin-mediated signaling locally regulates protein kinase B/Akt and glycogen synthase kinase 3beta.	The Journal of biological chemistry	2002	85
12719654	Phosphatidylinositols	Yamada K	Brain-derived neurotrophic factor/TrkB signaling in memory processes.	Journal of pharmacological sciences	2003	85
12782577	Phosphatidylinositols	Choe G	Analysis of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma patients in vivo.	Cancer research	2003	109
14528310	Phosphatidylinositols	Rong R	PI3 kinase enhancer-Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis.	Nature neuroscience	2003	96
14749507	Phosphatidylinositols	Myers MG Jr	Leptin receptor signaling and the regulation of mammalian physiology.	Recent progress in hormone research	2004	115
15467468	Phosphatidylinositols	Samuels Y	Oncogenic mutations of PIK3CA in human cancers.	Cell cycle	2004	131
16288007	Phosphatidylinositols	García-Rostán G	Mutation of the PIK3CA gene in anaplastic thyroid cancer.	Cancer research	2005	84
16618748	Phosphatidylinositols	Nakamura K	Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1alpha in neuroblastoma cells.	Cancer research	2006	67
16738242	Phosphatidylinositols	Wang L	Matrix metalloproteinase 2 (MMP2) and MMP9 secreted by erythropoietin-activated endothelial cells promote neural progenitor cell migration.	The Journal of neuroscience 	2006	98
16939974	Phosphatidylinositols	Reichardt LF	Neurotrophin-regulated signalling pathways.	Philosophical transactions of the Royal Society of London. Series B, Biological sciences	2006	483
17372210	Phosphatidylinositols	Mehrian-Shai R	Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancer.	Proceedings of the National Academy of Sciences of the United States of America	2007	62
17698586	Phosphatidylinositols	Jossin Y	Reelin signals through phosphatidylinositol 3-kinase and Akt to control cortical development and through mTor to regulate dendritic growth.	Molecular and cellular biology	2007	68
17872411	Phosphatidylinositols	Stommel JM	Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies.	Science	2007	349
18852283	Phosphatidylinositols	Shimizu T	Stabilized beta-catenin functions through TCF/LEF proteins and the Notch/RBP-Jkappa complex to promote proliferation and suppress differentiation of neural precursor cells.	Molecular and cellular biology	2008	59
19176518	Phosphatidylinositols	Fan QW	EGFR signals to mTOR through PKC and independently of Akt in glioma.	Science signaling	2009	66
19412429	Phosphatidylinositols	Pillay V	The plasticity of oncogene addiction: implications for targeted therapies directed to receptor tyrosine kinases.	Neoplasia	2009	50
19668216	Phosphatidylinositols	Bielas SL	Mutations in INPP5E, encoding inositol polyphosphate-5-phosphatase E, link phosphatidyl inositol signaling to the ciliopathies.	Nature genetics	2009	124
19789314	Phosphatidylinositols	Platt FM	Spectrum of phosphatidylinositol 3-kinase pathway gene alterations in bladder cancer.	Clinical cancer research 	2009	71
20405009	Phosphatidylinositols	Gómez Ravetti M	Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.	PloS one	2010	41
20668162	Phosphatidylinositols	Goodman CA	A phosphatidylinositol 3-kinase/protein kinase B-independent activation of mammalian target of rapamycin signaling is sufficient to induce skeletal muscle hypertrophy.	Molecular biology of the cell	2010	42
21753002	Phosphatidylinositols	Van Humbeeck C	Parkin interacts with Ambra1 to induce mitophagy.	The Journal of neuroscience 	2011	60
21807103	Phosphatidylinositols	Chaumeil MM	Hyperpolarized 13C MR spectroscopic imaging can be used to monitor Everolimus treatment in vivo in an orthotopic rodent model of glioblastoma.	NeuroImage	2012	34
21820214	Phosphatidylinositols	Xu J	Extracellular progranulin protects cortical neurons from toxic insults by activating survival signaling.	Neurobiology of aging	2011	38
22619466	Phosphatidylinositols	Wen PY	Current clinical development of PI3K pathway inhibitors in glioblastoma.	Neuro-oncology	2012	40
23487788	Phosphatidylinositols	Takeuchi K	Dysregulation of synaptic plasticity precedes appearance of morphological defects in a Pten conditional knockout mouse model of autism.	Proceedings of the National Academy of Sciences of the United States of America	2013	27
23602987	Phosphatidylinositols	Leal G	BDNF-induced local protein synthesis and synaptic plasticity.	Neuropharmacology	2014	46
24042850	Phosphatidylinositols	Giese KP	The roles of protein kinases in learning and memory.	Learning & memory	2013	35
24076665	Phosphatidylinositols	Filbin MG	Coordinate activation of Shh and PI3K signaling in PTEN-deficient glioblastoma: new therapeutic opportunities.	Nature medicine	2013	41
24867100	Phosphatidylinositols	Wang F	MiRNA-181c inhibits EGFR-signaling-dependent MMP9 activation via suppressing Akt phosphorylation in glioblastoma.	Tumour biology 	2014	22
25534823	Phosphatidylinositols	Kaul A	Akt- or MEK-mediated mTOR inhibition suppresses Nf1 optic glioma growth.	Neuro-oncology	2015	17
25650317	Phosphatidylinositols	Ghosh JC	Adaptive mitochondrial reprogramming and resistance to PI3K therapy.	Journal of the National Cancer Institute	2015	27
27159400	Phosphatidylinositols	Mirzaa GM	Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism.	JAMA neurology	2016	14
7822316	Sirolimus	Sabers CJ	Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells.	The Journal of biological chemistry	1995	184
12563289	Sirolimus	Jacinto E	Tor signalling in bugs, brain and brawn.	Nature reviews. Molecular cell biology	2003	151
12842888	Sirolimus	Castro AF	Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner.	The Journal of biological chemistry	2003	109
12869586	Sirolimus	Inoki K	Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling.	Genes & development	2003	529
14607085	Sirolimus	Manning BD	Rheb fills a GAP between TSC and TOR.	Trends in biochemical sciences	2003	134
14729330	Sirolimus	Li Y	TSC2: filling the GAP in the mTOR signaling pathway.	Trends in biochemical sciences	2004	112
15094765	Sirolimus	Fingar DC	Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression.	Oncogene	2004	333
15805275	Sirolimus	Dasgupta B	Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors.	Cancer research	2005	81
16098202	Sirolimus	Li X	Levels of mTOR and its downstream targets 4E-BP1, eEF2, and eEF2 kinase in relationships with tau in Alzheimer's disease brain.	The FEBS journal	2005	68
16203860	Sirolimus	Yu WH	Macroautophagy--a novel Beta-amyloid peptide-generating pathway activated in Alzheimer's disease.	The Journal of cell biology	2005	237
16354680	Sirolimus	Tzatsos A	Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation.	Molecular and cellular biology	2006	125
16627617	Sirolimus	Yang Q	TSC1/TSC2 and Rheb have different effects on TORC1 and TORC2 activity.	Proceedings of the National Academy of Sciences of the United States of America	2006	67
16714284	Sirolimus	Cao Y	Autophagy is disrupted in a knock-in mouse model of juvenile neuronal ceroid lipofuscinosis.	The Journal of biological chemistry	2006	79
16799564	Sirolimus	Androutsellis-Theotokis A	Notch signalling regulates stem cell numbers in vitro and in vivo.	Nature	2006	271
16912159	Sirolimus	Wang MY	Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells.	Cancer research	2006	100
16915281	Sirolimus	Bernardi R	PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR.	Nature	2006	132
17502379	Sirolimus	Land SC	Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif.	The Journal of biological chemistry	2007	123
17671177	Sirolimus	Ma L	Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer.	Cancer research	2007	58
17689501	Sirolimus	Morimoto N	Increased autophagy in transgenic mice with a G93A mutant SOD1 gene.	Brain research	2007	57
17913600	Sirolimus	Swiech L	Role of mTOR in physiology and pathology of the nervous system.	Biochimica et biophysica acta	2008	99
18089801	Sirolimus	Masri J	mTORC2 activity is elevated in gliomas and promotes growth and cell motility via overexpression of rictor.	Cancer research	2007	92
18160642	Sirolimus	Narayanan U	FMRP phosphorylation reveals an immediate-early signaling pathway triggered by group I mGluR and mediated by PP2A.	The Journal of neuroscience 	2007	97
18184959	Sirolimus	Bissler JJ	Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis.	The New England journal of medicine	2008	296
18215105	Sirolimus	Cloughesy TF	Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma.	PLoS medicine	2008	205
18276609	Sirolimus	Tang G	Autophagy induced by Alexander disease-mutant GFAP accumulation is regulated by p38/MAPK and mTOR signaling pathways.	Human molecular genetics	2008	53
18466115	Sirolimus	Huang J	The TSC1-TSC2 complex: a molecular switchboard controlling cell growth.	The Biochemical journal	2008	331
18474609	Sirolimus	Narayanan U	S6K1 phosphorylates and regulates fragile X mental retardation protein (FMRP) with the neuronal protein synthesis-dependent mammalian target of rapamycin (mTOR) signaling cascade.	The Journal of biological chemistry	2008	90
18722871	Sirolimus	Curatolo P	Tuberous sclerosis.	Lancet	2008	171
19211884	Sirolimus	Zhou J	Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice.	The Journal of neuroscience 	2009	149
19420259	Sirolimus	Di Nardo A	Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner.	The Journal of neuroscience 	2009	63
19470613	Sirolimus	Ljungberg MC	Rapamycin suppresses seizures and neuronal hypertrophy in a mouse model of cortical dysplasia.	Disease models & mechanisms	2009	68
19556253	Sirolimus	Neves-Pereira M	Deregulation of EIF4E: a novel mechanism for autism.	Journal of medical genetics	2009	48
19651785	Sirolimus	Caccamo A	Rapamycin rescues TDP-43 mislocalization and the associated low molecular mass neurofilament instability.	The Journal of biological chemistry	2009	49
19778506	Sirolimus	Kim JY	DISC1 regulates new neuron development in the adult brain via modulation of AKT-mTOR signaling through KIAA1212.	Neuron	2009	128
19817806	Sirolimus	Wong M	Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsies.	Epilepsia	2010	59
19963289	Sirolimus	Hoeffer CA	mTOR signaling: at the crossroads of plasticity, memory and disease.	Trends in neurosciences	2010	292
20146692	Sirolimus	Orlova KA	The tuberous sclerosis complex.	Annals of the New York Academy of Sciences	2010	102
20174468	Sirolimus	Crews L	Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy.	PloS one	2010	92
20563248	Sirolimus	Molina JR	Invasive glioblastoma cells acquire stemness and increased Akt activation.	Neoplasia	2010	62
20616807	Sirolimus	Kang YJ	The TSC1 and TSC2 tumor suppressors are required for proper ER stress response and protect cells from ER stress-induced apoptosis.	Cell death and differentiation	2011	42
21047224	Sirolimus	Krueger DA	Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis.	The New England journal of medicine	2010	226
21084617	Sirolimus	Osterweil EK	Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome.	The Journal of neuroscience 	2010	128
21115397	Sirolimus	Ehninger D	Rapamycin for treating Tuberous sclerosis and Autism spectrum disorders.	Trends in molecular medicine	2011	59
21212100	Sirolimus	Ricciardi S	Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model.	Human molecular genetics	2011	69
21269838	Sirolimus	Howell JJ	mTOR couples cellular nutrient sensing to organismal metabolic homeostasis.	Trends in endocrinology and metabolism	2011	113
21460795	Sirolimus	Galan-Moya EM	Secreted factors from brain endothelial cells maintain glioblastoma stem-like cell expansion through the mTOR pathway.	EMBO reports	2011	44
21613408	Sirolimus	Lovly CM	Insights into ALK-driven cancers revealed through development of novel ALK tyrosine kinase inhibitors.	Cancer research	2011	51
21646862	Sirolimus	Grishchuk Y	Beclin 1-independent autophagy contributes to apoptosis in cortical neurons.	Autophagy	2011	50
21907282	Sirolimus	Carson RP	Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin.	Neurobiology of disease	2012	57
21915260	Sirolimus	Dabora SL	Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF- D levels decrease.	PloS one	2011	48
22025691	Sirolimus	Goto J	Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex.	Proceedings of the National Academy of Sciences of the United States of America	2011	61
22268788	Sirolimus	Hoeffer CA	Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome.	Genes, brain, and behavior	2012	51
22402744	Sirolimus	Weeraratne SD	Pleiotropic effects of miR-183~96~182 converge to regulate cell survival, proliferation and migration in medulloblastoma.	Acta neuropathologica	2012	57
22431589	Sirolimus	Suh SS	MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme.	Proceedings of the National Academy of Sciences of the United States of America	2012	41
22729223	Sirolimus	Lee JH	De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly.	Nature genetics	2012	135
22795129	Sirolimus	Dibble CC	TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1.	Molecular cell	2012	136
22810227	Sirolimus	Urbanska M	Mammalian target of rapamycin complex 1 (mTORC1) and 2 (mTORC2) control the dendritic arbor morphology of hippocampal neurons.	The Journal of biological chemistry	2012	34
22817723	Sirolimus	O'Neill C	Insulin and IGF-1 signalling: longevity, protein homoeostasis and Alzheimer's disease.	Biochemical Society transactions	2012	38
22895726	Sirolimus	Weston MC	Multiple roles for mammalian target of rapamycin signaling in both glutamatergic and GABAergic synaptic transmission.	The Journal of neuroscience 	2012	36
23064229	Sirolimus	Carrieri C	Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat.	Nature	2012	205
23081885	Sirolimus	Tsai V	Fetal brain mTOR signaling activation in tuberous sclerosis complex.	Cerebral cortex	2014	22
23121022	Sirolimus	Pierce A	Over-expression of heat shock factor 1 phenocopies the effect of chronic inhibition of TOR by rapamycin and is sufficient to ameliorate Alzheimer's-like deficits in mice modeling the disease.	Journal of neurochemistry	2013	26
23123587	Sirolimus	Reith RM	Loss of Tsc2 in Purkinje cells is associated with autistic-like behavior in a mouse model of tuberous sclerosis complex.	Neurobiology of disease	2013	42
23152448	Sirolimus	Kaul A	Pediatric glioma-associated KIAA1549:BRAF expression regulates neuroglial cell growth in a cell type-specific and mTOR-dependent manner.	Genes & development	2012	33
23155049	Sirolimus	Avrahami L	Inhibition of glycogen synthase kinase-3 ameliorates β-amyloid pathology and restores lysosomal acidification and mammalian target of rapamycin activity in the Alzheimer disease mouse model: in vivo and in vitro studies.	The Journal of biological chemistry	2013	43
23158522	Sirolimus	Franz DN	Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial.	Lancet	2013	129
23570274	Sirolimus	Theoharides TC	Focal brain inflammation and autism.	Journal of neuroinflammation	2013	30
23644232	Sirolimus	Wong M	Mammalian target of rapamycin (mTOR) pathways in neurological diseases.	Biomedical journal	2013	32
23729812	Sirolimus	Balu DT	Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction.	Proceedings of the National Academy of Sciences of the United States of America	2013	53
24165680	Sirolimus	Costa-Mattioli M	mTOR complexes in neurodevelopmental and neuropsychiatric disorders.	Nature neuroscience	2013	62
24311635	Sirolimus	Kahn J	The mTORC1/mTORC2 inhibitor AZD2014 enhances the radiosensitivity of glioblastoma stem-like cells.	Neuro-oncology	2014	23
24585383	Sirolimus	Scheffer IE	Mutations in mammalian target of rapamycin regulator DEPDC5 cause focal epilepsy with brain malformations.	Annals of neurology	2014	34
24666346	Sirolimus	Neasta J	mTOR complex 1: a key player in neuroadaptations induced by drugs of abuse.	Journal of neurochemistry	2014	25
24728411	Sirolimus	Ota KT	REDD1 is essential for stress-induced synaptic loss and depressive behavior.	Nature medicine	2014	50
24899720	Sirolimus	Caccamo A	Genetic reduction of mammalian target of rapamycin ameliorates Alzheimer's disease-like cognitive and pathological deficits by restoring hippocampal gene expression signature.	The Journal of neuroscience 	2014	34
25224527	Sirolimus	Kumari D	Identification of fragile X syndrome specific molecular markers in human fibroblasts: a useful model to test the efficacy of therapeutic drugs.	Human mutation	2014	21
25311365	Sirolimus	Oguro-Ando A	Increased CYFIP1 dosage alters cellular and dendritic morphology and dysregulates mTOR.	Molecular psychiatry	2015	15
25374355	Sirolimus	Lipton JO	The neurology of mTOR.	Neuron	2014	71
25599672	Sirolimus	D'Gama AM	Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia.	Annals of neurology	2015	36
25645581	Sirolimus	Tramutola A	Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.	Journal of neurochemistry	2015	25
25791428	Sirolimus	Tang Z	mTor mediates tau localization and secretion: Implication for Alzheimer's disease.	Biochimica et biophysica acta	2015	19
25813405	Sirolimus	Wang Y	CRNDE, a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling.	Cancer letters	2015	45
26018084	Sirolimus	Nakashima M	Somatic Mutations in the MTOR gene cause focal cortical dysplasia type IIb.	Annals of neurology	2015	26
26134657	Sirolimus	Du K	Pten Deletion Promotes Regrowth of Corticospinal Tract Axons 1 Year after Spinal Cord Injury.	The Journal of neuroscience 	2015	21
26721390	Sirolimus	Lin AL	Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer's disease.	Journal of cerebral blood flow and metabolism 	2017	12
27226234	Sirolimus	Henske EP	Tuberous sclerosis complex.	Nature reviews. Disease primers	2016	22
27889578	Sirolimus	Switon K	Molecular neurobiology of mTOR.	Neuroscience	2017	17
28292440	Sirolimus	Fan Q	A Kinase Inhibitor Targeted to mTORC1 Drives Regression in Glioblastoma.	Cancer cell	2017	7
11520931	Oxytocin	Meaney MJ	Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations.	Annual review of neuroscience	2001	454
15589267	Oxytocin	Landgraf R	Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication.	Frontiers in neuroendocrinology	2004	190
16890230	Oxytocin	Lim MM	Neuropeptidergic regulation of affiliative behavior and social bonding in animals.	Hormones and behavior	2006	139
17118932	Oxytocin	Hammock EA	Oxytocin, vasopressin and pair bonding: implications for autism.	Philosophical transactions of the Royal Society of London. Series B, Biological sciences	2006	68
17137561	Oxytocin	Domes G	Oxytocin improves "mind-reading" in humans.	Biological psychiatry	2007	237
17287729	Oxytocin	Jin D	CD38 is critical for social behaviour by regulating oxytocin secretion.	Nature	2007	142
17383819	Oxytocin	Jacob S	Association of the oxytocin receptor gene (OXTR) in Caucasian children and adolescents with autism.	Neuroscience letters	2007	122
17435137	Oxytocin	Carter CS	Oxytocin: behavioral associations and potential as a salivary biomarker.	Annals of the New York Academy of Sciences	2007	63
17617382	Oxytocin	Domes G	Oxytocin attenuates amygdala responses to emotional faces regardless of valence.	Biological psychiatry	2007	172
18343353	Oxytocin	Guastella AJ	Oxytocin enhances the encoding of positive social memories in humans.	Biological psychiatry	2008	77
18498743	Oxytocin	Baumgartner T	Oxytocin shapes the neural circuitry of trust and trust adaptation in humans.	Neuron	2008	232
18579733	Oxytocin	Petrovic P	Oxytocin attenuates affective evaluations of conditioned faces and amygdala activity.	The Journal of neuroscience 	2008	116
18601710	Oxytocin	Neumann ID	Brain oxytocin: a key regulator of emotional and social behaviours in both females and males.	Journal of neuroendocrinology	2008	134
18988842	Oxytocin	Donaldson ZR	Oxytocin, vasopressin, and the neurogenetics of sociality.	Science	2008	320
19005082	Oxytocin	Cyranowski JM	Evidence of dysregulated peripheral oxytocin release among depressed women.	Psychosomatic medicine	2008	53
19015103	Oxytocin	Bakermans-Kranenburg MJ	Oxytocin receptor (OXTR) and serotonin transporter (5-HTT) genes associated with observed parenting.	Social cognitive and affective neuroscience	2008	123
19481567	Oxytocin	Ross HE	Oxytocin and the neural mechanisms regulating social cognition and affiliative behavior.	Frontiers in neuroendocrinology	2009	164
19482229	Oxytocin	Lee HJ	Oxytocin: the great facilitator of life.	Progress in neurobiology	2009	169
19580564	Oxytocin	Barraza JA	Empathy toward strangers triggers oxytocin release and subsequent generosity.	Annals of the New York Academy of Sciences	2009	51
19710635	Oxytocin	Strathearn L	Adult attachment predicts maternal brain and oxytocin response to infant cues.	Neuropsychopharmacology 	2009	136
19934046	Oxytocin	Rodrigues SM	Oxytocin receptor genetic variation relates to empathy and stress reactivity in humans.	Proceedings of the National Academy of Sciences of the United States of America	2009	156
20047458	Oxytocin	Macdonald K	The peptide that binds: a systematic review of oxytocin and its prosocial effects in humans.	Harvard review of psychiatry	2010	87
20220015	Oxytocin	Tolson KP	Postnatal Sim1 deficiency causes hyperphagic obesity and reduced Mc4r and oxytocin expression.	The Journal of neuroscience 	2010	51
20346754	Oxytocin	Insel TR	The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior.	Neuron	2010	214
20371820	Oxytocin	Hurlemann R	Oxytocin enhances amygdala-dependent, socially reinforced learning and emotional empathy in humans.	The Journal of neuroscience 	2010	129
20421469	Oxytocin	Gamer M	Different amygdala subregions mediate valence-related and attentional effects of oxytocin in humans.	Proceedings of the National Academy of Sciences of the United States of America	2010	113
20435366	Oxytocin	Munesue T	Two genetic variants of CD38 in subjects with autism spectrum disorder and controls.	Neuroscience research	2010	56
20538951	Oxytocin	De Dreu CK	The neuropeptide oxytocin regulates parochial altruism in intergroup conflict among humans.	Science	2010	156
20558167	Oxytocin	Feldman R	The cross-generation transmission of oxytocin in humans.	Hormones and behavior	2010	41
20647384	Oxytocin	Tost H	A common allele in the oxytocin receptor gene (OXTR) impacts prosocial temperament and human hypothalamic-limbic structure and function.	Proceedings of the National Academy of Sciences of the United States of America	2010	116
20720535	Oxytocin	Labuschagne I	Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder.	Neuropsychopharmacology 	2010	115
20832055	Oxytocin	Inoue H	Association between the oxytocin receptor gene and amygdalar volume in healthy adults.	Biological psychiatry	2010	46
21208749	Oxytocin	Furman DJ	Variant in oxytocin receptor gene is associated with amygdala volume.	Psychoneuroendocrinology	2011	43
21220339	Oxytocin	De Dreu CK	Oxytocin promotes human ethnocentrism.	Proceedings of the National Academy of Sciences of the United States of America	2011	87
21470595	Oxytocin	Riem MM	Oxytocin modulates amygdala, insula, and inferior frontal gyrus responses to infant crying: a randomized controlled trial.	Biological psychiatry	2011	86
21676095	Oxytocin	Feldman R	Maternal and paternal plasma, salivary, and urinary oxytocin and parent-infant synchrony: considering stress and affiliation components of human bonding.	Developmental science	2011	68
21696997	Oxytocin	Bartz JA	Social effects of oxytocin in humans: context and person matter.	Trends in cognitive sciences	2011	282
21840129	Oxytocin	Rilling JK	Effects of intranasal oxytocin and vasopressin on cooperative behavior and associated brain activity in men.	Psychoneuroendocrinology	2012	76
21881566	Oxytocin	Atzil S	Specifying the neurobiological basis of human attachment: brain, hormones, and behavior in synchronous and intrusive mothers.	Neuropsychopharmacology 	2011	57
22055739	Oxytocin	De Dreu CK	Oxytocin modulates the link between adult attachment and cooperation through reduced betrayal aversion.	Psychoneuroendocrinology	2012	30
22100184	Oxytocin	Bosch OJ	Both oxytocin and vasopressin are mediators of maternal care and aggression in rodents: from central release to sites of action.	Hormones and behavior	2012	76
22189289	Oxytocin	Riem MM	No laughing matter: intranasal oxytocin administration changes functional brain connectivity during exposure to infant laughter.	Neuropsychopharmacology 	2012	44
22197271	Oxytocin	Churchland PS	Modulating social behavior with oxytocin: how does it work? What does it mean?	Hormones and behavior	2012	97
22198308	Oxytocin	McGregor IS	Breaking the loop: oxytocin as a potential treatment for drug addiction.	Hormones and behavior	2012	59
22215593	Oxytocin	Chang SW	Inhaled oxytocin amplifies both vicarious reinforcement and self reinforcement in rhesus macaques (Macaca mulatta).	Proceedings of the National Academy of Sciences of the United States of America	2012	71
22245314	Oxytocin	Ebstein RP	The contributions of oxytocin and vasopressin pathway genes to human behavior.	Hormones and behavior	2012	67
22265852	Oxytocin	Guastella AJ	A critical review of the influence of oxytocin nasal spray on social cognition in humans: evidence and future directions.	Hormones and behavior	2012	83
22281209	Oxytocin	Schneiderman I	Oxytocin during the initial stages of romantic attachment: relations to couples' interactive reciprocity.	Psychoneuroendocrinology	2012	32
22285934	Oxytocin	Feldman R	Oxytocin and social affiliation in humans.	Hormones and behavior	2012	87
22326707	Oxytocin	Zink CF	Human neuroimaging of oxytocin and vasopressin in social cognition.	Hormones and behavior	2012	46
22336563	Oxytocin	Feldman R	Sensitive parenting is associated with plasma oxytocin and polymorphisms in the OXTR and CD38 genes.	Biological psychiatry	2012	75
22365820	Oxytocin	Lischke A	Oxytocin increases amygdala reactivity to threatening scenes in females.	Psychoneuroendocrinology	2012	47
22647521	Oxytocin	Sripada CS	Oxytocin enhances resting-state connectivity between amygdala and medial frontal cortex.	The international journal of neuropsychopharmacology	2013	39
22795645	Oxytocin	Weisman O	Oxytocin administration to parent enhances infant physiological and behavioral readiness for social engagement.	Biological psychiatry	2012	48
22840551	Oxytocin	Atzil S	Synchrony and specificity in the maternal and the paternal brain: relations to oxytocin and vasopressin.	Journal of the American Academy of Child and Adolescent Psychiatry	2012	33
22892716	Oxytocin	Unternaehrer E	Dynamic changes in DNA methylation of stress-associated genes (OXTR, BDNF ) after acute psychosocial stress.	Translational psychiatry	2012	48
22974560	Oxytocin	Neumann ID	Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors.	Trends in neurosciences	2012	139
22981649	Oxytocin	Lukas M	Oxytocin and vasopressin in rodent behaviors related to social dysfunctions in autism spectrum disorders.	Behavioural brain research	2013	30
22999263	Oxytocin	Weisman O	Plasma oxytocin distributions in a large cohort of women and men and their gender-specific associations with anxiety.	Psychoneuroendocrinology	2013	28
23025690	Oxytocin	Pedersen CA	Intranasal oxytocin blocks alcohol withdrawal in human subjects.	Alcoholism, clinical and experimental research	2013	34
23040812	Oxytocin	Stoop R	Neuromodulation by oxytocin and vasopressin.	Neuron	2012	77
23055480	Oxytocin	Yamasue H	Integrative approaches utilizing oxytocin to enhance prosocial behavior: from animal and human social behavior to autistic social dysfunction.	The Journal of neuroscience 	2012	33
23074247	Oxytocin	Striepens N	Oxytocin facilitates protective responses to aversive social stimuli in males.	Proceedings of the National Academy of Sciences of the United States of America	2012	43
23135822	Oxytocin	Chapman CD	Intranasal treatment of central nervous system dysfunction in humans.	Pharmaceutical research	2013	34
23147382	Oxytocin	Grillon C	Oxytocin increases anxiety to unpredictable threat.	Molecular psychiatry	2013	31
23159011	Oxytocin	Bethlehem RA	Oxytocin, brain physiology, and functional connectivity: a review of intranasal oxytocin fMRI studies.	Psychoneuroendocrinology	2013	56
23325323	Oxytocin	Feldman R	Parental oxytocin and early caregiving jointly shape children's oxytocin response and social reciprocity.	Neuropsychopharmacology 	2013	39
23333868	Oxytocin	Rilling JK	The neural and hormonal bases of human parental care.	Neuropsychologia	2013	30
23419544	Oxytocin	Groppe SE	Oxytocin influences processing of socially relevant cues in the ventral tegmental area of the human brain.	Biological psychiatry	2013	40
23508240	Oxytocin	Macdonald K	Helping oxytocin deliver: considerations in the development of oxytocin-based therapeutics for brain disorders.	Frontiers in neuroscience	2013	35
23510581	Oxytocin	Domes G	Effects of intranasal oxytocin on the neural basis of face processing in autism spectrum disorder.	Biological psychiatry	2013	45
23575742	Oxytocin	Shahrestani S	The impact of a single administration of intranasal oxytocin on the recognition of basic emotions in humans: a meta-analysis.	Neuropsychopharmacology 	2013	39
23579082	Oxytocin	Neumann ID	Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice.	Psychoneuroendocrinology	2013	104
23872596	Oxytocin	Guzmán YF	Fear-enhancing effects of septal oxytocin receptors.	Nature neuroscience	2013	31
23916423	Oxytocin	Tops M	Why social attachment and oxytocin protect against addiction and stress: Insights from the dynamics between ventral and dorsal corticostriatal systems.	Pharmacology, biochemistry, and behavior	2014	31
24050183	Oxytocin	Carter CS	Oxytocin pathways and the evolution of human behavior.	Annual review of psychology	2014	73
24067301	Oxytocin	Domes G	Oxytocin promotes facial emotion recognition and amygdala reactivity in adults with asperger syndrome.	Neuropsychopharmacology 	2014	22
24157401	Oxytocin	Rilling JK	Sex differences in the neural and behavioral response to intranasal oxytocin and vasopressin during human social interaction.	Psychoneuroendocrinology	2014	57
24190025	Oxytocin	Huang H	Chronic and acute intranasal oxytocin produce divergent social effects in mice.	Neuropsychopharmacology 	2014	38
24216134	Oxytocin	Kanat M	Oxytocin and the social brain: neural mechanisms and perspectives in human research.	Brain research	2014	21
24277856	Oxytocin	Scheele D	Oxytocin enhances brain reward system responses in men viewing the face of their female partner.	Proceedings of the National Academy of Sciences of the United States of America	2013	43
24297883	Oxytocin	Gordon I	Oxytocin enhances brain function in children with autism.	Proceedings of the National Academy of Sciences of the United States of America	2013	69
24508578	Oxytocin	Anagnostou E	Intranasal oxytocin in the treatment of autism spectrum disorders: a review of literature and early safety and efficacy data in youth.	Brain research	2014	30
24594871	Oxytocin	Dodhia S	Modulation of resting-state amygdala-frontal functional connectivity by oxytocin in generalized social anxiety disorder.	Neuropsychopharmacology 	2014	31
24694924	Oxytocin	Scheele D	An oxytocin-induced facilitation of neural and emotional responses to social touch correlates inversely with autism traits.	Neuropsychopharmacology 	2014	31
25416642	Oxytocin	Feng C	Oxytocin and vasopressin effects on the neural response to social cooperation are modulated by sex in humans.	Brain imaging and behavior	2015	18
25499958	Oxytocin	Paloyelis Y	A Spatiotemporal Profile of In Vivo Cerebral Blood Flow Changes Following Intranasal Oxytocin in Humans.	Biological psychiatry	2016	19
25520163	Oxytocin	Wigton R	Neurophysiological effects of acute oxytocin administration: systematic review and meta-analysis of placebo-controlled imaging studies.	Journal of psychiatry & neuroscience 	2015	25
25526824	Oxytocin	Quintana DS	Do delivery routes of intranasally administered oxytocin account for observed effects on social cognition and behavior? A two-level model.	Neuroscience and biobehavioral reviews	2015	19
25542304	Oxytocin	Eckstein M	Oxytocin facilitates the extinction of conditioned fear in humans.	Biological psychiatry	2015	22
25652247	Oxytocin	Modi ME	Melanocortin Receptor Agonists Facilitate Oxytocin-Dependent Partner Preference Formation in the Prairie Vole.	Neuropsychopharmacology 	2015	15
25668435	Oxytocin	Auyeung B	Oxytocin increases eye contact during a real-time, naturalistic social interaction in males with and without autism.	Translational psychiatry	2015	24
25675509	Oxytocin	Puglia MH	Epigenetic modification of the oxytocin receptor gene influences the perception of anger and fear in the human brain.	Proceedings of the National Academy of Sciences of the United States of America	2015	28
25908497	Oxytocin	De Dreu CK	Oxytocin Conditions Intergroup Relations Through Upregulated In-Group Empathy, Cooperation, Conformity, and Defense.	Biological psychiatry	2016	17
25951955	Oxytocin	Dumais KM	Vasopressin and oxytocin receptor systems in the brain: Sex differences and sex-specific regulation of social behavior.	Frontiers in neuroendocrinology	2016	36
25997760	Oxytocin	Feldman R	Sensitive periods in human social development: New insights from research on oxytocin, synchrony, and high-risk parenting.	Development and psychopathology	2015	17
26001309	Oxytocin	Grinevich V	Assembling the Puzzle: Pathways of Oxytocin Signaling in the Brain.	Biological psychiatry	2016	19
26061800	Oxytocin	Unternaehrer E	Childhood maternal care is associated with DNA methylation of the genes for brain-derived neurotrophic factor (BDNF) and oxytocin receptor (OXTR) in peripheral blood cells in adult men and women.	Stress	2015	17
26208744	Oxytocin	Neumann ID	Oxytocin in General Anxiety and Social Fear: A Translational Approach.	Biological psychiatry	2016	28
26210057	Oxytocin	Walum H	Statistical and Methodological Considerations for the Interpretation of Intranasal Oxytocin Studies.	Biological psychiatry	2016	37
26257243	Oxytocin	Guastella AJ	Oxytocin Treatment, Circuitry, and Autism: A Critical Review of the Literature Placing Oxytocin Into the Autism Context.	Biological psychiatry	2016	23
26392129	Oxytocin	Feldman R	Oxytocin Pathway Genes: Evolutionary Ancient System Impacting on Human Affiliation, Sociality, and Psychopathology.	Biological psychiatry	2016	40
26410353	Oxytocin	Feifel D	A Review of Oxytocin's Effects on the Positive, Negative, and Cognitive Domains of Schizophrenia.	Biological psychiatry	2016	14
26893121	Oxytocin	King LB	Variation in the Oxytocin Receptor Gene Predicts Brain Region-Specific Expression and Social Attachment.	Biological psychiatry	2016	18
26991328	Oxytocin	Lane A	Is there a Publication Bias in Behavioural Intranasal Oxytocin Research on Humans? Opening the File Drawer of One Laboratory.	Journal of neuroendocrinology	2016	11
27325780	Oxytocin	Gao S	Oxytocin, the peptide that bonds the sexes also divides them.	Proceedings of the National Academy of Sciences of the United States of America	2016	12
9989453	Antioxidants	Smith KJ	Demyelination: the role of reactive oxygen and nitrogen species.	Brain pathology	1999	98
12580704	Antioxidants	Luchsinger JA	Antioxidant vitamin intake and risk of Alzheimer disease.	Archives of neurology	2003	88
12751781	Antioxidants	Dringen R	Glutathione pathways in the brain.	Biological chemistry	2003	97
15896810	Antioxidants	Calabrese V	Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.	Journal of the neurological sciences	2005	66
16267240	Antioxidants	Shih AY	A small-molecule-inducible Nrf2-mediated antioxidant response provides effective prophylaxis against cerebral ischemia in vivo.	The Journal of neuroscience 	2005	94
17326724	Antioxidants	van der Pluijm I	Impaired genome maintenance suppresses the growth hormone--insulin-like growth factor 1 axis in mice with Cockayne syndrome.	PLoS biology	2007	84
18003920	Antioxidants	Fang J	S-nitrosylation of peroxiredoxin 2 promotes oxidative stress-induced neuronal cell death in Parkinson's disease.	Proceedings of the National Academy of Sciences of the United States of America	2007	75
19162177	Antioxidants	Harrison FE	Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2.	Free radical biology & medicine	2009	93
19448625	Antioxidants	Herrero-Mendez A	The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1.	Nature cell biology	2009	188
19654589	Antioxidants	Ramirez SH	Methamphetamine disrupts blood-brain barrier function by induction of oxidative stress in brain endothelial cells.	Journal of cerebral blood flow and metabolism 	2009	59
21294650	Antioxidants	Carrano A	Amyloid Beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy.	Antioxidants & redox signaling	2011	51
21616142	Antioxidants	Batinic-Haberle I	Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics.	Free radical biology & medicine	2011	50
22036626	Antioxidants	Agrawal L	HIV-1 Tat neurotoxicity: a model of acute and chronic exposure, and neuroprotection by gene delivery of antioxidant enzymes.	Neurobiology of disease	2012	30
22138445	Antioxidants	Backos DS	The role of glutathione in brain tumor drug resistance.	Biochemical pharmacology	2012	31
22739839	Antioxidants	Pandi-Perumal SR	Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.	Neurotoxicity research	2013	33
23025925	Antioxidants	Zhang M	Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection.	Progress in neurobiology	2013	69
23547621	Antioxidants	Cornelius C	Traumatic brain injury: oxidative stress and neuroprotection.	Antioxidants & redox signaling	2013	46
24300239	Antioxidants	Dunn L	Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease.	Neurobiology of aging	2014	23
24350853	Antioxidants	Rodríguez-Rodríguez A	Oxidative stress in traumatic brain injury.	Current medicinal chemistry	2014	31
25576182	Antioxidants	Ruszkiewicz J	Changes in the mitochondrial antioxidant systems in neurodegenerative diseases and acute brain disorders.	Neurochemistry international	2015	19
25644686	Antioxidants	Bar-Or D	Oxidative stress in severe acute illness.	Redox biology	2015	15
25667085	Antioxidants	Picone P	Metformin increases APP expression and processing via oxidative stress, mitochondrial dysfunction and NF-κB activation: Use of insulin to attenuate metformin's effect.	Biochimica et biophysica acta	2015	16
26768768	Antioxidants	Pan H	SIRT6 safeguards human mesenchymal stem cells from oxidative stress by coactivating NRF2.	Cell research	2016	28
27259148	Antioxidants	Kubben N	Repression of the Antioxidant NRF2 Pathway in Premature Aging.	Cell	2016	36
9768839	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Rutherford LC	BDNF has opposite effects on the quantal amplitude of pyramidal neuron and interneuron excitatory synapses.	Neuron	1998	110
10364548	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Shi SH	Rapid spine delivery and redistribution of AMPA receptors after synaptic NMDA receptor activation.	Science	1999	292
10627585	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Banke TG	Control of GluR1 AMPA receptor function by cAMP-dependent protein kinase.	The Journal of neuroscience 	2000	151
10862698	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Husi H	Proteomic analysis of NMDA receptor-adhesion protein signaling complexes.	Nature neuroscience	2000	279
11348590	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Shi S	Subunit-specific rules governing AMPA receptor trafficking to synapses in hippocampal pyramidal neurons.	Cell	2001	288
11466413	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Perez JL	PICK1 targets activated protein kinase Calpha to AMPA receptor clusters in spines of hippocampal neurons and reduces surface levels of the AMPA-type glutamate receptor subunit 2.	The Journal of neuroscience 	2001	101
11477425	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Roche KW	Molecular determinants of NMDA receptor internalization.	Nature neuroscience	2001	135
12843250	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Stein V	Postsynaptic density-95 mimics and occludes hippocampal long-term potentiation and enhances long-term depression.	The Journal of neuroscience 	2003	102
14622580	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Greger IH	AMPA receptor tetramerization is mediated by Q/R editing.	Neuron	2003	98
15254094	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Lavezzari G	Subunit-specific regulation of NMDA receptor endocytosis.	The Journal of neuroscience 	2004	83
15312654	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Krapivinsky G	SynGAP-MUPP1-CaMKII synaptic complexes regulate p38 MAP kinase activity and NMDA receptor-dependent synaptic AMPA receptor potentiation.	Neuron	2004	84
15504326	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Nakagawa T	Quaternary structure, protein dynamics, and synaptic function of SAP97 controlled by L27 domain interactions.	Neuron	2004	97
15603741	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Fukata M	Identification of PSD-95 palmitoylating enzymes.	Neuron	2004	190
15758178	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Priel A	Stargazin reduces desensitization and slows deactivation of the AMPA-type glutamate receptors.	The Journal of neuroscience 	2005	86
16055064	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Lu W	PICK1 interacts with ABP/GRIP to regulate AMPA receptor trafficking.	Neuron	2005	84
16221846	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Kwon OB	Neuregulin-1 reverses long-term potentiation at CA1 hippocampal synapses.	The Journal of neuroscience 	2005	72
16492745	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Chang EH	AMPA receptor downscaling at the onset of Alzheimer's disease pathology in double knockin mice.	Proceedings of the National Academy of Sciences of the United States of America	2006	63
17582333	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Kim J	Regulation of dendritic excitability by activity-dependent trafficking of the A-type K+ channel subunit Kv4.2 in hippocampal neurons.	Neuron	2007	143
17632064	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Giorgi C	The EJC factor eIF4AIII modulates synaptic strength and neuronal protein expression.	Cell	2007	119
18394466	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Sacktor TC	PKMzeta, LTP maintenance, and the dynamic molecular biology of memory storage.	Progress in brain research	2008	81
18854855	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Kerchner GA	Silent synapses and the emergence of a postsynaptic mechanism for LTP.	Nature reviews. Neuroscience	2008	202
18984164	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Wang Z	Myosin Vb mobilizes recycling endosomes and AMPA receptors for postsynaptic plasticity.	Cell	2008	152
19805234	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Durakoglugil MS	Reelin signaling antagonizes beta-amyloid at the synapse.	Proceedings of the National Academy of Sciences of the United States of America	2009	55
20032460	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Zhao WQ	Inhibition of calcineurin-mediated endocytosis and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors prevents amyloid beta oligomer-induced synaptic disruption.	The Journal of biological chemistry	2010	49
20434989	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Kennedy MJ	Syntaxin-4 defines a domain for activity-dependent exocytosis in dendritic spines.	Cell	2010	91
20547867	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Chen Y	ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling.	Proceedings of the National Academy of Sciences of the United States of America	2010	86
20835250	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Gu J	ADF/cofilin-mediated actin dynamics regulate AMPA receptor trafficking during synaptic plasticity.	Nature neuroscience	2010	92
21147983	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Citri A	Calcium binding to PICK1 is essential for the intracellular retention of AMPA receptors underlying long-term depression.	The Journal of neuroscience 	2010	50
21148011	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Schwarz LA	Activity-dependent ubiquitination of GluA1 mediates a distinct AMPA receptor endocytosis and sorting pathway.	The Journal of neuroscience 	2010	63
21338354	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Lin A	Nedd4-mediated AMPA receptor ubiquitination regulates receptor turnover and trafficking.	Journal of neurochemistry	2011	52
21450454	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Xu W	PSD-95-like membrane associated guanylate kinases (PSD-MAGUKs) and synaptic plasticity.	Current opinion in neurobiology	2011	46
21808020	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Etherton M	Autism-linked neuroligin-3 R451C mutation differentially alters hippocampal and cortical synaptic function.	Proceedings of the National Academy of Sciences of the United States of America	2011	77
22325201	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Thomas GM	Palmitoylation by DHHC5/8 targets GRIP1 to dendritic endosomes to regulate AMPA-R trafficking.	Neuron	2012	44
22371606	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Noh KM	Repressor element-1 silencing transcription factor (REST)-dependent epigenetic remodeling is critical to ischemia-induced neuronal death.	Proceedings of the National Academy of Sciences of the United States of America	2012	42
22749718	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Santello M	TNFα in synaptic function: switching gears.	Trends in neurosciences	2012	49
23100419	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Arons MH	Autism-associated mutations in ProSAP2/Shank3 impair synaptic transmission and neurexin-neuroligin-mediated transsynaptic signaling.	The Journal of neuroscience 	2012	45
25155957	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Incontro S	Efficient, complete deletion of synaptic proteins using CRISPR.	Neuron	2014	32
25369168	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Peng X	Cellular plasticity induced by anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor encephalitis antibodies.	Annals of neurology	2015	24
25422582	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Tuttolomondo A	Studies of selective TNF inhibitors in the treatment of brain injury from stroke and trauma: a review of the evidence to date.	Drug design, development and therapy	2014	29
25778475	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Chanda S	Pathogenic mechanism of an autism-associated neuroligin mutation involves altered AMPA-receptor trafficking.	Molecular psychiatry	2016	11
26247861	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Levy JM	Synaptic Consolidation Normalizes AMPAR Quantal Size following MAGUK Loss.	Neuron	2015	16
27041503	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Tracy TE	Acetylated Tau Obstructs KIBRA-Mediated Signaling in Synaptic Plasticity and Promotes Tauopathy-Related Memory Loss.	Neuron	2016	18
27365450	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	Twomey EC	Elucidation of AMPA receptor-stargazin complexes by cryo-electron microscopy.	Science	2016	12
7972084	Adenosine	Kim U	Molecular cloning of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing.	Proceedings of the National Academy of Sciences of the United States of America	1994	128
8559253	Adenosine	Melcher T	A mammalian RNA editing enzyme.	Nature	1996	152
9153397	Adenosine	Burns CM	Regulation of serotonin-2C receptor G-protein coupling by RNA editing.	Nature	1997	290
10836796	Adenosine	Chen CX	A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains.	RNA	2000	134
10894545	Adenosine	Higuchi M	Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2.	Nature	2000	275
11717408	Adenosine	Maas S	Underediting of glutamate receptor GluR-B mRNA in malignant gliomas.	Proceedings of the National Academy of Sciences of the United States of America	2001	105
12048240	Adenosine	Morse DP	RNA hairpins in noncoding regions of human brain and Caenorhabditis elegans mRNA are edited by adenosine deaminases that act on RNA.	Proceedings of the National Academy of Sciences of the United States of America	2002	92
15939761	Adenosine	Vitali P	ADAR2-mediated editing of RNA substrates in the nucleolus is inhibited by C/D small nucleolar RNAs.	The Journal of cell biology	2005	72
16357084	Adenosine	Koehler RC	Role of astrocytes in cerebrovascular regulation.	Journal of applied physiology	2006	69
17030429	Adenosine	Schwarzschild MA	Targeting adenosine A2A receptors in Parkinson's disease.	Trends in neurosciences	2006	91
17056128	Adenosine	Boison D	Adenosine kinase, epilepsy and stroke: mechanisms and therapies.	Trends in pharmacological sciences	2006	79
17599088	Adenosine	Kawahara Y	RNA editing of the microRNA-151 precursor blocks cleavage by the Dicer-TRBP complex.	EMBO reports	2007	151
17646043	Adenosine	Schiffmann SN	Adenosine A2A receptors and basal ganglia physiology.	Progress in neurobiology	2007	86
17908822	Adenosine	Paz N	Altered adenosine-to-inosine RNA editing in human cancer.	Genome research	2007	95
18178553	Adenosine	Cenci C	Down-regulation of RNA editing in pediatric astrocytomas: ADAR2 editing activity inhibits cell migration and proliferation.	The Journal of biological chemistry	2008	64
18537670	Adenosine	Ferré S	An update on adenosine A2A-dopamine D2 receptor interactions: implications for the function of G protein-coupled receptors.	Current pharmaceutical design	2008	53
18684997	Adenosine	Kawahara Y	Frequency and fate of microRNA editing in human brain.	Nucleic acids research	2008	111
18809461	Adenosine	Scharf MT	The energy hypothesis of sleep revisited.	Progress in neurobiology	2008	52
19075717	Adenosine	Krueger JM	The role of cytokines in sleep regulation.	Current pharmaceutical design	2008	87
19478186	Adenosine	Li JB	Genome-wide identification of human RNA editing sites by parallel DNA capturing and sequencing.	Science	2009	207
19525944	Adenosine	Orr AG	Adenosine A(2A) receptor mediates microglial process retraction.	Nature neuroscience	2009	75
19639293	Adenosine	Stone TW	Adenosine receptors and neurological disease: neuroprotection and neurodegeneration.	Handbook of experimental pharmacology	2009	46
19705571	Adenosine	Anwyl R	Metabotropic glutamate receptor-dependent long-term potentiation.	Neuropharmacology	2009	59
20164566	Adenosine	Ribeiro JA	Caffeine and adenosine.	Journal of Alzheimer's disease 	2010	43
20394819	Adenosine	Morabito MV	Mice with altered serotonin 2C receptor RNA editing display characteristics of Prader-Willi syndrome.	Neurobiology of disease	2010	50
20566853	Adenosine	Paz-Yaacov N	Adenosine-to-inosine RNA editing shapes transcriptome diversity in primates.	Proceedings of the National Academy of Sciences of the United States of America	2010	52
21876681	Adenosine	Hamza TH	Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee.	PLoS genetics	2011	78
22215671	Adenosine	Rittiner JE	AMP is an adenosine A1 receptor agonist.	The Journal of biological chemistry	2012	42
22499667	Adenosine	Alon S	Systematic identification of edited microRNAs in the human brain.	Genome research	2012	60
22674620	Adenosine	Koizumi S	Purinergic receptors in microglia: functional modal shifts of microglia mediated by P2 and P1 receptors.	Glia	2013	31
22700220	Adenosine	Boison D	Adenosine dysfunction in epilepsy.	Glia	2012	32
23093778	Adenosine	Choudhury Y	Attenuated adenosine-to-inosine editing of microRNA-376a* promotes invasiveness of glioblastoma cells.	The Journal of clinical investigation	2012	40
23248274	Adenosine	Hikida T	Pathway-specific modulation of nucleus accumbens in reward and aversive behavior via selective transmitter receptors.	Proceedings of the National Academy of Sciences of the United States of America	2013	31
24165678	Adenosine	Li JB	Deciphering the functions and regulation of brain-enriched A-to-I RNA editing.	Nature neuroscience	2013	44
24169640	Adenosine	Hwang Y	Gene expression profiling by mRNA sequencing reveals increased expression of immune/inflammation-related genes in the hippocampus of individuals with schizophrenia.	Translational psychiatry	2013	38
24485196	Adenosine	Daniel C	Alu elements shape the primate transcriptome by cis-regulation of RNA editing.	Genome biology	2014	25
24552284	Adenosine	Zhou Q	Early-onset stroke and vasculopathy associated with mutations in ADA2.	The New England journal of medicine	2014	47
25262373	Adenosine	Kim DG	A2A Adenosine Receptor Regulates the Human Blood-Brain Barrier Permeability.	Molecular neurobiology	2015	15
25708366	Adenosine	Chen T	ADAR1 is required for differentiation and neural induction by regulating microRNA processing in a catalytically independent manner.	Cell research	2015	15
26100888	Adenosine	Bonaventura J	Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer.	Proceedings of the National Academy of Sciences of the United States of America	2015	25
27348216	Adenosine	Hwang T	Dynamic regulation of RNA editing in human brain development and disease.	Nature neuroscience	2016	22
27365148	Adenosine	Cunha RA	How does adenosine control neuronal dysfunction and neurodegeneration?	Journal of neurochemistry	2016	19
9862320	Neuropeptide Y	Elias CF	Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area.	The Journal of comparative neurology	1998	143
12848939	Neuropeptide Y	Wu Q	Developmental control of foraging and social behavior by the Drosophila neuropeptide Y-like system.	Neuron	2003	115
16254186	Neuropeptide Y	Luquet S	NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates.	Science	2005	308
16935329	Neuropeptide Y	Arora S	Role of neuropeptides in appetite regulation and obesity--a review.	Neuropeptides	2006	73
18385673	Neuropeptide Y	Zhou Z	Genetic variation in human NPY expression affects stress response and emotion.	Nature	2008	122
19756388	Neuropeptide Y	Moonat S	Neuroscience of alcoholism: molecular and cellular mechanisms.	Cellular and molecular life sciences 	2010	51
20308990	Neuropeptide Y	Lesch KP	Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree.	Molecular psychiatry	2011	37
20974464	Neuropeptide Y	Yang Y	Increased interstitial white matter neuron density in the dorsolateral prefrontal cortex of people with schizophrenia.	Biological psychiatry	2011	36
21976046	Neuropeptide Y	Cohen H	The neuropeptide Y (NPY)-ergic system is associated with behavioral resilience to stress exposure in an animal model of post-traumatic stress disorder.	Neuropsychopharmacology 	2012	45
22979996	Neuropeptide Y	Holzer P	Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis.	Neuropeptides	2012	52
25662369	Neuropeptide Y	Loh K	Regulation of energy homeostasis by the NPY system.	Trends in endocrinology and metabolism	2015	17
26441327	Neuropeptide Y	Reichmann F	Neuropeptide Y: A stressful review.	Neuropeptides	2016	22
8101394	Cocaine	Volkow ND	Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers.	Synapse	1993	218
9126740	Cocaine	Volkow ND	Relationship between subjective effects of cocaine and dopamine transporter occupancy.	Nature	1997	133
9331351	Cocaine	Breiter HC	Acute effects of cocaine on human brain activity and emotion.	Neuron	1997	248
9766762	Cocaine	Volkow ND	Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate.	The American journal of psychiatry	1998	118
11923456	Cocaine	Park WK	Cocaine administered into the medial prefrontal cortex reinstates cocaine-seeking behavior by increasing AMPA receptor-mediated glutamate transmission in the nucleus accumbens.	The Journal of neuroscience 	2002	96
14614461	Cocaine	Kim SJ	Activation of the TRPC1 cation channel by metabotropic glutamate receptor mGluR1.	Nature	2003	102
16376315	Cocaine	Liu QR	Rodent BDNF genes, novel promoters, novel splice variants, and regulation by cocaine.	Brain research	2006	108
17084911	Cocaine	Lu L	Role of ERK in cocaine addiction.	Trends in neurosciences	2006	119
17895916	Cocaine	Li CS	Neural correlates of impulse control during stop signal inhibition in cocaine-dependent men.	Neuropsychopharmacology 	2008	77
18199998	Cocaine	Brimijoin S	A cocaine hydrolase engineered from human butyrylcholinesterase selectively blocks cocaine toxicity and reinstatement of drug seeking in rats.	Neuropsychopharmacology 	2008	69
18414406	Cocaine	Wang JC	Genetic variation in the CHRNA5 gene affects mRNA levels and is associated with risk for alcohol dependence.	Molecular psychiatry	2009	107
18579413	Cocaine	Chang L	Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse.	NeuroImage	2008	62
18772040	Cocaine	Bubar MJ	Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse.	Progress in brain research	2008	55
19564918	Cocaine	Tomasi D	Dopamine transporters in striatum correlate with deactivation in the default mode network during visuospatial attention.	PloS one	2009	64
19703567	Cocaine	Chandrasekar V	microRNAs miR-124, let-7d and miR-181a regulate cocaine-induced plasticity.	Molecular and cellular neurosciences	2009	85
19732758	Cocaine	McGinty JF	Brain-derived neurotrophic factor and cocaine addiction.	Brain research	2010	71
19738093	Cocaine	Volkow ND	Evaluating dopamine reward pathway in ADHD: clinical implications.	JAMA	2009	133
20223200	Cocaine	Hnasko TS	Vesicular glutamate transport promotes dopamine storage and glutamate corelease in vivo.	Neuron	2010	128
20711185	Cocaine	Im HI	MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212.	Nature neuroscience	2010	164
20856250	Cocaine	Volkow ND	Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway.	Molecular psychiatry	2011	65
21150907	Cocaine	Moyer RA	Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse.	Neuropsychopharmacology 	2011	48
21232547	Cocaine	Lee BR	Cocaine-induced metaplasticity in the nucleus accumbens: silent synapse and beyond.	Neuropharmacology	2011	40
21307844	Cocaine	Chandrasekar V	Regulation of MiR-124, Let-7d, and MiR-181a in the accumbens affects the expression, extinction, and reinstatement of cocaine-induced conditioned place preference.	Neuropsychopharmacology 	2011	56
21383264	Cocaine	Alia-Klein N	Gene x disease interaction on orbitofrontal gray matter in cocaine addiction.	Archives of general psychiatry	2011	39
21508219	Cocaine	Yao H	Cocaine hijacks σ1 receptor to initiate induction of activated leukocyte cell adhesion molecule: implication for increased monocyte adhesion and migration in the CNS.	The Journal of neuroscience 	2011	41
21835346	Cocaine	Bruchas MR	Selective p38α MAPK deletion in serotonergic neurons produces stress resilience in models of depression and addiction.	Neuron	2011	89
21885214	Cocaine	Connolly CG	The neurobiology of cognitive control in successful cocaine abstinence.	Drug and alcohol dependence	2012	47
22243750	Cocaine	Taniguchi M	Histone deacetylase 5 limits cocaine reward through cAMP-induced nuclear import.	Neuron	2012	39
22714667	Cocaine	Clark KH	Psychostimulant abuse and neuroinflammation: emerging evidence of their interconnection.	Neurotoxicity research	2013	42
23467346	Cocaine	Robison AJ	Behavioral and structural responses to chronic cocaine require a feedforward loop involving ΔFosB and calcium/calmodulin-dependent protein kinase II in the nucleus accumbens shell.	The Journal of neuroscience 	2013	52
23485852	Cocaine	Luo X	Error processing and gender-shared and -specific neural predictors of relapse in cocaine dependence.	Brain 	2013	37
23727437	Cocaine	Loweth JA	Adaptations in AMPA receptor transmission in the nucleus accumbens contributing to incubation of cocaine craving.	Neuropharmacology	2014	33
24102293	Cocaine	Calipari ES	Extended access of cocaine self-administration results in tolerance to the dopamine-elevating and locomotor-stimulating effects of cocaine.	Journal of neurochemistry	2014	22
24934288	Cocaine	Dragicevic E	Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons.	Brain 	2014	25
25505168	Cocaine	Howell LL	Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder.	Pharmacological reviews	2015	31
25644383	Cocaine	Northcutt AL	DAT isn't all that: cocaine reward and reinforcement require Toll-like receptor 4 signaling.	Molecular psychiatry	2015	26
25762666	Cocaine	Slaker M	Removal of perineuronal nets in the medial prefrontal cortex impairs the acquisition and reconsolidation of a cocaine-induced conditioned place preference memory.	The Journal of neuroscience 	2015	24
26202104	Cocaine	Taylor AM	Neuroimmune Regulation of GABAergic Neurons Within the Ventral Tegmental Area During Withdrawal from Chronic Morphine.	Neuropsychopharmacology 	2016	14
15685439	O-(6)-methylguanine	Ohgaki H	Epidemiology and etiology of gliomas.	Acta neuropathologica	2005	228
18483356	O-(6)-methylguanine	Sarkaria JN	Mechanisms of chemoresistance to alkylating agents in malignant glioma.	Clinical cancer research 	2008	83
18757334	O-(6)-methylguanine	Hegi ME	Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity.	Journal of clinical oncology 	2008	179
19088037	O-(6)-methylguanine	Pallini R	Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme.	Clinical cancer research 	2008	95
19107440	O-(6)-methylguanine	Ohgaki H	Epidemiology of brain tumors.	Methods in molecular biology	2009	92
19805672	O-(6)-methylguanine	Weller M	Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network.	Journal of clinical oncology 	2009	142
20150378	O-(6)-methylguanine	Rivera AL	MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma.	Neuro-oncology	2010	60
20309962	O-(6)-methylguanine	Pistollato F	Intratumoral hypoxic gradient drives stem cells distribution and MGMT expression in glioblastoma.	Stem cells	2010	66
20714900	O-(6)-methylguanine	Riemenschneider MJ	Molecular diagnostics of gliomas: state of the art.	Acta neuropathologica	2010	47
20880848	O-(6)-methylguanine	Zhang WB	Activation of AMP-activated protein kinase by temozolomide contributes to apoptosis in glioblastoma cells via p53 activation and mTORC1 inhibition.	The Journal of biological chemistry	2010	43
21292686	O-(6)-methylguanine	Kunz M	Hot spots in dynamic (18)FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas.	Neuro-oncology	2011	37
21895872	O-(6)-methylguanine	Lakomy R	MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients.	Cancer science	2011	46
22139906	O-(6)-methylguanine	Reifenberger G	Predictive impact of MGMT promoter methylation in glioblastoma of the elderly.	International journal of cancer	2012	52
22244911	O-(6)-methylguanine	Silber JR	O(6)-methylguanine-DNA methyltransferase in glioma therapy: promise and problems.	Biochimica et biophysica acta	2012	30
22294349	O-(6)-methylguanine	Quillien V	Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, MethyLight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNA-methyltranferase in a series of 100 glioblastoma patients.	Cancer	2012	42
22810491	O-(6)-methylguanine	Bady P	MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status.	Acta neuropathologica	2012	51
23095825	O-(6)-methylguanine	Weller M	Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice.	Neuro-oncology	2012	31
23726844	O-(6)-methylguanine	Zhang XQ	A long non-coding RNA signature in glioblastoma multiforme predicts survival.	Neurobiology of disease	2013	53
23904111	O-(6)-methylguanine	Wiestler B	ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis.	Acta neuropathologica	2013	51
24367102	O-(6)-methylguanine	Weiler M	mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy.	Proceedings of the National Academy of Sciences of the United States of America	2014	39
24469053	O-(6)-methylguanine	Zhang LH	TRIM24 promotes glioma progression and enhances chemoresistance through activation of the PI3K/Akt signaling pathway.	Oncogene	2015	16
24510240	O-(6)-methylguanine	Molenaar RJ	The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone.	Neuro-oncology	2014	26
24912512	O-(6)-methylguanine	Wick W	MGMT testing--the challenges for biomarker-based glioma treatment.	Nature reviews. Neurology	2014	59
25355681	O-(6)-methylguanine	Berghoff AS	Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma.	Neuro-oncology	2015	83
26948350	O-(6)-methylguanine	Masui K	Molecular classification of gliomas.	Handbook of clinical neurology	2016	14
11145488	Cholinesterase Inhibitors	McKeith I	Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study.	Lancet	2000	93
16854944	Cholinesterase Inhibitors	Engler H	Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.	Brain 	2006	162
19118806	Cholinesterase Inhibitors	Roher AE	Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease.	Alzheimer's & dementia 	2009	63
19234858	Cholinesterase Inhibitors	Weller RO	Microvasculature changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy.	Acta neuropathologica	2009	67
21056464	Cholinesterase Inhibitors	van Eijk MM	Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial.	Lancet	2010	51
23435942	Cholinesterase Inhibitors	Anand P	A review on cholinesterase inhibitors for Alzheimer's disease.	Archives of pharmacal research	2013	33
26795874	Cholinesterase Inhibitors	Henderson EJ	Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial.	The Lancet. Neurology	2016	15
9620775	Reactive Oxygen Species	Parkes TL	Extension of Drosophila lifespan by overexpression of human SOD1 in motorneurons.	Nature genetics	1998	166
11786404	Reactive Oxygen Species	Coraci IS	CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils.	The American journal of pathology	2002	100
15791003	Reactive Oxygen Species	Zhang W	Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease.	FASEB journal 	2005	259
17116235	Reactive Oxygen Species	Lambert MP	Monoclonal antibodies that target pathological assemblies of Abeta.	Journal of neurochemistry	2007	109
17127365	Reactive Oxygen Species	Mancuso C	Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders.	Frontiers in bioscience 	2007	70
17250680	Reactive Oxygen Species	Haorah J	Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction.	Journal of neurochemistry	2007	79
17586731	Reactive Oxygen Species	Schreibelt G	Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling.	FASEB journal 	2007	73
17704323	Reactive Oxygen Species	Zhao W	Oxidative damage pathways in relation to normal tissue injury.	The British journal of radiology	2007	56
18245082	Reactive Oxygen Species	Devi L	Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain.	The Journal of biological chemistry	2008	198
19023330	Reactive Oxygen Species	Moisoi N	Mitochondrial dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific transcriptional stress response.	Cell death and differentiation	2009	47
19059306	Reactive Oxygen Species	Garrido AM	NADPH oxidases and angiotensin II receptor signaling.	Molecular and cellular endocrinology	2009	99
19135149	Reactive Oxygen Species	S Roriz-Filho J	(Pre)diabetes, brain aging, and cognition.	Biochimica et biophysica acta	2009	68
19285945	Reactive Oxygen Species	Gandhi S	PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death.	Molecular cell	2009	170
19309263	Reactive Oxygen Species	Sorce S	NOX enzymes in the central nervous system: from signaling to disease.	Antioxidants & redox signaling	2009	122
19751828	Reactive Oxygen Species	Niizuma K	Mitochondrial and apoptotic neuronal death signaling pathways in cerebral ischemia.	Biochimica et biophysica acta	2010	61
20186336	Reactive Oxygen Species	Krebiehl G	Reduced basal autophagy and impaired mitochondrial dynamics due to loss of Parkinson's disease-associated protein DJ-1.	PloS one	2010	88
20574517	Reactive Oxygen Species	Venkataraman S	MicroRNA 128a increases intracellular ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer cell growth by promoting senescence.	PloS one	2010	55
20639397	Reactive Oxygen Species	Irrcher I	Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics.	Human molecular genetics	2010	115
20689558	Reactive Oxygen Species	Tobaben S	Bid-mediated mitochondrial damage is a key mechanism in glutamate-induced oxidative stress and AIF-dependent cell death in immortalized HT-22 hippocampal neurons.	Cell death and differentiation	2011	41
20880500	Reactive Oxygen Species	Lull ME	Microglial activation and chronic neurodegeneration.	Neurotherapeutics 	2010	124
21211782	Reactive Oxygen Species	Le Belle JE	Proliferative neural stem cells have high endogenous ROS levels that regulate self-renewal and neurogenesis in a PI3K/Akt-dependant manner.	Cell stem cell	2011	168
22072942	Reactive Oxygen Species	Chen SD	Roles of oxidative stress, apoptosis, PGC-1α and mitochondrial biogenesis in cerebral ischemia.	International journal of molecular sciences	2011	49
22366799	Reactive Oxygen Species	Fischer MT	NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury.	Brain 	2012	87
22367679	Reactive Oxygen Species	Kaur C	Roles of activated microglia in hypoxia induced neuroinflammation in the developing brain and the retina.	Journal of neuroimmune pharmacology 	2013	29
22388960	Reactive Oxygen Species	Wu LJ	The voltage-gated proton channel Hv1 enhances brain damage from ischemic stroke.	Nature neuroscience	2012	60
22549002	Reactive Oxygen Species	Barone E	Heme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairment.	Free radical biology & medicine	2012	32
22639965	Reactive Oxygen Species	Niu J	Leucine-rich repeat kinase 2 disturbs mitochondrial dynamics via Dynamin-like protein.	Journal of neurochemistry	2012	32
22887998	Reactive Oxygen Species	Wanka C	Tp53-induced glycolysis and apoptosis regulator (TIGAR) protects glioma cells from starvation-induced cell death by up-regulating respiration and improving cellular redox homeostasis.	The Journal of biological chemistry	2012	41
22937798	Reactive Oxygen Species	Radermacher KA	Neuroprotection after stroke by targeting NOX4 as a source of oxidative stress.	Antioxidants & redox signaling	2013	30
23003569	Reactive Oxygen Species	Cheng G	Mitochondria in traumatic brain injury and mitochondrial-targeted multipotential therapeutic strategies.	British journal of pharmacology	2012	39
23472786	Reactive Oxygen Species	Santos CX	Endoplasmic reticulum stress and Nox-mediated reactive oxygen species signaling in the peripheral vasculature: potential role in hypertension.	Antioxidants & redox signaling	2014	25
24048902	Reactive Oxygen Species	Park S	The mitochondrial antiviral protein MAVS associates with NLRP3 and regulates its inflammasome activity.	Journal of immunology	2013	31
24185179	Reactive Oxygen Species	Sato A	Pivotal role for ROS activation of p38 MAPK in the control of differentiation and tumor-initiating capacity of glioma-initiating cells.	Stem cell research	2014	26
24381719	Reactive Oxygen Species	Popa-Wagner A	ROS and brain diseases: the good, the bad, and the ugly.	Oxidative medicine and cellular longevity	2013	29
24455696	Reactive Oxygen Species	Hsieh HL	Role of redox signaling in neuroinflammation and neurodegenerative diseases.	BioMed research international	2013	59
24979777	Reactive Oxygen Species	Alavian KN	An uncoupling channel within the c-subunit ring of the F1FO ATP synthase is the mitochondrial permeability transition pore.	Proceedings of the National Academy of Sciences of the United States of America	2014	110
25091898	Reactive Oxygen Species	Bordt EA	NADPH oxidase- and mitochondria-derived reactive oxygen species in proinflammatory microglial activation: a bipartisan affair?	Free radical biology & medicine	2014	23
25409632	Reactive Oxygen Species	Ma R	HIV Tat-Mediated Induction of Human Brain Microvascular Endothelial Cell Apoptosis Involves Endoplasmic Reticulum Stress and Mitochondrial Dysfunction.	Molecular neurobiology	2016	10
25416158	Reactive Oxygen Species	Harischandra DS	α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson's disease.	Toxicological sciences 	2015	22
25722131	Reactive Oxygen Species	Li L	ROS and Autophagy: Interactions and Molecular Regulatory Mechanisms.	Cellular and molecular neurobiology	2015	32
26968531	Reactive Oxygen Species	Bolaños JP	Bioenergetics and redox adaptations of astrocytes to neuronal activity.	Journal of neurochemistry	2016	13
27127546	Reactive Oxygen Species	Minutoli L	ROS-Mediated NLRP3 Inflammasome Activation in Brain, Heart, Kidney, and Testis Ischemia/Reperfusion Injury.	Oxidative medicine and cellular longevity	2016	17
9952257	Kainic Acid	Bragin A	Hippocampal and entorhinal cortex high-frequency oscillations (100--500 Hz) in human epileptic brain and in kainic acid--treated rats with chronic seizures.	Epilepsia	1999	131
16968951	Kainic Acid	Farooqui AA	Inhibitors of brain phospholipase A2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders.	Pharmacological reviews	2006	68
17149751	Kainic Acid	Aid T	Mouse and rat BDNF gene structure and expression revisited.	Journal of neuroscience research	2007	264
17299517	Kainic Acid	Beneyto M	Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders.	Neuropsychopharmacology 	2007	106
18793656	Kainic Acid	Jane DE	Kainate receptors: pharmacology, function and therapeutic potential.	Neuropharmacology	2009	70
18952671	Kainic Acid	Balosso S	A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta.	Brain 	2008	53
20592204	Kainic Acid	Hu X	BACE1 deficiency causes altered neuronal activity and neurodegeneration.	The Journal of neuroscience 	2010	57
21256604	Kainic Acid	Contractor A	Kainate receptors coming of age: milestones of two decades of research.	Trends in neurosciences	2011	72
21411646	Kainic Acid	Zattoni M	Brain infiltration of leukocytes contributes to the pathophysiology of temporal lobe epilepsy.	The Journal of neuroscience 	2011	48
23296467	Kainic Acid	Luo J	Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival.	The Journal of experimental medicine	2013	39
23523633	Kainic Acid	Iori V	Receptor for Advanced Glycation Endproducts is upregulated in temporal lobe epilepsy and contributes to experimental seizures.	Neurobiology of disease	2013	28
25316333	Kainic Acid	Palacios-Filardo J	Synaptic Targeting of Kainate Receptors.	Cerebral cortex	2016	11
25636686	Kainic Acid	Kuzniewska B	Adult Deletion of SRF Increases Epileptogenesis and Decreases Activity-Induced Gene Expression.	Molecular neurobiology	2016	10
26439639	Kainic Acid	Gautier HO	Neuronal activity regulates remyelination via glutamate signalling to oligodendrocyte progenitors.	Nature communications	2015	16
28219683	Kainic Acid	Yuzaki M	The C1q complement family of synaptic organizers: not just complementary.	Current opinion in neurobiology	2017	7
18927145	Formaldehyde	Gouw AA	Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology.	Brain 	2008	75
20150367	Formaldehyde	Colman H	A multigene predictor of outcome in glioblastoma.	Neuro-oncology	2010	124
21138945	Formaldehyde	Barrow J	Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas.	Neuro-oncology	2011	42
21638088	Formaldehyde	Capper D	Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody.	Acta neuropathologica	2011	79
22331473	Formaldehyde	Lu Y	MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer.	Carcinogenesis	2012	51
23195594	Formaldehyde	Prudente CN	Neuropathology of cervical dystonia.	Experimental neurology	2013	32
24242678	Formaldehyde	Heinzelmann J	MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.	Annals of surgical oncology	2014	21
24412053	Formaldehyde	Visani M	Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.	Molecular oncology	2014	23
25752754	Formaldehyde	Korshunov A	Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers.	Acta neuropathologica	2015	27
26976201	Formaldehyde	Thompson EM	Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis.	The Lancet. Oncology	2016	13
27372395	Formaldehyde	Martines RB	Pathology of congenital Zika syndrome in Brazil: a case series.	Lancet	2016	42
10918705	Adrenocorticotropic Hormone	Heim C	Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood.	JAMA	2000	334
11282691	Adrenocorticotropic Hormone	Heim C	Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse.	The American journal of psychiatry	2001	137
11430844	Adrenocorticotropic Hormone	Heim C	The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies.	Biological psychiatry	2001	488
11862370	Adrenocorticotropic Hormone	O'Malley SS	Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.	Psychopharmacology	2002	151
12764219	Adrenocorticotropic Hormone	Schommer NC	Dissociation between reactivity of the hypothalamus-pituitary-adrenal axis and the sympathetic-adrenal-medullary system to repeated psychosocial stress.	Psychosomatic medicine	2003	81
12832253	Adrenocorticotropic Hormone	Capuron L	Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy.	The American journal of psychiatry	2003	78
12845411	Adrenocorticotropic Hormone	Sinha R	Hypothalamic-pituitary-adrenal axis and sympatho-adreno-medullary responses during stress-induced and drug cue-induced cocaine craving states.	Psychopharmacology	2003	103
12944327	Adrenocorticotropic Hormone	Raison CL	When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders.	The American journal of psychiatry	2003	207
15946990	Adrenocorticotropic Hormone	Ito N	Human hair follicles display a functional equivalent of the hypothalamic-pituitary-adrenal axis and synthesize cortisol.	FASEB journal 	2005	96
16472586	Adrenocorticotropic Hormone	Dinan TG	Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?	Gastroenterology	2006	117
16845409	Adrenocorticotropic Hormone	Arck PC	Neuroimmunology of stress: skin takes center stage.	The Journal of investigative dermatology	2006	69
17408865	Adrenocorticotropic Hormone	Wilhelm I	Is the cortisol awakening rise a response to awakening?	Psychoneuroendocrinology	2007	68
17678633	Adrenocorticotropic Hormone	Felger JC	Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression.	Biological psychiatry	2007	59
17716089	Adrenocorticotropic Hormone	Southwick SM	The psychobiology of depression and resilience to stress: implications for prevention and treatment.	Annual review of clinical psychology	2005	155
17825799	Adrenocorticotropic Hormone	Heim C	The dexamethasone/corticotropin-releasing factor test in men with major depression: role of childhood trauma.	Biological psychiatry	2008	66
18339361	Adrenocorticotropic Hormone	Tyrka AR	Childhood parental loss and adult hypothalamic-pituitary-adrenal function.	Biological psychiatry	2008	74
18394919	Adrenocorticotropic Hormone	Bornstein SR	Dissociation of ACTH and glucocorticoids.	Trends in endocrinology and metabolism	2008	62
18684212	Adrenocorticotropic Hormone	Chang L	Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome.	Neurogastroenterology and motility 	2009	56
19125209	Adrenocorticotropic Hormone	Anisman H	Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder.	Journal of psychiatry & neuroscience 	2009	81
19571587	Adrenocorticotropic Hormone	Papadimitriou A	Regulation of the hypothalamic-pituitary-adrenal axis.	Neuroimmunomodulation	2009	50
20160137	Adrenocorticotropic Hormone	Wood SK	Individual differences in reactivity to social stress predict susceptibility and resilience to a depressive phenotype: role of corticotropin-releasing factor.	Endocrinology	2010	69
21257974	Adrenocorticotropic Hormone	Stetler C	Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research.	Psychosomatic medicine	2011	131
21792580	Adrenocorticotropic Hormone	Sinha R	New findings on biological factors predicting addiction relapse vulnerability.	Current psychiatry reports	2011	38
22663896	Adrenocorticotropic Hormone	Aiello G	Stress abnormalities in individuals at risk for psychosis: a review of studies in subjects with familial risk or with "at risk" mental state.	Psychoneuroendocrinology	2012	30
24495607	Adrenocorticotropic Hormone	Belvederi Murri M	HPA axis and aging in depression: systematic review and meta-analysis.	Psychoneuroendocrinology	2014	30
25559807	Adrenocorticotropic Hormone	Chemaitilly W	Anterior hypopituitarism in adult survivors of childhood cancers treated with cranial radiotherapy: a report from the St Jude Lifetime Cohort study.	Journal of clinical oncology 	2015	18
26004339	Adrenocorticotropic Hormone	Lacroix A	Cushing's syndrome.	Lancet	2015	44
26773400	Adrenocorticotropic Hormone	Stephens MA	Hypothalamic-pituitary-adrenal axis response to acute psychosocial stress: Effects of biological sex and circulating sex hormones.	Psychoneuroendocrinology	2016	15
2549856	Cyclic AMP	Cohen P	The structure and regulation of protein phosphatases.	Annual review of biochemistry	1989	405
9634236	Cyclic AMP	Ludwig A	A family of hyperpolarization-activated mammalian cation channels.	Nature	1998	218
11448722	Cyclic AMP	Robbins J	KCNQ potassium channels: physiology, pathophysiology, and pharmacology.	Pharmacology & therapeutics	2001	111
15013227	Cyclic AMP	Nguyen PV	Regulation of hippocampal synaptic plasticity by cyclic AMP-dependent protein kinases.	Progress in neurobiology	2003	92
16054096	Cyclic AMP	Woods A	Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells.	Cell metabolism	2005	364
16799259	Cyclic AMP	Miyamoto E	Molecular mechanism of neuronal plasticity: induction and maintenance of long-term potentiation in the hippocampus.	Journal of pharmacological sciences	2006	76
17224405	Cyclic AMP	Kuramoto N	Phospho-dependent functional modulation of GABA(B) receptors by the metabolic sensor AMP-dependent protein kinase.	Neuron	2007	62
17277774	Cyclic AMP	Vijayraghavan S	Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory.	Nature neuroscience	2007	255
18316612	Cyclic AMP	Sarkar D	Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1.	Cancer research	2008	87
19136996	Cyclic AMP	Villanueva EC	Leptin receptor signaling and the regulation of mammalian physiology.	International journal of obesity	2008	55
20186705	Cyclic AMP	Yoshii A	Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity, and disease.	Developmental neurobiology	2010	132
21346730	Cyclic AMP	Altarejos JY	CREB and the CRTC co-activators: sensors for hormonal and metabolic signals.	Nature reviews. Molecular cell biology	2011	233
21796118	Cyclic AMP	Wang M	Neuronal basis of age-related working memory decline.	Nature	2011	98
21989194	Cyclic AMP	Robison AJ	Transcriptional and epigenetic mechanisms of addiction.	Nature reviews. Neuroscience	2011	244
22578011	Cyclic AMP	Ramesh V	Disrupted sleep without sleep curtailment induces sleepiness and cognitive dysfunction via the tumor necrosis factor-α pathway.	Journal of neuroinflammation	2012	34
22614013	Cyclic AMP	Palumbo T	Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN-AKT pathway.	Oncogene	2013	28
23706743	Cyclic AMP	Leprivier G	The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation.	Cell	2013	88
26419764	Cyclic AMP	Ehrlich DE	Plasticity-related genes in brain development and amygdala-dependent learning.	Genes, brain, and behavior	2016	10
27402953	Cyclic AMP	Inda C	Different cAMP sources are critically involved in G protein-coupled receptor CRHR1 signaling.	The Journal of cell biology	2016	11
27599210	Cyclic AMP	Geisler JG	DNP, mitochondrial uncoupling, and neuroprotection: A little dab'll do ya.	Alzheimer's & dementia 	2017	8
10791374	Natriuretic Peptide, Brain	Troughton RW	Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations.	Lancet	2000	133
12135939	Natriuretic Peptide, Brain	McCullough PA	B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study.	Circulation	2002	90
12225726	Natriuretic Peptide, Brain	Redfield MM	Plasma brain natriuretic peptide concentration: impact of age and gender.	Journal of the American College of Cardiology	2002	111
12892964	Natriuretic Peptide, Brain	de Lemos JA	B-type natriuretic peptide in cardiovascular disease.	Lancet	2003	111
14769680	Natriuretic Peptide, Brain	Wang TJ	Impact of obesity on plasma natriuretic peptide levels.	Circulation	2004	137
15774989	Natriuretic Peptide, Brain	Doust JA	How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review.	BMJ	2005	95
15781736	Natriuretic Peptide, Brain	Sackner-Bernstein JD	Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure.	Circulation	2005	95
17090767	Natriuretic Peptide, Brain	Bursi F	Systolic and diastolic heart failure in the community.	JAMA	2006	183
18154959	Natriuretic Peptide, Brain	Daniels LB	Natriuretic peptides.	Journal of the American College of Cardiology	2007	143
18480203	Natriuretic Peptide, Brain	Zethelius B	Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.	The New England journal of medicine	2008	186
18598886	Natriuretic Peptide, Brain	Anderson PA	Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study.	Journal of the American College of Cardiology	2008	63
18760965	Natriuretic Peptide, Brain	Maisel A	State of the art: using natriuretic peptide levels in clinical practice.	European journal of heart failure	2008	98
19176440	Natriuretic Peptide, Brain	Pfisterer M	BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial.	JAMA	2009	64
19245965	Natriuretic Peptide, Brain	Frankel DS	Resistin, adiponectin, and risk of heart failure the Framingham offspring study.	Journal of the American College of Cardiology	2009	60
19567439	Natriuretic Peptide, Brain	Melander O	Novel and conventional biomarkers for prediction of incident cardiovascular events in the community.	JAMA	2009	117
19917883	Natriuretic Peptide, Brain	Di Angelantonio E	B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies.	Circulation	2009	72
20038857	Natriuretic Peptide, Brain	Fremont RD	Acute lung injury in patients with traumatic injuries: utility of a panel of biomarkers for diagnosis and pathogenesis.	The Journal of trauma	2010	42
20048208	Natriuretic Peptide, Brain	Schnabel RB	Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community.	Circulation	2010	69
20103775	Natriuretic Peptide, Brain	Witham MD	The effects of vitamin D supplementation on physical function and quality of life in older patients with heart failure: a randomized controlled trial.	Circulation. Heart failure	2010	40
20331902	Natriuretic Peptide, Brain	Sturgess DJ	Prediction of hospital outcome in septic shock: a prospective comparison of tissue Doppler and cardiac biomarkers.	Critical care	2010	43
21616287	Natriuretic Peptide, Brain	Fallah-Rad N	The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy.	Journal of the American College of Cardiology	2011	66
21733911	Natriuretic Peptide, Brain	Seiler S	The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation.	European heart journal	2011	38
21791540	Natriuretic Peptide, Brain	Maisel AS	Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial.	European journal of heart failure	2011	44
22026577	Natriuretic Peptide, Brain	de Boer RA	The fibrosis marker galectin-3 and outcome in the general population.	Journal of internal medicine	2012	49
22431676	Natriuretic Peptide, Brain	Kavousi M	Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study.	Annals of internal medicine	2012	65
22589298	Natriuretic Peptide, Brain	Agarwal SK	Prediction of incident heart failure in general practice: the Atherosclerosis Risk in Communities (ARIC) Study.	Circulation. Heart failure	2012	36
22744937	Natriuretic Peptide, Brain	Sawaya H	Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab.	Circulation. Cardiovascular imaging	2012	73
22806632	Natriuretic Peptide, Brain	van Heerebeek L	Low myocardial protein kinase G activity in heart failure with preserved ejection fraction.	Circulation	2012	63
22907935	Natriuretic Peptide, Brain	Wang TJ	Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study.	Circulation	2012	71
22939561	Natriuretic Peptide, Brain	Ho JE	Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community.	Journal of the American College of Cardiology	2012	82
23065358	Natriuretic Peptide, Brain	Vrtovec B	Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up.	Circulation research	2013	52
23500300	Natriuretic Peptide, Brain	van Veldhuisen DJ	B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction.	Journal of the American College of Cardiology	2013	60
23608605	Natriuretic Peptide, Brain	Pinney JH	Senile systemic amyloidosis: clinical features at presentation and outcome.	Journal of the American Heart Association	2013	28
23797610	Natriuretic Peptide, Brain	Chavali V	Differential expression of dicer, miRNAs, and inflammatory markers in diabetic Ins2+/- Akita hearts.	Cell biochemistry and biophysics	2014	25
24033321	Natriuretic Peptide, Brain	Patel AR	Cardiovascular risk, myocardial injury, and exacerbations of chronic obstructive pulmonary disease.	American journal of respiratory and critical care medicine	2013	34
24275629	Natriuretic Peptide, Brain	Matsuzawa Y	Peripheral endothelial function and cardiovascular events in high-risk patients.	Journal of the American Heart Association	2013	32
25037055	Natriuretic Peptide, Brain	Sinner MF	B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies.	Europace 	2014	22
15561405	Atrial Natriuretic Factor	Simard M	The neurobiology of glia in the context of water and ion homeostasis.	Neuroscience	2004	120
16289003	Atrial Natriuretic Factor	Nishikimi T	The role of natriuretic peptides in cardioprotection.	Cardiovascular research	2006	76
19477358	Atrial Natriuretic Factor	Tsukamoto O	Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure.	Journal of the American College of Cardiology	2009	51
23434587	Atrial Natriuretic Factor	Hohl M	HDAC4 controls histone methylation in response to elevated cardiac load.	The Journal of clinical investigation	2013	43
9292723	polyglutamine	Paulson HL	Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3.	Neuron	1997	139
9398841	polyglutamine	White JK	Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion.	Nature genetics	1997	132
9620770	polyglutamine	Cummings CJ	Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1.	Nature genetics	1998	178
9679147	polyglutamine	tom Dieck S	Bassoon, a novel zinc-finger CAG/glutamine-repeat protein selectively localized at the active zone of presynaptic nerve terminals.	The Journal of cell biology	1998	102
10814708	polyglutamine	Luthi-Carter R	Decreased expression of striatal signaling genes in a mouse model of Huntington's disease.	Human molecular genetics	2000	137
11007884	polyglutamine	Kegel KB	Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy.	The Journal of neuroscience 	2000	108
11264541	polyglutamine	Nucifora FC Jr	Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity.	Science	2001	212
11394998	polyglutamine	Hara J	Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity.	Neuron	2001	282
11967539	polyglutamine	Mantamadiotis T	Disruption of CREB function in brain leads to neurodegeneration.	Nature genetics	2002	174
11988536	polyglutamine	Dunah AW	Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease.	Science	2002	177
12062094	polyglutamine	Humbert S	The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt.	Developmental cell	2002	116
12089530	polyglutamine	Panov AV	Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines.	Nature neuroscience	2002	208
12191472	polyglutamine	Lunkes A	Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions.	Molecular cell	2002	93
12223539	polyglutamine	Wellington CL	Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease.	The Journal of neuroscience 	2002	85
15152038	polyglutamine	Chevalier-Larsen ES	Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy.	The Journal of neuroscience 	2004	72
15483602	polyglutamine	Arrasate M	Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death.	Nature	2004	553
15664989	polyglutamine	Jana NR	Co-chaperone CHIP associates with expanded polyglutamine protein and promotes their degradation by proteasomes.	The Journal of biological chemistry	2005	84
15811941	polyglutamine	Harper SQ	RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model.	Proceedings of the National Academy of Sciences of the United States of America	2005	195
16076956	polyglutamine	Slow EJ	Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions.	Proceedings of the National Academy of Sciences of the United States of America	2005	76
16122429	polyglutamine	Tsuda H	The AXH domain of Ataxin-1 mediates neurodegeneration through its interaction with Gfi-1/Senseless proteins.	Cell	2005	77
16452635	polyglutamine	Benchoua A	Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin.	Molecular biology of the cell	2006	67
16473015	polyglutamine	Chang DT	Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons.	Neurobiology of disease	2006	75
16522639	polyglutamine	Shibata M	Regulation of intracellular accumulation of mutant Huntingtin by Beclin 1.	The Journal of biological chemistry	2006	134
17034350	polyglutamine	Browne SE	Oxidative damage in Huntington's disease pathogenesis.	Antioxidants & redox signaling	2006	90
17190598	polyglutamine	Lam YC	ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology.	Cell	2006	120
17687326	polyglutamine	Bennett EJ	Global changes to the ubiquitin system in Huntington's disease.	Nature	2007	184
18337722	polyglutamine	Lim J	Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1.	Nature	2008	130
18418684	polyglutamine	Lastres-Becker I	Spinocerebellar ataxia 2 (SCA2).	Cerebellum	2008	56
18434538	polyglutamine	Johnson BS	A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity.	Proceedings of the National Academy of Sciences of the United States of America	2008	156
18488016	polyglutamine	Yang SH	Towards a transgenic model of Huntington's disease in a non-human primate.	Nature	2008	115
18550760	polyglutamine	Gray M	Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice.	The Journal of neuroscience 	2008	194
18599482	polyglutamine	Winborn BJ	The deubiquitinating enzyme ataxin-3, a polyglutamine disease protein, edits Lys63 linkages in mixed linkage ubiquitin chains.	The Journal of biological chemistry	2008	93
18758459	polyglutamine	Lee Y	miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis.	Nature neuroscience	2008	70
19118166	polyglutamine	Packer AN	The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease.	The Journal of neuroscience 	2008	226
19153604	polyglutamine	Todi SV	Ubiquitination directly enhances activity of the deubiquitinating enzyme ataxin-3.	The EMBO journal	2009	48
19334076	polyglutamine	Drouet V	Sustained effects of nonallele-specific Huntingtin silencing.	Annals of neurology	2009	78
19487684	polyglutamine	Nekooki-Machida Y	Distinct conformations of in vitro and in vivo amyloids of huntingtin-exon1 show different cytotoxicity.	Proceedings of the National Academy of Sciences of the United States of America	2009	81
19498170	polyglutamine	Subramaniam S	Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity.	Science	2009	99
19608102	polyglutamine	van der Burg JM	Beyond the brain: widespread pathology in Huntington's disease.	The Lancet. Neurology	2009	76
19710014	polyglutamine	Aiken CT	Phosphorylation of threonine 3: implications for Huntingtin aggregation and neurotoxicity.	The Journal of biological chemistry	2009	50
19910924	polyglutamine	Fiesel FC	Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6.	The EMBO journal	2010	90
20026656	polyglutamine	Thompson LM	IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome.	The Journal of cell biology	2009	115
20152113	polyglutamine	Twelvetrees AE	Delivery of GABAARs to synapses is mediated by HAP1-KIF5 and disrupted by mutant huntingtin.	Neuron	2010	71
20220138	polyglutamine	Legleiter J	Mutant huntingtin fragments form oligomers in a polyglutamine length-dependent manner in vitro and in vivo.	The Journal of biological chemistry	2010	69
20236390	polyglutamine	Han I	Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features.	Journal of neurochemistry	2010	41
20451302	polyglutamine	Persengiev S	Genome-wide analysis of miRNA expression reveals a potential role for miR-144 in brain aging and spinocerebellar ataxia pathogenesis.	Neurobiology of aging	2011	38
20664076	polyglutamine	Zuccato C	Molecular mechanisms and potential therapeutical targets in Huntington's disease.	Physiological reviews	2010	222
20670829	polyglutamine	Miller JP	Matrix metalloproteinases are modifiers of huntingtin proteolysis and toxicity in Huntington's disease.	Neuron	2010	54
20685997	polyglutamine	Miller J	Quantitative relationships between huntingtin levels, polyglutamine length, inclusion body formation, and neuronal death provide novel insight into huntington's disease molecular pathogenesis.	The Journal of neuroscience 	2010	42
20723845	polyglutamine	Durr A	Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond.	The Lancet. Neurology	2010	94
21048129	polyglutamine	Xie Y	BDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice.	The Journal of neuroscience 	2010	65
21109527	polyglutamine	Kino Y	Intracellular localization and splicing regulation of FUS/TLS are variably affected by amyotrophic lateral sclerosis-linked mutations.	Nucleic acids research	2011	46
21163446	polyglutamine	Ross CA	Huntington's disease: from molecular pathogenesis to clinical treatment.	The Lancet. Neurology	2011	293
21311053	polyglutamine	Ehrnhoefer DE	Small changes, big impact: posttranslational modifications and function of huntingtin in Huntington disease.	The Neuroscientist 	2011	36
21555070	polyglutamine	Wilburn B	An antisense CAG repeat transcript at JPH3 locus mediates expanded polyglutamine protein toxicity in Huntington's disease-like 2 mice.	Neuron	2011	62
22017874	polyglutamine	Matsumoto G	Serine 403 phosphorylation of p62/SQSTM1 regulates selective autophagic clearance of ubiquitinated proteins.	Molecular cell	2011	148
22113611	polyglutamine	Koch P	Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease.	Nature	2011	80
22179319	polyglutamine	Jiang M	Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets.	Nature medicine	2011	91
22446390	polyglutamine	Costa V	Shaping the role of mitochondria in the pathogenesis of Huntington's disease.	The EMBO journal	2012	37
22590724	polyglutamine	Jia H	Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease.	Neurobiology of disease	2012	40
22613578	polyglutamine	Juopperi TA	Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells.	Molecular brain	2012	72
22684686	polyglutamine	Seidel K	Brain pathology of spinocerebellar ataxias.	Acta neuropathologica	2012	53
23160193	polyglutamine	Kwan W	Mutant huntingtin impairs immune cell migration in Huntington disease.	The Journal of clinical investigation	2012	37
23438480	polyglutamine	Rüb U	Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7.	Progress in neurobiology	2013	45
23768628	polyglutamine	Labbadia J	Huntington's disease: underlying molecular mechanisms and emerging concepts.	Trends in biochemical sciences	2013	58
23781027	polyglutamine	Costanzo M	Transfer of polyglutamine aggregates in neuronal cells occurs in tunneling nanotubes.	Journal of cell science	2013	46
24742458	polyglutamine	Cortes CJ	Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy.	Neuron	2014	38
25274774	polyglutamine	Kino Y	Nuclear localization of MBNL1: splicing-mediated autoregulation and repression of repeat-derived aberrant proteins.	Human molecular genetics	2015	18
25437566	polyglutamine	Brehme M	A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease.	Cell reports	2014	69
25556834	polyglutamine	Lee JH	Reinstating aberrant mTORC1 activity in Huntington's disease mice improves disease phenotypes.	Neuron	2015	24
25723488	polyglutamine	Lim J	Proteotoxic stress induces phosphorylation of p62/SQSTM1 by ULK1 to regulate selective autophagic clearance of protein aggregates.	PLoS genetics	2015	38
26388396	polyglutamine	Guedes-Dias P	Mitochondrial dynamics and quality control in Huntington's disease.	Neurobiology of disease	2016	13
26590344	polyglutamine	Bañez-Coronel M	RAN Translation in Huntington Disease.	Neuron	2015	39
9236543	Antidepressive Agents	Duman RS	A molecular and cellular theory of depression.	Archives of general psychiatry	1997	285
9537821	Antidepressive Agents	Tatsumi M	Pharmacological profile of antidepressants and related compounds at human monoamine transporters.	European journal of pharmacology	1997	127
11274650	Antidepressive Agents	Pariante CM	Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment.	Biological psychiatry	2001	183
11522260	Antidepressive Agents	Chen B	Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication.	Biological psychiatry	2001	182
12559651	Antidepressive Agents	Blier P	Is there a role for 5-HT1A agonists in the treatment of depression?	Biological psychiatry	2003	81
12706957	Antidepressive Agents	Manji HK	Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression.	Biological psychiatry	2003	88
12842310	Antidepressive Agents	Shimizu E	Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants.	Biological psychiatry	2003	183
15001809	Antidepressive Agents	Duman RS	Role of neurotrophic factors in the etiology and treatment of mood disorders.	Neuromolecular medicine	2004	94
15565110	Antidepressive Agents	Binder EB	Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment.	Nature genetics	2004	202
15885777	Antidepressive Agents	Dunn AJ	Cytokines as mediators of depression: what can we learn from animal studies?	Neuroscience and biobehavioral reviews	2005	86
16012532	Antidepressive Agents	Maciag D	Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry.	Neuropsychopharmacology 	2006	72
16400147	Antidepressive Agents	Svenningsson P	Alterations in 5-HT1B receptor function by p11 in depression-like states.	Science	2006	121
16457782	Antidepressive Agents	Blendy JA	The role of CREB in depression and antidepressant treatment.	Biological psychiatry	2006	64
16631126	Antidepressive Agents	Duman RS	A neurotrophic model for stress-related mood disorders.	Biological psychiatry	2006	675
17049922	Antidepressive Agents	Castrén E	Role of neurotrophic factors in depression.	Current opinion in pharmacology	2007	139
17726474	Antidepressive Agents	Martinowich K	New insights into BDNF function in depression and anxiety.	Nature neuroscience	2007	231
17762509	Antidepressive Agents	Schmidt HD	The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior.	Behavioural pharmacology	2007	177
18571629	Antidepressive Agents	Sen S	Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications.	Biological psychiatry	2008	216
18580840	Antidepressive Agents	Maes M	The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression.	Neuro endocrinology letters	2008	54
18639564	Antidepressive Agents	Le François B	Transcriptional regulation at a HTR1A polymorphism associated with mental illness.	Neuropharmacology	2008	55
18639865	Antidepressive Agents	Krishnan V	AKT signaling within the ventral tegmental area regulates cellular and behavioral responses to stressful stimuli.	Biological psychiatry	2008	64
18982004	Antidepressive Agents	Kato M	Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder.	Molecular psychiatry	2010	87
19224657	Antidepressive Agents	Khairova RA	A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder.	The international journal of neuropsychopharmacology	2009	51
19403806	Antidepressive Agents	Coryell MW	Acid-sensing ion channel-1a in the amygdala, a novel therapeutic target in depression-related behavior.	The Journal of neuroscience 	2009	52
19541429	Antidepressive Agents	Calabrese F	Neuronal plasticity: a link between stress and mood disorders.	Psychoneuroendocrinology	2009	70
19606083	Antidepressive Agents	Boldrini M	Antidepressants increase neural progenitor cells in the human hippocampus.	Neuropsychopharmacology 	2009	165
19744406	Antidepressive Agents	Machado-Vieira R	Brain-derived neurotrophic factor and initial antidepressant response to an N-methyl-D-aspartate antagonist.	The Journal of clinical psychiatry	2009	47
20138063	Antidepressive Agents	Lucassen PJ	Decreased numbers of progenitor cells but no response to antidepressant drugs in the hippocampus of elderly depressed patients.	Neuropharmacology	2010	43
20152112	Antidepressive Agents	Richardson-Jones JW	5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants.	Neuron	2010	114
20186711	Antidepressive Agents	Castrén E	The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity.	Developmental neurobiology	2010	168
20399565	Antidepressive Agents	Anacker C	The glucocorticoid receptor: pivot of depression and of antidepressant treatment?	Psychoneuroendocrinology	2011	70
21131999	Antidepressive Agents	Yu H	The role of BDNF in depression on the basis of its location in the neural circuitry.	Acta pharmacologica Sinica	2011	40
21483429	Antidepressive Agents	Anacker C	Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor.	Molecular psychiatry	2011	77
21525974	Antidepressive Agents	Perera TD	Necessity of hippocampal neurogenesis for the therapeutic action of antidepressants in adult nonhuman primates.	PloS one	2011	68
21796103	Antidepressive Agents	Hannestad J	The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis.	Neuropsychopharmacology 	2011	119
22217452	Antidepressive Agents	Duman RS	Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents.	Trends in neurosciences	2012	95
22407616	Antidepressive Agents	Autry AE	Brain-derived neurotrophic factor and neuropsychiatric disorders.	Pharmacological reviews	2012	169
22442074	Antidepressive Agents	Yu H	Variant brain-derived neurotrophic factor Val66Met polymorphism alters vulnerability to stress and response to antidepressants.	The Journal of neuroscience 	2012	70
22547115	Antidepressive Agents	Lopez JP	Epigenetic regulation of BDNF expression according to antidepressant response.	Molecular psychiatry	2013	31
22580182	Antidepressive Agents	Bufalino C	The role of immune genes in the association between depression and inflammation: a review of recent clinical studies.	Brain, behavior, and immunity	2013	37
22632977	Antidepressive Agents	Schmidt EF	Identification of the cortical neurons that mediate antidepressant responses.	Cell	2012	46
22652019	Antidepressive Agents	Boldrini M	Hippocampal angiogenesis and progenitor cell proliferation are increased with antidepressant use in major depression.	Biological psychiatry	2012	64
22771240	Antidepressive Agents	Laje G	Brain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patients.	Biological psychiatry	2012	43
22826346	Antidepressive Agents	Duman RS	A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists.	Philosophical transactions of the Royal Society of London. Series B, Biological sciences	2012	38
22990943	Antidepressive Agents	Cattaneo A	Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'.	Neuropsychopharmacology 	2013	66
23062356	Antidepressive Agents	Monteggia LM	The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine.	Biological psychiatry	2013	30
23201587	Antidepressive Agents	Rawdin BJ	Dysregulated relationship of inflammation and oxidative stress in major depression.	Brain, behavior, and immunity	2013	45
23303074	Antidepressive Agents	Boldrini M	Hippocampal granule neuron number and dentate gyrus volume in antidepressant-treated and untreated major depression.	Neuropsychopharmacology 	2013	50
23401542	Antidepressive Agents	Mineur YS	Cholinergic signaling in the hippocampus regulates social stress resilience and anxiety- and depression-like behavior.	Proceedings of the National Academy of Sciences of the United States of America	2013	56
23534055	Antidepressive Agents	Kavalali ET	Synaptic mechanisms underlying rapid antidepressant action of ketamine.	The American journal of psychiatry	2012	61
23706576	Antidepressive Agents	Artigas F	Developments in the field of antidepressants, where do we go now?	European neuropsychopharmacology 	2015	15
23733030	Antidepressive Agents	Niitsu T	Pharmacogenetics in major depression: a comprehensive meta-analysis.	Progress in neuro-psychopharmacology & biological psychiatry	2013	30
23735822	Antidepressive Agents	Lang UE	Molecular mechanisms of depression: perspectives on new treatment strategies.	Cellular physiology and biochemistry 	2013	43
23958957	Antidepressive Agents	Molendijk ML	Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484).	Molecular psychiatry	2014	72
23990563	Antidepressive Agents	Li K	βCaMKII in lateral habenula mediates core symptoms of depression.	Science	2013	48
24002251	Antidepressive Agents	Svenningsson P	p11 and its role in depression and therapeutic responses to antidepressants.	Nature reviews. Neuroscience	2013	29
24908571	Antidepressive Agents	Lopez JP	miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment.	Nature medicine	2014	49
24912158	Antidepressive Agents	Gideons ES	Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses.	Proceedings of the National Academy of Sciences of the United States of America	2014	45
25446562	Antidepressive Agents	Nestler EJ	∆FosB: a transcriptional regulator of stress and antidepressant responses.	European journal of pharmacology	2015	20
25467702	Antidepressive Agents	Dutta A	Ketamine and other potential glutamate antidepressants.	Psychiatry research	2015	21
25582786	Antidepressive Agents	Duman CH	Spine synapse remodeling in the pathophysiology and treatment of depression.	Neuroscience letters	2015	23
25823514	Antidepressive Agents	Fakhoury M	Revisiting the Serotonin Hypothesis: Implications for Major Depressive Disorders.	Molecular neurobiology	2016	11
25891220	Antidepressive Agents	Gyurak A	Frontoparietal Activation During Response Inhibition Predicts Remission to Antidepressants in Patients With Major Depression.	Biological psychiatry	2016	12
26290246	Antidepressive Agents	Muthukumaraswamy SD	Evidence that Subanesthetic Doses of Ketamine Cause Sustained Disruptions of NMDA and AMPA-Mediated Frontoparietal Connectivity in Humans.	The Journal of neuroscience 	2015	18
26519901	Antidepressive Agents	Björkholm C	BDNF - a key transducer of antidepressant effects.	Neuropharmacology	2016	26
26650973	Antidepressive Agents	Sanches RF	Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study.	Journal of clinical psychopharmacology	2016	19
26657969	Antidepressive Agents	Schuch FB	Neurobiological effects of exercise on major depressive disorder: A systematic review.	Neuroscience and biobehavioral reviews	2016	13
26786147	Antidepressive Agents	Zhang JC	Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets.	Current neuropharmacology	2016	13
26976569	Antidepressive Agents	Ren Q	Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress.	Proceedings of the National Academy of Sciences of the United States of America	2016	27
27145449	Antidepressive Agents	Redlich R	Prediction of Individual Response to Electroconvulsive Therapy via Machine Learning on Structural Magnetic Resonance Imaging Data.	JAMA psychiatry	2016	14
11229973	Antipsychotic Agents	Kapur S	Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis.	The American journal of psychiatry	2001	108
14642968	Antipsychotic Agents	Kapur S	Half a century of antipsychotics and still a central role for dopamine D2 receptors.	Progress in neuro-psychopharmacology & biological psychiatry	2003	102
15329307	Antipsychotic Agents	Bramon E	Meta-analysis of the P300 and P50 waveforms in schizophrenia.	Schizophrenia research	2004	107
15655562	Antipsychotic Agents	Angelucci F	BDNF in schizophrenia, depression and corresponding animal models.	Molecular psychiatry	2005	97
15684088	Antipsychotic Agents	Veldic M	In psychosis, cortical interneurons overexpress DNA-methyltransferase 1.	Proceedings of the National Academy of Sciences of the United States of America	2005	78
17822540	Antipsychotic Agents	Saetre P	Inflammation-related genes up-regulated in schizophrenia brains.	BMC psychiatry	2007	74
19736350	Antipsychotic Agents	Schobel SA	Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders.	Archives of general psychiatry	2009	126
20602722	Antipsychotic Agents	Watanabe Y	Cytokine hypothesis of schizophrenia pathogenesis: evidence from human studies and animal models.	Psychiatry and clinical neurosciences	2010	41
20643630	Antipsychotic Agents	Seeman P	Dopamine D2 receptors as treatment targets in schizophrenia.	Clinical schizophrenia & related psychoses	2010	43
21036897	Antipsychotic Agents	Sathyasaikumar KV	Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia.	Schizophrenia bulletin	2011	50
21074545	Antipsychotic Agents	Guidotti A	Epigenetic GABAergic targets in schizophrenia and bipolar disorder.	Neuropharmacology	2011	64
22761806	Antipsychotic Agents	de Jong S	A gene co-expression network in whole blood of schizophrenia patients is independent of antipsychotic-use and enriched for brain-expressed genes.	PloS one	2012	48
22864611	Antipsychotic Agents	Kurita M	HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity.	Nature neuroscience	2012	61
24170294	Antipsychotic Agents	Georgiev D	Lower gene expression for KCNS3 potassium channel subunit in parvalbumin-containing neurons in the prefrontal cortex in schizophrenia.	The American journal of psychiatry	2014	22
25266124	Antipsychotic Agents	Fernandes BS	Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications.	Molecular psychiatry	2015	22
25981171	Antipsychotic Agents	Datta D	Altered expression of CDC42 signaling pathway components in cortical layer 3 pyramidal cells in schizophrenia.	Biological psychiatry	2015	24
26315980	Antipsychotic Agents	Sarpal DK	Baseline Striatal Functional Connectivity as a Predictor of Response to Antipsychotic Drug Treatment.	The American journal of psychiatry	2016	18
27444795	Antipsychotic Agents	Chung DW	Pathological Basis for Deficient Excitatory Drive to Cortical Parvalbumin Interneurons in Schizophrenia.	The American journal of psychiatry	2016	12
27832841	Antipsychotic Agents	Urs NM	New Concepts in Dopamine D2 Receptor Biased Signaling and Implications for Schizophrenia Therapy.	Biological psychiatry	2017	9
15623696	Fluorodeoxyglucose F18	Mosconi L	MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET.	Neurology	2004	88
17327884	Fluorodeoxyglucose F18	Capuron L	Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy.	Neuropsychopharmacology 	2007	67
17470495	Fluorodeoxyglucose F18	Huang C	Changes in network activity with the progression of Parkinson's disease.	Brain 	2007	94
17586305	Fluorodeoxyglucose F18	Kaplitt MG	Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial.	Lancet	2007	283
19349228	Fluorodeoxyglucose F18	Langbaum JB	Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI).	NeuroImage	2009	105
20034578	Fluorodeoxyglucose F18	la Fougère C	Real versus imagined locomotion: a 18F-FDG PET-fMRI comparison.	NeuroImage	2010	55
20375137	Fluorodeoxyglucose F18	Jayadev S	Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2.	Brain 	2010	42
21670386	Fluorodeoxyglucose F18	Lo RY	Longitudinal change of biomarkers in cognitive decline.	Archives of neurology	2011	66
22047634	Fluorodeoxyglucose F18	Weiner MW	The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.	Alzheimer's & dementia 	2012	181
23232293	Fluorodeoxyglucose F18	Shaffer JL	Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers.	Radiology	2013	42
23280791	Fluorodeoxyglucose F18	Vemuri P	Effect of lifestyle activities on Alzheimer disease biomarkers and cognition.	Annals of neurology	2012	43
23281216	Fluorodeoxyglucose F18	Min K	Umbilical cord blood therapy potentiated with erythropoietin for children with cerebral palsy: a double-blind, randomized, placebo-controlled trial.	Stem cells	2013	31
23932184	Fluorodeoxyglucose F18	Weiner MW	The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.	Alzheimer's & dementia 	2013	97
24029656	Fluorodeoxyglucose F18	Tamura K	64Cu-DOTA-trastuzumab PET imaging in patients with HER2-positive breast cancer.	Journal of nuclear medicine 	2013	37
26073027	Fluorodeoxyglucose F18	Weiner MW	2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.	Alzheimer's & dementia 	2015	46
26139022	Fluorodeoxyglucose F18	Yau WW	Longitudinal assessment of neuroimaging and clinical markers in autosomal dominant Alzheimer's disease: a prospective cohort study.	The Lancet. Neurology	2015	16
26597325	Fluorodeoxyglucose F18	Jack CR Jr	Transition rates between amyloid and neurodegeneration biomarker states and to dementia: a population-based, longitudinal cohort study.	The Lancet. Neurology	2016	15
1683703	Creatine	Smith CD	Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.	Proceedings of the National Academy of Sciences of the United States of America	1991	187
11246152	Creatine	Aksenov MY	Protein oxidation in the brain in Alzheimer's disease.	Neuroscience	2001	93
11592034	Creatine	Brockington M	Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan.	American journal of human genetics	2001	112
12354300	Creatine	Castegna A	Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71.	Journal of neurochemistry	2002	110
12897283	Creatine	van den Hout HM	The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature.	Pediatrics	2003	90
18588971	Creatine	Sorolla MA	Proteomic and oxidative stress analysis in human brain samples of Huntington disease.	Free radical biology & medicine	2008	57
19556448	Creatine	Floriano PN	Use of saliva-based nano-biochip tests for acute myocardial infarction at the point of care: a feasibility study.	Clinical chemistry	2009	45
21246320	Creatine	Letendre SL	Chemokines in cerebrospinal fluid correlate with cerebral metabolite patterns in HIV-infected individuals.	Journal of neurovirology	2011	40
24481242	Creatine	Haroon E	IFN-alpha-induced cortical and subcortical glutamate changes assessed by magnetic resonance spectroscopy.	Neuropsychopharmacology 	2014	24
9457170	Neurotransmitter Agents	Verkhratsky A	Glial calcium: homeostasis and signaling function.	Physiological reviews	1998	104
11404227	Neurotransmitter Agents	Gruetter R	A mathematical model of compartmentalized neurotransmitter metabolism in the human brain.	American journal of physiology. Endocrinology and metabolism	2001	93
11976437	Neurotransmitter Agents	Wilson RI	Endocannabinoid signaling in the brain.	Science	2002	237
12136507	Neurotransmitter Agents	Teicher MH	Developmental neurobiology of childhood stress and trauma.	The Psychiatric clinics of North America	2002	82
12578875	Neurotransmitter Agents	Weinberg EO	Identification of serum soluble ST2 receptor as a novel heart failure biomarker.	Circulation	2003	82
12600714	Neurotransmitter Agents	Carrasco GA	Neuroendocrine pharmacology of stress.	European journal of pharmacology	2003	134
15263023	Neurotransmitter Agents	Kögler G	A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential.	The Journal of experimental medicine	2004	186
17473959	Neurotransmitter Agents	Koepsell H	Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications.	Pharmaceutical research	2007	191
17496890	Neurotransmitter Agents	Kiyonaka S	RIM1 confers sustained activity and neurotransmitter vesicle anchoring to presynaptic Ca2+ channels.	Nature neuroscience	2007	79
18395805	Neurotransmitter Agents	Lisman JE	Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia.	Trends in neurosciences	2008	322
18495419	Neurotransmitter Agents	Vezzani A	The role of cytokines in the pathophysiology of epilepsy.	Brain, behavior, and immunity	2008	100
18805468	Neurotransmitter Agents	Smith Y	The thalamostriatal systems: anatomical and functional organization in normal and parkinsonian states.	Brain research bulletin	2009	68
20147364	Neurotransmitter Agents	Wonodi I	Cortical kynurenine pathway metabolism: a novel target for cognitive enhancement in Schizophrenia.	Schizophrenia bulletin	2010	43
20152114	Neurotransmitter Agents	Nemani VM	Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis.	Neuron	2010	268
20186955	Neurotransmitter Agents	van den Maagdenberg AM	High cortical spreading depression susceptibility and migraine-associated symptoms in Ca(v)2.1 S218L mice.	Annals of neurology	2010	44
20664079	Neurotransmitter Agents	Golombek DA	Physiology of circadian entrainment.	Physiological reviews	2010	153
21145878	Neurotransmitter Agents	Gomes CV	Adenosine receptors and brain diseases: neuroprotection and neurodegeneration.	Biochimica et biophysica acta	2011	60
21248787	Neurotransmitter Agents	Thathiah A	The role of G protein-coupled receptors in the pathology of Alzheimer's disease.	Nature reviews. Neuroscience	2011	47
22036572	Neurotransmitter Agents	Yao J	Doc2 is a Ca2+ sensor required for asynchronous neurotransmitter release.	Cell	2011	60
23469922	Neurotransmitter Agents	Rajkowska G	Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue.	Current drug targets	2013	65
24672753	Neurotransmitter Agents	Yu DX	Modeling hippocampal neurogenesis using human pluripotent stem cells.	Stem cell reports	2014	57
24842998	Neurotransmitter Agents	Trimbuch T	Re-examining how complexin inhibits neurotransmitter release.	eLife	2014	23
25583178	Neurotransmitter Agents	Koob GF	The dark side of emotion: the addiction perspective.	European journal of pharmacology	2015	31
14749508	Neuropeptides	Bjørbaek C	Leptin signaling in the central nervous system and the periphery.	Recent progress in hormone research	2004	97
16303870	Neuropeptides	Wismer Fries AB	Early experience in humans is associated with changes in neuropeptides critical for regulating social behavior.	Proceedings of the National Academy of Sciences of the United States of America	2005	104
16904760	Neuropeptides	Harris GC	Arousal and reward: a dichotomy in orexin function.	Trends in neurosciences	2006	159
17471287	Neuropeptides	Hashimoto T	Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia.	Molecular psychiatry	2008	178
17910982	Neuropeptides	Ohno K	Orexin neuronal circuitry: role in the regulation of sleep and wakefulness.	Frontiers in neuroendocrinology	2008	56
18164737	Neuropeptides	Kaye W	Neurobiology of anorexia and bulimia nervosa.	Physiology & behavior	2008	83
18655894	Neuropeptides	Heinrichs M	Neuropeptides and social behaviour: effects of oxytocin and vasopressin in humans.	Progress in brain research	2008	84
19084465	Neuropeptides	Skuse DH	Dopaminergic-neuropeptide interactions in the social brain.	Trends in cognitive sciences	2009	68
19117547	Neuropeptides	Funato H	Enhanced orexin receptor-2 signaling prevents diet-induced obesity and improves leptin sensitivity.	Cell metabolism	2009	71
20027225	Neuropeptides	Ubuka T	Identification of human GnIH homologs, RFRP-1 and RFRP-3, and the cognate receptor, GPR147 in the human hypothalamic pituitary axis.	PloS one	2009	50
20338186	Neuropeptides	Cason AM	Role of orexin/hypocretin in reward-seeking and addiction: implications for obesity.	Physiology & behavior	2010	70
21034217	Neuropeptides	Scammell TE	Orexin receptors: pharmacology and therapeutic opportunities.	Annual review of pharmacology and toxicology	2011	60
21041246	Neuropeptides	Fung SJ	Expression of interneuron markers in the dorsolateral prefrontal cortex of the developing human and in schizophrenia.	The American journal of psychiatry	2010	126
21852800	Neuropeptides	Meyer-Lindenberg A	Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine.	Nature reviews. Neuroscience	2011	311
22369786	Neuropeptides	Parker JA	Hypothalamic neuropeptides and the regulation of appetite.	Neuropharmacology	2012	35
22710442	Neuropeptides	Maniam J	The link between stress and feeding behaviour.	Neuropharmacology	2012	43
22813973	Neuropeptides	Johnson PL	Orexin, stress, and anxiety/panic states.	Progress in brain research	2012	36
23040809	Neuropeptides	van den Pol AN	Neuropeptide transmission in brain circuits.	Neuron	2012	106
23040815	Neuropeptides	Schank JR	Stress-related neuropeptides and addictive behaviors: beyond the usual suspects.	Neuron	2012	33
24210138	Neuropeptides	Kormos V	Role of neuropeptides in anxiety, stress, and depression: from animals to humans.	Neuropeptides	2013	36
24277819	Neuropeptides	Sears RM	Orexin/hypocretin system modulates amygdala-dependent threat learning through the locus coeruleus.	Proceedings of the National Academy of Sciences of the United States of America	2013	34
24997035	Neuropeptides	Holzer P	Neuropeptides and the microbiota-gut-brain axis.	Advances in experimental medicine and biology	2014	35
25301357	Neuropeptides	Sakurai T	The role of orexin in motivated behaviours.	Nature reviews. Neuroscience	2014	48
26733323	Neuropeptides	Li SB	Hypocretins, Neural Systems, Physiology, and Psychiatric Disorders.	Current psychiatry reports	2016	11
10578452	N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide	Drevets WC	PET imaging of serotonin 1A receptor binding in depression.	Biological psychiatry	1999	124
10665620	N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide	Sargent PA	Brain serotonin1A receptor binding measured by positron emission tomography with 11CWAY-100635: effects of depression and antidepressant treatment.	Archives of general psychiatry	2000	105
15758168	N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide	David SP	A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans.	The Journal of neuroscience 	2005	77
16979141	N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide	Lanzenberger RR	Reduced serotonin-1A receptor binding in social anxiety disorder.	Biological psychiatry	2007	60
1383826	Amyloid beta-Peptides	Haass C	Amyloid beta-peptide is produced by cultured cells during normal metabolism.	Nature	1992	281
7706234	Amyloid beta-Peptides	Gravina SA	Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43).	The Journal of biological chemistry	1995	124
7845465	Amyloid beta-Peptides	Games D	Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.	Nature	1995	321
8043280	Amyloid beta-Peptides	Iwatsubo T	Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).	Neuron	1994	285
8103819	Amyloid beta-Peptides	Poirier J	Apolipoprotein E polymorphism and Alzheimer's disease.	Lancet	1993	169
8415756	Amyloid beta-Peptides	Schmechel DE	Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.	Proceedings of the National Academy of Sciences of the United States of America	1993	259
9037091	Amyloid beta-Peptides	Johnson-Wood K	Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease.	Proceedings of the National Academy of Sciences of the United States of America	1997	175
9190286	Amyloid beta-Peptides	Harper JD	Observation of metastable Abeta amyloid protofibrils by atomic force microscopy.	Chemistry & biology	1997	148
9354781	Amyloid beta-Peptides	Bales KR	Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition.	Nature genetics	1997	144
9354812	Amyloid beta-Peptides	Mattson MP	Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives.	Physiological reviews	1997	138
10077666	Amyloid beta-Peptides	Hsia AY	Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models.	Proceedings of the National Academy of Sciences of the United States of America	1999	283
10487842	Amyloid beta-Peptides	Lue LF	Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.	The American journal of pathology	1999	400
10591213	Amyloid beta-Peptides	Yan R	Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity.	Nature	1999	275
10735393	Amyloid beta-Peptides	Näslund J	Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline.	JAMA	2000	260
10932230	Amyloid beta-Peptides	Bard F	Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease.	Nature medicine	2000	454
10978169	Amyloid beta-Peptides	Walsh DM	The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain.	Biochemistry	2000	118
11193794	Amyloid beta-Peptides	Selkoe DJ	Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein.	Annals of the New York Academy of Sciences	2000	117
11683988	Amyloid beta-Peptides	Selkoe DJ	Clearing the brain's amyloid cobwebs.	Neuron	2001	132
11733217	Amyloid beta-Peptides	Butterfield DA	Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide.	Trends in molecular medicine	2001	186
11815632	Amyloid beta-Peptides	Zhang Y	Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons.	The Journal of cell biology	2002	96
11932745	Amyloid beta-Peptides	Walsh DM	Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo.	Nature	2002	1048
12084879	Amyloid beta-Peptides	Thal DR	Phases of A beta-deposition in the human brain and its relevance for the development of AD.	Neurology	2002	463
12415125	Amyloid beta-Peptides	Selkoe DJ	Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics.	Annual review of pharmacology and toxicology	2003	176
12925731	Amyloid beta-Peptides	Gong Y	Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss.	Proceedings of the National Academy of Sciences of the United States of America	2003	251
14742275	Amyloid beta-Peptides	Fukumoto H	Beta-secretase activity increases with aging in human, monkey, and mouse brain.	The American journal of pathology	2004	77
14978286	Amyloid beta-Peptides	Li R	Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients.	Proceedings of the National Academy of Sciences of the United States of America	2004	149
15037694	Amyloid beta-Peptides	Ingelsson M	Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain.	Neurology	2004	181
15056716	Amyloid beta-Peptides	Wang Q	Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5.	The Journal of neuroscience 	2004	123
15140180	Amyloid beta-Peptides	Zlokovic BV	Clearing amyloid through the blood-brain barrier.	Journal of neurochemistry	2004	85
15339642	Amyloid beta-Peptides	Tanzi RE	Clearance of Alzheimer's Abeta peptide: the many roads to perdition.	Neuron	2004	115
15459432	Amyloid beta-Peptides	Deane R	RAGE (yin) versus LRP (yang) balance regulates alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier.	Stroke	2004	93
15647487	Amyloid beta-Peptides	Qi-Takahara Y	Longer forms of amyloid beta protein: implications for the mechanism of intramembrane cleavage by gamma-secretase.	The Journal of neuroscience 	2005	112
15708439	Amyloid beta-Peptides	Caccamo A	Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders.	Neurobiology of aging	2005	79
15808355	Amyloid beta-Peptides	Zlokovic BV	Neurovascular mechanisms of Alzheimer's neurodegeneration.	Trends in neurosciences	2005	188
15834427	Amyloid beta-Peptides	Klyubin I	Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo.	Nature medicine	2005	143
15857927	Amyloid beta-Peptides	Liu Y	LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide.	Brain 	2005	79
15987683	Amyloid beta-Peptides	Dominguez D	Phenotypic and biochemical analyses of BACE1- and BACE2-deficient mice.	The Journal of biological chemistry	2005	97
16469784	Amyloid beta-Peptides	Townsend M	Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers.	The Journal of physiology	2006	180
17046788	Amyloid beta-Peptides	Yan Y	Abeta42 is more rigid than Abeta40 at the C terminus: implications for Abeta aggregation and toxicity.	Journal of molecular biology	2006	64
17077814	Amyloid beta-Peptides	Bell RD	Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system.	Journal of cerebral blood flow and metabolism 	2007	149
17286590	Amyloid beta-Peptides	Walsh DM	A beta oligomers - a decade of discovery.	Journal of neurochemistry	2007	548
17430246	Amyloid beta-Peptides	Deane R	Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease.	Current Alzheimer research	2007	104
17664130	Amyloid beta-Peptides	Butterfield DA	Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.	Free radical biology & medicine	2007	111
17694066	Amyloid beta-Peptides	Sagare A	Clearance of amyloid-beta by circulating lipoprotein receptors.	Nature medicine	2007	119
18359102	Amyloid beta-Peptides	Selkoe DJ	Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior.	Behavioural brain research	2008	318
18417702	Amyloid beta-Peptides	Klyubin I	Amyloid beta protein dimer-containing human CSF disrupts synaptic plasticity: prevention by systemic passive immunization.	The Journal of neuroscience 	2008	108
18673201	Amyloid beta-Peptides	Deane R	The role of the cell surface LRP and soluble LRP in blood-brain barrier Abeta clearance in Alzheimer's disease.	Current pharmaceutical design	2008	58
19098903	Amyloid beta-Peptides	Bell RD	SRF and myocardin regulate LRP-mediated amyloid-beta clearance in brain vascular cells.	Nature cell biology	2009	89
19319544	Amyloid beta-Peptides	Bell RD	Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.	Acta neuropathologica	2009	198
19757208	Amyloid beta-Peptides	Ondrejcak T	Alzheimer's disease amyloid beta-protein and synaptic function.	Neuromolecular medicine	2010	43
19759000	Amyloid beta-Peptides	Noguchi A	Isolation and characterization of patient-derived, toxic, high mass amyloid beta-protein (Abeta) assembly from Alzheimer disease brains.	The Journal of biological chemistry	2009	48
20148964	Amyloid beta-Peptides	Sakono M	Amyloid oligomers: formation and toxicity of Abeta oligomers.	The FEBS journal	2010	86
20209079	Amyloid beta-Peptides	Soscia SJ	The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide.	PloS one	2010	162
20632195	Amyloid beta-Peptides	Heneka MT	Neuroinflammatory processes in Alzheimer's disease.	Journal of neural transmission	2010	92
22009041	Amyloid beta-Peptides	Cenini G	Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome.	Biochimica et biophysica acta	2012	33
25744023	Amyloid beta-Peptides	Kaushal V	Neuronal NLRP1 inflammasome activation of Caspase-1 coordinately regulates inflammatory interleukin-1-beta production and axonal degeneration-associated Caspase-6 activation.	Cell death and differentiation	2015	22
16139959	Arginine Vasopressin	Kajantie E	The effects of sex and hormonal status on the physiological response to acute psychosocial stress.	Psychoneuroendocrinology	2006	162
17696996	Arginine Vasopressin	Knafo A	Individual differences in allocation of funds in the dictator game associated with length of the arginine vasopressin 1a receptor RS3 promoter region and correlation between RS3 length and hippocampal mRNA.	Genes, brain, and behavior	2008	67
18655867	Arginine Vasopressin	Goodson JL	Nonapeptides and the evolutionary patterning of sociality.	Progress in brain research	2008	56
18765804	Arginine Vasopressin	Walum H	Genetic variation in the vasopressin receptor 1a gene (AVPR1A) associates with pair-bonding behavior in humans.	Proceedings of the National Academy of Sciences of the United States of America	2008	108
22504348	Arginine Vasopressin	McCall C	The animal and human neuroendocrinology of social cognition, motivation and behavior.	Nature neuroscience	2012	60
22717656	Arginine Vasopressin	Wentworth BA	Post-traumatic stress disorder: a fast track to premature cardiovascular disease?	Cardiology in review	2013	27
24964815	Arginine Vasopressin	Zoicas I	Brain oxytocin in social fear conditioning and its extinction: involvement of the lateral septum.	Neuropsychopharmacology 	2014	22
12097494	Neuroprotective Agents	Cao G	In Vivo Delivery of a Bcl-xL Fusion Protein Containing the TAT Protein Transduction Domain Protects against Ischemic Brain Injury and Neuronal Apoptosis.	The Journal of neuroscience 	2002	90
12563316	Neuroprotective Agents	Cheng T	Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective.	Nature medicine	2003	151
19919699	Neuroprotective Agents	Lakhan SE	Inflammatory mechanisms in ischemic stroke: therapeutic approaches.	Journal of translational medicine	2009	196
21792905	Neuroprotective Agents	Kim K	Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics.	Journal of cellular physiology	2011	72
21930182	Neuroprotective Agents	Zhang F	Protective effects and mechanisms of sirtuins in the nervous system.	Progress in neurobiology	2011	43
22633825	Neuroprotective Agents	Dorhout Mees SM	Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial.	Lancet	2012	44
22942700	Neuroprotective Agents	Dobolyi A	The neuroprotective functions of transforming growth factor beta proteins.	International journal of molecular sciences	2012	34
23838428	Neuroprotective Agents	Beazley-Long N	VEGF-A165b is an endogenous neuroprotective splice isoform of vascular endothelial growth factor A in vivo and in vitro.	The American journal of pathology	2013	25
23999914	Neuroprotective Agents	Hölscher C	Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases.	The Journal of endocrinology	2014	36
24026771	Neuroprotective Agents	Chaturvedi M	Mmp-9 inhibition: a therapeutic strategy in ischemic stroke.	Molecular neurobiology	2014	35
24390152	Neuroprotective Agents	Freret T	Mechanisms underlying the neuroprotective effect of brain reserve against late life depression.	Journal of neural transmission	2015	28
25362113	Neuroprotective Agents	Villapol S	Neuroprotective effects of angiotensin receptor blockers.	American journal of hypertension	2015	18
25534356	Neuroprotective Agents	O'Gorman RL	Tract-based spatial statistics to assess the neuroprotective effect of early erythropoietin on white matter development in preterm infants.	Brain 	2015	21
27009601	Neuroprotective Agents	Lastres-Becker I	Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease.	Antioxidants & redox signaling	2016	15
27381825	Neuroprotective Agents	Shi X	Sestrin2, as a negative feedback regulator of mTOR, provides neuroprotection by activation AMPK phosphorylation in neonatal hypoxic-ischemic encephalopathy in rat pups.	Journal of cerebral blood flow and metabolism 	2017	7
7585152	decitabine	Merlo A	5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers.	Nature medicine	1995	286
11593392	decitabine	Fulda S	Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer.	Oncogene	2001	88
17679729	decitabine	Blum W	Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemia.	Journal of clinical oncology 	2007	93
19308264	decitabine	Garzia L	MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma.	PloS one	2009	79
20103663	decitabine	Di Tomaso T	Immunobiological characterization of cancer stem cells isolated from glioblastoma patients.	Clinical cancer research 	2010	63
24077826	decitabine	Turcan S	Efficient induction of differentiation and growth inhibition in IDH1 mutant glioma cells by the DNMT Inhibitor Decitabine.	Oncotarget	2013	49
24166615	decitabine	Belzil VV	Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood.	Acta neuropathologica	2013	66
24806409	decitabine	Liu EY	C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD.	Acta neuropathologica	2014	42
10649826	2beta-carbomethoxy-3beta-(4-iodophenyl)tropane	Heinz A	Genotype influences in vivo dopamine transporter availability in human striatum.	Neuropsychopharmacology 	2000	123
15293269	2beta-carbomethoxy-3beta-(4-iodophenyl)tropane	Ponsen MM	Idiopathic hyposmia as a preclinical sign of Parkinson's disease.	Annals of neurology	2004	101
15872345	2beta-carbomethoxy-3beta-(4-iodophenyl)tropane	van Dyck CH	Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene.	Journal of nuclear medicine 	2005	82
14732621	donepezil	Grundman M	Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials.	Archives of neurology	2004	185
17452062	donepezil	Jack CR Jr	Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI.	Neurobiology of aging	2008	53
18672400	donepezil	Lannfelt L	Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial.	The Lancet. Neurology	2008	119
20143386	donepezil	Apostolova LG	3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI.	Human brain mapping	2010	43
20200346	donepezil	Feldman HH	Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe.	Neurology	2010	91
22035455	donepezil	Salomone S	New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs.	British journal of clinical pharmacology	2012	54
22245641	donepezil	Li W	Changes in regional cerebral blood flow and functional connectivity in the cholinergic pathway associated with cognitive performance in subjects with mild Alzheimer's disease after 12-week donepezil treatment.	NeuroImage	2012	36
25539902	donepezil	Gjerløff T	Imaging acetylcholinesterase density in peripheral organs in Parkinson's disease with 11C-donepezil PET.	Brain 	2015	15
28103749	donepezil	O'Brien JT	Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology.	Journal of psychopharmacology	2017	9
11724467	Docosahexaenoic Acids	Salem N Jr	Mechanisms of action of docosahexaenoic acid in the nervous system.	Lipids	2001	165
17101822	Docosahexaenoic Acids	Schaefer EJ	Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study.	Archives of neurology	2006	117
17622276	Docosahexaenoic Acids	Plourde M	Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements.	Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme	2007	63
21045096	Docosahexaenoic Acids	Quinn JF	Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial.	JAMA	2010	123
21106917	Docosahexaenoic Acids	Koletzko B	Genetic variants of the fatty acid desaturase gene cluster predict amounts of red blood cell docosahexaenoic and other polyunsaturated fatty acids in pregnant women: findings from the Avon Longitudinal Study of Parents and Children.	The American journal of clinical nutrition	2011	45
23481688	Docosahexaenoic Acids	Hjorth E	Omega-3 fatty acids enhance phagocytosis of Alzheimer's disease-related amyloid-β42 by human microglia and decrease inflammatory markers.	Journal of Alzheimer's disease 	2013	30
23515006	Docosahexaenoic Acids	Stonehouse W	DHA supplementation improved both memory and reaction time in healthy young adults: a randomized controlled trial.	The American journal of clinical nutrition	2013	39
24345162	Docosahexaenoic Acids	Vandal M	Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2.	Journal of neurochemistry	2014	22
28114437	Docosahexaenoic Acids	Yassine HN	Association of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E ε4 Carriers: A Review.	JAMA neurology	2017	8
10514096	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	Langston JW	Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure.	Annals of neurology	1999	154
12477707	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	Timmermann L	The cerebral oscillatory network of parkinsonian resting tremor.	Brain 	2003	86
15026254	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	Song DD	Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP.	Experimental neurology	2004	81
17360686	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	Höglinger GU	The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease.	Proceedings of the National Academy of Sciences of the United States of America	2007	63
19628698	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	Junn E	Repression of alpha-synuclein expression and toxicity by microRNA-7.	Proceedings of the National Academy of Sciences of the United States of America	2009	144
20473298	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	Huang E	The role of Cdk5-mediated apurinic/apyrimidinic endonuclease 1 phosphorylation in neuronal death.	Nature cell biology	2010	42
20823226	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	Ko HS	Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function.	Proceedings of the National Academy of Sciences of the United States of America	2010	75
21228155	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	Rieker C	Nucleolar disruption in dopaminergic neurons leads to oxidative damage and parkinsonism through repression of mammalian target of rapamycin signaling.	The Journal of neuroscience 	2011	42
23041626	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	Martens LH	Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury.	The Journal of clinical investigation	2012	58
27347320	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	Gong X	miR-124 regulates cell apoptosis and autophagy in dopaminergic neurons and protects them by regulating AMPK/mTOR pathway in Parkinson's disease.	American journal of translational research	2016	10
10914698	temozolomide	Friedman HS	Temozolomide and treatment of malignant glioma.	Clinical cancer research 	2000	128
15041700	temozolomide	Hegi ME	Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide.	Clinical cancer research 	2004	146
15758010	temozolomide	Hegi ME	MGMT gene silencing and benefit from temozolomide in glioblastoma.	The New England journal of medicine	2005	1193
15956649	temozolomide	Haas-Kogan DA	Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib.	Journal of the National Cancer Institute	2005	137
16405512	temozolomide	Hermisson M	O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells.	Journal of neurochemistry	2006	70
16618716	temozolomide	Hunter C	A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy.	Cancer research	2006	90
16946731	temozolomide	Katayama M	DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells.	Cell death and differentiation	2007	99
17140455	temozolomide	Liu G	Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma.	Molecular cancer	2006	509
17196391	temozolomide	Clement V	HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity.	Current biology 	2007	303
17404084	temozolomide	Cahill DP	Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment.	Clinical cancer research 	2007	91
17522861	temozolomide	Jordan JT	Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy.	Cancer immunology, immunotherapy 	2008	77
17827463	temozolomide	Stupp R	Chemoradiotherapy in malignant glioma: standard of care and future directions.	Journal of clinical oncology 	2007	118
18445844	temozolomide	Brandes AA	MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients.	Journal of clinical oncology 	2008	146
18565887	temozolomide	Murat A	Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma.	Journal of clinical oncology 	2008	233
18632623	temozolomide	Beier D	Temozolomide preferentially depletes cancer stem cells in glioblastoma.	Cancer research	2008	83
19075262	temozolomide	Prados MD	Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma.	Journal of clinical oncology 	2009	97
19188675	temozolomide	Brandes AA	Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation With MGMT promoter methylation status.	Journal of clinical oncology 	2009	52
19204207	temozolomide	van den Bent MJ	Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.	Journal of clinical oncology 	2009	123
19221744	temozolomide	Banissi C	Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model.	Cancer immunology, immunotherapy 	2009	57
19265662	temozolomide	Bleau AM	PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells.	Cell stem cell	2009	239
19269895	temozolomide	Stupp R	Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.	The Lancet. Oncology	2009	1345
19536096	temozolomide	Dunn J	Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy.	British journal of cancer	2009	67
19584161	temozolomide	Yip S	MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance.	Clinical cancer research 	2009	83
19901110	temozolomide	Wick W	NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.	Journal of clinical oncology 	2009	140
19960228	temozolomide	Peereboom DM	Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme.	Journal of neuro-oncology	2010	59
20146084	temozolomide	Ardon H	Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study.	Journal of neuro-oncology	2010	44
20167819	temozolomide	De Witt Hamer PC	Small molecule kinase inhibitors in glioblastoma: a systematic review of clinical studies.	Neuro-oncology	2010	42
20388803	temozolomide	Hattermann K	The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects.	Cancer research	2010	81
20423999	temozolomide	Keating AK	Inhibition of Mer and Axl receptor tyrosine kinases in astrocytoma cells leads to increased apoptosis and improved chemosensitivity.	Molecular cancer therapeutics	2010	56
20439646	temozolomide	Stupp R	Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma.	Journal of clinical oncology 	2010	99
20530668	temozolomide	McEllin B	PTEN loss compromises homologous recombination repair in astrocytes: implications for glioblastoma therapy with temozolomide or poly(ADP-ribose) polymerase inhibitors.	Cancer research	2010	81
20633539	temozolomide	Shi L	MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity.	Brain research	2010	67
20855119	temozolomide	Minniti G	Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide.	Radiotherapy and oncology 	2010	40
20921459	temozolomide	Sampson JH	Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma.	Journal of clinical oncology 	2010	205
20957337	temozolomide	Ulasov IV	Inhibition of Sonic hedgehog and Notch pathways enhances sensitivity of CD133(+) glioma stem cells to temozolomide therapy.	Molecular medicine	2011	46
20975057	temozolomide	Houillier C	IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas.	Neurology	2010	92
21135282	temozolomide	Lai A	Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme.	Journal of clinical oncology 	2011	140
21149254	temozolomide	Sampson JH	Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma.	Neuro-oncology	2011	92
21156036	temozolomide	Etcheverry A	DNA methylation in glioblastoma: impact on gene expression and clinical outcome.	BMC genomics	2010	58
21242296	temozolomide	Wolf A	Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme.	The Journal of experimental medicine	2011	162
21317208	temozolomide	Prasad G	Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide.	Neuro-oncology	2011	48
21339192	temozolomide	Cohen KJ	Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group.	Neuro-oncology	2011	55
21425258	temozolomide	Felsberg J	Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas.	International journal of cancer	2011	49
21606416	temozolomide	de Groot JF	Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium study.	Journal of clinical oncology 	2011	47
21709196	temozolomide	Gállego Pérez-Larraya J	Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial.	Journal of clinical oncology 	2011	44
21737504	temozolomide	Grossman SA	Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide.	Clinical cancer research 	2011	84
21768296	temozolomide	Mitchell DA	Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humans.	Blood	2011	45
21988793	temozolomide	Beier D	Chemoresistance of glioblastoma cancer stem cells--much more complex than expected.	Molecular cancer	2011	80
22034964	temozolomide	SongTao Q	IDH mutations predict longer survival and response to temozolomide in secondary glioblastoma.	Cancer science	2012	39
22035272	temozolomide	Narayana A	A clinical trial of bevacizumab, temozolomide, and radiation for newly diagnosed glioblastoma.	Journal of neurosurgery	2012	39
22045118	temozolomide	Johnson DR	Glioblastoma survival in the United States before and during the temozolomide era.	Journal of neuro-oncology	2012	152
22156195	temozolomide	Agnihotri S	Alkylpurine-DNA-N-glycosylase confers resistance to temozolomide in xenograft models of glioblastoma multiforme and is associated with poor survival in patients.	The Journal of clinical investigation	2012	32
22383993	temozolomide	Sampson JH	A pilot study of IL-2Rα blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma.	PloS one	2012	33
22469979	temozolomide	Wagner L	Smac mimetic sensitizes glioblastoma cells to Temozolomide-induced apoptosis in a RIP1- and NF-κB-dependent manner.	Oncogene	2013	28
22570426	temozolomide	Zhang W	miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expression.	Neuro-oncology	2012	44
22578793	temozolomide	Wick W	Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial.	The Lancet. Oncology	2012	136
22593187	temozolomide	Janouskova H	Integrin α5β1 plays a critical role in resistance to temozolomide by interfering with the p53 pathway in high-grade glioma.	Cancer research	2012	32
22877848	temozolomide	Malmström A	Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial.	The Lancet. Oncology	2012	134
22984531	temozolomide	Safdie F	Fasting enhances the response of glioma to chemo- and radiotherapy.	PloS one	2012	33
23047041	temozolomide	Triscott J	Disulfiram, a drug widely used to control alcoholism, suppresses the self-renewal of glioblastoma and over-rides resistance to temozolomide.	Oncotarget	2012	33
23115158	temozolomide	Li S	Overexpression of isocitrate dehydrogenase mutant proteins renders glioma cells more sensitive to radiation.	Neuro-oncology	2013	38
23183822	temozolomide	Asuthkar S	Epigenetic regulation of miRNA-211 by MMP-9 governs glioma cell apoptosis, chemosensitivity and radiosensitivity.	Oncotarget	2012	49
23258846	temozolomide	Miranda-Gonçalves V	Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets.	Neuro-oncology	2013	52
23569323	temozolomide	Rubenstein JL	Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202).	Journal of clinical oncology 	2013	49
23818228	temozolomide	Siebzehnrubl FA	The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance.	EMBO molecular medicine	2013	76
24101040	temozolomide	Gilbert MR	Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial.	Journal of clinical oncology 	2013	119
24336570	temozolomide	Johnson BE	Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma.	Science	2014	244
24552317	temozolomide	Gilbert MR	A randomized trial of bevacizumab for newly diagnosed glioblastoma.	The New England journal of medicine	2014	381
24552318	temozolomide	Chinot OL	Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma.	The New England journal of medicine	2014	358
24608791	temozolomide	Auffinger B	Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy.	Cell death and differentiation	2014	58
24675463	temozolomide	Munoz JL	Temozolomide resistance in glioblastoma cells occurs partly through epidermal growth factor receptor-mediated induction of connexin 43.	Cell death & disease	2014	25
24861879	temozolomide	Shi Z	MiR-124 governs glioma growth and angiogenesis and enhances chemosensitivity by targeting R-Ras and N-Ras.	Neuro-oncology	2014	36
24980823	temozolomide	Wang L	MiR-143 acts as a tumor suppressor by targeting N-RAS and enhances temozolomide-induced apoptosis in glioma.	Oncotarget	2014	43
25093489	temozolomide	Han S	Exogenous IGFBP-2 promotes proliferation, invasion, and chemoresistance to temozolomide in glioma cells via the integrin β1-ERK pathway.	British journal of cancer	2014	26
25105369	temozolomide	Adair JE	Gene therapy enhances chemotherapy tolerance and efficacy in glioblastoma patients.	The Journal of clinical investigation	2014	20
25135958	temozolomide	Bao ZS	RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas.	Genome research	2014	41
25163906	temozolomide	Stupp R	Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial.	The Lancet. Oncology	2014	126
25283382	temozolomide	Shi J	Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation.	Tumour biology 	2015	22
25364264	temozolomide	Lee JK	Targeting the epithelial to mesenchymal transition in glioblastoma: the emerging role of MET signaling.	OncoTargets and therapy	2014	23
25468223	temozolomide	Cohen AL	Glioma biology and molecular markers.	Cancer treatment and research	2015	30
25526733	temozolomide	Ma DJ	A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K.	Neuro-oncology	2015	18
25542083	temozolomide	Zanotto-Filho A	Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas.	Cancer letters	2015	23
25586468	temozolomide	Schuster J	A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study.	Neuro-oncology	2015	66
25595896	temozolomide	Munoz JL	Temozolomide resistance in glioblastoma occurs by miRNA-9-targeted PTCH1, independent of sonic hedgehog level.	Oncotarget	2015	17
25605243	temozolomide	Wang Z	Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors.	Oncotarget	2015	18
25609063	temozolomide	Pokorny JL	The Efficacy of the Wee1 Inhibitor MK-1775 Combined with Temozolomide Is Limited by Heterogeneous Distribution across the Blood-Brain Barrier in Glioblastoma.	Clinical cancer research 	2015	16
25609769	temozolomide	Suchorska B	Biological tumor volume in 18FET-PET before radiochemotherapy correlates with survival in GBM.	Neurology	2015	17
25655102	temozolomide	Weller M	MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial.	Clinical cancer research 	2015	23
25724300	temozolomide	van Thuijl HF	Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment.	Acta neuropathologica	2015	19
25762461	temozolomide	Nabors LB	Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study.	Neuro-oncology	2015	30
25867026	temozolomide	Sesen J	Metformin inhibits growth of human glioblastoma cells and enhances therapeutic response.	PloS one	2015	25
25959588	temozolomide	Shao H	Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma.	Nature communications	2015	43
26124478	temozolomide	Sandmann T	Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial.	Journal of clinical oncology 	2015	48
26188279	temozolomide	Yu Z	NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.	Cancer letters	2015	19
26373279	temozolomide	Kim J	Spatiotemporal Evolution of the Primary Glioblastoma Genome.	Cancer cell	2015	32
26431379	temozolomide	Yu Z	Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo.	Oncotarget	2015	22
26542214	temozolomide	Murphy SF	Connexin 43 Inhibition Sensitizes Chemoresistant Glioblastoma Cells to Temozolomide.	Cancer research	2016	12
26878385	temozolomide	Garros-Regulez L	mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance.	Expert opinion on therapeutic targets	2016	14
27370396	temozolomide	Wick W	Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide.	Neuro-oncology	2016	11
27503138	temozolomide	Arita H	A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas.	Acta neuropathologica communications	2016	12
27686946	temozolomide	Baumert BG	Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.	The Lancet. Oncology	2016	15
28187000	temozolomide	Chen W	MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression.	Oncotarget	2017	8
28202508	temozolomide	Lu Y	Chemosensitivity of IDH1-Mutated Gliomas Due to an Impairment in PARP1-Mediated DNA Repair.	Cancer research	2017	11
28233083	temozolomide	Ludwig K	Molecular markers in glioma.	Journal of neuro-oncology	2017	9
28668966	temozolomide	Li H	Long Non-Coding RNA MALAT1 Decreases the Sensitivity of Resistant Glioblastoma Cell Lines to Temozolomide.	Cellular physiology and biochemistry 	2017	7
28844499	temozolomide	Weller M	Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.	The Lancet. Oncology	2017	11
1822725	thioflavin T	Arnold SE	The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease.	Cerebral cortex	1991	244
10611368	thioflavin T	Bales KR	Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease.	Proceedings of the National Academy of Sciences of the United States of America	1999	101
10704204	thioflavin T	Conway KA	Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.	Biochemistry	2000	167
12217698	thioflavin T	Hoyer W	Dependence of alpha-synuclein aggregate morphology on solution conditions.	Journal of molecular biology	2002	100
14729357	thioflavin T	Anderson DH	Characterization of beta amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration.	Experimental eye research	2004	88
14985348	thioflavin T	Davis J	Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor.	The Journal of biological chemistry	2004	121
16207713	thioflavin T	Koldamova R	Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice.	The Journal of biological chemistry	2005	95
16982417	thioflavin T	Mueller-Steiner S	Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease.	Neuron	2006	104
18096717	thioflavin T	Colby DW	Prion detection by an amyloid seeding assay.	Proceedings of the National Academy of Sciences of the United States of America	2007	73
20198645	thioflavin T	Li JY	Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease.	Movement disorders 	2010	54
21427723	thioflavin T	Cohen TJ	The acetylation of tau inhibits its function and promotes pathological tau aggregation.	Nature communications	2011	113
21802369	thioflavin T	Murray ME	Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study.	The Lancet. Neurology	2011	145
22031526	thioflavin T	Peden AH	Sensitive and specific detection of sporadic Creutzfeldt-Jakob disease brain prion protein using real-time quaking-induced conversion.	The Journal of general virology	2012	35
23526723	thioflavin T	Lesage S	G51D α-synuclein mutation causes a novel parkinsonian-pyramidal syndrome.	Annals of neurology	2013	114
24281246	thioflavin T	Kohli N	Oral delivery of bioencapsulated proteins across blood-brain and blood-retinal barriers.	Molecular therapy 	2014	29
25253695	thioflavin T	Benilova I	The Alzheimer disease protective mutation A2T modulates kinetic and thermodynamic properties of amyloid-β (Aβ) aggregation.	The Journal of biological chemistry	2014	30
28140404	thioflavin T	Cacciottolo M	Particulate air pollutants, APOE alleles and their contributions to cognitive impairment in older women and to amyloidogenesis in experimental models.	Translational psychiatry	2017	7
11164622	anandamide	Pertwee RG	Cannabinoid receptors and pain.	Progress in neurobiology	2001	111
11606325	anandamide	Bisogno T	Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.	British journal of pharmacology	2001	125
12461523	anandamide	Kathuria S	Modulation of anxiety through blockade of anandamide hydrolysis.	Nature medicine	2003	400
12960289	anandamide	Klein TW	The cannabinoid system and immune modulation.	Journal of leukocyte biology	2003	134
15354183	anandamide	Giuffrida A	Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms.	Neuropsychopharmacology 	2004	82
16596770	anandamide	Pertwee RG	Pharmacological actions of cannabinoids.	Handbook of experimental pharmacology	2005	120
17406653	anandamide	Mahler SV	Endocannabinoid hedonic hotspot for sensory pleasure: anandamide in nucleus accumbens shell enhances 'liking' of a sweet reward.	Neuropsychopharmacology 	2007	104
18482430	anandamide	Pertwee RG	Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond.	Addiction biology	2008	56
19389627	anandamide	Ahn K	Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain.	Chemistry & biology	2009	145
20098669	anandamide	Cencioni MT	Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors.	PloS one	2010	58
21175579	anandamide	De Petrocellis L	Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.	British journal of pharmacology	2011	83
22029953	anandamide	Heyman E	Intense exercise increases circulating endocannabinoid and BDNF levels in humans--possible implications for reward and depression.	Psychoneuroendocrinology	2012	37
22688188	anandamide	Gunduz-Cinar O	Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity.	Molecular psychiatry	2013	88
23127915	anandamide	Guindon J	Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.	Pharmacological research	2013	35
23954677	anandamide	Piomelli D	More surprises lying ahead. The endocannabinoids keep us guessing.	Neuropharmacology	2014	34
24035186	anandamide	Hill MN	Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks.	Psychoneuroendocrinology	2013	34
24325918	anandamide	Gunduz-Cinar O	Amygdala FAAH and anandamide: mediating protection and recovery from stress.	Trends in pharmacological sciences	2013	47
24747340	anandamide	Ohno-Shosaku T	Endocannabinoid-mediated retrograde modulation of synaptic transmission.	Current opinion in neurobiology	2014	39
25651941	anandamide	Hind WH	Endocannabinoids modulate human blood-brain barrier permeability in vitro.	British journal of pharmacology	2015	15
25731744	anandamide	Dincheva I	FAAH genetic variation enhances fronto-amygdala function in mouse and human.	Nature communications	2015	46
26068727	anandamide	Morena M	Neurobiological Interactions Between Stress and the Endocannabinoid System.	Neuropsychopharmacology 	2016	41
26698193	anandamide	Lu HC	An Introduction to the Endogenous Cannabinoid System.	Biological psychiatry	2016	36
15927244	Endocannabinoids	Viveros MP	Endocannabinoid system and stress and anxiety responses.	Pharmacology, biochemistry, and behavior	2005	85
18615177	Endocannabinoids	Ashton JC	The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration.	Current neuropharmacology	2007	57
20929960	Endocannabinoids	Blázquez C	Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease.	Brain 	2011	41
21148657	Endocannabinoids	Voscopoulos C	When does acute pain become chronic?	British journal of anaesthesia	2010	48
24571856	Endocannabinoids	Xu JY	Endocannabinoids in synaptic plasticity and neuroprotection.	The Neuroscientist 	2015	19
24582908	Endocannabinoids	McLaughlin RJ	A critical role for prefrontocortical endocannabinoid signaling in the regulation of stress and emotional behavior.	Neuroscience and biobehavioral reviews	2014	23
25891509	Endocannabinoids	Soltesz I	Weeding out bad waves: towards selective cannabinoid circuit control in epilepsy.	Nature reviews. Neuroscience	2015	24
25981172	Endocannabinoids	Jenniches I	Anxiety, Stress, and Fear Response in Mice With Reduced Endocannabinoid Levels.	Biological psychiatry	2016	23
28625718	Endocannabinoids	Araque A	Synaptic functions of endocannabinoid signaling in health and disease.	Neuropharmacology	2017	7
9776413	Lomustine	Cairncross JG	Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.	Journal of the National Cancer Institute	1998	190
23071237	Lomustine	van den Bent MJ	Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.	Journal of clinical oncology 	2013	157
23269986	Lomustine	Erdem-Eraslan L	Intrinsic molecular subtypes of glioma are prognostic and predict benefit from adjuvant procarbazine, lomustine, and vincristine chemotherapy in combination with other prognostic factors in anaplastic oligodendroglial brain tumors: a report from EORTC study 26951.	Journal of clinical oncology 	2013	26
24516018	Lomustine	Cairncross JG	Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH.	Journal of clinical oncology 	2014	65
26354927	Lomustine	Dubbink HJ	Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.	Neuro-oncology	2016	19
27050206	Lomustine	Buckner JC	Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma.	The New England journal of medicine	2016	55
15717292	hydrogen sulfite	Abdolmaleky HM	Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report.	American journal of medical genetics. Part B, Neuropsychiatric genetics 	2005	117
15822191	hydrogen sulfite	Esteller M	Aberrant DNA methylation as a cancer-inducing mechanism.	Annual review of pharmacology and toxicology	2005	101
17471289	hydrogen sulfite	Kuratomi G	Aberrant DNA methylation associated with bipolar disorder identified from discordant monozygotic twins.	Molecular psychiatry	2008	52
17591937	hydrogen sulfite	Mikeska T	Optimization of quantitative MGMT promoter methylation analysis using pyrosequencing and combined bisulfite restriction analysis.	The Journal of molecular diagnostics 	2007	56
18045775	hydrogen sulfite	Al-Mahdawi S	The Friedreich ataxia GAA repeat expansion mutation induces comparable epigenetic changes in human and transgenic mouse brain and heart tissues.	Human molecular genetics	2008	90
18835857	hydrogen sulfite	Hogart A	Chromosome 15q11-13 duplication syndrome brain reveals epigenetic alterations in gene expression not predicted from copy number.	Journal of medical genetics	2009	46
19124685	hydrogen sulfite	Ernst C	Alternative splicing, methylation state, and expression profile of tropomyosin-related kinase B in the frontal cortex of suicide completers.	Archives of general psychiatry	2009	52
20375269	hydrogen sulfite	Nguyen A	Global methylation profiling of lymphoblastoid cell lines reveals epigenetic contributions to autism spectrum disorders and a novel autism candidate gene, RORA, whose protein product is reduced in autistic brain.	FASEB journal 	2010	107
20583129	hydrogen sulfite	Toledo-Rodriguez M	Maternal smoking during pregnancy is associated with epigenetic modifications of the brain-derived neurotrophic factor-6 exon in adolescent offspring.	American journal of medical genetics. Part B, Neuropsychiatric genetics 	2010	46
23325432	hydrogen sulfite	Varley KE	Dynamic DNA methylation across diverse human cell lines and tissues.	Genome research	2013	214
24183680	hydrogen sulfite	Bender S	Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas.	Cancer cell	2013	114
24662927	hydrogen sulfite	Nagy C	Astrocytic abnormalities and global DNA methylation patterns in depression and suicide.	Molecular psychiatry	2015	39
24929637	hydrogen sulfite	Dempster EL	Genome-wide methylomic analysis of monozygotic twins discordant for adolescent depression.	Biological psychiatry	2014	31
26012557	hydrogen sulfite	Andoh-Noda T	Differentiation of multipotent neural stem cells derived from Rett syndrome patients is biased toward the astrocytic lineage.	Molecular brain	2015	18
26923874	hydrogen sulfite	Johann PD	Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes.	Cancer cell	2016	31
26977886	hydrogen sulfite	Chun HE	Genome-Wide Profiles of Extra-cranial Malignant Rhabdoid Tumors Reveal Heterogeneity and Dysregulated Developmental Pathways.	Cancer cell	2016	14
15365071	pro-brain natriuretic peptide (1-76)	Dispenzieri A	Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis.	Journal of clinical oncology 	2004	79
15477419	pro-brain natriuretic peptide (1-76)	Latini R	Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.	Circulation	2004	86
15716560	pro-brain natriuretic peptide (1-76)	Kragelund C	N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.	The New England journal of medicine	2005	81
15811980	pro-brain natriuretic peptide (1-76)	Kistorp C	N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.	JAMA	2005	110
16157772	pro-brain natriuretic peptide (1-76)	Kistorp C	Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure.	Circulation	2005	110
16979009	pro-brain natriuretic peptide (1-76)	van Kimmenade RR	Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure.	Journal of the American College of Cardiology	2006	70
17692745	pro-brain natriuretic peptide (1-76)	Januzzi JL Jr	Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study.	Journal of the American College of Cardiology	2007	61
18378613	pro-brain natriuretic peptide (1-76)	Sabatine MS	Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction.	Circulation	2008	52
20659949	pro-brain natriuretic peptide (1-76)	Damman K	Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate.	Heart	2010	47
21070922	pro-brain natriuretic peptide (1-76)	Smith JG	Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation.	Journal of the American College of Cardiology	2010	48
21178018	pro-brain natriuretic peptide (1-76)	Ky B	High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure.	Circulation. Heart failure	2011	60
21835901	pro-brain natriuretic peptide (1-76)	Colish J	Obstructive sleep apnea: effects of continuous positive airway pressure on cardiac remodeling as assessed by cardiac biomarkers, echocardiography, and cardiac MRI.	Chest	2012	32
22016505	pro-brain natriuretic peptide (1-76)	Felker GM	Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study.	Circulation. Heart failure	2012	32
22331953	pro-brain natriuretic peptide (1-76)	Kumar S	Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements.	Journal of clinical oncology 	2012	40
22370326	pro-brain natriuretic peptide (1-76)	Lipshultz SE	Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes.	Journal of clinical oncology 	2012	45
22633655	pro-brain natriuretic peptide (1-76)	van der Linde D	Aggressive cardiovascular phenotype of aneurysms-osteoarthritis syndrome caused by pathogenic SMAD3 variants.	Journal of the American College of Cardiology	2012	30
23471272	pro-brain natriuretic peptide (1-76)	Folsom AR	Troponin T, N-terminal pro-B-type natriuretic peptide, and incidence of stroke: the atherosclerosis risk in communities study.	Stroke	2013	32
23547171	pro-brain natriuretic peptide (1-76)	Devaux Y	MicroRNA-150: a novel marker of left ventricular remodeling after acute myocardial infarction.	Circulation. Cardiovascular genetics	2013	28
23563576	pro-brain natriuretic peptide (1-76)	McMurray JJ	Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF).	European journal of heart failure	2013	29
23696613	pro-brain natriuretic peptide (1-76)	Ellis KL	Circulating microRNAs as candidate markers to distinguish heart failure in breathless patients.	European journal of heart failure	2013	38
23733199	pro-brain natriuretic peptide (1-76)	Lazo M	NH2-terminal pro-brain natriuretic peptide and risk of diabetes.	Diabetes	2013	27
23967079	pro-brain natriuretic peptide (1-76)	Devaux Y	A panel of 4 microRNAs facilitates the prediction of left ventricular contractility after acute myocardial infarction.	PloS one	2013	26
24216390	pro-brain natriuretic peptide (1-76)	Troughton R	Natriuretic peptide-guided heart failure management.	European heart journal	2014	23
24733959	pro-brain natriuretic peptide (1-76)	Ji Q	Elevated plasma IL-37, IL-18, and IL-18BP concentrations in patients with acute coronary syndrome.	Mediators of inflammation	2014	23
25414155	pro-brain natriuretic peptide (1-76)	Lovshin JA	Liraglutide promotes natriuresis but does not increase circulating levels of atrial natriuretic peptide in hypertensive subjects with type 2 diabetes.	Diabetes care	2015	18
25643195	pro-brain natriuretic peptide (1-76)	Cakmak HA	The prognostic value of circulating microRNAs in heart failure: preliminary results from a genome-wide expression study.	Journal of cardiovascular medicine	2015	19
25765696	pro-brain natriuretic peptide (1-76)	Zannad F	Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial.	Lancet	2015	82
26390057	pro-brain natriuretic peptide (1-76)	Kato N	Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation.	Nature genetics	2015	58
26497848	pro-brain natriuretic peptide (1-76)	Chan MM	Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction.	European journal of heart failure	2016	10
28199174	pro-brain natriuretic peptide (1-76)	Zardavas D	Role of Troponins I and T and N-Terminal Prohormone of Brain Natriuretic Peptide in Monitoring Cardiac Safety of Patients With Early-Stage Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Trastuzumab: A Herceptin Adjuvant Study Cardiac Marker Substudy.	Journal of clinical oncology 	2017	6
11381111	catechol	Egan MF	Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia.	Proceedings of the National Academy of Sciences of the United States of America	2001	561
15457404	catechol	Chen J	Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain.	American journal of human genetics	2004	370
15673663	catechol	Smolka MN	Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex.	The Journal of neuroscience 	2005	96
16234808	catechol	Gothelf D	COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome.	Nature neuroscience	2005	85
17483451	catechol	Yacubian J	Gene-gene interaction associated with neural reward sensitivity.	Proceedings of the National Academy of Sciences of the United States of America	2007	90
17636131	catechol	Tan HY	Epistasis between catechol-O-methyltransferase and type II metabotropic glutamate receptor 3 genes on working memory brain function.	Proceedings of the National Academy of Sciences of the United States of America	2007	63
17726000	catechol	Tan HY	Dysfunctional and compensatory prefrontal cortical systems, genes and the pathogenesis of schizophrenia.	Cerebral cortex	2007	68
17767149	catechol	Straub RE	Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression.	Molecular psychiatry	2007	98
18958202	catechol	Nagel IE	Human aging magnifies genetic effects on executive functioning and working memory.	Frontiers in human neuroscience	2008	57
19175757	catechol	Lonsdorf TB	Genetic gating of human fear learning and extinction: possible implications for gene-environment interaction in anxiety disorder.	Psychological science	2009	66
19210038	catechol	Raz N	Genetic and vascular modifiers of age-sensitive cognitive skills: effects of COMT, BDNF, ApoE, and hypertension.	Neuropsychology	2009	55
19225597	catechol	Lindenberger U	Age-related decline in brain resources modulates genetic effects on cognitive functioning.	Frontiers in neuroscience	2008	55
19417742	catechol	Mier D	Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis.	Molecular psychiatry	2010	134
19446012	catechol	Dickinson D	Genes, cognition and brain through a COMT lens.	Neuroscience	2009	56
21543598	catechol	Ursini G	Stress-related methylation of the catechol-O-methyltransferase Val 158 allele predicts human prefrontal cognition and activity.	The Journal of neuroscience 	2011	56
22487033	catechol	Collins AG	How much of reinforcement learning is working memory, not reinforcement learning? A behavioral, computational, and neurogenetic analysis.	The European journal of neuroscience	2012	48
23283688	catechol	Knickmeyer RC	Common variants in psychiatric risk genes predict brain structure at birth.	Cerebral cortex	2014	38
18985363	isocitric acid	Balss J	Analysis of the IDH1 codon 132 mutation in brain tumors.	Acta neuropathologica	2008	234
19246647	isocitric acid	Watanabe T	IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas.	The American journal of pathology	2009	202
19554337	isocitric acid	Hartmann C	Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.	Acta neuropathologica	2009	240
19636000	isocitric acid	Sanson M	Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.	Journal of clinical oncology 	2009	197
19737147	isocitric acid	Ohgaki H	Genetic alterations and signaling pathways in the evolution of gliomas.	Cancer science	2009	106
19903171	isocitric acid	Capper D	Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors.	Brain pathology	2010	89
20427748	isocitric acid	Labussière M	All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2.	Neurology	2010	63
21163902	isocitric acid	Christensen BC	DNA methylation, isocitrate dehydrogenase mutation, and survival in glioma.	Journal of the National Cancer Institute	2011	92
21446051	isocitric acid	Huse JT	Molecular subclassification of diffuse gliomas: seeing order in the chaos.	Glia	2011	77
22270850	isocitric acid	Bleeker FE	Recent advances in the molecular understanding of glioblastoma.	Journal of neuro-oncology	2012	44
23104868	isocitric acid	Kannan K	Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma.	Oncotarget	2012	60
24842956	isocitric acid	Ostrom QT	The epidemiology of glioma in adults: a "state of the science" review.	Neuro-oncology	2014	127
25081751	isocitric acid	Chan AK	TERT promoter mutations contribute to subset prognostication of lower-grade gliomas.	Modern pathology 	2015	21
25225364	isocitric acid	Chen R	Hominoid-specific enzyme GLUD2 promotes growth of IDH1R132H glioma.	Proceedings of the National Academy of Sciences of the United States of America	2014	25
25701198	isocitric acid	Olar A	IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas.	Acta neuropathologica	2015	21
25783747	isocitric acid	Weller M	Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups.	Acta neuropathologica	2015	28
26188014	isocitric acid	Waitkus MS	Isocitrate dehydrogenase mutations in gliomas.	Neuro-oncology	2016	25
26945349	isocitric acid	Chen JR	Isocitrate Dehydrogenase (IDH)1/2 Mutations as Prognostic Markers in Patients With Glioblastomas.	Medicine	2016	13
27353503	isocitric acid	Zhang B	Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas.	Neuro-oncology	2017	8
27370400	isocitric acid	Garber ST	Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies.	Neuro-oncology	2016	11
27820599	isocitric acid	Miroshnikova YA	Tissue mechanics promote IDH1-dependent HIF1α-tenascin C feedback to regulate glioblastoma aggression.	Nature cell biology	2016	12
28124097	isocitric acid	Pusch S	Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivo.	Acta neuropathologica	2017	7
28360267	isocitric acid	Venteicher AS	Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq.	Science	2017	29
10681545	amyloid beta-protein (1-42)	Wang HY	beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology.	The Journal of biological chemistry	2000	152
11520119	amyloid beta-protein (1-42)	Lue LF	Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism.	Experimental neurology	2001	87
12607822	amyloid beta-protein (1-42)	Butterfield DA	Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.	Free radical research	2002	95
15473992	amyloid beta-protein (1-42)	Ikonomovic MD	Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury.	Experimental neurology	2004	105
19251758	amyloid beta-protein (1-42)	Schuff N	MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers.	Brain 	2009	177
19273754	amyloid beta-protein (1-42)	Qin W	PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia.	Archives of neurology	2009	79
20373342	amyloid beta-protein (1-42)	Vemuri P	Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease.	Annals of neurology	2010	64
20592257	amyloid beta-protein (1-42)	Landau SM	Comparing predictors of conversion and decline in mild cognitive impairment.	Neurology	2010	163
20625167	amyloid beta-protein (1-42)	Vemuri P	Serial MRI and CSF biomarkers in normal aging, MCI, and AD.	Neurology	2010	66
17362834	2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane	McKeith I	Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study.	The Lancet. Neurology	2007	62
28180961	2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane	Doppler K	Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.	Acta neuropathologica	2017	8
19935646	alpha-hydroxyglutarate	Dang L	Cancer-associated IDH1 mutations produce 2-hydroxyglutarate.	Nature	2009	751
20513808	alpha-hydroxyglutarate	Reitman ZJ	Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism.	Journal of the National Cancer Institute	2010	110
20615753	alpha-hydroxyglutarate	Kloosterhof NK	Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?	The Lancet. Oncology	2011	47
20692206	alpha-hydroxyglutarate	Dang L	IDH mutations in glioma and acute myeloid leukemia.	Trends in molecular medicine	2010	94
20847235	alpha-hydroxyglutarate	Kranendijk M	IDH2 mutations in patients with D-2-hydroxyglutaric aciduria.	Science	2010	48
21045145	alpha-hydroxyglutarate	Seltzer MJ	Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1.	Cancer research	2010	148
21289278	alpha-hydroxyglutarate	Reitman ZJ	Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome.	Proceedings of the National Academy of Sciences of the United States of America	2011	164
21326614	alpha-hydroxyglutarate	Jin G	2-hydroxyglutarate production, but not dominant negative function, is conferred by glioma-derived NADP-dependent isocitrate dehydrogenase mutations.	PloS one	2011	49
21913188	alpha-hydroxyglutarate	Capper D	2-Hydroxyglutarate concentration in serum from patients with gliomas does not correlate with IDH1/2 mutation status or tumor size.	International journal of cancer	2012	36
22015945	alpha-hydroxyglutarate	Pope WB	Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy.	Journal of neuro-oncology	2012	62
22166263	alpha-hydroxyglutarate	Luchman HA	An in vivo patient-derived model of endogenous IDH1-mutant glioma.	Neuro-oncology	2012	47
22238332	alpha-hydroxyglutarate	Andronesi OC	Detection of 2-hydroxyglutarate in IDH-mutated glioma patients by in vivo spectral-editing and 2D correlation magnetic resonance spectroscopy.	Science translational medicine	2012	85
22238333	alpha-hydroxyglutarate	Elkhaled A	Magnetic resonance of 2-hydroxyglutarate in IDH1-mutated low-grade gliomas.	Science translational medicine	2012	53
22281806	alpha-hydroxyglutarate	Choi C	2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas.	Nature medicine	2012	150
22343896	alpha-hydroxyglutarate	Koivunen P	Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation.	Nature	2012	198
23204232	alpha-hydroxyglutarate	Jin G	Disruption of wild-type IDH1 suppresses D-2-hydroxyglutarate production in IDH1-mutated gliomas.	Cancer research	2013	35
23532369	alpha-hydroxyglutarate	Cohen AL	IDH1 and IDH2 mutations in gliomas.	Current neurology and neuroscience reports	2013	54
23877318	alpha-hydroxyglutarate	Zhang C	IDH1/2 mutations target a key hallmark of cancer by deregulating cellular metabolism in glioma.	Neuro-oncology	2013	29
23999439	alpha-hydroxyglutarate	Andronesi OC	Detection of oncogenic IDH1 mutations using magnetic resonance spectroscopy of 2-hydroxyglutarate.	The Journal of clinical investigation	2013	32
24019001	alpha-hydroxyglutarate	Chaumeil MM	Non-invasive in vivo assessment of IDH1 mutational status in glioma.	Nature communications	2013	38
24077805	alpha-hydroxyglutarate	Borodovsky A	5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft.	Oncotarget	2013	37
24333121	alpha-hydroxyglutarate	Emadi A	Inhibition of glutaminase selectively suppresses the growth of primary acute myeloid leukemia cells with IDH mutations.	Experimental hematology	2014	37
24366912	alpha-hydroxyglutarate	Chesnelong C	Lactate dehydrogenase A silencing in IDH mutant gliomas.	Neuro-oncology	2014	32
24590270	alpha-hydroxyglutarate	Ohka F	Quantitative metabolome analysis profiles activation of glutaminolysis in glioma with IDH1 mutation.	Tumour biology 	2014	25
25706986	alpha-hydroxyglutarate	Izquierdo-Garcia JL	Metabolic reprogramming in mutant IDH1 glioma cells.	PloS one	2015	18
26045167	alpha-hydroxyglutarate	Izquierdo-Garcia JL	IDH1 Mutation Induces Reprogramming of Pyruvate Metabolism.	Cancer research	2015	22
26534967	alpha-hydroxyglutarate	Andronesi OC	Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate.	Clinical cancer research 	2016	14
26669865	alpha-hydroxyglutarate	Emir UE	Noninvasive Quantification of 2-Hydroxyglutarate in Human Gliomas with IDH1 and IDH2 Mutations.	Cancer research	2016	19
26678339	alpha-hydroxyglutarate	Tateishi K	Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion.	Cancer cell	2015	40
26691210	alpha-hydroxyglutarate	de la Fuente MI	Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma.	Neuro-oncology	2016	22
11201742	polyleucine	Fournier AE	Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration.	Nature	2001	239
15541309	polyleucine	Zimprich A	Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.	Neuron	2004	622
15680457	polyleucine	Gilks WP	A common LRRK2 mutation in idiopathic Parkinson's disease.	Lancet	2005	161
16269541	polyleucine	West AB	Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity.	Proceedings of the National Academy of Sciences of the United States of America	2005	319
16437584	polyleucine	Giasson BI	Biochemical and pathological characterization of Lrrk2.	Annals of neurology	2006	68
17114044	polyleucine	MacLeod D	The familial Parkinsonism gene LRRK2 regulates neurite process morphology.	Neuron	2006	223
17363510	polyleucine	Sarkaria JN	Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel.	Molecular cancer therapeutics	2007	101
17722061	polyleucine	Nakano I	Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells.	Journal of neuroscience research	2008	64
18367605	polyleucine	Wang L	The chaperone activity of heat shock protein 90 is critical for maintaining the stability of leucine-rich repeat kinase 2.	The Journal of neuroscience 	2008	73
18397888	polyleucine	Greggio E	The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation.	The Journal of biological chemistry	2008	121
18539534	polyleucine	Healy DG	Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study.	The Lancet. Neurology	2008	283
19524782	polyleucine	Lees AJ	Parkinson's disease.	Lancet	2009	382
19640926	polyleucine	Alegre-Abarrategui J	LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model.	Human molecular genetics	2009	148
19717560	polyleucine	Donkor J	A conserved serine residue is required for the phosphatidate phosphatase activity but not the transcriptional coactivator functions of lipin-1 and lipin-2.	The Journal of biological chemistry	2009	51
20519524	polyleucine	Siddiqui TJ	LRRTMs and neuroligins bind neurexins with a differential code to cooperate in glutamate synapse development.	The Journal of neuroscience 	2010	93
20663977	polyleucine	Irani SR	Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia.	Brain 	2010	185
21168496	polyleucine	Winner B	Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S mice.	Neurobiology of disease	2011	54
21307259	polyleucine	Piccoli G	LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool.	The Journal of neuroscience 	2011	83
21804599	polyleucine	Molina JR	PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma.	Oncogene	2012	53
23560750	polyleucine	Davies P	Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodies.	The Biochemical journal	2013	30
15615769	cytidylyl-3'-5'-guanosine	Samaco RC	Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3.	Human molecular genetics	2005	118
15652398	cytidylyl-3'-5'-guanosine	Farina C	Preferential expression and function of Toll-like receptor 3 in human astrocytes.	Journal of neuroimmunology	2005	71
17296936	cytidylyl-3'-5'-guanosine	Nan X	Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation.	Proceedings of the National Academy of Sciences of the United States of America	2007	75
17486179	cytidylyl-3'-5'-guanosine	Nagarajan RP	Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation.	Epigenetics	2006	101
18321864	cytidylyl-3'-5'-guanosine	Samaco RC	A partial loss of function allele of methyl-CpG-binding protein 2 predicts a human neurodevelopmental syndrome.	Human molecular genetics	2008	82
18571142	cytidylyl-3'-5'-guanosine	Ariani F	FOXG1 is responsible for the congenital variant of Rett syndrome.	American journal of human genetics	2008	88
18588526	cytidylyl-3'-5'-guanosine	Gil JM	Mechanisms of neurodegeneration in Huntington's disease.	The European journal of neuroscience	2008	92
18817733	cytidylyl-3'-5'-guanosine	Fyffe SL	Deletion of Mecp2 in Sim1-expressing neurons reveals a critical role for MeCP2 in feeding behavior, aggression, and the response to stress.	Neuron	2008	94
19386901	cytidylyl-3'-5'-guanosine	Maezawa I	Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions.	The Journal of neuroscience 	2009	116
20393567	cytidylyl-3'-5'-guanosine	Thomson JP	CpG islands influence chromatin structure via the CpG-binding protein Cfp1.	Nature	2010	214
21051541	cytidylyl-3'-5'-guanosine	Sephton CF	Identification of neuronal RNA targets of TDP-43-containing ribonucleoprotein complexes.	The Journal of biological chemistry	2011	130
21085180	cytidylyl-3'-5'-guanosine	Muotri AR	L1 retrotransposition in neurons is modulated by MeCP2.	Nature	2010	195
21721946	cytidylyl-3'-5'-guanosine	Guy J	The role of MeCP2 in the brain.	Annual review of cell and developmental biology	2011	149
12150997	4-azidophenylpropionamide	Baek SH	Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and beta-amyloid precursor protein.	Cell	2002	184
16452683	4-azidophenylpropionamide	Offe K	The lipoprotein receptor LR11 regulates amyloid beta production and amyloid precursor protein traffic in endosomal compartments.	The Journal of neuroscience 	2006	99
17121991	4-azidophenylpropionamide	Sun X	Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression.	Proceedings of the National Academy of Sciences of the United States of America	2006	122
18492093	4-azidophenylpropionamide	Chen XH	A lack of amyloid beta plaques despite persistent accumulation of amyloid beta in axons of long-term survivors of traumatic brain injury.	Brain pathology	2009	62
19287391	4-azidophenylpropionamide	Loane DJ	Amyloid precursor protein secretases as therapeutic targets for traumatic brain injury.	Nature medicine	2009	94
19457065	4-azidophenylpropionamide	Hardy J	The amyloid hypothesis for Alzheimer's disease: a critical reappraisal.	Journal of neurochemistry	2009	186
19523444	4-azidophenylpropionamide	Killick R	Deletion of Irs2 reduces amyloid deposition and rescues behavioural deficits in APP transgenic mice.	Biochemical and biophysical research communications	2009	50
19523517	4-azidophenylpropionamide	Tomic JL	Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction.	Neurobiology of disease	2009	103
19699201	4-azidophenylpropionamide	Lazarov O	Neurogenesis and Alzheimer's disease: at the crossroads.	Experimental neurology	2010	74
19705461	4-azidophenylpropionamide	Mori T	Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease.	Glia	2010	53
20303415	4-azidophenylpropionamide	Vetrivel KS	Membrane rafts in Alzheimer's disease beta-amyloid production.	Biochimica et biophysica acta	2010	52
20881129	4-azidophenylpropionamide	Lane RF	Diabetes-associated SorCS1 regulates Alzheimer's amyloid-beta metabolism: evidence for involvement of SorL1 and the retromer complex.	The Journal of neuroscience 	2010	54
21280075	4-azidophenylpropionamide	Reitz C	SORCS1 alters amyloid precursor protein processing and variants may increase Alzheimer's disease risk.	Annals of neurology	2011	42
22733824	4-azidophenylpropionamide	Long JM	MicroRNA-153 physiologically inhibits expression of amyloid-β precursor protein in cultured human fetal brain cells and is dysregulated in a subset of Alzheimer disease patients.	The Journal of biological chemistry	2012	34
22988240	4-azidophenylpropionamide	Hitt B	β-Site amyloid precursor protein (APP)-cleaving enzyme 1 (BACE1)-deficient mice exhibit a close homolog of L1 (CHL1) loss-of-function phenotype involving axon guidance defects.	The Journal of biological chemistry	2012	34
23167973	4-azidophenylpropionamide	Hirst J	Adaptor protein complexes AP-4 and AP-5: new players in endosomal trafficking and progressive spastic paraplegia.	Traffic	2013	42
24352696	4-azidophenylpropionamide	Long JM	MicroRNA-339-5p down-regulates protein expression of β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) in human primary brain cultures and is reduced in brain tissue specimens of Alzheimer disease subjects.	The Journal of biological chemistry	2014	27
14638850	gefitinib	Rich JN	Phase II trial of gefitinib in recurrent glioblastoma.	Journal of clinical oncology 	2004	134
16278407	gefitinib	Lassman AB	Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01.	Clinical cancer research 	2005	68
17085664	gefitinib	Balak MN	Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor-mutant lung adenocarcinomas with acquired resistance to kinase inhibitors.	Clinical cancer research 	2006	213
18829483	gefitinib	Lo HW	Constitutively activated STAT3 frequently coexpresses with epidermal growth factor receptor in high-grade gliomas and targeting STAT3 sensitizes them to Iressa and alkylators.	Clinical cancer research 	2008	68
19018475	gefitinib	Kreisl TN	A pilot study of everolimus and gefitinib in the treatment of recurrent glioblastoma (GBM).	Journal of neuro-oncology	2009	48
19157632	gefitinib	Kim JE	Epidermal growth factor receptor tyrosine kinase inhibitors as a first-line therapy for never-smokers with adenocarcinoma of the lung having asymptomatic synchronous brain metastasis.	Lung cancer	2009	48
20146086	gefitinib	Clarke JL	High dose weekly erlotinib achieves therapeutic concentrations in CSF and is effective in leptomeningeal metastases from epidermal growth factor receptor mutant lung cancer.	Journal of neuro-oncology	2010	57
21030498	gefitinib	Heon S	Development of central nervous system metastases in patients with advanced non-small cell lung cancer and somatic EGFR mutations treated with gefitinib or erlotinib.	Clinical cancer research 	2010	50
21471286	gefitinib	Hegi ME	Pathway analysis of glioblastoma tissue after preoperative treatment with the EGFR tyrosine kinase inhibitor gefitinib--a phase II trial.	Molecular cancer therapeutics	2011	42
22057914	gefitinib	Cheng Y	MK-2206, a novel allosteric inhibitor of Akt, synergizes with gefitinib against malignant glioma via modulating both autophagy and apoptosis.	Molecular cancer therapeutics	2012	40
22127113	gefitinib	Brand TM	The nuclear epidermal growth factor receptor signaling network and its role in cancer.	Discovery medicine	2011	63
22167408	gefitinib	Jamal-Hanjani M	Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of epidermal growth factor receptor-mutant non-small cell lung cancer metastatic to the brain.	Clinical cancer research 	2012	37
22677429	gefitinib	Park SJ	Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 mutation.	Lung cancer	2012	63
22733536	gefitinib	Heon S	The impact of initial gefitinib or erlotinib versus chemotherapy on central nervous system progression in advanced non-small cell lung cancer with EGFR mutations.	Clinical cancer research 	2012	36
24021541	gefitinib	Iuchi T	Phase II trial of gefitinib alone without radiation therapy for Japanese patients with brain metastases from EGFR-mutant lung adenocarcinoma.	Lung cancer	2013	38
24269963	gefitinib	Roskoski R Jr	The ErbB/HER family of protein-tyrosine kinases and cancer.	Pharmacological research	2014	150
26308162	gefitinib	Russo A	A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives.	Oncotarget	2015	38
26724471	gefitinib	Lin JJ	Five-Year Survival in EGFR-Mutant Metastatic Lung Adenocarcinoma Treated with EGFR-TKIs.	Journal of thoracic oncology 	2016	24
27083334	gefitinib	Park K	Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial.	The Lancet. Oncology	2016	78
28426106	gefitinib	Paz-Ares L	Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial.	Annals of oncology 	2017	20
9467011	Amino Acids	Marsh DJ	Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation.	Human molecular genetics	1998	121
9560156	Amino Acids	Kitada T	Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.	Nature	1998	978
11336708	Amino Acids	Wang X	Crystal structure of a Pumilio homology domain.	Molecular cell	2001	89
11441147	Amino Acids	Reick M	NPAS2: an analog of clock operative in the mammalian forebrain.	Science	2001	142
12906785	Amino Acids	Tee AR	Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb.	Current biology 	2003	359
14530974	Amino Acids	Kanai Y	The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects.	Pflugers Archiv 	2004	75
14718572	Amino Acids	Lemmers C	CRB3 binds directly to Par6 and regulates the morphogenesis of the tight junctions in mammalian epithelial cells.	Molecular biology of the cell	2004	84
15572176	Amino Acids	Barbeito LH	A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis.	Brain research. Brain research reviews	2004	84
15586325	Amino Acids	Jensen LR	Mutations in the JARID1C gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation.	American journal of human genetics	2005	110
15689365	Amino Acids	Pauleit D	O-(2-18Ffluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas.	Brain 	2005	70
15878852	Amino Acids	Long X	Rheb binding to mammalian target of rapamycin (mTOR) is regulated by amino acid sufficiency.	The Journal of biological chemistry	2005	112
16176982	Amino Acids	Nobukuni T	Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase.	Proceedings of the National Academy of Sciences of the United States of America	2005	255
16365087	Amino Acids	Kimball SR	Signaling pathways and molecular mechanisms through which branched-chain amino acids mediate translational control of protein synthesis.	The Journal of nutrition	2006	109
16491080	Amino Acids	Carvalho RF	Silencing of EphA3 through a cis interaction with ephrinA5.	Nature neuroscience	2006	74
16621917	Amino Acids	Horvath R	Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene.	Brain 	2006	87
17156977	Amino Acids	Bendikov I	A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia.	Schizophrenia research	2007	66
17261713	Amino Acids	Bano D	Ca2+ signals and neuronal death in brain ischemia.	Stroke	2007	56
17517883	Amino Acids	Oshiro N	The proline-rich Akt substrate of 40 kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1.	The Journal of biological chemistry	2007	106
17988630	Amino Acids	Yasuda S	Activity-induced protocadherin arcadlin regulates dendritic spine number by triggering N-cadherin endocytosis via TAO2beta and p38 MAP kinases.	Neuron	2007	59
18401019	Amino Acids	Eberling JL	Results from a phase I safety trial of hAADC gene therapy for Parkinson disease.	Neurology	2008	101
18550814	Amino Acids	Sun Y	Phospholipase D1 is an effector of Rheb in the mTOR pathway.	Proceedings of the National Academy of Sciences of the United States of America	2008	84
18765678	Amino Acids	Avruch J	Amino acid regulation of TOR complex 1.	American journal of physiology. Endocrinology and metabolism	2009	146
19228619	Amino Acids	Yan H	IDH1 and IDH2 mutations in gliomas.	The New England journal of medicine	2009	1088
19234517	Amino Acids	Hartman TR	The role of the Birt-Hogg-Dubé protein in mTOR activation and renal tumorigenesis.	Oncogene	2009	62
19443489	Amino Acids	Wang JC	Risk for nicotine dependence and lung cancer is conferred by mRNA expression levels and amino acid change in CHRNA5.	Human molecular genetics	2009	87
19674479	Amino Acids	Koshimizu H	Multiple functions of precursor BDNF to CNS neurons: negative regulation of neurite growth, spine formation and cell survival.	Molecular brain	2009	47
19709627	Amino Acids	Jackson WS	Spontaneous generation of prion infectivity in fatal familial insomnia knockin mice.	Neuron	2009	49
19713214	Amino Acids	Kim KK	Identification of neuronal nuclei (NeuN) as Fox-3, a new member of the Fox-1 gene family of splicing factors.	The Journal of biological chemistry	2009	115
19907493	Amino Acids	Konopka G	Human-specific transcriptional regulation of CNS development genes by FOXP2.	Nature	2009	114
19996293	Amino Acids	Yan H	Mutant metabolic enzymes are at the origin of gliomas.	Cancer research	2009	46
20053679	Amino Acids	Flinn RJ	The late endosome is essential for mTORC1 signaling.	Molecular biology of the cell	2010	69
20124201	Amino Acids	Van Langenhove T	Genetic contribution of FUS to frontotemporal lobar degeneration.	Neurology	2010	49
20159109	Amino Acids	Giannandrea M	Mutations in the small GTPase gene RAB39B are responsible for X-linked mental retardation associated with autism, epilepsy, and macrocephaly.	American journal of human genetics	2010	61
20381137	Amino Acids	Sancak Y	Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids.	Cell	2010	653
20580095	Amino Acids	Miguel-Hidalgo JJ	Glial and glutamatergic markers in depression, alcoholism, and their comorbidity.	Journal of affective disorders	2010	46
20724292	Amino Acids	Costigan M	Multiple chronic pain states are associated with a common amino acid-changing allele in KCNS1.	Brain 	2010	71
21138990	Amino Acids	Wang X	mTORC1 signaling: what we still don't know.	Journal of molecular cell biology	2011	49
21292473	Amino Acids	Tischfield MA	Phenotypic spectrum of the tubulin-related disorders and functional implications of disease-causing mutations.	Current opinion in genetics & development	2011	64
21307646	Amino Acids	Chong ZZ	Mammalian target of rapamycin: hitting the bull's-eye for neurological disorders.	Oxidative medicine and cellular longevity	2010	56
21390129	Amino Acids	McLean CY	Human-specific loss of regulatory DNA and the evolution of human-specific traits.	Nature	2011	117
21521612	Amino Acids	Kohli MA	The neuronal transporter gene SLC6A15 confers risk to major depression.	Neuron	2011	52
21527325	Amino Acids	Wang H	Inhibitory neurotransmission in animal models of tinnitus: maladaptive plasticity.	Hearing research	2011	42
21784859	Amino Acids	Yoshida S	Redox regulates mammalian target of rapamycin complex 1 (mTORC1) activity by modulating the TSC1/TSC2-Rheb GTPase pathway.	The Journal of biological chemistry	2011	43
21852950	Amino Acids	Schmolke M	Differential contribution of PB1-F2 to the virulence of highly pathogenic H5N1 influenza A virus in mammalian and avian species.	PLoS pathogens	2011	45
22084578	Amino Acids	Chen Y	Kynurenine pathway metabolites in humans: disease and healthy States.	International journal of tryptophan research 	2009	87
22101681	Amino Acids	Chen WJ	Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia.	Nature genetics	2011	74
22574197	Amino Acids	Ögmundsdóttir MH	Proton-assisted amino acid transporter PAT1 complexes with Rag GTPases and activates TORC1 on late endosomal and lysosomal membranes.	PloS one	2012	48
23307866	Amino Acids	Choudhury NR	Tissue-specific control of brain-enriched miR-7 biogenesis.	Genes & development	2013	42
23842546	Amino Acids	Chae YC	Landscape of the mitochondrial Hsp90 metabolome in tumours.	Nature communications	2013	39
24155668	Amino Acids	Willard SS	Glutamate, glutamate receptors, and downstream signaling pathways.	International journal of biological sciences	2013	34
24529380	Amino Acids	Demetriades C	Regulation of TORC1 in response to amino acid starvation via lysosomal recruitment of TSC2.	Cell	2014	85
25411133	Amino Acids	Galldiks N	Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-18Ffluoroethyl)-L-tyrosine PET.	European journal of nuclear medicine and molecular imaging	2015	26
25820230	Amino Acids	Carelli V	Syndromic parkinsonism and dementia associated with OPA1 missense mutations.	Annals of neurology	2015	19
25963655	Amino Acids	Jung J	Amino Acid-Dependent mTORC1 Regulation by the Lysosomal Membrane Protein SLC38A9.	Molecular and cellular biology	2015	53
26084023	Amino Acids	Kolev M	Complement Regulates Nutrient Influx and Metabolic Reprogramming during Th1 Cell Responses.	Immunity	2015	27
26389641	Amino Acids	Park YY	Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma.	Hepatology	2016	14
26577932	Amino Acids	Muller CL	The serotonin system in autism spectrum disorder: From biomarker to animal models.	Neuroscience	2016	27
26724577	Amino Acids	Bhutia YD	Glutamine transporters in mammalian cells and their functions in physiology and cancer.	Biochimica et biophysica acta	2016	12
26742086	Amino Acids	Carroll B	Control of TSC2-Rheb signaling axis by arginine regulates mTORC1 activity.	eLife	2016	22
26902204	Amino Acids	Hinrich AJ	Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense oligonucleotides.	EMBO molecular medicine	2016	13
26996412	Amino Acids	March ZM	Prion-like domains as epigenetic regulators, scaffolds for subcellular organization, and drivers of neurodegenerative disease.	Brain research	2016	22
27023624	Amino Acids	Cooper AJ	Central Role of Glutamate Metabolism in the Maintenance of Nitrogen Homeostasis in Normal and Hyperammonemic Brain.	Biomolecules	2016	17
27106405	Amino Acids	Albert NL	Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.	Neuro-oncology	2016	24
27114849	Amino Acids	Plummer S	The Neuroprotective Properties of the Amyloid Precursor Protein Following Traumatic Brain Injury.	Aging and disease	2016	17
27240091	Amino Acids	Li B	Landscape of tumor-infiltrating T cell repertoire of human cancers.	Nature genetics	2016	26
27309342	Amino Acids	Wilson C	Actin filaments-A target for redox regulation.	Cytoskeleton	2016	12
27442752	Amino Acids	Garwood CJ	Review: Astrocytes in Alzheimer's disease and other age-associated dementias: a supporting player with a central role.	Neuropathology and applied neurobiology	2017	7
27595347	Amino Acids	Clairfeuille T	A molecular code for endosomal recycling of phosphorylated cargos by the SNX27-retromer complex.	Nature structural & molecular biology	2016	12
27816754	Amino Acids	Kim Y	Characterizing the mode of action of extracellular Connexin43 channel blocking mimetic peptides in an in vitro ischemia injury model.	Biochimica et biophysica acta	2017	5
27824355	Amino Acids	Mechawar N	Neuropathology of mood disorders: do we see the stigmata of inflammation?	Translational psychiatry	2016	17
28261941	Amino Acids	Takahashi RH	Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease.	Pathology international	2017	10
28424515	Amino Acids	Canul-Tec JC	Structure and allosteric inhibition of excitatory amino acid transporter 1.	Nature	2017	6
18421051	lapatinib	Lin NU	Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer.	Journal of clinical oncology 	2008	101
18664652	lapatinib	Gril B	Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain.	Journal of the National Cancer Institute	2008	78
19056914	lapatinib	Polli JW	An unexpected synergist role of P-glycoprotein and breast cancer resistance protein on the central nervous system penetration of the tyrosine kinase inhibitor lapatinib (N-{3-chloro-4-(3-fluorobenzyl)oxyphenyl}-6-5-({2-(methylsulfonyl)ethylamino}methyl)-2-furyl-4-quinazolinamine; GW572016).	Drug metabolism and disposition	2009	66
19228746	lapatinib	Lin NU	Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer.	Clinical cancer research 	2009	115
19499221	lapatinib	Thiessen B	A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation.	Cancer chemotherapy and pharmacology	2010	43
20009104	lapatinib	Guo D	EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy.	Science signaling	2009	82
22059152	lapatinib	Guo D	An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway.	Cancer discovery	2011	70
23122784	lapatinib	Bachelot T	Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study.	The Lancet. Oncology	2013	84
25025958	lapatinib	Singh JC	HER2-positive advanced breast cancer: optimizing patient outcomes and opportunities for drug development.	British journal of cancer	2014	25
25622903	lapatinib	Zhang L	Heparanase mediates a novel mechanism in lapatinib-resistant brain metastatic breast cancer.	Neoplasia	2015	17
17502554	2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole	Rowe CC	Imaging beta-amyloid burden in aging and dementia.	Neurology	2007	276
17698496	2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole	Lockhart A	PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis.	Brain 	2007	100
19617318	2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole	Nelissen N	Phase 1 study of the Pittsburgh compound B derivative 18F-flutemetamol in healthy volunteers and patients with probable Alzheimer disease.	Journal of nuclear medicine 	2009	62
20008651	2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole	Storandt M	Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition.	Archives of neurology	2009	132
20538372	2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole	Apostolova LG	3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects.	Neurobiology of aging	2010	56
21159973	2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole	Sheline YI	APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF Aβ42.	The Journal of neuroscience 	2010	135
21280088	2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole	Villemagne VL	Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.	Annals of neurology	2011	196
21282074	2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole	Weigand SD	Transforming cerebrospinal fluid Aβ42 measures into calculated Pittsburgh Compound B units of brain Aβ amyloid.	Alzheimer's & dementia 	2011	42
21422459	2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole	Gupta VB	Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging.	Neurology	2011	49
22232206	2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole	Head D	Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid Deposition.	Archives of neurology	2012	60
22551733	2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole	Knopman DS	Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease.	Neurology	2012	94
22693110	2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole	Gomperts SN	Brain amyloid and cognition in Lewy body diseases.	Movement disorders 	2012	34
23102118	2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole	Toledo JB	Cardiovascular risk factors, cortisol, and amyloid-β deposition in Alzheimer's Disease Neuroimaging Initiative.	Alzheimer's & dementia 	2012	32
23243071	2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole	Gomperts SN	Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia.	Neurology	2013	43
23424091	2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole	Gurol ME	Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study.	Annals of neurology	2013	40
23775979	2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole	Kreisl WC	In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease.	Brain 	2013	65
24623839	2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole	Yates PA	Incidence of cerebral microbleeds in preclinical Alzheimer disease.	Neurology	2014	23
25043908	2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole	Willette AA	Insulin resistance predicts brain amyloid deposition in late middle-aged adults.	Alzheimer's & dementia 	2015	32
25805643	2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole	Murray ME	Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum.	Brain 	2015	59
26147946	2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole	Sutphen CL	Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age.	JAMA neurology	2015	41
27532692	2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole	Yassine HN	Association of Serum Docosahexaenoic Acid With Cerebral Amyloidosis.	JAMA neurology	2016	12
21610077	5-hydroxymethylcytosine	Kinney SM	Tissue-specific distribution and dynamic changes of 5-hydroxymethylcytosine in mammalian genomes.	The Journal of biological chemistry	2011	49
22037496	5-hydroxymethylcytosine	Szulwach KE	5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging.	Nature neuroscience	2011	247
22048458	5-hydroxymethylcytosine	Gavin DP	Growth arrest and DNA-damage-inducible, beta (GADD45b)-mediated DNA demethylation in major psychosis.	Neuropsychopharmacology 	2012	36
22052461	5-hydroxymethylcytosine	Jin SG	5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations.	Cancer research	2011	121
22688054	5-hydroxymethylcytosine	Müller T	Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomas.	The American journal of pathology	2012	31
22824796	5-hydroxymethylcytosine	Wang P	Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas.	Oncogene	2013	81
22829908	5-hydroxymethylcytosine	Orr BA	Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma.	PloS one	2012	44
22948384	5-hydroxymethylcytosine	Dong E	Upregulation of TET1 and downregulation of APOBEC3A and APOBEC3C in the parietal cortex of psychotic patients.	Translational psychiatry	2012	35
22948975	5-hydroxymethylcytosine	Grayson DR	The dynamics of DNA methylation in schizophrenia and related psychiatric disorders.	Neuropsychopharmacology 	2013	69
23042784	5-hydroxymethylcytosine	Wang T	Genome-wide DNA hydroxymethylation changes are associated with neurodevelopmental genes in the developing human cerebellum.	Human molecular genetics	2012	45
23260135	5-hydroxymethylcytosine	Mellén M	MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system.	Cell	2012	283
23385980	5-hydroxymethylcytosine	Villar-Menéndez I	Increased 5-methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A2AR levels in Huntington's disease.	Neuromolecular medicine	2013	29
23828890	5-hydroxymethylcytosine	Lister R	Global epigenomic reconfiguration during mammalian brain development.	Science	2013	449
24012631	5-hydroxymethylcytosine	Bradley-Whitman MA	Epigenetic changes in the progression of Alzheimer's disease.	Mechanisms of ageing and development	2013	33
24108107	5-hydroxymethylcytosine	Yao B	Genome-wide alteration of 5-hydroxymethylcytosine in a mouse model of fragile X-associated tremor/ataxia syndrome.	Human molecular genetics	2014	24
24448211	5-hydroxymethylcytosine	Zhubi A	Increased binding of MeCP2 to the GAD1 and RELN promoters may be mediated by an enrichment of 5-hmC in autism spectrum disorder (ASD) cerebellum.	Translational psychiatry	2014	45
24594098	5-hydroxymethylcytosine	Wen L	Whole-genome analysis of 5-hydroxymethylcytosine and 5-methylcytosine at base resolution in the human brain.	Genome biology	2014	70
25284789	5-hydroxymethylcytosine	Takai H	5-Hydroxymethylcytosine plays a critical role in glioblastomagenesis by recruiting the CHTOP-methylosome complex.	Cell reports	2014	22
25290267	5-hydroxymethylcytosine	James SJ	Elevated 5-hydroxymethylcytosine in the Engrailed-2 (EN-2) promoter is associated with increased gene expression and decreased MeCP2 binding in autism cerebellum.	Translational psychiatry	2014	22
25482556	5-hydroxymethylcytosine	Rampal R	DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia.	Cell reports	2014	55
15229249	beta-amyloid peptide 1-42 (E22delta) click peptide	Caricasole A	Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain.	The Journal of neuroscience 	2004	79
15286784	beta-amyloid peptide 1-42 (E22delta) click peptide	He W	Reticulon family members modulate BACE1 activity and amyloid-beta peptide generation.	Nature medicine	2004	87
15731448	beta-amyloid peptide 1-42 (E22delta) click peptide	Stokin GB	Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease.	Science	2005	310
16279840	beta-amyloid peptide 1-42 (E22delta) click peptide	Jankowsky JL	Persistent amyloidosis following suppression of Abeta production in a transgenic model of Alzheimer disease.	PLoS medicine	2005	96
16799555	beta-amyloid peptide 1-42 (E22delta) click peptide	Bateman RJ	Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo.	Nature medicine	2006	146
17204939	beta-amyloid peptide 1-42 (E22delta) click peptide	Ramsey CP	Expression of Nrf2 in neurodegenerative diseases.	Journal of neuropathology and experimental neurology	2007	104
17478722	beta-amyloid peptide 1-42 (E22delta) click peptide	Roberson ED	Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model.	Science	2007	519
17553989	beta-amyloid peptide 1-42 (E22delta) click peptide	Klunk WE	Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees.	The Journal of neuroscience 	2007	117
17894374	beta-amyloid peptide 1-42 (E22delta) click peptide	Josephs KA	Beta-amyloid burden is not associated with rates of brain atrophy.	Annals of neurology	2008	56
18234899	beta-amyloid peptide 1-42 (E22delta) click peptide	Wang WX	The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1.	The Journal of neuroscience 	2008	226
18343778	beta-amyloid peptide 1-42 (E22delta) click peptide	Zhang J	CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases.	American journal of clinical pathology	2008	65
18458217	beta-amyloid peptide 1-42 (E22delta) click peptide	Bian H	CSF biomarkers in frontotemporal lobar degeneration with known pathology.	Neurology	2008	59
18497889	beta-amyloid peptide 1-42 (E22delta) click peptide	Pickford F	The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice.	The Journal of clinical investigation	2008	267
18586353	beta-amyloid peptide 1-42 (E22delta) click peptide	Simpson JE	Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain.	Neurobiology of aging	2010	63
18604209	beta-amyloid peptide 1-42 (E22delta) click peptide	Halle A	The NALP3 inflammasome is involved in the innate immune response to amyloid-beta.	Nature immunology	2008	512
19038212	beta-amyloid peptide 1-42 (E22delta) click peptide	Small SA	Linking Abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesis.	Neuron	2008	134
19104446	beta-amyloid peptide 1-42 (E22delta) click peptide	Julien C	Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease.	Journal of neuropathology and experimental neurology	2009	63
19139294	beta-amyloid peptide 1-42 (E22delta) click peptide	Sonnen JA	Different patterns of cerebral injury in dementia with or without diabetes.	Archives of neurology	2009	64
19204149	beta-amyloid peptide 1-42 (E22delta) click peptide	Palop JJ	Epilepsy and cognitive impairments in Alzheimer disease.	Archives of neurology	2009	156
19204726	beta-amyloid peptide 1-42 (E22delta) click peptide	Chapuis J	Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease.	Molecular psychiatry	2009	48
19225789	beta-amyloid peptide 1-42 (E22delta) click peptide	Revesz T	Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies.	Acta neuropathologica	2009	51
19228952	beta-amyloid peptide 1-42 (E22delta) click peptide	Meilandt WJ	Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice.	The Journal of neuroscience 	2009	58
19288297	beta-amyloid peptide 1-42 (E22delta) click peptide	Achim CL	Increased accumulation of intraneuronal amyloid beta in HIV-infected patients.	Journal of neuroimmune pharmacology 	2009	62
19293237	beta-amyloid peptide 1-42 (E22delta) click peptide	Mahad DJ	Mitochondrial changes within axons in multiple sclerosis.	Brain 	2009	82
19339619	beta-amyloid peptide 1-42 (E22delta) click peptide	Mandrekar S	Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis.	The Journal of neuroscience 	2009	125
19339974	beta-amyloid peptide 1-42 (E22delta) click peptide	Bu G	Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy.	Nature reviews. Neuroscience	2009	264
19587325	beta-amyloid peptide 1-42 (E22delta) click peptide	Okello A	Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study.	Neurology	2009	116
19605646	beta-amyloid peptide 1-42 (E22delta) click peptide	Wang X	Impaired balance of mitochondrial fission and fusion in Alzheimer's disease.	The Journal of neuroscience 	2009	280
19657023	beta-amyloid peptide 1-42 (E22delta) click peptide	Tampellini D	Synaptic activity reduces intraneuronal Abeta, promotes APP transport to synapses, and protects against Abeta-related synaptic alterations.	The Journal of neuroscience 	2009	50
19725828	beta-amyloid peptide 1-42 (E22delta) click peptide	Soontornniyomkij V	Cerebral microinfarcts associated with severe cerebral beta-amyloid angiopathy.	Brain pathology	2010	45
19815015	beta-amyloid peptide 1-42 (E22delta) click peptide	Hampel H	Biological markers of amyloid beta-related mechanisms in Alzheimer's disease.	Experimental neurology	2010	45
19828790	beta-amyloid peptide 1-42 (E22delta) click peptide	Vassar R	The beta-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential.	The Journal of neuroscience 	2009	161
19828810	beta-amyloid peptide 1-42 (E22delta) click peptide	Abdul HM	Cognitive decline in Alzheimer's disease is associated with selective changes in calcineurin/NFAT signaling.	The Journal of neuroscience 	2009	77
19838821	beta-amyloid peptide 1-42 (E22delta) click peptide	Palop JJ	Synaptic depression and aberrant excitatory network activity in Alzheimer's disease: two faces of the same coin?	Neuromolecular medicine	2010	48
19937043	beta-amyloid peptide 1-42 (E22delta) click peptide	Schrag M	Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study.	Acta neuropathologica	2010	57
19940172	beta-amyloid peptide 1-42 (E22delta) click peptide	Cohen AD	Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve.	The Journal of neuroscience 	2009	78
19951690	beta-amyloid peptide 1-42 (E22delta) click peptide	Sun B	Imbalance between GABAergic and Glutamatergic Transmission Impairs Adult Neurogenesis in an Animal Model of Alzheimer's Disease.	Cell stem cell	2009	52
19955384	beta-amyloid peptide 1-42 (E22delta) click peptide	Dumanis SB	ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo.	The Journal of neuroscience 	2009	66
20147537	beta-amyloid peptide 1-42 (E22delta) click peptide	Fjell AM	CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease.	The Journal of neuroscience 	2010	74
20164570	beta-amyloid peptide 1-42 (E22delta) click peptide	Butterfield DA	Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: many pathways to neurodegeneration.	Journal of Alzheimer's disease 	2010	58
20186853	beta-amyloid peptide 1-42 (E22delta) click peptide	Morris JC	APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging.	Annals of neurology	2010	277
20308787	beta-amyloid peptide 1-42 (E22delta) click peptide	Li Y	GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease.	Journal of Alzheimer's disease 	2010	65
20573181	beta-amyloid peptide 1-42 (E22delta) click peptide	Pham E	Progressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins.	The FEBS journal	2010	66
20603455	beta-amyloid peptide 1-42 (E22delta) click peptide	Thambisetty M	Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease.	Archives of general psychiatry	2010	94
20844121	beta-amyloid peptide 1-42 (E22delta) click peptide	Crews L	Increased BMP6 levels in the brains of Alzheimer's disease patients and APP transgenic mice are accompanied by impaired neurogenesis.	The Journal of neuroscience 	2010	44
20847408	beta-amyloid peptide 1-42 (E22delta) click peptide	Valla J	Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE ε4 allele, the major late-onset Alzheimer's susceptibility gene.	Journal of Alzheimer's disease 	2010	57
20854368	beta-amyloid peptide 1-42 (E22delta) click peptide	Zlokovic BV	Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid β-peptide elimination from the brain.	Journal of neurochemistry	2010	67
21035623	beta-amyloid peptide 1-42 (E22delta) click peptide	Craig-Schapiro R	YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease.	Biological psychiatry	2010	86
21113149	beta-amyloid peptide 1-42 (E22delta) click peptide	Cissé M	Reversing EphB2 depletion rescues cognitive functions in Alzheimer model.	Nature	2011	150
21158978	beta-amyloid peptide 1-42 (E22delta) click peptide	Morgan D	Immunotherapy for Alzheimer's disease.	Journal of internal medicine	2011	56
21220680	beta-amyloid peptide 1-42 (E22delta) click peptide	Reitz C	Meta-analysis of the association between variants in SORL1 and Alzheimer disease.	Archives of neurology	2011	63
21228179	beta-amyloid peptide 1-42 (E22delta) click peptide	Roberson ED	Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease.	The Journal of neuroscience 	2011	188
21273420	beta-amyloid peptide 1-42 (E22delta) click peptide	Zhu Y	CD45 deficiency drives amyloid-β peptide oligomers and neuronal loss in Alzheimer's disease mice.	The Journal of neuroscience 	2011	39
21307170	beta-amyloid peptide 1-42 (E22delta) click peptide	Poels MM	Incidence of cerebral microbleeds in the general population: the Rotterdam Scan Study.	Stroke	2011	47
21391232	beta-amyloid peptide 1-42 (E22delta) click peptide	Chibnik LB	CR1 is associated with amyloid plaque burden and age-related cognitive decline.	Annals of neurology	2011	67
21846727	beta-amyloid peptide 1-42 (E22delta) click peptide	Emmer KL	E46K human alpha-synuclein transgenic mice develop Lewy-like and tau pathology associated with age-dependent, detrimental motor impairment.	The Journal of biological chemistry	2011	38
22116809	beta-amyloid peptide 1-42 (E22delta) click peptide	Hartz AM	Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy.	Stroke	2012	38
22305802	beta-amyloid peptide 1-42 (E22delta) click peptide	Sperling R	Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis.	The Lancet. Neurology	2012	78
23132858	beta-amyloid peptide 1-42 (E22delta) click peptide	Li J	Differential regulation of amyloid-β endocytic trafficking and lysosomal degradation by apolipoprotein E isoforms.	The Journal of biological chemistry	2012	45
23539189	beta-amyloid peptide 1-42 (E22delta) click peptide	Ryan NS	Magnetic resonance imaging evidence for presymptomatic change in thalamus and caudate in familial Alzheimer's disease.	Brain 	2013	46
24713533	beta-amyloid peptide 1-42 (E22delta) click peptide	Romero JR	Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart Study.	Stroke	2014	35
26251237	beta-amyloid peptide 1-42 (E22delta) click peptide	Gold M	β-amyloid, microglia, and the inflammasome in Alzheimer's disease.	Seminars in immunopathology	2015	17
26595683	beta-amyloid peptide 1-42 (E22delta) click peptide	Petersen RC	Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the Community.	JAMA neurology	2016	22
9267033	thymosin beta(1)	Davies SW	Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.	Cell	1997	464
9302293	thymosin beta(1)	DiFiglia M	Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.	Science	1997	592
9808466	thymosin beta(1)	Jiang YH	Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation.	Neuron	1998	219
10973942	thymosin beta(1)	Imai Y	Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity.	The Journal of biological chemistry	2000	159
11439185	thymosin beta(1)	Imai Y	An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin.	Cell	2001	191
11447297	thymosin beta(1)	Suzuki Y	Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death.	Proceedings of the National Academy of Sciences of the United States of America	2001	152
12160938	thymosin beta(1)	Castegna A	Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.	Free radical biology & medicine	2002	117
12495618	thymosin beta(1)	Petrucelli L	Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons.	Neuron	2002	132
14642282	thymosin beta(1)	Colledge M	Ubiquitination regulates PSD-95 degradation and AMPA receptor surface expression.	Neuron	2003	187
14722078	thymosin beta(1)	Choi J	Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases.	The Journal of biological chemistry	2004	129
16613895	thymosin beta(1)	Josephs KA	Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech.	Brain 	2006	156
16807328	thymosin beta(1)	Dickey CA	Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho- and caspase-3-cleaved tau species.	The Journal of neuroscience 	2006	81
17469116	thymosin beta(1)	Mackenzie IR	Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.	Annals of neurology	2007	216
18166704	thymosin beta(1)	Josephs KA	Progressive aphasia secondary to Alzheimer disease vs FTLD pathology.	Neurology	2008	65
18391962	thymosin beta(1)	Kordower JH	Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease.	Nature medicine	2008	358
18701681	thymosin beta(1)	Bedford L	Depletion of 26S proteasomes in mouse brain neurons causes neurodegeneration and Lewy-like inclusions resembling human pale bodies.	The Journal of neuroscience 	2008	86
19228967	thymosin beta(1)	Carrettiero DC	The cochaperone BAG2 sweeps paired helical filament- insoluble tau from the microtubule.	The Journal of neuroscience 	2009	56
20159448	thymosin beta(1)	Drinjakovic J	E3 ligase Nedd4 promotes axon branching by downregulating PTEN.	Neuron	2010	72
16814448	2'-O-methoxyethylguanosine	Pulvermüller F	Language outside the focus of attention: the mismatch negativity as a tool for studying higher cognitive processes.	Progress in neurobiology	2006	74
16950225	2'-O-methoxyethylguanosine	Wilson TW	Children and adolescents with autism exhibit reduced MEG steady-state gamma responses.	Biological psychiatry	2007	99
17698205	2'-O-methoxyethylguanosine	Srinivasan R	EEG and MEG coherence: measures of functional connectivity at distinct spatial scales of neocortical dynamics.	Journal of neuroscience methods	2007	80
18155612	2'-O-methoxyethylguanosine	Brookes MJ	Optimising experimental design for MEG beamformer imaging.	NeuroImage	2008	58
19360734	2'-O-methoxyethylguanosine	Kiebel SJ	Dynamic causal modeling for EEG and MEG.	Human brain mapping	2009	58
19961941	2'-O-methoxyethylguanosine	Daunizeau J	Dynamic causal modelling: a critical review of the biophysical and statistical foundations.	NeuroImage	2011	69
20607220	2'-O-methoxyethylguanosine	Iannetti GD	From the neuromatrix to the pain matrix (and back).	Experimental brain research	2010	86
22001162	2'-O-methoxyethylguanosine	Lohmann G	Critical comments on dynamic causal modelling.	NeuroImage	2012	33
22723684	2'-O-methoxyethylguanosine	Sohoglu E	Predictive top-down integration of prior knowledge during speech perception.	The Journal of neuroscience 	2012	62
22815496	2'-O-methoxyethylguanosine	Poil SS	Critical-state dynamics of avalanches and oscillations jointly emerge from balanced excitation/inhibition in neuronal networks.	The Journal of neuroscience 	2012	49
21747008	florbetapir	Fleisher AS	Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease.	Archives of neurology	2011	84
22633529	florbetapir	Fleisher AS	Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease.	Neurobiology of aging	2013	42
23137949	florbetapir	Fleisher AS	Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study.	The Lancet. Neurology	2012	57
23238736	florbetapir	Jagust WJ	Apolipoprotein E, not fibrillar β-amyloid, reduces cerebral glucose metabolism in normal aging.	The Journal of neuroscience 	2012	53
23419831	florbetapir	Ramanan VK	APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study.	Molecular psychiatry	2014	52
23553344	florbetapir	Rodrigue KM	Risk factors for β-amyloid deposition in healthy aging: vascular and genetic effects.	JAMA neurology	2013	46
24614494	florbetapir	Doraiswamy PM	Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study.	Molecular psychiatry	2014	45
25541191	florbetapir	Mattsson N	Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.	Brain 	2015	43
25745091	florbetapir	Chen K	Improved power for characterizing longitudinal amyloid-β PET changes and evaluating amyloid-modifying treatments with a cerebral white matter reference region.	Journal of nuclear medicine 	2015	20
28399252	florbetapir	Gottesman RF	Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition.	JAMA	2017	16
22640478	vemurafenib	Ascierto PA	Sequencing of BRAF inhibitors and ipilimumab in patients with metastatic melanoma: a possible algorithm for clinical use.	Journal of translational medicine	2012	31
23369684	vemurafenib	Jang S	Which drug, and when, for patients with BRAF-mutant melanoma?	The Lancet. Oncology	2013	47
24133630	vemurafenib	Niessner H	Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases.	Cancer medicine	2013	29
24295639	vemurafenib	Dummer R	Vemurafenib in patients with BRAF(V600) mutation-positive melanoma with symptomatic brain metastases: final results of an open-label pilot study.	European journal of cancer	2014	43
24336571	vemurafenib	Shalem O	Genome-scale CRISPR-Cas9 knockout screening in human cells.	Science	2014	744
24725538	vemurafenib	Robinson GW	Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy.	BMC cancer	2014	29
24823863	vemurafenib	Levy JM	Autophagy inhibition improves chemosensitivity in BRAF(V600E) brain tumors.	Cancer discovery	2014	40
28094001	vemurafenib	Mulcahy Levy JM	Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumors.	eLife	2017	8
23154552	crizotinib	Weickhardt AJ	Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small-cell lung cancer.	Journal of thoracic oncology 	2012	97
24819116	crizotinib	Johnson TW	Discovery of (10R)-7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo4,3-h2,5,11-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a macrocyclic inhibitor of anaplastic lymphoma kinase (ALK) and c-ros oncogene 1 (ROS1) with preclinical brain exposure and broad-spectrum potency against ALK-resistant mutations.	Journal of medicinal chemistry	2014	47
25153538	crizotinib	Gadgeel SM	Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1/2 study.	The Lancet. Oncology	2014	126
27432917	crizotinib	Crinò L	Multicenter Phase II Study of Whole-Body and Intracranial Activity With Ceritinib in Patients With ALK-Rearranged Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy and Crizotinib: Results From ASCEND-2.	Journal of clinical oncology 	2016	38
28475456	crizotinib	Kim DW	Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial.	Journal of clinical oncology 	2017	24
28520527	crizotinib	Lim SM	Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 Rearrangement.	Journal of clinical oncology 	2017	8
9731525	cholecystokinin C-terminal flanking peptide	Allen KM	PAK3 mutation in nonsyndromic X-linked mental retardation.	Nature genetics	1998	103
10391244	cholecystokinin C-terminal flanking peptide	Lu PJ	The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.	Nature	1999	169
12857750	cholecystokinin C-terminal flanking peptide	Jacobs FM	FoxO6, a novel member of the FoxO class of transcription factors with distinct shuttling dynamics.	The Journal of biological chemistry	2003	94
14654844	cholecystokinin C-terminal flanking peptide	Lorenz K	Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2.	Nature	2003	91
15111319	cholecystokinin C-terminal flanking peptide	Bao L	Prevalent overexpression of prolyl isomerase Pin1 in human cancers.	The American journal of pathology	2004	96
16702191	cholecystokinin C-terminal flanking peptide	Gandhi S	PINK1 protein in normal human brain and Parkinson's disease.	Brain 	2006	83
16751189	cholecystokinin C-terminal flanking peptide	Qin W	Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction.	The Journal of biological chemistry	2006	163
17562708	cholecystokinin C-terminal flanking peptide	Hanger DP	Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis.	The Journal of biological chemistry	2007	86
17906618	cholecystokinin C-terminal flanking peptide	Plun-Favreau H	The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1.	Nature cell biology	2007	151
18003639	cholecystokinin C-terminal flanking peptide	Weihofen A	Pink1 Parkinson mutations, the Cdc37/Hsp90 chaperones and Parkin all influence the maturation or subcellular distribution of Pink1.	Human molecular genetics	2008	53
18184780	cholecystokinin C-terminal flanking peptide	Terunuma M	Deficits in phosphorylation of GABA(A) receptors by intimately associated protein kinase C activity underlie compromised synaptic inhibition during status epilepticus.	The Journal of neuroscience 	2008	57
18184784	cholecystokinin C-terminal flanking peptide	Zhang S	Cdk5 regulates the phosphorylation of tyrosine 1472 NR2B and the surface expression of NMDA receptors.	The Journal of neuroscience 	2008	54
19065142	cholecystokinin C-terminal flanking peptide	Basu AC	Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior.	Molecular psychiatry	2009	83
19573808	cholecystokinin C-terminal flanking peptide	Miao H	EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt.	Cancer cell	2009	121
19655382	cholecystokinin C-terminal flanking peptide	Borroni B	Mutation within TARDBP leads to frontotemporal dementia without motor neuron disease.	Human mutation	2009	71
19966812	cholecystokinin C-terminal flanking peptide	Cooney R	NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation.	Nature medicine	2010	313
20159449	cholecystokinin C-terminal flanking peptide	Kawabe H	Regulation of Rap2A by the ubiquitin ligase Nedd4-1 controls neurite development.	Neuron	2010	49
21248166	cholecystokinin C-terminal flanking peptide	McCormick JA	The WNKs: atypical protein kinases with pleiotropic actions.	Physiological reviews	2011	78
21399631	cholecystokinin C-terminal flanking peptide	Cremona ML	Flotillin-1 is essential for PKC-triggered endocytosis and membrane microdomain localization of DAT.	Nature neuroscience	2011	60
23075850	cholecystokinin C-terminal flanking peptide	Liu GH	Progressive degeneration of human neural stem cells caused by pathogenic LRRK2.	Nature	2012	82
